<SEC-DOCUMENT>0001628280-22-020656.txt : 20220803
<SEC-HEADER>0001628280-22-020656.hdr.sgml : 20220803
<ACCEPTANCE-DATETIME>20220803164546
ACCESSION NUMBER:		0001628280-22-020656
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		56
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220803
DATE AS OF CHANGE:		20220803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		221133333

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>med-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:9cb14b1a-882e-4c5a-abba-92937aa2b6a2,g:d04941c9-f1d8-4931-a062-5edb28a6369a,d:4563bf4792014469bdc8cd3ee0a97965--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:med="http://www.medifast1.com/20220630" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>med-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8yNi0xLTEtMS0zMDc1Ng_076c13f4-81a9-41ce-8942-5382f0954280">0000910329</ix:nonNumeric><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8yNy0xLTEtMS0zMDc1Ng_b584a943-b47f-433f-b20d-106c33bed797">12-31</ix:nonNumeric><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8yOC0xLTEtMS0zMDc1Ng_885b7f81-ba3e-4612-afb9-402fe9f8f5b7">2022</ix:nonNumeric><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8yOS0xLTEtMS0zMDc1Ng_bda44bd0-072d-49ab-8f50-7ae38b28bb57">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8zMC0xLTEtMS0zMDc1Ng_c384b40f-952d-4f49-affb-59bc7422039c">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="med-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c83b2d6bd3c4cee96349c87ec14ea1b_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i18c77be8472d4605bfa303d562fd60b2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib948ed90768e446fa2a7da19901058c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2cb2cb83f1f4e5db44b278f12bea8b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib717e1074bde42e0901aeb7e954bcbd3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib007aabffb2f44fe8073ab3215a03eb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70994f711ef24ed1b554ae05170a0beb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8d42d0328604314b103add648897899_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idddb1d1de99c4ffb96425d0fb0935d42_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if19addb8cd514cfab707066c1d48a8b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81a10d1a3ea1444f9c9554929870ed73_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eb1b28eb5c740d291bf7d672b2ecc4b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f614cfb222b45358fd4a8d8202d5a51_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1329ce8de55b48caa47ae30f8e7f1fdd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c17c93c4db5400dbad4c963bf804dcc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3323f77d983c40708d7df03f365955c7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia51614e2d87f471b9611cdd907dfd3b9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0989ccad19040f5b5d63fd9ed61ec3b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic011d96c5d0e44b897ab88e6c880715d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d77050a9aad4a668e670082595a0872_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94cfceef1c49443a98b3eccf024ccd8c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie77b0f4c612645f4b5db58aa9f5feb14_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7d57531d9c1486fa7935451b76cc244_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f1ba3aafeb246248eb2f5d8d106e124_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i330f682e6d384eddbd2ad742ee94e292_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadacc573ef8c41f4b06a98194c3c83bb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ee4cc608c6743ce9b79d053c9413fd0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7926d7c8beee47bb8f67125936a7efb8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b12b911b3be4af1927784cfc0ea5a2f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic153d5cbf75b48c8801f45f3ff6868aa_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i420f82e6dd774834a5ff44c9e9ab77df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eae09b33bec4a8a86534172345a885f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if15858c6593a4308a5b4a5f453163253_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f6f8991b244fb491b90bb6cd39d68f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabdffcc0da434db48bba66473c5942b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8fcce8f57b4164b5fd496a4762fb6c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29d77b83c536442c87946833f8aa3fd5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87de8628b754ed199047a89c561a717_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2cd41ad8c1f47a58b8e56c0545a424f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4084eaf131484e538b813c92b9a8808a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9cd5e00468f4c31a6ad35b46dc5f678_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3603223f943940e8bb0e20a4b0812f09_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64da106a0256487891ae3679ee954695_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i994c40f6e8264eb9846533b735f22532_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95794c49258c433a90e7170fa1e44931_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6420c7cef69b48e4a74f0ced80372d52_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i339725a880774411bbaef2b210a31022_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i854bc7faa0594c56b36981f871a1e7bd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ceaf5d8702b4db0b4f91c3787bd2a76_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e0a3cd16fbf42e3a67ec29910bd258d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32eb764f079c4b1d8469239466030d0a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ef1256755c4d0f8435ea934548d592_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75fbb52e386d4f8a9bcf066f87b0150f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7698f0af5074b91b7c210b87f471501_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3c6300a2f004db38274d065e4c9bac3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7841ac501214a4ea7e05c285cf32e72_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd64b09ae9b9490f9048feed73ccf44e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12734edec8f6435d8dd9b0e550bf268d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf47d02920404be79f49c2edef3bd952_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id55dd95aa3bc470e9e56ec5f8723d097_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1602479b512c4de9830dc7270e25407f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58a4c9c4abd041de9a9bf0f6ab581c1b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b570ba8f30648dfacf09a049d1a4224_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0372fb43e9d841769683ae47a2e205e0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf143fc967754c9285fe98b52326ac85_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id508aa7830c34993b9ba67211a0443ef_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50220b2625794fccbe511347ebb66670_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i829d85fe933a4eda921636a7a3a375d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib21e0e3f9ad94913bf93467edc85ce06_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia759f6e591be41e886afe18c17d6e776_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b609542b4c460580805a1e4f761438_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5f1116c90194300a342749eb3892747_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i791f345fa7fe442d9a480bb5934ca24a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id10455ed7a30470c8ce16fd0347a1491_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id36d21034a864432b8162b094357f768_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ee521e8f7844c1f94e09336bcfd86db_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf790b22c1264d739149650b115efb43_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea89962a06654099aa9ce6020660ce2c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b6e347e922e48cf858c12fd486caacd_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61d036694b67452fbbdb85aea52976a0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i236cdbac8a54499bae6a9b834bcc1d9b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib227523b7a72441886b57ff4d5975e64_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id089f7cb3778424d85b3c0a0ba3abe64_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dc76c8e56a84d50b6f056f5427ad729_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icec11bcf6e124a15853dea3f1b683cbc_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie16284d30a4743a2bbed4a4f253b25b4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i054b770bfe6145718c8c3e0c92dd66d4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ec22b44a1b94e7db889140b0beb2981_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4060674f7e11431e987e42f39d8bd999_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73edf9ea6315403eb92729cc50508941_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i064f238b1a2c484cae33fd7a5814ff0f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i452fd630b64a4bebb247b038e9162298_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc759c3471364896ad8b5e7747af27bd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a55b7020a694cb9930ecf0c3056192a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if49b585270844361a9f23ee1a6dd8b32_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28c9596a0f004e71bab401ece8aceb03_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24907f08c3c549f2a30017b51b01cb28_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8acefb9e79bd4ae1a22dc956c10939ee_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f1cb1cd2be465aa4baf8f6ad80e124_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i666df92b88214be186d1a29032aab0cb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b46dfbb84c942a2876f386c170b5410_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee065151388c4c8cbe6affcd09c55b2b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i332a69d5d4c54c2094cc9048eb80a99c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57509a5816a14b6e9f710cd2a1430d7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89eed6193bce41109d7fcaa6ca2460a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cac6b725df74e8ea420f955e6941daa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">med:GovernmentAgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icea4ee9f85da4ed49ceb9bda111639c6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">med:GovernmentAgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d5f95ffbfb34e22af63161d1bed6f55_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8938f1db545249db980bb8fc24aee80f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibad7c8db12bd42e2809f2f8c2ced2539_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9333a141fdf6464bb3ce95b9dd9b08ea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49b6f09335094cb2b7b85ec6ae9e598c_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6945a9410a34cf18dd01065cbc232f2_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2123a6dc9f841d696b311320dc700c8_D20210413-20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-13</xbrli:startDate><xbrli:endDate>2021-04-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i247bb176b7b847c4ab8a1f139e0b0856_D20210413-20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-13</xbrli:startDate><xbrli:endDate>2021-04-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f63e1a4da2439cb942d7e717740fd6_D20210413-20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-13</xbrli:startDate><xbrli:endDate>2021-04-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b76567e652341a8bc33402177cf2fb8_D20210413-20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-13</xbrli:startDate><xbrli:endDate>2021-04-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88c992e95e9b4995a92a40903056360e_I20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4e372b4b4424facb12f398698cc062e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0923735811e44b48bfa510c4594688c6_D20220531-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-31</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4563bf4792014469bdc8cd3ee0a97965_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:21.6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzIy_12c6f0c8-6c9b-4dd9-ae5e-f3a17b2280a8">10-Q</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzIz_09b899a4-6f9f-4f1c-a01a-59fc98e47e22">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF80OTQ3ODAyMzI3MzQ1_72edb8b4-a4cd-4ffe-beae-3daaac4a87ea">June 30, 2022</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI4_e4f99fb4-3e9c-4dc6-b395-80200662087d">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from________ to ________.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE3_2266de62-1e50-454c-aad5-f08f3870f9ec">001-31573</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI5_9100d065-f359-44d4-8a54-c2b91f784c64">Medifast, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6MjAxNDlkMzdkNGU4NDA2NmEzNDk5MzdiYjFiZTljY2IvdGFibGVyYW5nZToyMDE0OWQzN2Q0ZTg0MDY2YTM0OTkzN2JiMWJlOWNjYl8wLTAtMS0xLTMwNzU2_5ed25742-6e4f-48be-9bd4-557263f6c5a5">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6MjAxNDlkMzdkNGU4NDA2NmEzNDk5MzdiYjFiZTljY2IvdGFibGVyYW5nZToyMDE0OWQzN2Q0ZTg0MDY2YTM0OTkzN2JiMWJlOWNjYl8wLTItMS0xLTMwNzU2_3c57994c-c459-4aaf-abb3-359caccbcf15">13-3714405</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE4_fcfe60ef-c5b9-4761-b94c-ab2e507e793a">100 International Drive</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI3_f723fdca-e3a7-43b6-b619-eea3c2997a64">Baltimore</ix:nonNumeric>, <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE5_43455566-615d-42bb-ba39-b4746d89d718">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI1_72831519-b9d1-49ff-a524-e3da9f1d8168">21202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Telephone Number: (<ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE1_01ce5ce3-daae-426c-9492-d49ab50638da">410</ix:nonNumeric>) <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI2_9da9b16e-c748-4311-a19a-a09e8b102add">581-8042</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices, Zip Code and Telephone Number, Including Area Code)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.28pt;text-align:center;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;text-indent:-7.2pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6YzE3MzdhOTAxZjQ3NDkwOWEwMTIxMjExZmQzNjliZjcvdGFibGVyYW5nZTpjMTczN2E5MDFmNDc0OTA5YTAxMjEyMTFmZDM2OWJmN18xLTAtMS0xLTMwNzU2_afeba404-4a05-4dea-8bf1-8380ff3bdf3c">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6YzE3MzdhOTAxZjQ3NDkwOWEwMTIxMjExZmQzNjliZjcvdGFibGVyYW5nZTpjMTczN2E5MDFmNDc0OTA5YTAxMjEyMTFmZDM2OWJmN18xLTItMS0xLTMwNzU2_d4f77a46-6cf7-4146-bc7d-907f48a689ba">MED</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6YzE3MzdhOTAxZjQ3NDkwOWEwMTIxMjExZmQzNjliZjcvdGFibGVyYW5nZTpjMTczN2E5MDFmNDc0OTA5YTAxMjEyMTFmZDM2OWJmN18xLTQtMS0xLTMwNzU2_3e62b640-8f03-4c81-b376-9ad931c5c0f5">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzIw_6bc8665f-e198-431a-8183-348f992a09bc">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE2_eb10bde4-fa13-4ed3-8231-5bc258a94280">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6OWU2YjMxMWM4NzQ2NDM3MTg0OGY3OWZkNzM3OTYxOTcvdGFibGVyYW5nZTo5ZTZiMzExYzg3NDY0MzcxODQ4Zjc5ZmQ3Mzc5NjE5N18wLTAtMS0xLTMwNzU2_d8731aa8-abb8-4305-94ff-fde43e519ecb">Large accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Non-accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6OWU2YjMxMWM4NzQ2NDM3MTg0OGY3OWZkNzM3OTYxOTcvdGFibGVyYW5nZTo5ZTZiMzExYzg3NDY0MzcxODQ4Zjc5ZmQ3Mzc5NjE5N18xLTMtMS0xLTMwNzU2_2f852c38-6113-4aea-a468-86ed44081d14">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Emerging growth company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6OWU2YjMxMWM4NzQ2NDM3MTg0OGY3OWZkNzM3OTYxOTcvdGFibGVyYW5nZTo5ZTZiMzExYzg3NDY0MzcxODQ4Zjc5ZmQ3Mzc5NjE5N18yLTEtMS0xLTMwNzU2_b174d6c2-e4d8-46fb-a13a-d7159af08472">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by checkmark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzIx_3afa8000-1266-4c71-b339-470d1eac7c78">x</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding at July&#160;25, 2022 was <ix:nonFraction unitRef="shares" contextRef="i1c83b2d6bd3c4cee96349c87ec14ea1b_I20220725" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzEx_55fbdb38-50ca-4111-be98-488723a135fa">11,017,899</ix:nonFraction>.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medifast, Inc. and Subsidiaries</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_10">Part 1 &#8211; Financial Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_13">Item 1 &#8211; Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_16">Condensed Consolidated Statements of Income (unaudited) for the</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_16"> Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_16">Six Months Ended June 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_16">2</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_19">Condensed Consolidated Statements of Comprehensive Income (unaudited) for the</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_19"> Three and</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_19"> Six Months Ended June 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_19">3</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_22">Condensed Consolidated Balance Sheets (unaudited) as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_22">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_22">, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_22">4</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_25">Condensed Consolidated Statements of Cash Flows (unaudited) for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_25">Six</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_25">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_25">, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_25">5</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_28">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity (unaudited) for the</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_28"> Three and</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_28"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_28">Six</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_28">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_28">, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_28">6</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_31">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_31">8</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_58">Item 2 &#8211; Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_58">14</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_79">Item 3 &#8211; Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_79">22</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_82">Item 4 &#8211; Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_82">23</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_85">Part II &#8211; Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_88">Item 1 &#8211; Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_88">24</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_91">Item 1A &#8211; Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_91">24</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_94">Item 2 &#8211; Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_94">24</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_97">Item 6 &#8211; Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i4563bf4792014469bdc8cd3ee0a97965_97">25</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except per share amounts &amp; dividend data)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMy0xLTEtMS0zMDc1Ng_f5d9f8d4-9e7d-4f64-9e8d-4cff6add4a31">453,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMy0zLTEtMS0zMDc1Ng_5bea65d6-0282-4929-ac93-0543248b28fd">394,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMy01LTEtMS0zMTEzNg_b8acb137-791f-4bab-b877-0cc7c80284f0">870,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMy03LTEtMS0zMTEzNg_38594dcf-9cb9-48ab-95d9-743f7e021e3f">734,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNC0xLTEtMS0zMDc1Ng_f5d7c48b-0a7e-497b-9be5-c6fc1e814ca0">131,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNC0zLTEtMS0zMDc1Ng_0d9a704c-293c-4189-b736-ef324e614661">100,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNC01LTEtMS0zMTEzNg_633002d7-65ad-4b50-ac0e-845b3b72f0af">246,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNC03LTEtMS0zMTEzNg_3bae00ce-3d58-4e99-b3e5-0c152142fbb7">192,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNS0xLTEtMS0zMDc1Ng_02bcef5a-579e-42a2-921e-b6c921a640b9">321,682</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNS0zLTEtMS0zMDc1Ng_c237720c-d3fb-4ffc-8ea0-5abfb2c735d9">293,707</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNS01LTEtMS0zMTEzNg_15e1626e-5e04-4a17-92b1-135da3cb8f2f">623,968</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNS03LTEtMS0zMTEzNg_bc532b32-4ab7-409f-a7eb-99afe9add4c1">542,254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNy0xLTEtMS0zMDc1Ng_b1ea6d3b-aa5e-4ad3-ab9b-99926dc2d0f7">272,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNy0zLTEtMS0zMDc1Ng_19fc4a52-f2a6-42a8-a4a6-b06c56390639">232,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNy01LTEtMS0zMTEzOQ_eccf9f6f-568d-4696-83c4-335f1662907c">519,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNy03LTEtMS0zMTEzOQ_4470d690-df5b-47f3-bafa-554e45dcdc69">428,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfOS0xLTEtMS0zMDc1Ng_a1de639a-8c03-4913-ba39-e4b79fe15911">48,964</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfOS0zLTEtMS0zMDc1Ng_b4886215-aa16-42d0-b957-58bab16af696">61,434</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfOS01LTEtMS0zMTEzOQ_71f7c00d-dea5-4341-811b-c9f4b79fd58d">104,051</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfOS03LTEtMS0zMTEzOQ_c56c8b94-c7b7-4825-b6c8-683b7929c62d">114,233</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTItMS0xLTEtMzA3NTY_c648a873-aafb-4a85-8cda-80badd308459">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTItMy0xLTEtMzA3NTY_8f4e9eea-41e7-44a5-b0a2-f3b8417c1be4">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTItNS0xLTEtMzExNDI_c53b2c88-d89b-465d-af6a-1284a912b8d6">259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTItNy0xLTEtMzExNDI_2395fde4-ed73-4434-b3b8-74c9763aee2c">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTMtMS0xLTEtMzA3NTY_7441fa6f-0d9c-4477-a39a-8bca708283d2">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTMtMy0xLTEtMzA3NTY_2a5e043a-9200-4c54-86cf-2c9721da60d6">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTMtNS0xLTEtMzExNDI_83b16a2f-6fe2-4b51-be87-181b203c04a3">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTMtNy0xLTEtMzExNDI_ed47c4bf-9e08-47e4-92cc-87595fecbeb1">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTQtMS0xLTEtMzA3NTY_2fbdc9c9-9f19-48c3-9ff7-cb3caa945633">168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTQtMy0xLTEtMzA3NTY_622a630b-38f1-460d-bf33-5717b61273b9">89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTQtNS0xLTEtMzExNDI_c1839abe-9c23-425d-9975-c4b6320dbae3">279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTQtNy0xLTEtMzExNDI_8f81bb12-c112-462e-9a76-f52bcd9f6480">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTYtMS0xLTEtMzA3NTY_f219aaea-585d-441b-925a-53cdf3f0ff3d">48,796</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTYtMy0xLTEtMzA3NTY_9ec9fe2e-4953-4753-811b-f0746dbe66f0">61,345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTYtNS0xLTEtMzExNDU_2d250b50-e11e-4712-a4ca-57fa6fe2a4f6">103,772</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTYtNy0xLTEtMzExNDU_e16f46ea-d0f8-464d-bec9-88f67cd5fd39">114,186</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTgtMS0xLTEtMzA3NTY_c7200ce5-064e-4c39-9fde-bc79a983082e">9,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTgtMy0xLTEtMzA3NTY_efc1ef98-7de9-46cd-944f-6bdc4cbf91f7">14,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTgtNS0xLTEtMzExNDU_66ae6e31-ea5f-46a7-a956-1bcd56fe6a81">22,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTgtNy0xLTEtMzExNDU_8962c99a-8705-4499-acde-e1e213610253">26,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjAtMS0xLTEtMzA3NTY_ac1091bf-f657-4115-be12-bd07aa6f65bb">39,113</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjAtMy0xLTEtMzA3NTY_988d66a8-44ca-4efa-8793-00597d9c8ff8">46,963</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjAtNS0xLTEtMzExNDU_8b57b49d-9ddb-49f2-b2c3-c95c943599dd">80,894</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjAtNy0xLTEtMzExNDU_a0eba421-492d-439c-a3fb-de31ff66611f">88,026</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjItMS0xLTEtMzA3NTY_1125cbc7-7539-4a01-8c3f-efed7e8a83fd">3.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjItMy0xLTEtMzA3NTY_d8be4a57-9336-4d17-8b93-345e29e479c4">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjItNS0xLTEtMzExNDU_ad05fbad-b60d-40d8-b29f-f45bf9661b3e">7.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjItNy0xLTEtMzExNDU_c4d6a7e4-cc88-422d-b561-ae8ffe38eb59">7.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjQtMS0xLTEtMzA3NTY_df99ef0b-ede2-47a3-be41-a1212cefc9d6">3.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjQtMy0xLTEtMzA3NTY_ec6f4c1a-d7f4-40d6-8de6-f019d056b1ba">3.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjQtNS0xLTEtMzExNDU_a100e2ef-017e-4687-a01b-fbc2d37140ee">7.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjQtNy0xLTEtMzExNDU_49e3ebd1-f8fb-4447-88be-9478b4e9e3e6">7.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted average shares outstanding </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjctMS0xLTEtMzA3NTY_7577dc15-d983-4736-a571-35518363c7ed">11,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjctMy0xLTEtMzA3NTY_9e4ef948-df41-4da5-82c7-47c871ff630c">11,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjctNS0xLTEtMzExNDU_55fcac73-586a-4cd3-8c48-599f93bc1f75">11,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjctNy0xLTEtMzExNDU_c80c8806-8fce-45e0-b3a4-95bdcb106475">11,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjgtMS0xLTEtMzA3NTY_cc4903ff-fdbc-4732-9ff1-6ca118cf3712">11,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjgtMy0xLTEtMzA3NTY_a9eaa7f3-d4db-472d-bc2b-7259f782892f">11,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjgtNS0xLTEtMzM1NzE_f4eb82e1-592a-446a-ba7c-dbe79d0ab33d">11,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjgtNy0xLTEtMzM1NzM_8e3574a2-492c-4ed2-9f91-670f26468fb0">11,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash dividends declared per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMzAtMS0xLTEtMzA3NTY_e9d11463-10d0-4cbb-a120-7eb1e1c33122">1.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMzAtMy0xLTEtMzA3NTY_de7d3e9b-2513-4ef9-81c1-f3efb50c2adc">1.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMzAtNS0xLTEtMzExNDU_59cffb36-1ccc-4782-9443-7ae21d1b0ae7">3.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMzAtNy0xLTEtMzExNDU_80ee417c-231f-4915-a8b4-2949d4d5f0ae">2.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMy0xLTEtMS0zMDc1Ng_43be901c-982c-4d9d-9a59-af564ebbdb25">39,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMy0zLTEtMS0zMDc1Ng_5a5dc5b5-bf3a-4add-86c7-feb4998e23b4">46,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMy01LTEtMS0zMDc1Ng_153be390-2bc9-4fd9-8cb4-b78820607c49">80,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMy03LTEtMS0zMDc1Ng_de3e4db0-88c7-44c5-afa5-0f89ffa924a2">88,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNi0xLTEtMS0zMDc1Ng_734a67c2-d1aa-45f8-bf19-83c6b00da786">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNi0zLTEtMS0zMDc1Ng_613be27f-9655-43b6-9ddd-9ac2edb41269">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNi01LTEtMS0zMDc1Ng_441bb869-68d5-4f83-9303-5458d0754f56">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNi03LTEtMS0zMDc1Ng_ea60d116-72ae-4e39-ace0-12179c19f533">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized losses on investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNy0xLTEtMS0zMDc1Ng_200b7fe8-e2a5-45ff-9a91-88ddc9206148">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNy0zLTEtMS0zMDc1Ng_5540c180-4b52-44c4-be86-77c2a12c597a">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNy01LTEtMS0zMDc1Ng_1db2a7ab-c9d4-4052-ab52-18bdc18bbfbb">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNy03LTEtMS0zMDc1Ng_8944a9b5-afe4-48d5-9d59-5b8fbce6aa30">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfOC0xLTEtMS0zMDc1Ng_e6b4107f-044f-496b-8163-39a36de24370">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfOC0zLTEtMS0zMDc1Ng_6083f97b-323a-4e68-a558-30b462f77ec0">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfOC01LTEtMS0zMDc1Ng_4aa7815d-ee6a-4518-bed5-0055bc3e95d2">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfOC03LTEtMS0zMDc1Ng_cf4c7401-94b7-4f33-a07f-53ac2bb4f0f4">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMTAtMS0xLTEtMzA3NTY_7cb88e86-5ce1-43a8-82b7-96f1156e1cc1">39,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMTAtMy0xLTEtMzA3NTY_9f0679f6-2a89-493c-ab43-863cb83309bd">46,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMTAtNS0xLTEtMzA3NTY_b7bf31cc-c0eb-4355-b321-78940aaaf73d">81,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMTAtNy0xLTEtMzA3NTY_5ce7f16f-56fa-4ac8-9c34-9059c4200f49">88,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except par value)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:58.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNC0xLTEtMS0zMDc1Ng_344e9ec3-1dad-40aa-b975-ac1f1d2abe4e">61,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNC0zLTEtMS0zMDc1Ng_f671faaa-4e70-4c51-9bb3-60ec878377d9">104,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNS0xLTEtMS0zMDc1Ng_ac0fd3b4-01a0-46d1-be5c-e34d6a53dfce">156,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNS0zLTEtMS0zMDc1Ng_ba0e63eb-ac36-4845-9330-10889c958112">180,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNi0xLTEtMS0zMDc1Ng_5d4ac63b-633a-4509-9ac1-075cb7368f00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNi0zLTEtMS0zMDc1Ng_dd8185e8-8140-4e52-ab25-06c9f5eb60a5">5,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes, prepaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNy0xLTEtMS0zMDc1Ng_05ba8309-8874-4d3a-896c-84ebeab4fba5">8,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNy0zLTEtMS0zMDc1Ng_4000768b-ca82-4128-8188-2975647c01e9">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfOC0xLTEtMS0zMDc1Ng_2dca4482-fb37-40f5-8e31-458d1a71371b">16,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfOC0zLTEtMS0zMDc1Ng_78b3d75f-2f4f-47a4-8ca6-5d3f927f8e23">16,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfOS0xLTEtMS0zMDc1Ng_a99a8352-514d-46ea-8db8-069ce2f79c36">243,300</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfOS0zLTEtMS0zMDc1Ng_6aef4fbb-d1df-4084-aa14-d785be89fb88">306,866</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Property, plant and equipment - net of accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTEtMS0xLTEtMzA3NTY_a7cf5ab2-5783-409f-bd2f-7a49b0dd7826">58,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTEtMy0xLTEtMzA3NTY_a904c53e-70e5-4558-9a01-b3b2dda9574b">56,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTItMS0xLTEtMzA3NTY_8a97f341-a276-4a06-924b-adb1904ac10f">21,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTItMy0xLTEtMzA3NTY_50a7f352-27f1-4dd6-8f64-91b240e39f57">24,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTMtMS0xLTEtMzA3NTY_6b829787-54f2-48f6-bbd4-1012622fe9ec">12,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTMtMy0xLTEtMzA3NTY_5bd4f04b-2964-4a47-b07d-7b4d9c9f4116">6,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTQtMS0xLTEtMzA3NTY_e7e48a92-2607-4ae3-be9a-a5852ad299cd">4,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTQtMy0xLTEtMzA3NTY_ca1791ac-3f0f-4b50-9abf-f7ec3e58f4f0">4,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTctMS0xLTEtMzA3NTY_ae9635db-6b85-4df5-a3ad-faa1cc69bc2b">340,550</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTctMy0xLTEtMzA3NTY_d018efe7-140f-4d0a-ae2b-da662f2ece62">398,326</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjEtMS0xLTEtMzA3NTY_7175d666-8795-4a3f-bb10-37ec9097a261">154,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjEtMy0xLTEtMzA3NTY_cd463718-5efa-40e0-b09e-a6d6a616e63a">163,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Revolving credit facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjItMS0xLTEtMzUzMDE_6ba09c68-6ca0-4747-961c-68467f0d592e">27,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjItMy0xLTEtMzUzMDE_2440af42-0c53-47a0-a917-985c5b392e6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;Current lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjItMS0xLTEtMzA3NTY_c65139bb-801d-4683-a2d2-cfd09acee46e">6,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjItMy0xLTEtMzA3NTY_93e16ab0-21d6-4d3c-8370-eec595ed5759">6,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjMtMS0xLTEtMzA3NTY_51eb1611-0fd6-4ec5-b14f-218305954c45">188,160</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjMtMy0xLTEtMzA3NTY_b64c2b88-b265-42a7-b6de-d1d9f81779d0">169,832</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Lease obligations, net of current lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjUtMS0xLTEtMzA3NTY_6811be2b-9273-45ab-9c57-6109c122e621">22,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjUtMy0xLTEtMzA3NTY_8f2ce670-3e3c-48f2-877f-283f8977bb80">26,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjYtMS0xLTEtMzA3NTY_2903247a-32df-4800-9bfc-72b84cd41dff">211,074</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjYtMy0xLTEtMzA3NTY_4d964602-9314-42ab-aeaa-59e74b0bf890">195,852</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjktMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjo3MzcyNDNmNWQ1NmQ0MTE4ODY3YzI2NTVmMTNlNzUyY18yOA_8331eee4-a2d6-4b27-8a30-741d1fe73658"><ix:nonFraction unitRef="usdPerShare" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjktMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjo3MzcyNDNmNWQ1NmQ0MTE4ODY3YzI2NTVmMTNlNzUyY18yOA_c36b5f57-37ba-401f-a5d9-b81549042825">0.001</ix:nonFraction></ix:nonFraction> per share: <ix:nonFraction unitRef="shares" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjktMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjo3MzcyNDNmNWQ1NmQ0MTE4ODY3YzI2NTVmMTNlNzUyY180Mg_01de1bca-2778-48a9-9715-1b64b19d2d00"><ix:nonFraction unitRef="shares" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjktMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjo3MzcyNDNmNWQ1NmQ0MTE4ODY3YzI2NTVmMTNlNzUyY180Mg_7dc1e2ea-1b2a-48e1-8309-83d389be2781">20,000</ix:nonFraction></ix:nonFraction> shares authorized;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzAtMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjozNzdkYmY1MjQ2ZmI0ZGY1YTZiODA5NzA0ZDgwNmU0Zl80_7637d3dd-d881-45a5-85e3-399f848f0d29">11,019</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzAtMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjozNzdkYmY1MjQ2ZmI0ZGY1YTZiODA5NzA0ZDgwNmU0Zl8xMQ_7c85eb18-0777-4eeb-a4f1-2809b0ca0988">11,594</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzAtMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjozNzdkYmY1MjQ2ZmI0ZGY1YTZiODA5NzA0ZDgwNmU0Zl8yNQ_ff489509-c490-4cdf-aed0-59c115092214">11,018</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzAtMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjozNzdkYmY1MjQ2ZmI0ZGY1YTZiODA5NzA0ZDgwNmU0Zl8zMg_fab48a62-5d30-44f0-87f6-717f31ada7d4">11,593</ix:nonFraction> outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">at June&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzEtMS0xLTEtMzA3NTY_1d616c6e-2814-4e2b-b068-8789258cb44b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzEtMy0xLTEtMzA3NTY_46e74d38-3db4-40c8-b6e3-40fdfd97b3be">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzItMS0xLTEtMzA3NTY_12d91404-5820-4c93-9421-5ca55a9f2ed7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzItMy0xLTEtMzA3NTY_6c47324d-c706-445c-965e-c3cd421d3cb9">12,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzMtMS0xLTEtMzA3NTY_d3b0e5ca-d87e-476d-a283-41bb417bf9ca">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzMtMy0xLTEtMzA3NTY_f8b41a3b-880a-45da-b026-ec3f468cddcf">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Retained earnings </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzQtMS0xLTEtMzA3NTY_ea0f33d0-ecb0-4020-96db-377ee05aa3a5">129,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzQtMy0xLTEtMzA3NTY_2d3e251a-54f0-46c4-a7cb-0228288ea590">190,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzYtMS0xLTEtMzA3NTY_54c862d3-13e9-4c0b-b933-2d7b7b9968b7">129,476</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzYtMy0xLTEtMzA3NTY_ff412b08-b00a-4bdf-bbbb-769854aa16cc">202,474</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzgtMS0xLTEtMzA3NTY_5e036933-0e8f-47f5-9530-1b010e019014">340,550</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzgtMy0xLTEtMzA3NTY_a59d6488-ac33-4184-a616-54ab9671d2c9">398,326</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollar in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:57.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.286%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNC0xLTEtMS0zMDc1Ng_448977c6-7459-4a67-8f57-80a953e0075b">80,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNC0zLTEtMS0zMDc1Ng_802eca88-954d-4793-b6e4-fecdeb36b8d9">88,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to reconcile net income to cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNi0xLTEtMS0zMDc1Ng_a23d4a51-9564-487f-beb4-337b8d3ce298">5,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNi0zLTEtMS0zMDc1Ng_09b39989-e1c1-4110-a2f7-e0f9f24aa08f">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-cash lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="med:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNy0xLTEtMS0zMDc1Ng_8dfe6967-3209-41df-92f9-a1fdb4559582">3,211</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="med:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNy0zLTEtMS0zMDc1Ng_8556fc0d-1ad9-44e5-bc05-f8349e7f750a">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfOC0xLTEtMS0zMDc1Ng_41795b20-aeb1-4a45-9bad-ae64d5826847">5,140</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfOC0zLTEtMS0zMDc1Ng_7b5ac22c-c502-49cf-8772-adc71d144eae">4,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Amortization of premium on investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="med:AmortizationOfPremiumOnInvestmentSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfOS0xLTEtMS0zMDc1Ng_47048525-0f37-4f48-a47e-a29003b3a6f8">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="med:AmortizationOfPremiumOnInvestmentSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfOS0zLTEtMS0zMDc1Ng_76d763e5-bb89-4e9e-b83f-573e4a7bd8d9">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTItMS0xLTEtMzA3NTY_116b969f-2146-4966-83f9-825d9cfe6246">23,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTItMy0xLTEtMzA3NTY_a439b3b0-1e2c-4151-8c7d-493ae668375a">42,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes, prepaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTMtMS0xLTEtMzA3NTY_0976208c-17e3-464f-9e70-5bcf65817968">7,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTMtMy0xLTEtMzA3NTY_05cb16c7-2755-4003-aae6-c24b7c55ade2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTQtMS0xLTEtMzA3NTY_cef186d4-d5c5-4af0-92b5-9501a5cfdd2c">376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTQtMy0xLTEtMzA3NTY_ca308c6a-88fa-4a06-96ad-9f4053138519">4,657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTUtMS0xLTEtMzA3NTY_c807946a-cc97-436f-ace5-1464809192ee">8,169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTUtMy0xLTEtMzA3NTY_13616498-7ce2-45cf-9b90-33c92632e707">762</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable and accrued expenses </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTYtMS0xLTEtMzA3NTY_4b44f396-a422-401c-832a-ff4ed51abee2">13,922</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTYtMy0xLTEtMzA3NTY_2510ac26-2ef3-4866-bad1-28650f1ec971">36,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash flow provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTctMS0xLTEtMzA3NTY_705df01a-19c0-4782-bd0e-762187c1d69b">87,435</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTctMy0xLTEtMzA3NTY_be5aeecc-a368-4353-bd26-771dbafd0967">86,204</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Sale and maturities of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjAtMS0xLTEtMzA3NTY_5fd11d89-b46f-41cf-956c-3c0c168f03c5">5,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjAtMy0xLTEtMzA3NTY_8034c4cd-faf6-4fbc-abf1-7f723c204b69">5,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjEtMS0xLTEtMzA3NTY_7d49b30f-4c50-494f-82b3-d5c319977061">5,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjEtMy0xLTEtMzA3NTY_55408650-314d-41b4-ab0d-80e1e37a5bca">12,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash flow used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjItMS0xLTEtMzA3NTY_8acea6f4-fdfd-4b0a-8b11-9280312cbda2">582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjItMy0xLTEtMzA3NTY_dbf46708-b879-463a-958a-27908ffaca2d">7,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Borrowing under revolving credit facility</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjYtMS0xLTEtMzc1ODk_4d5df550-e783-4e67-a5ab-61f131331686">27,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjYtMy0xLTEtMzc1OTY_cf825c5c-58da-44a1-a5ad-00ca6c288cd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Options exercised by executives and directors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjUtMS0xLTEtMzA3NTY_ed6488b9-f724-41cd-8ba2-259072ad9081">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjUtMy0xLTEtMzA3NTY_6ce5e4a3-ad90-451d-87cb-046d421455be">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfOtherEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjYtMS0xLTEtMzA3NTY_4c4550c2-7210-40ff-a98b-93cc7721dc3c">1,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfOtherEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjYtMy0xLTEtMzA3NTY_c6db1741-d366-4d25-b794-6a406e2ee695">1,833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash dividends paid to stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjctMS0xLTEtMzA3NTY_50d9ae27-67dc-4e4d-9009-d87ec874b523">35,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjctMy0xLTEtMzA3NTY_6eb73888-72dd-4a53-a8e3-b44a87fcff6b">30,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock repurchases, settled</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjgtMS0xLTEtMzA3NTY_ff68494f-576e-4e6d-af97-ad900e989032">100,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjgtMy0xLTEtMzA3NTY_3d294e73-9335-4526-9bd4-28e466f8d35a">19,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock repurchases, not yet settled</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="med:PaymentsForRepurchaseOfCommonStockNotYetSettled" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzEtMS0xLTEtMzc2MzQ_6f53d4b0-9f07-4262-a526-1836966f93d7">20,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="med:PaymentsForRepurchaseOfCommonStockNotYetSettled" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzEtMy0xLTEtMzc2NDI_008551cf-210b-4ad0-8c58-bd82c078f84b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash flow used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjktMS0xLTEtMzA3NTY_db354316-a951-437e-a11a-89cb11ef92db">130,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjktMy0xLTEtMzA3NTY_653fa3e5-7d4b-4e22-a150-8f1662984ccb">50,956</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzEtMS0xLTEtMzA3NTY_ff860433-bbf6-4583-a454-4dfe2efa0d45">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzEtMy0xLTEtMzA3NTY_e9e72e93-af12-44bd-b04d-7e9afe96ea5e">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(Decrease) Increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzMtMS0xLTEtMzA3NTY_0a9286e3-b4a7-4a77-b1c9-eaad7dd59de6">43,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzMtMy0xLTEtMzA3NTY_f0f73365-5723-4c39-b62c-abe67ef48b9d">28,264</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents - beginning of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzQtMS0xLTEtMzA3NTY_7d6a3f93-9d68-4ca2-b813-adadd164189a">104,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2cb2cb83f1f4e5db44b278f12bea8b9_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzQtMy0xLTEtMzA3NTY_491e21f9-9d28-4e3c-817d-e8a18f2cb63a">163,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents - end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzUtMS0xLTEtMzA3NTY_1bc986fd-98de-479b-91d4-a11d97667210">61,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib717e1074bde42e0901aeb7e954bcbd3_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzUtMy0xLTEtMzA3NTY_deaef80b-8ba9-43be-a010-b06d750f6503">191,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzgtMS0xLTEtMzA3NTY_8131b882-b533-4fde-b4e4-1e62bb868a75">30,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzgtMy0xLTEtMzA3NTY_c328d38c-f31e-40d0-ba6e-5cbdb53a74b2">26,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Dividends declared included in accounts payable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzktMS0xLTEtMzA3NTY_b9c605f4-85aa-40fa-896b-c12f910397b2">19,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzktMy0xLTEtMzA3NTY_98ae2bfd-19f4-46d9-b31a-fe84d14c0461">17,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:30.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Six months ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of<br/>Shares Issued</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Common Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Additional Paid-In <br/>Capital</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated Other <br/>Comprehensive Income</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Retained <br/>Earnings</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Treasury Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib007aabffb2f44fe8073ab3215a03eb5_I20211231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy0xLTEtMS0zMDc1Ng_a60c1946-bd2a-4590-8e9c-8e4c4cdbaa1a">11,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib007aabffb2f44fe8073ab3215a03eb5_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy0zLTEtMS0zMDc1Ng_ee659ff3-c713-4edb-8c81-25f33f3f3811">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70994f711ef24ed1b554ae05170a0beb_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy01LTEtMS0zMDc1Ng_1042e2b9-bc36-488c-bfd4-541e855c040a">12,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d42d0328604314b103add648897899_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy03LTEtMS0zMDc1Ng_9e6d66cc-2782-4bff-b66b-000838acb4f7">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idddb1d1de99c4ffb96425d0fb0935d42_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy05LTEtMS0zMDc1Ng_4c685f37-44e0-4905-89ed-23aa401f85dc">190,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if19addb8cd514cfab707066c1d48a8b9_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy0xMS0xLTEtMzA3NTY_7f948859-fdbe-4cff-80f5-4cb9f9391334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy0xMy0xLTEtMzA3NTY_0fb2448c-210f-4dc4-8109-e4e646d88118">202,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a10d1a3ea1444f9c9554929870ed73_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNC05LTEtMS0zMDc1Ng_e0720ff3-a401-42f1-b2db-04a8e49ce9ad">41,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNC0xMy0xLTEtMzA3NTY_67a31252-6731-4f21-8ac7-42dd5b672bb7">41,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7eb1b28eb5c740d291bf7d672b2ecc4b_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNS0xLTEtMS0zMDc1Ng_73ad3095-b019-4bdf-a68b-913a207eb841">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f614cfb222b45358fd4a8d8202d5a51_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNS01LTEtMS0zMDc1Ng_173445f3-da3d-430b-9fbd-ae4a12c14301">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNS0xMy0xLTEtMzA3NTY_b2e4d3f8-fb91-4b28-9b22-ac3470a1bbaf">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7eb1b28eb5c740d291bf7d672b2ecc4b_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNi0xLTEtMS0zMDc1Ng_43037913-78b7-4ed0-8597-c542e2c06c39">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f614cfb222b45358fd4a8d8202d5a51_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNi01LTEtMS0zMDc1Ng_8d4544f9-2456-4197-829c-2c28277501ce">1,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNi0xMy0xLTEtMzA3NTY_cfb7a5ef-dc33-447a-a7a3-49b0b25fbe45">1,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1329ce8de55b48caa47ae30f8e7f1fdd_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNy0xMS0xLTEtMzA3NTY_1f33f802-30f7-47bf-a617-b297442c64dc">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNy0xMy0xLTEtMzA3NTY_49e5bb93-ce32-4e18-8dd6-4b7a7e804283">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7eb1b28eb5c740d291bf7d672b2ecc4b_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOC0xLTEtMS0zMDc1Ng_7c9554dc-969a-4360-85cd-438c3ce5dbf6">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a10d1a3ea1444f9c9554929870ed73_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOC05LTEtMS0zMDc1Ng_33f4c50f-1bc8-45db-b99c-0c9d66c3ea0b">10,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1329ce8de55b48caa47ae30f8e7f1fdd_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOC0xMS0xLTEtMzA3NTY_ed13b251-b56e-497b-9ce6-992c57baf1c3">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOC0xMy0xLTEtMzA3NTY_1bf91224-4b0a-4154-995d-1d1b45557aa1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c17c93c4db5400dbad4c963bf804dcc_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOS03LTEtMS0zMDc1Ng_c820e39e-06a5-4a27-aa12-e6c4f35bb6fd">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOS0xMy0xLTEtMzA3NTY_4209b7b9-bfbb-4472-ac16-69f2ce896af4">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a10d1a3ea1444f9c9554929870ed73_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTAtOS0xLTEtMzA3NTY_17a80fe8-acb5-4c35-b9c3-f6856d7e5847">19,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTAtMTMtMS0xLTMwNzU2_492cd0e7-38bf-4264-a081-4b38a624aea8">19,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3323f77d983c40708d7df03f365955c7_I20220331" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItMS0xLTEtMzA3NTY_11063fd5-26fd-447f-82b2-4dd4db5df119">11,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3323f77d983c40708d7df03f365955c7_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItMy0xLTEtMzA3NTY_a7da8077-72d0-4ab9-a2e7-6adf062c342d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia51614e2d87f471b9611cdd907dfd3b9_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItNS0xLTEtMzA3NTY_fbdf8230-91e6-442e-809c-b153dcb3980a">12,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0989ccad19040f5b5d63fd9ed61ec3b_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItNy0xLTEtMzA3NTY_1d23116b-81ca-43bb-b091-0d3e5daf60bb">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic011d96c5d0e44b897ab88e6c880715d_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItOS0xLTEtMzA3NTY_5986b2a9-fd83-40f7-92cb-568eb8d3dcfa">203,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d77050a9aad4a668e670082595a0872_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItMTEtMS0xLTMwNzU2_3f75e30e-38e7-4063-a276-961d0c4c289b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cfceef1c49443a98b3eccf024ccd8c_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItMTMtMS0xLTMwNzU2_fa2a4c9e-e09b-4d07-80a1-2662d0e7252c">216,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTMtOS0xLTEtMzI3NTQ_565cac9e-beb9-4e8a-a4a1-a4148fcb57f1">39,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTMtMTMtMS0xLTMyNzU0_020e74d8-d6dc-4ff7-85b6-1f1e0640240b">39,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie77b0f4c612645f4b5db58aa9f5feb14_D20220401-20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTQtMS0xLTEtMzI3MzI_1d2469cb-c565-47a4-b169-8614ba225110">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d57531d9c1486fa7935451b76cc244_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTQtNS0xLTEtMzI3NTQ_8b06f245-22ee-4e7b-9b2b-a371ba62f8c7">2,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTQtMTMtMS0xLTMyNzU0_4d44b8ef-d108-46f8-8854-a4a75cada59d">2,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d57531d9c1486fa7935451b76cc244_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTUtNS0xLTEtMzI3NTQ_4bb7e012-e37c-467a-8679-c46c3d2936fc">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTUtMTMtMS0xLTMyNzU0_0d9f3a68-8aee-4490-9603-ffd1f97f9061">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f1ba3aafeb246248eb2f5d8d106e124_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTYtMTEtMS0xLTMyNzU0_285edbe0-d3e5-4e41-8f33-83790a7cb6a5">90,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTYtMTMtMS0xLTMyNzU0_b3c25d90-6ac0-44e6-aef8-8ec83f7aa101">90,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctMS0xLTEtMzI3MzI_581288a8-7ad4-454f-bbba-12e3288b5c37">535</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctMy0xLTEtMzI3NTQ_32758bb7-2feb-4517-b281-2d2d7a19c0fa">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctOS0xLTEtMzI3NTQ_2b1ff62a-55ad-442b-864e-8801fc782240">90,038</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f1ba3aafeb246248eb2f5d8d106e124_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctMTEtMS0xLTMyNzU0_89a2d208-84e8-4b43-a2b6-da812cadb8e9">90,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctMTMtMS0xLTMyNzU0_18fcbde0-9146-4e07-a556-9b550845afc3">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock repurchases, not yet settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7d57531d9c1486fa7935451b76cc244_D20220401-20220630" decimals="-3" name="med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtNS0xLTEtMzk1MDk_4ce506d0-cee7-4858-9032-775ee4165b0a">15,679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630" decimals="-3" name="med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtOS0xLTEtMzk1MDk_27d45925-f762-4db3-9120-23b2ef793819">4,331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtMTMtMS0xLTM5NTA5_77dd12e5-a540-4f28-9250-328ec3c817dd">20,010</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330f682e6d384eddbd2ad742ee94e292_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtNy0xLTEtMzI3NTQ_ef509cf1-775e-462f-8fe5-1a3e50890ff0">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtMTMtMS0xLTMyNzU0_5e238aa9-a143-4277-8037-61e12efebb60">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTktOS0xLTEtMzI3NTQ_b915f597-6fde-4f2a-a281-c8e1b583f3c0">18,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTktMTMtMS0xLTMyNzU0_d95fbfcc-be3c-4d31-9575-c2ed20cdddb0">18,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iadacc573ef8c41f4b06a98194c3c83bb_I20220630" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtMS0xLTEtMzI3MzI_7dd149ca-c541-42b8-81f0-3b1cccee6784">11,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadacc573ef8c41f4b06a98194c3c83bb_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtMy0xLTEtMzI3NTQ_34292c56-9763-41b9-99fa-541dbdf4a88f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee4cc608c6743ce9b79d053c9413fd0_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtNS0xLTEtMzI3NTQ_54a02abc-d4b0-4444-b156-9241e40b8512">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7926d7c8beee47bb8f67125936a7efb8_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtNy0xLTEtMzI3NTQ_42c81d7e-86a3-4bb8-a677-62bdc31ee7ba">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b12b911b3be4af1927784cfc0ea5a2f_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtOS0xLTEtMzI3NTQ_2b4cc646-1752-42af-a24b-e380d6595377">129,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic153d5cbf75b48c8801f45f3ff6868aa_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtMTEtMS0xLTMyNzU0_70297616-e0a1-44d2-92e4-e96dc43f72ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtMTMtMS0xLTMyNzU0_afe0e533-b6d8-4702-9ace-4650c0a7125a">129,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Six months ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of <br/>Shares Issued</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Common Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Additional Paid-In <br/>Capital</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated Other<br/>Comprehensive Income</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Retained <br/>Earnings</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Treasury Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i420f82e6dd774834a5ff44c9e9ab77df_I20201231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy0xLTEtMS0zMDc1Ng_408b23e9-d3b6-4668-bb6e-14130cba83fe">11,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i420f82e6dd774834a5ff44c9e9ab77df_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy0zLTEtMS0zMDc1Ng_36b075d2-bd3f-48d8-8371-03dcca72f461">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eae09b33bec4a8a86534172345a885f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy01LTEtMS0zMDc1Ng_7598e125-a54b-4937-8f2c-35ea73806987">7,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if15858c6593a4308a5b4a5f453163253_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy03LTEtMS0zMDc1Ng_09a36856-73bf-42e0-963c-a77f2c401e19">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f6f8991b244fb491b90bb6cd39d68f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy05LTEtMS0zMDc1Ng_fecc32c3-9048-43b7-8e19-7504070527e9">154,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabdffcc0da434db48bba66473c5942b8_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy0xMS0xLTEtMzA3NTY_4244607d-f1f6-4018-9b78-712bb4e3fa5f">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2cb2cb83f1f4e5db44b278f12bea8b9_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy0xMy0xLTEtMzA3NTY_0bc6c696-ddec-480e-94aa-5d6d15295aa5">157,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8fcce8f57b4164b5fd496a4762fb6c_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNC05LTEtMS0zMDc1Ng_0f5d5622-50e1-45a3-9d22-414f073655a3">41,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNC0xMy0xLTEtMzA3NTY_d5ffb22e-1154-487d-bdb6-c1a2c08ace0d">41,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29d77b83c536442c87946833f8aa3fd5_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNS0xLTEtMS0zMDc1Ng_465cb609-e73b-4de2-817b-0f533b7fb691">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87de8628b754ed199047a89c561a717_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNS01LTEtMS0zMDc1Ng_b73cc774-0ae2-4744-930e-78fe08708016">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNS0xMy0xLTEtMzA3NTY_05f930c0-dbd7-4901-aa55-6726c64c568d">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Options exercised by executives and directors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29d77b83c536442c87946833f8aa3fd5_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNi0xLTEtMS0zMDc1Ng_96abd861-5270-4506-835a-40025c4cc195">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87de8628b754ed199047a89c561a717_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNi01LTEtMS0zMDc1Ng_c6b1510a-f220-4361-bef3-f69e60265036">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNi0xMy0xLTEtMzA3NTY_164e618f-5530-4a64-8716-65e8d23e97d5">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i29d77b83c536442c87946833f8aa3fd5_D20210101-20210331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNy0xLTEtMS0zMDc1Ng_71220028-3e83-40bc-81e4-a24c757ea0ad">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id87de8628b754ed199047a89c561a717_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNy01LTEtMS0zMDc1Ng_556cc287-1a94-4c3a-862f-f35de2bac122">1,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f1ba3aafeb246248eb2f5d8d106e124_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNy0xMS0xLTEtMzA3NTY_dfede826-b3c3-40e0-aa5c-da981444a3d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNy0xMy0xLTEtMzA3NTY_bf826bcb-01e0-42dd-b3c1-25b420b30f15">1,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2cd41ad8c1f47a58b8e56c0545a424f_D20210101-20210331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfOC0xMS0xLTEtMzA3NTY_a7d0ab82-ae0d-4510-b6f7-283c5ab76195">7,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfOC0xMy0xLTEtMzA3NTY_6ea83858-7360-4f41-bd67-91c4b3cd191f">7,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4084eaf131484e538b813c92b9a8808a_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfOS03LTEtMS0zMDc1Ng_e7f53be4-294b-4fed-b1cd-d3e5f2dad1ff">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfOS0xMy0xLTEtMzA3NTY_03a1e54f-517a-492c-989c-ecb9eae2756d">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf8fcce8f57b4164b5fd496a4762fb6c_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTAtOS0xLTEtMzA3NTY_32aeacc1-e814-46a0-a7e9-527c846e4bec">16,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTAtMTMtMS0xLTMwNzU2_cf359dd0-cecb-40df-b751-865d1990b377">16,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9cd5e00468f4c31a6ad35b46dc5f678_I20210331" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItMS0xLTEtMzA3NTY_ad4dc7af-e50c-44c0-91fb-480a724d3eea">11,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9cd5e00468f4c31a6ad35b46dc5f678_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItMy0xLTEtMzA3NTY_2fb690fa-1411-4023-8e46-17df37fcb45d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3603223f943940e8bb0e20a4b0812f09_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItNS0xLTEtMzA3NTY_1e8f5369-605a-4f6c-91ba-48c808890a70">8,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64da106a0256487891ae3679ee954695_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItNy0xLTEtMzA3NTY_9322f322-61a2-45d6-803c-4a2c61cbdde5">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i994c40f6e8264eb9846533b735f22532_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItOS0xLTEtMzA3NTY_084d3f18-9b71-4522-a518-0593a9a2bbca">178,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95794c49258c433a90e7170fa1e44931_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItMTEtMS0xLTMwNzU2_58ec93d5-d5c6-4046-99dc-d26a3487d898">12,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6420c7cef69b48e4a74f0ced80372d52_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItMTMtMS0xLTMwNzU2_e0bc3b9c-3a98-4785-a9a5-c1e7e7ca19ee">174,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339725a880774411bbaef2b210a31022_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTMtOS0xLTEtMzI4ODA_31947099-7a45-40aa-88e8-34af502136f5">46,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTMtMTMtMS0xLTMyODgw_41c077fa-f1ee-4df7-868c-7565b0a754c1">46,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i854bc7faa0594c56b36981f871a1e7bd_D20210401-20210630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTQtMS0xLTEtMzI4ODA_8a9f4100-f1a6-41c9-881b-3711e298f03f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ceaf5d8702b4db0b4f91c3787bd2a76_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTQtNS0xLTEtMzI4ODA_114cbda3-ef4a-407d-9818-3d7e3036815b">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339725a880774411bbaef2b210a31022_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTQtOS0xLTEtMzI4ODA_d151c5ed-0bd1-48ca-9202-23150ff857e3">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTQtMTMtMS0xLTMyODgw_cab6bc30-9c20-4010-b4c6-be57a2faffd0">1,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Options exercised by executives and directors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i854bc7faa0594c56b36981f871a1e7bd_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTUtMS0xLTEtMzI4ODA_3301c89e-3547-49ae-8d27-86c755de4598">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ceaf5d8702b4db0b4f91c3787bd2a76_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTUtNS0xLTEtMzI4ODA_a1a7eaf1-cb38-4560-8f11-49deb12a9599">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTUtMTMtMS0xLTMyODgw_7aad5806-0411-406a-84bd-6d0afe347b78">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ceaf5d8702b4db0b4f91c3787bd2a76_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTYtNS0xLTEtMzI4ODA_6694d8dd-33b4-4f9d-8b30-ce54740a6f7b">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTYtMTEtMS0xLTMyODgw_28089e16-6f22-4da9-8ed6-ade1ec2510b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTYtMTMtMS0xLTMyODgw_2fc87729-bf6f-4b03-aa55-9ac9c2d922cb">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e0a3cd16fbf42e3a67ec29910bd258d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTctNy0xLTEtMzI4ODA_7c0717bc-8e4e-49c7-9fc1-abd3583b8fc3">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTctMTEtMS0xLTMyODgw_2e41e6f0-9989-44fa-9ea9-29503961cd7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTctMTMtMS0xLTMyODgw_af233242-5326-4f2d-b51a-82181929390a">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTgtMTEtMS0xLTMyODgw_2ff33d16-d488-4b36-b18c-1154c3f26777">12,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTgtMTMtMS0xLTMyODgw_e90c46f1-ef30-49b3-9f66-e2a6859e5ebd">12,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTktMS0xLTEtMzI4ODA_17a91887-614e-4a4f-aaa9-a206674de2ff">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i339725a880774411bbaef2b210a31022_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTktOS0xLTEtMzI4ODA_32488049-449a-4536-be72-85cdbe6ace0c">23,383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTktMTEtMS0xLTMyODgw_5549c1a7-c8a3-452d-9426-65f1db5da92a">23,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTktMTMtMS0xLTMyODgw_747890c8-747d-4443-a619-e582a9a0cc27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i339725a880774411bbaef2b210a31022_D20210401-20210630" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjAtOS0xLTEtMzI4ODA_2610f684-e2cd-4d11-b31e-9a6433299071">16,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjAtMTMtMS0xLTMyODgw_53eae9b5-c91f-401e-8df2-2897e4b49d2e">16,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32eb764f079c4b1d8469239466030d0a_I20210630" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItMS0xLTEtMzI4ODA_ded2cba5-b998-4039-a24f-97bdcf7912cb">11,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32eb764f079c4b1d8469239466030d0a_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItMy0xLTEtMzI4ODA_787a98c3-e176-4c04-ba43-47b066fd074a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ef1256755c4d0f8435ea934548d592_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItNS0xLTEtMzI4ODA_7573652b-5dfb-4b56-9f88-7643ba296d30">10,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75fbb52e386d4f8a9bcf066f87b0150f_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItNy0xLTEtMzI4ODA_b95f7550-0a56-46e4-92b3-3766bbd4268d">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7698f0af5074b91b7c210b87f471501_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItOS0xLTEtMzI4ODA_3144a93b-6912-4c03-b8a0-b0a37e214cba">185,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c6300a2f004db38274d065e4c9bac3_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItMTEtMS0xLTMyODgw_caab5e38-5c65-4fdb-9e44-fbc4a20304ac">1,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib717e1074bde42e0901aeb7e954bcbd3_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItMTMtMS0xLTMyODgw_942429e2-1317-4b16-9dea-84c1fc24b038">194,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_34"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5Mg_f6ac8d95-bbf2-44f4-9e48-9445bed20737" continuedAt="i1eb767c9ca4c4f748822cafeb446242e" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i1eb767c9ca4c4f748822cafeb446242e" continuedAt="i2636d8203ad1436fac1c8e4f6e516bb7"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5Mw_bdf59432-45f4-4943-98e5-b03514f5d3d3" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#8220;Medifast,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#8220;2021 Form 10-K&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the 2021 audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5NA_4679c47a-9b67-4ce8-9e0a-6d5818cb4e32" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Statements -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.</span></ix:nonNumeric></div><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5NQ_2eea652c-557d-474c-a188-94f85d7e66d1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span></ix:nonNumeric></div><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5Ng_013adb41-8a21-44be-9c24-9fdc3043901f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span></ix:nonNumeric></div><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5Nw_a18d55c1-dcb6-4b1d-b4c3-47fc2b589fad" continuedAt="ief2aa0fc11b846e2980e45da7324ee2e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:nonNumeric></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><ix:continuation id="i2636d8203ad1436fac1c8e4f6e516bb7" continuedAt="iada7a3c684674c5d9a96d15ef5cedbf2"><ix:continuation id="ief2aa0fc11b846e2980e45da7324ee2e" continuedAt="i8727ea21f4a94c4a97c10bbac23d5da6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update ("ASU") 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iada7a3c684674c5d9a96d15ef5cedbf2"><ix:continuation id="i8727ea21f4a94c4a97c10bbac23d5da6">, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.</ix:continuation></ix:continuation>  </span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RleHRyZWdpb246YmUyMTVlZWE1ZmUzNDRiMTkwNDdmODhhNTIyM2NhOTlfNjAy_efa846c0-406a-4766-81e2-5b743783b5a5" continuedAt="i5e03d1f2c30c436494f3a74fc6565740" escape="true">INVENTORIES</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5e03d1f2c30c436494f3a74fc6565740" continuedAt="i9cff2a1de182463b8fd4408047f60e6b">Inventories consist principally of raw materials, non-food finished goods and packaged meal replacements held in the Company&#8217;s warehouses and outsourced distribution centers. Inventories are stated at the lower of cost or net realizable value, utilizing the first-in, first-out method. The cost of finished goods includes the cost of raw materials, packaging supplies, direct </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><ix:continuation id="i9cff2a1de182463b8fd4408047f60e6b"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and indirect labor and other indirect manufacturing costs. On a quarterly basis, management reviews inventories for unsalable or obsolete inventories.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company donated inventory with an aggregate cost of $<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-5" name="us-gaap:NoncashContributionExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RleHRyZWdpb246YmUyMTVlZWE1ZmUzNDRiMTkwNDdmODhhNTIyM2NhOTlfMTI2NDQzODM3MjI4MzE_39fa819f-6bd3-4dae-ba17-09f6be33b93e">9.4</ix:nonFraction>&#160;million to Ukrainian refugees and those in need in Ukraine, increasing SG&amp;A during the three months ended June 30, 2022. The donations were made to two 501(c)(3) organizations that are coordinating the distribution throughout refugee camps in Europe and in Ukraine.</span></div><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RleHRyZWdpb246YmUyMTVlZWE1ZmUzNDRiMTkwNDdmODhhNTIyM2NhOTlfNjAz_f27091db-c9d6-4858-86a9-053f2b447bfb" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfMi0xLTEtMS0zMDc1Ng_18fa88d9-331b-4add-9407-a14d5805c2de">12,942</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfMi0zLTEtMS0zMDc1Ng_42c0b3c7-b6e6-4596-897d-22f7c9b01510">15,196</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfMy0xLTEtMS0zMDc1Ng_be80b231-253c-4cf9-a55b-360f57153ea4">2,987</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfMy0zLTEtMS0zMDc1Ng_bd82f2d4-cdac-4ee7-b423-505ab27d13c2">3,641</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-food finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="med:InventoryNonFoodFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNC0xLTEtMS0zMDc1Ng_df7becbd-41d0-459d-954d-8c9a5eccc846">12,810</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="med:InventoryNonFoodFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNC0zLTEtMS0zMDc1Ng_41f8093c-4032-45cd-a522-2bf3e52fd678">15,991</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNS0xLTEtMS0zMDc1Ng_7bf1eb56-098e-4592-b8ef-0ea9e2f0393d">131,435</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNS0zLTEtMS0zMDc1Ng_ec504c3a-8d42-4f4f-9ec9-5c7b4c838462">152,687</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Reserve for obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNi0xLTEtMS0zMDc1Ng_60cdaa67-68d4-43ea-9fd5-4c10e385a5b2">3,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNi0zLTEtMS0zMDc1Ng_a45ae057-db8c-4e9b-96a3-d327f976be6f">7,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNy0xLTEtMS0zMDc1Ng_7b6f7108-5f66-4ed7-a1f2-4e7bc3e3b0b6">156,974</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNy0zLTEtMS0zMDc1Ng_baa15147-ff60-4973-bd80-0493838fda0a">180,043</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4563bf4792014469bdc8cd3ee0a97965_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNjE4_ba7a1f3c-3810-4393-b9cc-68ae6b099402" continuedAt="i7b9ddad200c44185bb42b4c3621c3bc3" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i7b9ddad200c44185bb42b4c3621c3bc3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) computations are calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding during the periods presented. Diluted EPS is calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding adjusted for the effect of dilutive common stock equivalents.</span></div><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNjE5_2648f4a5-44e3-4ed6-9407-11561e4d0ba2" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNC0xLTEtMS0zMDc1Ng_ac1091bf-f657-4115-be12-bd07aa6f65bb">39,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNC0zLTEtMS0zMDc1Ng_988d66a8-44ca-4efa-8793-00597d9c8ff8">46,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNC01LTEtMS0zMDc1Ng_8b57b49d-9ddb-49f2-b2c3-c95c943599dd">80,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNC03LTEtMS0zMDc1Ng_a0eba421-492d-439c-a3fb-de31ff66611f">88,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNy0xLTEtMS0zMDc1Ng_7577dc15-d983-4736-a571-35518363c7ed">11,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNy0zLTEtMS0zMDc1Ng_9e4ef948-df41-4da5-82c7-47c871ff630c">11,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNy01LTEtMS0zMDc1Ng_55fcac73-586a-4cd3-8c48-599f93bc1f75">11,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNy03LTEtMS0zMDc1Ng_c80c8806-8fce-45e0-b3a4-95bdcb106475">11,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOC0xLTEtMS0zMDc1Ng_2aa6a864-5ed0-4e35-9c06-7fe446426c03">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOC0zLTEtMS0zMDc1Ng_4877db27-700c-4c13-a10d-8cc60bb0cd56">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOC01LTEtMS0zMDc1Ng_bed21dbd-b3ba-4717-8697-3d02e5f6bf3e">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOC03LTEtMS0zMDc1Ng_db4b8d3a-7bae-46f0-8d2f-b6d85bae22a1">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOS0xLTEtMS0zMDc1Ng_cc4903ff-fdbc-4732-9ff1-6ca118cf3712">11,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOS0zLTEtMS0zMDc1Ng_a9eaa7f3-d4db-472d-bc2b-7259f782892f">11,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOS01LTEtMS0zMDc1Ng_f4eb82e1-592a-446a-ba7c-dbe79d0ab33d">11,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOS03LTEtMS0zMDc1Ng_8e3574a2-492c-4ed2-9f91-670f26468fb0">11,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTEtMS0xLTEtMzA3NTY_e09acaab-c6a2-4599-8730-67aafb6a7573">3.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTEtMy0xLTEtMzA3NTY_e01dc267-bdd5-4d1e-aaaf-180c088e8722">4.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTEtNS0xLTEtMzA3NTY_015b0ca5-ddb9-4229-8712-4dd8640881b3">7.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTEtNy0xLTEtMzA3NTY_b64bf8aa-7f44-4d90-8ada-de2db020a00c">7.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTMtMS0xLTEtMzA3NTY_33c9dbd3-0dd8-44a2-8e8a-b59a81e40b12">3.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTMtMy0xLTEtMzA3NTY_da458125-b28a-44c9-b18a-207227188c7b">3.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTMtNS0xLTEtMzA3NTY_c89f39c0-a627-4469-9f7b-518b966ddcdc">7.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTMtNy0xLTEtMzA3NTY_7e249096-de08-4925-852a-28642bc080f9">7.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted EPS excluded <ix:nonFraction unitRef="shares" contextRef="if7841ac501214a4ea7e05c285cf32e72_D20220401-20220630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNTQ5NzU1ODE0NjM2_45ebb655-3e5c-4beb-8085-01ac3a3e7f62">3</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="icd64b09ae9b9490f9048feed73ccf44e_D20210401-20210630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNTQ5NzU1ODE0NjQw_6ef93f16-1989-4843-9a3f-b30a136c75d6">0</ix:nonFraction> antidilutive restricted stock awards for the three months ended June 30, 2022 and 2021, respectively, and <ix:nonFraction unitRef="shares" contextRef="i12734edec8f6435d8dd9b0e550bf268d_D20220101-20220630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNTM5_294dbb0f-ac9e-4b2e-9d50-127d658d73fa">1</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ibf47d02920404be79f49c2edef3bd952_D20210101-20210630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNTQ2_dca6e3ab-dae2-445e-832b-478f32abaa1b">0</ix:nonFraction> antidilutive restricted stock awards for the six months ended June 30, 2022 and 2021, respectively. EPS is computed independently for each of the periods presented above, and accordingly, the sum of the quarterly earnings per common share may not equal the year-to-date total computed.</span></div></ix:continuation><div id="i4563bf4792014469bdc8cd3ee0a97965_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYxOQ_4f9aad88-2a93-47f0-892b-c4bd04f65414" continuedAt="i069d66741fc748a9ac7349e8bd8e88d9" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i069d66741fc748a9ac7349e8bd8e88d9" continuedAt="i48be0793aefd4b42bfa07263878f4fc2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued non-qualified and incentive stock options to employees and non-employee directors. The fair value of these options are estimated on the date of grant using the Black-Scholes option pricing model, which requires estimates of the expected term of the option, the risk-free interest rate, the expected volatility of the price of the Company&#8217;s common stock, and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><ix:continuation id="i48be0793aefd4b42bfa07263878f4fc2" continuedAt="iaae647a257e64ce4a7d7799dde4001ba"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividend yield. Options outstanding as of June&#160;30, 2022 generally vest over a period of <ix:nonNumeric contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTA1_2876211d-efe3-4b44-a36b-5615ae1a002b">three years</ix:nonNumeric> and expire <ix:nonNumeric contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTE5_6106d055-7624-49b1-b950-247d96a56160">ten years</ix:nonNumeric> from the date of grant. The exercise price of these options ranges from $<ix:nonFraction unitRef="usdPerShare" contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTk0_5034f2ae-ca90-4b7f-94ad-5ccf765d90d4">26.52</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNjAw_0ffee3b1-b1e4-4667-aa01-61ec662facef">66.68</ix:nonFraction>. Due to the Company&#8217;s lack of option exercise history on the date of grant, the expected term is calculated using the simplified method defined as the midpoint between the vesting period and the contractual term of each option. The risk free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant that most closely corresponds to the expected term of the option. The expected volatility is based on the historical volatility of the Company&#8217;s common stock over the period of time equivalent to the expected term for each award. The dividend yield is computed as the annualized dividend rate at the grant date divided by the strike price of the stock option. For the six months ended June 30, 2022 and 2021, the Company did <ix:nonFraction unitRef="shares" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMyNw_1e03862c-1ea1-4e5a-9fd4-67cc3060d44d"><ix:nonFraction unitRef="shares" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMyNw_3fdbb92e-4c56-4fd1-b310-802c0443c1d8">no</ix:nonFraction></ix:nonFraction>t grant stock options. </span></div><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYyMA_8ec228fb-2b66-49d5-bf49-9694a2c8569e" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our stock option activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id55dd95aa3bc470e9e56ec5f8723d097_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNC0xLTEtMS0zMDc1Ng_62b25046-804c-473a-83d5-1343f9f89567">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id55dd95aa3bc470e9e56ec5f8723d097_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNC0zLTEtMS0zMDc1Ng_63de0c4f-26db-4329-8d94-8b52696d121e">54.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1602479b512c4de9830dc7270e25407f_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNC01LTEtMS0zMDc1Ng_510c4b76-773f-4d3f-83bf-24cd8135007d">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1602479b512c4de9830dc7270e25407f_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNC03LTEtMS0zMDc1Ng_26ce48ca-9ec5-4bff-9318-c78bc9e4c63d">48.19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58a4c9c4abd041de9a9bf0f6ab581c1b_D20220101-20220630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNS0xLTEtMS0zMDc1Ng_9c0f8bac-f830-4a10-9d8a-18b3c8a99703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i58a4c9c4abd041de9a9bf0f6ab581c1b_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNS0zLTEtMS0zMDc1Ng_c7668e2a-d189-46de-b225-b6cb9dcaa603">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7b570ba8f30648dfacf09a049d1a4224_D20210101-20210630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNS01LTEtMS0zMDc1Ng_3a6cc6f1-7974-44c1-a14d-e5e7b8fab8bc">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b570ba8f30648dfacf09a049d1a4224_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNS03LTEtMS0zMDc1Ng_7ba28dfb-7a2e-4955-b675-2d420b9de9d6">50.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0372fb43e9d841769683ae47a2e205e0_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNy0xLTEtMS0zMDc1Ng_6e1712b0-5b83-4813-a1a7-cf0623519780">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0372fb43e9d841769683ae47a2e205e0_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNy0zLTEtMS0zMDc1Ng_e5470bc5-2e2d-490e-aa45-a3d30717bde0">54.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf143fc967754c9285fe98b52326ac85_I20210630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNy01LTEtMS0zMDc1Ng_0d8ad110-07f3-4a0a-b443-4907eadfe0c6">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf143fc967754c9285fe98b52326ac85_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNy03LTEtMS0zMDc1Ng_49aa3dd3-0208-483d-bc6f-8bb4a5b147c2">47.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at end of the period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0372fb43e9d841769683ae47a2e205e0_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfOC0xLTEtMS0zMDc1Ng_be35c1b4-6681-4176-a4ba-d4e7062e6b45">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0372fb43e9d841769683ae47a2e205e0_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfOC0zLTEtMS0zMDc1Ng_4624b99c-deac-42a3-8378-d0387ddb08ec">52.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf143fc967754c9285fe98b52326ac85_I20210630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfOC01LTEtMS0zMDc1Ng_0d672cdf-659a-4867-966a-55b435c97e74">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf143fc967754c9285fe98b52326ac85_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfOC03LTEtMS0zMDc1Ng_06b686d3-5cb3-4f37-99b2-fa0ce56a7ccd">42.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the weighted-average remaining contractual life for outstanding stock options was <ix:nonNumeric contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4Njcw_c9d338d2-9d1f-488d-9138-2485007b02cb">4.8</ix:nonNumeric> years with an aggregate intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="id508aa7830c34993b9ba67211a0443ef_I20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTU4OA_b45438fa-0242-47cb-af1d-ddd4dafce34f">4.2</ix:nonFraction> million and the weighted-average remaining contractual life for exercisable stock options was <ix:nonNumeric contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTY3Nw_a39c8a07-856a-4509-9d32-3667cac0fdfd">4.7</ix:nonNumeric> years with an aggregate intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="id508aa7830c34993b9ba67211a0443ef_I20220630" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTcxNw_1a6e8501-82e1-4164-9342-ab488d803169">3.6</ix:nonFraction> million. The unrecognized compensation expense calculated under the fair value method for stock options expected to vest as of June&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="id508aa7830c34993b9ba67211a0443ef_I20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTg0Ng_844d05eb-cfb5-4cb8-973e-1fb78c49dc73">0.1</ix:nonFraction> million and is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTkxNg_550568e1-64fa-40d3-a0ca-9309db649c87">0.6</ix:nonNumeric> year. For the six months ended June 30, 2022, there was no exercise activity of stock options. For the six months ended June 30, 2021, the Company received $<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjAxNA_471b4bb0-414d-45ae-944f-0a7f8f1c5f32">0.7</ix:nonFraction> million in cash proceeds from the exercise of stock options. The total intrinsic value for stock options exercised during the six months ended June 30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i50220b2625794fccbe511347ebb66670_D20210101-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjE0Mg_f69940fb-f379-407d-9895-c1c6b0816452">2.3</ix:nonFraction> million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued restricted stock to employees and non-employee directors generally with vesting terms up to <ix:nonNumeric contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjI3OA_5c1e64b9-fb3c-4215-9454-871e15168c27">five years</ix:nonNumeric> after the date of grant. The fair value of the restricted stock is equal to the market price of the Company&#8217;s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period.</span></div><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYyMQ_92615779-8451-40d1-8409-07ca9a077bbe" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our restricted stock activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.617%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i829d85fe933a4eda921636a7a3a375d6_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNC0xLTEtMS0zMDc1Ng_9ad01a64-cd02-4343-a248-42e9f77d7ed5">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i829d85fe933a4eda921636a7a3a375d6_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNC0zLTEtMS0zMDc1Ng_6d4d7f5e-7c74-4f8c-81d0-f8b4f7533e47">183.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib21e0e3f9ad94913bf93467edc85ce06_I20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNC01LTEtMS0zMDc1Ng_ba0e41d8-3d25-4ab7-9378-3cee00c41330">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib21e0e3f9ad94913bf93467edc85ce06_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNC03LTEtMS0zMDc1Ng_f70a180a-40c3-4185-8786-e70ca3c24bc5">116.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNS0xLTEtMS0zMDc1Ng_d5ee2171-12cc-4b64-9f1b-23b7620b4476">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNS0zLTEtMS0zMDc1Ng_ee46c85c-452c-410d-b14a-0e679766ec64">176.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNS01LTEtMS0zMDc1Ng_8e4dfff0-db3a-4f03-a562-22b218f8f8b9">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNS03LTEtMS0zMDc1Ng_149e849d-9a8e-4f9c-878d-ba3a50b3ba93">267.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNi0xLTEtMS0zMDc1Ng_f13f9f0a-a86c-4e19-bf95-c6d6fdd2213f">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNi0zLTEtMS0zMDc1Ng_354595b3-d18f-4760-a317-476e6aeef805">155.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNi01LTEtMS0zMDc1Ng_e820d014-e64e-47c4-a110-97a8aaf4ba48">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNi03LTEtMS0zMDc1Ng_ec201394-06a8-43b5-a4ec-07109cf89707">113.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNy0xLTEtMS0zMDc1Ng_53724b80-60d7-4147-85d5-3c6a777ccbdf">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNy0zLTEtMS0zMDc1Ng_327ee4c6-d412-48e6-9f04-c3424c59b288">186.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNy01LTEtMS0zMDc1Ng_5608b8d0-ea46-4f49-b7e8-75002949d3ea">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNy03LTEtMS0zMDc1Ng_f5204b1e-0a83-4f58-a205-d5825c3fcb60">154.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia759f6e591be41e886afe18c17d6e776_I20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfOC0xLTEtMS0zMDc1Ng_40b1df22-1667-4eae-b8f7-d50f85ebf524">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia759f6e591be41e886afe18c17d6e776_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfOC0zLTEtMS0zMDc1Ng_04cd03a2-9dac-4652-a8be-89939df8fad7">187.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21b609542b4c460580805a1e4f761438_I20210630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfOC01LTEtMS0zMDc1Ng_72930f6c-b128-40bc-b977-356afa4d70d2">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21b609542b4c460580805a1e4f761438_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfOC03LTEtMS0zMDc1Ng_2ea5be90-93f8-4a04-af95-bf688751b966">182.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company withheld approximately <ix:nonFraction unitRef="shares" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjYzOA_cbca5ab7-1302-45ec-8165-52c2825a2c32">8,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjY0NQ_b26c20a0-53f7-4666-8e45-0e3ef22629e3">7,000</ix:nonFraction> shares of the Company&#8217;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of restricted stock for the six months ended June 30, 2022 and 2021, respectively. The total fair value of restricted stock awards vested during the six months ended June 30, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4NTcz_4e37ac6d-2c97-4746-9a78-99ebfb7ba0a6">3.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4NTgx_171b39db-ed99-4c95-a8a4-ee7ea6a2178c">6.7</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Performance-based Share Awards</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><ix:continuation id="iaae647a257e64ce4a7d7799dde4001ba"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued market and performance-based share awards to certain key executives who were granted deferred shares and may earn between <ix:nonFraction unitRef="number" contextRef="ib5f1116c90194300a342749eb3892747_D20220101-20220630" decimals="INF" name="med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMxOTQxMzk1MzkwODY_eb424b2e-ca09-4099-91d3-bf0af579799e">0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i791f345fa7fe442d9a480bb5934ca24a_D20220101-20220630" decimals="INF" name="med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMxOTQxMzk1MzkwOTA_bedbc448-ba63-4b1e-bdc7-2d91da9e6c4f">250</ix:nonFraction>% of the target number depending upon both the Company's total stockholder return and the Company's performance against predetermined performance goals over a <ix:nonNumeric contextRef="id10455ed7a30470c8ce16fd0347a1491_D20220101-20220630" name="med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMxOTQxMzk1MzkxMDY_6cc0a27e-23e9-469d-a3ae-ee786278d537">three-year</ix:nonNumeric> performance period after the date of grant. Market and performance-based share awards that are tied to the Company&#8217;s total stockholder return are valued using the Monte Carlo method and are recognized ratably as expense over the award&#8217;s performance period. The fair value of the performance-based share awards is equal to the market price of the Company&#8217;s common stock on the date of grant adjusted by expected level of achievement over the performance period. Expense for performance-based share awards is amortized ratably over the performance period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is recorded in selling, general, and administrative expense in the accompanying Condensed Consolidated Statements of Income. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYxNw_d6ff10e2-5eab-41d2-a580-61c3c22dfc8f" continuedAt="i53a076a98bec4a3d8cabe60530649951" escape="true">The total expenses during the three months ended June 30, 2022 and 2021 are as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i53a076a98bec4a3d8cabe60530649951"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id36d21034a864432b8162b094357f768_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfMy0xLTEtMS0zMjk2NA_8dffd47a-539f-4bdb-a288-4138be7d1001">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id36d21034a864432b8162b094357f768_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfMy0zLTEtMS0zMjk2NA_3040ce47-91f5-4302-bf4f-c6775a93cdfa">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ee521e8f7844c1f94e09336bcfd86db_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfMy01LTEtMS0zMjk2NA_bf4adf28-d129-4e1a-9ed8-bc2c1cf3f208">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ee521e8f7844c1f94e09336bcfd86db_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfMy03LTEtMS0zMjk2NA_5551beea-1f6c-4577-8f9d-1a3ad0441ad9">938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf790b22c1264d739149650b115efb43_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNC0xLTEtMS0zMjk2NA_5469257c-a1b8-470f-88db-97d30d8f0be4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf790b22c1264d739149650b115efb43_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNC0zLTEtMS0zMjk2NA_089fed77-5fff-404b-adc4-311f0431d059">433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea89962a06654099aa9ce6020660ce2c_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNC01LTEtMS0zMjk2NA_8a8b42a5-7891-4ea1-a0f2-e9e8cdce2187">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea89962a06654099aa9ce6020660ce2c_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNC03LTEtMS0zMjk2NA_0be2c502-2614-4c4e-bb8c-c37ed03a08e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b6e347e922e48cf858c12fd486caacd_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNS0xLTEtMS0zMjk2NA_1a5d5e94-eb3f-436f-afbe-8b2994d787ec">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b6e347e922e48cf858c12fd486caacd_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNS0zLTEtMS0zMjk2NA_b940f008-ed2d-42d8-ac9b-65953d88367a">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61d036694b67452fbbdb85aea52976a0_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNS01LTEtMS0zMjk2NA_895c603b-1b19-49be-beaa-c74d25e7931f">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61d036694b67452fbbdb85aea52976a0_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNS03LTEtMS0zMjk2NA_fea73e4e-3372-4e2c-811d-144187fe3b19">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i236cdbac8a54499bae6a9b834bcc1d9b_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNi0xLTEtMS0zMjk2NA_d429a3b0-8d55-4b9b-a871-e7b645e0769c">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236cdbac8a54499bae6a9b834bcc1d9b_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNi0zLTEtMS0zMjk2NA_b87592b2-9d81-462e-8405-21befe23abf3">474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib227523b7a72441886b57ff4d5975e64_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNi01LTEtMS0zMjk2NA_94cf25c4-2801-44de-bd77-1febec0cb596">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib227523b7a72441886b57ff4d5975e64_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNi03LTEtMS0zMjk2NA_7bf635b3-4aaa-4e48-9635-3cc702378f85">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id089f7cb3778424d85b3c0a0ba3abe64_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNy0xLTEtMS0zMjk2NA_0ef48cd2-167f-4107-81c7-8b07c4d838c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id089f7cb3778424d85b3c0a0ba3abe64_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNy0zLTEtMS0zMjk2NA_faf5023f-b3cb-465f-9f06-df3f913764c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1dc76c8e56a84d50b6f056f5427ad729_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNy01LTEtMS0zMjk2NA_13150951-e48f-4745-a43a-a7b0c842d274">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc76c8e56a84d50b6f056f5427ad729_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNy03LTEtMS0zMjk2NA_ab441d23-136b-4701-b46c-86be84d2baf1">711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfOC0xLTEtMS0zMjk2NA_3c7806d3-bc02-4ba9-8117-57af2340bf69">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfOC0zLTEtMS0zMjk2NA_9f780352-c4d8-4361-be92-c349cfd1cdf5">2,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfOC01LTEtMS0zMjk2NA_8f71da22-5c64-4e22-89d1-0f1d5a6ac3e9">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfOC03LTEtMS0zMjk2NA_686011e1-ac2d-487e-a237-d9f08ae15fb2">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total expenses during the six months ended June 30, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icec11bcf6e124a15853dea3f1b683cbc_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfMy0xLTEtMS0zMDc1Ng_eeb70314-0da0-401a-89be-23a4a6e55057">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icec11bcf6e124a15853dea3f1b683cbc_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfMy0zLTEtMS0zMDc1Ng_1cb534c6-da48-4ed3-8f45-2388314d10e3">2,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie16284d30a4743a2bbed4a4f253b25b4_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfMy01LTEtMS0zMDc1Ng_e7a29ed5-f5bd-4168-a479-20b07f564a8a">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie16284d30a4743a2bbed4a4f253b25b4_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfMy03LTEtMS0zMDc1Ng_ad44e966-6519-464b-81d9-89dbf3be607a">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i054b770bfe6145718c8c3e0c92dd66d4_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNC0xLTEtMS0zMDc1Ng_50dd928d-7a74-4222-bbac-fc0d4f17c566">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054b770bfe6145718c8c3e0c92dd66d4_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNC0zLTEtMS0zMDc1Ng_18508b3e-9861-4b37-89ae-c6d8d777e745">512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ec22b44a1b94e7db889140b0beb2981_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNC01LTEtMS0zMDc1Ng_0264627b-c61a-4dac-a312-06561c7eaa75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ec22b44a1b94e7db889140b0beb2981_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNC03LTEtMS0zMDc1Ng_07648504-c51a-4cb1-8179-622e9a80edda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4060674f7e11431e987e42f39d8bd999_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNS0xLTEtMS0zMDc1Ng_e3791722-5174-401c-bdb7-c349c018b75b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4060674f7e11431e987e42f39d8bd999_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNS0zLTEtMS0zMDc1Ng_b70e1b2a-ab03-4f1a-a98f-aeb6829ce266">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73edf9ea6315403eb92729cc50508941_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNS01LTEtMS0zMDc1Ng_a513de35-0880-4821-b818-e7993b982144">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73edf9ea6315403eb92729cc50508941_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNS03LTEtMS0zMDc1Ng_20ebb9be-91eb-4ced-aba7-bbc5425f4d24">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i064f238b1a2c484cae33fd7a5814ff0f_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNi0xLTEtMS0zMDc1Ng_e4207d7c-87bb-49d2-adb7-6a8eb5729fc6">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064f238b1a2c484cae33fd7a5814ff0f_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNi0zLTEtMS0zMDc1Ng_624f7ab9-1002-4fa2-ac28-cc672222eb9d">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i452fd630b64a4bebb247b038e9162298_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNi01LTEtMS0zMDc1Ng_0ab95343-f661-469d-bfa7-a9d0bf22b3ac">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452fd630b64a4bebb247b038e9162298_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNi03LTEtMS0zMDc1Ng_59a8b64e-0697-4390-9e5f-42fbb4784837">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icc759c3471364896ad8b5e7747af27bd_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNy0xLTEtMS0zMDc1Ng_21d02b22-f524-460d-b5ad-76f687491cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc759c3471364896ad8b5e7747af27bd_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNy0zLTEtMS0zMDc1Ng_d71a8580-22d9-4031-a42f-90c230e8d1d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a55b7020a694cb9930ecf0c3056192a_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNy01LTEtMS0zMDc1Ng_fa298423-5653-4fd9-98dc-a5c49d20998a">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a55b7020a694cb9930ecf0c3056192a_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNy03LTEtMS0zMDc1Ng_9d6c5a40-002e-4b72-8095-cb770ba6e7af">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfOC0xLTEtMS0zMDc1Ng_268a30b8-6907-4558-8c70-866c5aa58b67">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfOC0zLTEtMS0zMDc1Ng_ec9cf32b-ad4a-405b-9da0-e699415d7260">5,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfOC01LTEtMS0zMDc1Ng_c14a42d8-d4f4-4b8a-95dd-1e867bcecc6f">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfOC03LTEtMS0zMDc1Ng_8bc924e2-1b2d-49dd-8eb3-e8fa01b90e2c">4,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total income tax benefit recognized in the accompanying Condensed Consolidated Statements of Income for restricted stock awards was $<ix:nonFraction unitRef="usd" contextRef="if49b585270844361a9f23ee1a6dd8b32_D20220401-20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4Nzc3_2f130e01-85e5-4916-9d9b-ca11bbf86ec6">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i28c9596a0f004e71bab401ece8aceb03_D20210401-20210630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4Nzgy_eed4914c-51d3-439e-a150-7428dbd8130b">0.9</ix:nonFraction> million for the three months ended June 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4NTEx_bab9f347-3c8e-4b9d-a5ce-400f4d3c7990">0.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4NTQw_d04e7e1a-570a-49b9-b504-db2a8a3ba75e">2.1</ix:nonFraction>&#160;million for the six months ended June 30, 2022 and 2021, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was $<ix:nonFraction unitRef="usd" contextRef="ia759f6e591be41e886afe18c17d6e776_I20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDI2OA_90aa06c5-acd6-4ff4-a171-8294151a317d">8.9</ix:nonFraction> million of total unrecognized compensation cost related to restricted stock awards as of June&#160;30, 2022, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDQyNQ_951d0456-767f-429a-99c0-484f4b00087d">2.0</ix:nonNumeric> years. There was $<ix:nonFraction unitRef="usd" contextRef="i24907f08c3c549f2a30017b51b01cb28_I20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDQzOQ_d6a2014f-1baf-4bdd-a867-85f98829e369">9.4</ix:nonFraction> million of unrecognized compensation costs related to the <ix:nonFraction unitRef="shares" contextRef="id10455ed7a30470c8ce16fd0347a1491_D20220101-20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDQ5Mg_426482a0-fabc-4a28-9229-24c7a21c5f3d">65,477</ix:nonFraction> performance-based shares discussed above as of June&#160;30, 2022, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="id10455ed7a30470c8ce16fd0347a1491_D20220101-20220630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYxNQ_d97e4a53-3b9f-44cb-8081-3f92bad2e195">2.1</ix:nonNumeric> years.</span></div></ix:continuation><div id="i4563bf4792014469bdc8cd3ee0a97965_46"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTM0OA_19e021d8-fb18-44df-9a58-24a485af2acf" continuedAt="i6bc5b67c59004c5cb5cf02babb6b9961" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i6bc5b67c59004c5cb5cf02babb6b9961" continuedAt="if5e5f70253174e5aab234543ee95500d"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for office and warehouse space and certain equipment. In certain of the Company&#8217;s lease agreements, the rental payments are adjusted periodically based on defined terms within the lease. The Company did not have any finance leases as of June&#160;30, 2022 and 2021, respectively, or for the six-month periods then ended, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><ix:continuation id="if5e5f70253174e5aab234543ee95500d"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases relating to office and warehouse space have lease terms of <ix:nonNumeric contextRef="i8acefb9e79bd4ae1a22dc956c10939ee_I20220630" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNDQ1_e4674ae8-2d08-465f-9d3e-0948bd211f16">18</ix:nonNumeric> months to <ix:nonNumeric contextRef="i39f1cb1cd2be465aa4baf8f6ad80e124_I20220630" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNDUx_0d7e0261-59f8-417e-a0a9-fdae40b316aa">126</ix:nonNumeric> months. Our leases relating to equipment have lease terms of <ix:nonNumeric contextRef="i666df92b88214be186d1a29032aab0cb_I20220630" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNTA4_e711d512-fced-488d-8d44-f7f6a3aedb3a">24</ix:nonNumeric> months to <ix:nonNumeric contextRef="i0b46dfbb84c942a2876f386c170b5410_I20220630" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNTE0_6cb5f0d9-6a20-46c5-8adc-1ae8fc4b382e">203</ix:nonNumeric> months, with certain of them having automatic renewal clauses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s warehouse agreements also contain non-lease components, in the form of payments towards variable logistics services and labor charges, which the Company is obligated to pay based on the services consumed by it. Such amounts are not included in the measurement of the lease liability but are recognized as expenses when they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNTQ5NzU1ODE1MzQz_4d2664d7-2fba-4542-9f2f-b1996299c251">1.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNTQ5NzU1ODE1MzUx_ba201d0e-3cdc-42d3-b221-b1c935877ef8">1.4</ix:nonFraction>&#160;million for the three months ended June 30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfOTU3_0385cac5-8cae-49fb-b4fd-ce93b65583cf">3.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfOTY0_a7d0a49e-42e3-48e5-83cf-5949296b2dcd">2.4</ix:nonFraction> million for the six months ended June 30, 2022 and 2021, respectively.</span></div><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTM0OQ_62c7d0e3-7abd-4011-b58c-005ed56937a4" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company&#8217;s operating leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:63.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurements of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flow used in operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOmQ1YjAyMDM2ZmMxNTRkYTViZTMxNGEyZDg2OWQ0ZDBhL3RhYmxlcmFuZ2U6ZDViMDIwMzZmYzE1NGRhNWJlMzE0YTJkODY5ZDRkMGFfNC0xLTEtMS0zMDc1Ng_d97aa68f-66d6-420b-a0d9-c6d8dea80937">3,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOmQ1YjAyMDM2ZmMxNTRkYTViZTMxNGEyZDg2OWQ0ZDBhL3RhYmxlcmFuZ2U6ZDViMDIwMzZmYzE1NGRhNWJlMzE0YTJkODY5ZDRkMGFfNC0zLTEtMS0zMDc1Ng_95ef8a53-acd8-45f3-b611-8d638056229d">2,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOmQ1YjAyMDM2ZmMxNTRkYTViZTMxNGEyZDg2OWQ0ZDBhL3RhYmxlcmFuZ2U6ZDViMDIwMzZmYzE1NGRhNWJlMzE0YTJkODY5ZDRkMGFfNy0xLTEtMS0zMDc1Ng_2101f209-b5ae-4530-a38e-8906bf89527c">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOmQ1YjAyMDM2ZmMxNTRkYTViZTMxNGEyZDg2OWQ0ZDBhL3RhYmxlcmFuZ2U6ZDViMDIwMzZmYzE1NGRhNWJlMzE0YTJkODY5ZDRkMGFfNy0zLTEtMS0zMDc1Ng_fcdd699f-e2a9-4065-8aab-5a80851e7bba">9,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the weighted average remaining lease term was <ix:nonNumeric contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTE4NQ_0144c544-d66d-4b5d-b0eb-eed77e82c788">5.3</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTIzMg_aba506ee-b149-4add-a475-0ec8479d84b6">2.1</ix:nonFraction>%.</span></div><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTM1MA_7f60e5c0-7a20-45ba-b69f-f001d4a852fb" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company&#8217;s operating lease liabilities as of June&#160;30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:81.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2022 (excluding the six months ended June&#160;30, 2022)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfMC0xLTEtMS0zMDc1Ng_d312c929-e7ee-45af-a2a1-f6edb93717c9">3,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfMS0xLTEtMS0zMDc1Ng_d597c561-ee41-431f-a24e-ffa0d28599de">6,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfMi0xLTEtMS0zMDc1Ng_28f720e8-268e-4e32-9a80-4dc470eb9b0c">5,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfMy0xLTEtMS0zMDc1Ng_f29573ff-8638-414f-8504-4b75b2f722e8">5,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfNC0xLTEtMS0zMDc1Ng_b72b5ac3-ee29-4f9d-b6d8-5b18bfffd7b3">4,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="med:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfNS0xLTEtMS0zMDc1Ng_cca46bec-43cb-4032-957b-1f8fb8db25e4">5,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfNi0xLTEtMS0zMDc1Ng_bba0edae-f1b7-41aa-a63a-b04009bf2913">30,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfNy0xLTEtMS0zMDc1Ng_b2847e67-624b-49ee-9742-c9c65d5eb715">1,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfOC0xLTEtMS0zMDc1Ng_f2abd7bf-ebe4-439f-9df1-0a421df29802">29,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i4563bf4792014469bdc8cd3ee0a97965_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RleHRyZWdpb246NWVkYzgyZDEwMjkxNDZmY2FjMGJmNDEzOTlkOGM0Y2JfMTgx_bf51a096-20da-4c57-898e-d6bb1a6f9ce6" continuedAt="i8bb6d7a5d4f34f67aa15f821823c8e27" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME</ix:nonNumeric></span></div><ix:continuation id="i8bb6d7a5d4f34f67aa15f821823c8e27"><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RleHRyZWdpb246NWVkYzgyZDEwMjkxNDZmY2FjMGJmNDEzOTlkOGM0Y2JfMTgw_8f27009c-a35e-4417-ad48-aa1aa4be01bf" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:64.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfMi0xLTEtMS0zMDc1Ng_0aad3952-caf6-4472-ab6e-b6ccace3073d">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfMi0zLTEtMS0zMDc1Ng_bca4229e-5258-4220-937d-20d1fba24059">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized gains on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfMy0xLTEtMS0zMDc1Ng_195c6740-5d86-448f-9d39-83fe6afcac17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfMy0zLTEtMS0zMDc1Ng_7c1f41aa-36ef-400f-83c2-ef3940936e53">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfNC0xLTEtMS0zMDc1Ng_0bc3fc5c-ecdb-43ba-a6a8-dd623a3219a6">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfNC0zLTEtMS0zMDc1Ng_09067cec-4e29-4408-9974-43e4f345adb8">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfMTYwMg_b2a33e10-a0de-4e94-8405-284e07ebdd9b" continuedAt="i8cb7f81994cb468089e50d25b99430fd" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i8cb7f81994cb468089e50d25b99430fd" continuedAt="i4fbe0a8c4b8f4c868d5a2dedba2e477a"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain financial assets and liabilities are accounted for at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy prioritizes the inputs used to measure fair value:</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8211; Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#8217;s best estimate of fair value from the perspective of a market participant.</span></div><ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfMTYwMQ_4010b613-aa7b-46f5-a01e-93ff6d30f663" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee065151388c4c8cbe6affcd09c55b2b_I20220630" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMy0xLTEtMS0zMDc1Ng_7ad986ec-b5ba-4c8e-b01a-a6b82f5f3bfa">60,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee065151388c4c8cbe6affcd09c55b2b_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMy03LTEtMS0zMDc1Ng_5c7f3a9b-0ec9-4a83-a22a-79760da42fb7">60,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee065151388c4c8cbe6affcd09c55b2b_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMy05LTEtMS0zMDc1Ng_fc727f82-feea-48ec-ac34-70830d791488">60,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332a69d5d4c54c2094cc9048eb80a99c_I20220630" decimals="-3" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfNi0xLTEtMS0zMDc1Ng_f8df749e-dc61-494e-80ac-93172d9c3677">792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332a69d5d4c54c2094cc9048eb80a99c_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfNi03LTEtMS0zMDc1Ng_3b175fa9-6a7e-4667-989d-919569b96bea">792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332a69d5d4c54c2094cc9048eb80a99c_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfNi05LTEtMS0zMDc1Ng_adec2541-e386-41fb-9f85-733d5f58b6cd">792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtMS0xLTEtMzA3NTY_47d8087a-a73a-4d6a-949d-8d6f3344a3c2">61,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtMy0xLTEtMzA3NTY_b953017c-781d-45c9-9e17-37a7076946d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:InterestReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtNS0xLTEtMzA3NTY_7b28bf33-1ae6-4847-8768-9e053df2f3c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtNy0xLTEtMzA3NTY_d309f224-d701-4c0a-ac30-8e3625220500">61,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtOS0xLTEtMzA3NTY_8c57074d-d736-453c-a72c-a375eec37e20">61,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtMTEtMS0xLTMwNzU2_dcabcf5d-34da-42fc-b3b8-0f8a272f29d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57509a5816a14b6e9f710cd2a1430d7b_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMy0xLTEtMS0zMDc1Ng_6259eb57-cd35-4606-8213-488f25e02985">94,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57509a5816a14b6e9f710cd2a1430d7b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMy03LTEtMS0zMDc1Ng_715821c4-aa0c-409a-a9b6-95b46e83366a">94,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57509a5816a14b6e9f710cd2a1430d7b_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMy05LTEtMS0zMDc1Ng_2b71f896-4f88-4239-b039-0e45bbf65e74">94,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89eed6193bce41109d7fcaa6ca2460a3_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNi0xLTEtMS0zMDc1Ng_15ad3c13-72c8-46d0-899d-52b76eebdec1">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89eed6193bce41109d7fcaa6ca2460a3_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNi03LTEtMS0zMDc1Ng_e0d138b6-cf77-48fd-afb7-038977407bf0">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89eed6193bce41109d7fcaa6ca2460a3_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNi05LTEtMS0zMDc1Ng_1185b975-24fd-42c2-be7d-525348448050">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Government &amp; agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cac6b725df74e8ea420f955e6941daa_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNy0xLTEtMS0zMDc1Ng_1ed9a0b7-3007-492a-b5ae-915384827bc0">1,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea4ee9f85da4ed49ceb9bda111639c6_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNy0zLTEtMS0zMDc1Ng_47fb8029-cefd-47c7-ada9-6e8b413dfa74">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cac6b725df74e8ea420f955e6941daa_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNy03LTEtMS0zMDc1Ng_d78cb5ff-cfa4-4925-ada6-c892f2fcee8d">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cac6b725df74e8ea420f955e6941daa_I20211231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNy0xMS0xLTEtMzA3NTY_080dfd9f-fde1-4001-bf96-3c8e97bb9472">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC0xLTEtMS0zMDc1Ng_de45c68e-2eb4-4b88-80e5-45f6d21f04b9">10,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d5f95ffbfb34e22af63161d1bed6f55_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC0zLTEtMS0zMDc1Ng_6bceb952-56d4-4a8a-92a2-c4faaf4d1a2c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC03LTEtMS0zMDc1Ng_d59a750b-6626-48fd-a177-f001643bbfce">10,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC05LTEtMS0zMDc1Ng_8749740f-c2d3-4e51-a2fb-59086e50844e">9,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC0xMS0xLTEtMzA3NTY_1fcd8d37-34f1-490f-8e15-2e68f5c420fe">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Municipal bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8938f1db545249db980bb8fc24aee80f_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtMS0xLTEtMzA3NTY_debba084-34b8-426c-8786-6824d56b0440">3,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad7c8db12bd42e2809f2f8c2ced2539_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtMy0xLTEtMzA3NTY_eafcf975-c24f-4af5-ba71-bbb701b3e231">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8938f1db545249db980bb8fc24aee80f_I20211231" decimals="-3" name="us-gaap:InterestReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtNS0xLTEtMzA3NTY_7328229f-351f-4a2b-bc21-ca07188eb8c2">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8938f1db545249db980bb8fc24aee80f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtNy0xLTEtMzA3NTY_8f019995-be47-456a-b7d4-ab1b9212fe7a">3,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8938f1db545249db980bb8fc24aee80f_I20211231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtMTEtMS0xLTMwNzU2_2db53a2d-be86-43a3-a947-1de2b524f438">3,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtMS0xLTEtMzA3NTY_026e7bff-36c0-4076-9c3e-1e4e40bff7ca">109,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9333a141fdf6464bb3ce95b9dd9b08ea_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtMy0xLTEtMzA3NTY_16fbcbf2-01db-4a14-b86a-44313d9c533b">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:InterestReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtNS0xLTEtMzA3NTY_5518ad5a-73c1-4d08-9ce0-1a6bac96d9eb">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtNy0xLTEtMzA3NTY_ae034f72-0d31-4e7c-86ff-e5e569d7e4dc">109,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtOS0xLTEtMzA3NTY_86637d3f-e14e-48ea-92d4-317940b87199">104,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtMTEtMS0xLTMwNzU2_a9e65053-6c4d-4fe2-95a2-587c1c2be0eb">5,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"><ix:continuation id="i4fbe0a8c4b8f4c868d5a2dedba2e477a">The Company had a realized loss of $<ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfNjU5NzA2OTc2ODcwMg_18f77efe-3d24-42b5-be2e-0b550b84d2d1"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfNjU5NzA2OTc2ODcwMg_93581e60-3043-4988-8ff5-9cd6276d7e20">0.2</ix:nonFraction></ix:nonFraction>&#160;million for the three and six months ended June&#160;30, 2022 and <ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="INF" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfMTI2NDQzODM3MjI0OTM_4b51966f-5f84-4cc6-a1d3-251ab7245e53"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="INF" name="us-gaap:DebtAndEquitySecuritiesRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfMTI2NDQzODM3MjI0OTM_ab71fd19-815c-4076-8ab5-6d87f1511e58">no</ix:nonFraction></ix:nonFraction> realized gain or losses for the three and six months ended June&#160;30, 2021.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMzEwNg_25d149c5-fd4a-4859-84e8-42995f591429" continuedAt="i382b358bf2ee446abd13543189c0135f" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="i382b358bf2ee446abd13543189c0135f"><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#8220;Guarantors&#8221;) entered into a credit agreement (the &#8220;Credit Agreement&#8221;) among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on Secured Overnight Financing Rate (SOFR), from London Inter-Bank Offered Rate (LIBOR) (the &#8220;Amended Credit Agreement&#8221;).  The Amended Credit Agreement provides for a $<ix:nonFraction unitRef="usd" contextRef="i49b6f09335094cb2b7b85ec6ae9e598c_I20220531" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfNDM5ODA0NjUyMjQ0MA_030d383e-b454-471c-8c4d-c21f20cef587">225.0</ix:nonFraction> million senior secured revolving credit facility with a $<ix:nonFraction unitRef="usd" contextRef="ib6945a9410a34cf18dd01065cbc232f2_I20220531" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfNDM5ODA0NjUyMjQ2Nw_b6d38290-e443-43f2-9c6a-e77eac3495ca">20.0</ix:nonFraction> million letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to $<ix:nonFraction unitRef="usd" contextRef="ib6945a9410a34cf18dd01065cbc232f2_I20220531" decimals="-5" name="med:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfNDM5ODA0NjUyMjUwMw_3dc95660-3bad-46ae-a821-8f0e4e78f9d4">100.0</ix:nonFraction> million. The Amended Credit Agreement matures on April&#160;13, 2026.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the Amended Credit Agreement are guaranteed by the Guarantors. The obligations of the Company and the Guarantors are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the Company will pay to the administrative agent for the account of each revolving lender a commitment fee on a quarterly basis based on amounts committed but unused under the revolving facility from <ix:nonFraction unitRef="number" contextRef="ia2123a6dc9f841d696b311320dc700c8_D20210413-20210413" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMTE1MQ_fee92fd7-dcf0-4b50-aa76-255096bc6643">0.20</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i247bb176b7b847c4ab8a1f139e0b0856_D20210413-20210413" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMTE1Nw_9206df83-7fd0-49ed-ad46-54f62473e5fd">0.40</ix:nonFraction>% per annum depending on the Company&#8217;s Total Net Leverage Ratio (as defined in the Amended Credit Agreement). The Company is also obligated to pay the administrative agent customary fees for credit facilities of this size and type.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving borrowings under the Amended Credit Agreement bear interest at a rate per annum equal to (i) the Term SOFR Rate for the interest period plus the Applicable Rate (as defined in the Amended Credit Agreement) based on the Company&#8217;s Total Net Leverage Ratio or (ii) the Alternate Base Rate (as defined in the Amended Credit Agreement) as in effect from time to time plus the Applicable Rate based on the Company&#8217;s Total Net Leverage Ratio. As of June&#160;30, 2022, the Applicable Rate for Term SOFR Loans is <ix:nonFraction unitRef="number" contextRef="ie6f63e1a4da2439cb942d7e717740fd6_D20210413-20210413" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMTk3OQ_9d0d1e5d-8a9e-435c-a69d-49100f2d25b5">1.25</ix:nonFraction>% per annum and the Applicable Rate for ABR Loans is <ix:nonFraction unitRef="number" contextRef="i8b76567e652341a8bc33402177cf2fb8_D20210413-20210413" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMjAzMw_0cd2a06b-0038-4fbe-a995-bc54e64d0a79">0.25</ix:nonFraction>% per annum. SOFR based loans also include a Credit Spread Adjustment based on the duration of the borrowing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants that, among other things, limit or restrict the ability of the Company and its subsidiaries, subject to negotiated exceptions, to incur additional indebtedness and additional liens on their assets, engage in mergers or acquisitions or dispose of assets, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments and change the nature of their businesses. The Amended Credit Agreement also contains customary events of default, subject to thresholds and grace periods, including, among others, payment default, covenant default, cross default to other material indebtedness and judgment default. In addition, the Amended Credit Agreement requires the Company to maintain a Total Net Leverage Ratio of no more than <ix:nonFraction unitRef="number" contextRef="i88c992e95e9b4995a92a40903056360e_I20210413" decimals="2" name="med:MaximumTotalNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMjk3OQ_b43ca30a-9b6c-4fb1-8851-904b1fe3d5e6">2.75</ix:nonFraction> to 1.00 and an Interest Coverage Ratio of at least <ix:nonFraction unitRef="number" contextRef="i88c992e95e9b4995a92a40903056360e_I20210413" decimals="2" name="med:MinimumInterestCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMzAzMQ_6feac291-44c8-44c7-8cc1-bdf6a6356f7d">3.50</ix:nonFraction> to 1.00.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $<ix:nonFraction unitRef="usd" contextRef="ib4e372b4b4424facb12f398698cc062e_I20220630" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMzA1Nw_2547173c-b858-4871-9d64-4df39dac87ed">27.0</ix:nonFraction> million of borrowings outstanding under the Amended Credit Agreement as of June&#160;30, 2022.</span></div></ix:continuation><div><span><br/></span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_294"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">9. <ix:nonNumeric contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" name="us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOTQvZnJhZzo1Y2I4NzhlOGViNzc0NjE3YTkyZDE2NDZmMGI1MmNlMi90ZXh0cmVnaW9uOjVjYjg3OGU4ZWI3NzQ2MTdhOTJkMTY0NmYwYjUyY2UyXzQ5NDc4MDIzMjgyNjA_b6599a37-8dc2-479b-9520-79e8cac52fb7" continuedAt="i19e6edf471354c1bb9bec9a60cecfc06" escape="true">ACCELERATED SHARE REPURCHASE (&#8220;ASR&#8221;) PROGRAM</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i19e6edf471354c1bb9bec9a60cecfc06">In the second quarter of fiscal 2022, the Company entered into an ASR agreement with JPMorgan Chase, National Association ("JPMorgan Chase") to purchase shares of its common stock from JPMorgan Chase for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOTQvZnJhZzo1Y2I4NzhlOGViNzc0NjE3YTkyZDE2NDZmMGI1MmNlMi90ZXh0cmVnaW9uOjVjYjg3OGU4ZWI3NzQ2MTdhOTJkMTY0NmYwYjUyY2UyXzQ5NDc4MDIzMzIwMTQ_9ac953f7-b097-4609-9651-cf952e46b952">100.0</ix:nonFraction>&#160;million. Pursuant to the ASR program, the Company received an initial delivery of approximately <ix:nonFraction unitRef="shares" contextRef="i0923735811e44b48bfa510c4594688c6_D20220531-20220531" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOTQvZnJhZzo1Y2I4NzhlOGViNzc0NjE3YTkyZDE2NDZmMGI1MmNlMi90ZXh0cmVnaW9uOjVjYjg3OGU4ZWI3NzQ2MTdhOTJkMTY0NmYwYjUyY2UyXzQ5NDc4MDIzMzIwMDA_b9ab6f88-d017-42d3-877c-25f3067e027c">480</ix:nonFraction>&#160;thousand shares of common stock based on the closing price of the common stock on May 31, 2022. As a result, approximately $<ix:nonFraction unitRef="usd" contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOTQvZnJhZzo1Y2I4NzhlOGViNzc0NjE3YTkyZDE2NDZmMGI1MmNlMi90ZXh0cmVnaW9uOjVjYjg3OGU4ZWI3NzQ2MTdhOTJkMTY0NmYwYjUyY2UyXzQ5NDc4MDIzMzIwMzA_c203c2ec-1a9c-4593-ba67-5c4cebbbf179">20.0</ix:nonFraction>&#160;million remains at JPMorgan Chase for additional repurchases until the completion of the ASR program.  The final number of shares that will be delivered to the Company under the ASR agreement will be based on the average of the daily volume-weighted average trading prices of the Company&#8217;s common stock during the term of the ASR program, less a discount. The Company expects to receive the remaining shares no later than October 3, 2022. The effect of the potential share settlement is excluded in the diluted EPS calculation as the effect is anti-dilutive.</ix:continuation></span></div><div><span><br/></span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note Regarding Forward-Looking Statements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information in this report contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend," &#8220;anticipate,&#8221; &#8220;expect&#8221; or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. These statements are based on the current expectations of our management and are subject to certain events, risks, uncertainties and other factors. These risks and uncertainties include, but are not limited to, those described in our 2021 Form 10-K and those described from time to time in our future reports filed with the SEC. Although Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this report. All of the forward-looking statements contained herein speak only as of the date of this report.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and related notes appearing elsewhere herein.</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medifast is the global company behind one of the fastest-growing health and wellness communities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which offers Lifelong Transformation, One Healthy Habit at a Time</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Reflecting the success of our holistic approach to health and wellness, we have consistently grown revenue over the past five years. Of equal importance, we expect our differentiated model to continue to deliver growth in the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA brand offers a highly competitive and effective lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The program is built around four key components:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Independent OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Coaches: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provide individualized support and guidance to customers on the path to optimal health and wellbeing.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Community</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Community of like-hearted people providing each other with real-time connection and support.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">The Habits of Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Transformational System:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A proprietary system which offers easy steps to a sustainably healthy lifestyle. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Products &amp; Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinically proven plans and scientifically developed products, called &#8220;Fuelings,&#8221; backed by dietitians, scientists and physicians.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We help customers achieve their health goals through a network of approximately 68,000 independent </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches, about 90% of whom were customers first, and have impacted more than 2 million lives to date. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches introduce customers to a set of healthy habits, in most cases starting with the habit of healthy eating, and offer exclusive Fuelings, which are nutrient-dense, portion-controlled, nutritionally interchangeable and simple to use. They are formulated with high-quality ingredients and are fortified with probiotic cultures, vitamins and minerals, as well as other nutrients essential for good health. Our products support the process of integrating healthy habits into our customer&#8217;s day-to-day lives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA coaching model is customer-centric and boasts an energized health and wellness community. It promotes holistic health and wellness and positions healthy weight as a catalyst to greater lifestyle changes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches provide personalized support to customers and motivate them by sharing their passion for healthy living and lifestyle transformation. We believe this personal coaching is an essential factor in customer success based on findings from a clinical study published in Obesity Science and Practice in 2018, which validated the effectiveness of combining the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA meal plan with education and support consistent with that was provided by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The entrepreneurial spirit of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches is another key to our success, as they create a continuous cycle of growth, activating new customers, many of whom go on to become </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches. We offer economic incentives designed to support each </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach&#8217;s long-term success, which we believe plays an important role in their financial wellness, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">providing the opportunity to improve their finances while changing the health trajectory of families, communities and generations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches are independent contractors, not employees, who support customers and market our products and services primarily through word of mouth, email and social media channels such as Facebook, Instagram, Twitter and video conferencing platforms. As entrepreneurs, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches market our products to friends, family and other acquaintances.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA products are shipped directly to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA customers who are working with an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches do not handle or deliver merchandise to customers. This arrangement frees our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches from having to manage inventory and allows them to maintain an arms-length transactional relationship while focusing their attention on support and encouragement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are one of the fastest growing health and wellness companies in the United States ("U.S."), with a large and growing market opportunity. We believe our coach-based model is scalable and drives both customer success and growth. We expect our continued investment in fostering a robust community around our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA brand and our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaching model will continue to drive a sustainable, repeatable business rhythm focused on our mission of offering the world Lifelong Transformation, One Healthy Habit at a Time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are conducted through our wholly owned subsidiaries, Jason Pharmaceuticals, Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA (Hong Kong) Limited, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA (Singapore) PTE. LTD and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Health Consultation (Shanghai) Co., Ltd. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we previously disclosed, global expansion is an important component of our long-term growth strategy. In July 2019, we commenced our international operations, entering into the Asia Pacific markets of Hong Kong and Singapore. Our decision to enter these markets was based on industry market research that reflects a dynamic shift in how health care is being prioritized and consumed in those countries. We outsource a distribution center in Hong Kong to provide adequate product distribution capacity for the foreseeable future in these markets.</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Update </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A novel strain of coronavirus (&#8220;COVID-19&#8221;) surfaced in late 2019 and has spread around the world, including to the U.S. In March 2020, the World Health Organization declared COVID-19 a worldwide pandemic.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the pandemic, many governments implemented policies intended to stop or slow the further spread of the disease, such as social distancing guidelines, shelter-in-place orders and other measures. Nutritional supplements and health foods have been designated critical/essential infrastructure in the U.S. As a manufacturer and distributor of these products our manufacturing and distribution facilities remain fully operational to date and we have not experienced any meaningful disruption to our worldwide supply chain. The Company&#8217;s priorities during the COVID-19 pandemic continue to be protecting the health and safety of our employees and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches, and their families, and we have undertaken numerous steps and instituted additional precautions to protect their safety and well-being, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhanced safety protocols, limiting visitation to our plant and distribution center and rolling out additional sick leave (crisis pay) for our onsite essential employees;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">through the majority of 2021, our non-essential employees continued to work from home. Effective October 2021, the Company implemented a hybrid work approach which enables our non-essential employees the flexibility to work partially from home and partially from the office;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">established additional health and safety precautions in our headquarters and manufacturing and distribution centers, including use of personal protective equipment and frequent hand sanitization;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">created process controls in relation to social distancing, visitors, travel and quarantine; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">organized 16 vaccination clinics in partnership with the health department across all our operations.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA makes no guarantee of financial success. Success with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA results from successful sales efforts, which require hard work, diligence, skill, persistence, competence, and leadership. Please see the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA Income Disclosure Statement (http://bit.ly/ids</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA) for statistics on actual earnings of Coaches.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although vaccines are available in various countries where we operate, it is possible the COVID-19 pandemic could further impact our operations and the operations of our suppliers and vendors, particularly in light of the potential of variant strains of the virus to cause a resumption of high levels of infection and hospitalization. Should that occur, the extent to which the pandemic ultimately impacts the Company&#8217;s business, financial condition, results of operations, cash flows, and liquidity may differ from management&#8217;s current expectations. Factors that could cause actual results to differ from management&#8217;s expectations include inherent uncertainties regarding the duration and further spread of the outbreak, its severity, government actions taken to contain the virus or treat its impact, changes in consumer behavior resulting from the pandemic and how quickly and to what extent normal economic and operating conditions can resume. The senior management team meets regularly to review and assess the status of the Company&#8217;s operations and the health and safety of its various constituencies, and will continue to proactively respond to the situation and communicate with our supply chain partners to identify and mitigate risk and to manage inventory levels. The Company may take further actions that alter its business operations as may be required by governmental authorities, or that are determined to be in the best interests of employees, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches and customers.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These uncertainties make it challenging for our management to estimate our future business performance. However, we intend to continue to actively monitor the impact of COVID-19 and related developments on our business and will update our practices accordingly, as we have done throughout the pandemic.</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unaudited condensed consolidated financial statements are prepared in accordance with GAAP. Our significant accounting policies are described in Note 2 to the audited consolidated financial statements included in the 2021 Form 10-K. We consider all of our significant accounting policies and estimates to be critical. There were no significant changes in our critical accounting policies during the first six months of 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Management develops, and changes periodically, these estimates and assumptions based on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. There were no significant changes in our critical estimates during the first six months of 2022.</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Results of Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product sales accounted for approximately 98.0% of our revenues for each of the three and six months ended June&#160;30, 2022 and 2021, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect our income statements (in thousands, except percentages):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">453,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">394,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">321,682</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">293,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">27,975</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">272,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">48,964</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">61,434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(12,470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(20.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">48,796</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">61,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(12,549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(20.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">39,113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">46,963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7,850)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(16.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%;text-decoration:underline">% of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">870,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">623,968</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">542,254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">81,714</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">15.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">104,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">114,233</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(10,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">566.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">103,772</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">114,186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(9.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">80,894</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">88,026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7,132)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(8.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%;text-decoration:underline">% of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue increased $59.1 million, or 15.0%, to $453.3 million for the three months ended June 30, 2022 from $394.2 million for the three months ended June 30, 2021. The average revenue per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach was $6,667 for the three months ended June 30, 2022 compared to $6,662 for the three months ended June 30, 2021. Revenue increased $136.1 million, or 18.5%, to $870.9 million for the six months ended June 30, 2022 from $734.9 million for the six months ended June 30, 2021. The average revenue per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach was $6,602 for the six months ended June 30, 2022 compared to $6,558 for the six months ended June 30, 2021. Increase in the productivity per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach for the quarter was driven by an increase in the number of customers supported by each Coach. The year-over-year growth in revenue was primarily driven by the increase in the number of active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches and in the productivity per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of sales:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cost of sales increased $31.2 million, or 31.0%, to $131.7 million from $100.5 million for the three months ended June 30, 2022 from the corresponding period in 2021 and increased $54.4 million, or 28.2%, to $247.0 million from $192.6 million from the corresponding period in 2021. The increase in cost of sales was primarily driven by an increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA product sales and higher product costs resulting from inflation in raw ingredient costs, and labor costs. In addition, acceleration of demand for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA-branded products led to the increase in the Company&#8217;s use of co-manufacturers, which further increased cost of sales. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross profit:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended June 30, 2022, gross profit increased $28.0 million, or 9.5%, to $321.7 million from $293.7 million for the three months ended June 30, 2021.  As a percentage of revenue, gross profit decreased 350 basis points to 71.0% for 2022 from 74.5% for 2021. For the six months ended June 30, 2022, gross profit increased $81.7 million, or 15.1%, to $624.0 million from $542.3 million for the six months ended June 30, 2021. The increase in gross profit was primarily attributable to higher revenue partially offset by increased cost of sales. As a percentage of revenue, gross profit decreased 220 basis points to 71.6% for the six months ended June 30, 2022 from 73.8% for the corresponding period in 2021. The decrease in gross margin percentage for the first half of 2022 was primarily due to a customer acquisition program and higher product costs resulting from inflation in raw ingredient costs, and labor costs. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, general, and administrative:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general, and administrative (&#8220;SG&amp;A&#8221;) expenses were $272.7 million for the three months ended June 30, 2022, an increase of $40.4 million, or 17.4%, as compared to $232.3 million from the corresponding period in 2021. As a percentage of revenue, SG&amp;A expenses were 60.2% for the three months ended June 30, 2022 as compared to 58.9% for the corresponding period in 2021. SG&amp;A expenses included research and development costs of $1.2 million and $1.1 million for the three months ended June 30, 2022 and 2021, respectively, in connection with the development of new products and programs and clinical research activities. Selling, general, and administrative (&#8220;SG&amp;A&#8221;) expenses were $519.9 million for the six months ended June 30, 2022, an increase of $91.9 million, or 21.5%, as compared to $428.0 million from the corresponding period in 2021. As a percentage of revenue, SG&amp;A expenses were 59.7% for the six months ended June 30, 2022 as compared to 58.2% for the corresponding period in 2021. SG&amp;A expenses included research and development costs of $2.2 million and $2.2 million for the six months ended June 30, 2022 and 2021, respectively, in connection with the development of new products and programs and clinical research activities. The increase in SG&amp;A expenses for the six months ended June 30, 2022 was primarily due to higher </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach compensation expense, donations made to the Ukraine refugees, incremental costs related to continued investment in information technology and distribution infrastructure, as well as the increased credit card fees resulting from higher sales. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP adjusted SG&amp;A expenses were $263.3&#160;million for the three months ended June 30, 2022, an increase of $31.0&#160;million, or 13.4%, as compared to $232.3&#160;million from the corresponding period in 2021. Non-GAAP adjusted SG&amp;A expenses were $510.5&#160;million for the six months ended June 30, 2022, an increase of $82.5&#160;million, or 19.3%, as compared to 428.0 million from the corresponding period in 2021. Non-GAAP adjusted SG&amp;A excludes expenses in connection with the Ukraine Donations of $9.4&#160;million. Refer to &#8220;Non-GAAP Financial Measures&#8221; section below for a reconciliation of each of Non-GAAP financial measures to its most comparable GAAP financial measure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach compensation expense, which is a variable expense, increased $28.2 million, or 16.4%, to $200.6 million for the three months ended June 30, 2022 from $172.4 million for the corresponding period in 2021. For the six months ended June 30, 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA compensation expense increased $64.9 million, or 20.4%, to $383.6 million from $318.7 million for the corresponding period in 2021. The increase was primarily the result of increased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA product sales. The total number of active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches for the three months ended June 30, 2022 increased to 68,000 from 59,200 for the corresponding period in 2021, an increase of 14.9%. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income from operations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended June 30, 2022, income from operations decreased $12.5 million to $49.0 million from $61.4 million for the corresponding period in 2021 primarily as a result of increased SG&amp;A expenses partially offset by increased gross profit. Income from operations as a percentage of revenue decreased to 10.8% for the three months ended June 30, 2022 from 15.6% for the corresponding period in 2021 due to the factors described above impacting gross profit and SG&amp;A expenses. For the six months ended June 30, 2022, income from operations decreased $10.2 million to $104.1 million from $114.2 million for the corresponding period in 2021 primarily as a result of increased SG&amp;A expenses partially offset by increased gross profit. Income from operations as a percentage of revenue decreased to 11.9% for the six months ended June 30, 2022 from 15.5% for the corresponding period in 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP adjusted income from operations was $58.4&#160;million for the three months ended June 30, 2022, a decrease of $3.0&#160;million, or 5.0%, as compared to $61.4&#160;million from the corresponding period in 2021. Non-GAAP adjusted income from operations was $113.5&#160;million for the six months ended June 30, 2022, a decrease of $0.7&#160;million, or 0.7%, as compared to $114.2&#160;million from the corresponding period in 2021. Refer to &#8220;Non-GAAP Financial Measures&#8221; section below for a reconciliation of each of Non-GAAP financial measures to its most comparable GAAP financial measure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Provision for income taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> For the three months ended June 30, 2022, the Company recorded $9.7 million in income tax expense, an effective tax rate of 19.8%, as compared to $14.4 million in income tax expense, an effective tax rate of 23.4%, for the three months ended June 30, 2021. For the six months ended June 30, 2022, the Company recorded $22.9 million in income tax expense, an effective tax rate of 22.0%, as compared to $26.2 million in income tax expense, an effective tax rate of 22.9%, for the six months ended June 30, 2021. The decrease in the effective tax rate for the quarter and six months ended June 30, 2022 was primarily driven by the tax benefit for inventory donations in the quarter, partially offset by an increase in state income tax rate and a decrease in the tax benefit of stock compensation. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-GAAP adjusted income tax provision was $13.9&#160;million for the three months ended June 30, 2022, an effective tax rate of 23.9% as compared to 23.4% for the corresponding period in 2021. Non-GAAP adjusted income tax provision was $27.1&#160;million for the six months ended June 30, 2022, an effective tax rate of 24.0%, as compared to 22.9% for the corresponding period in 2021. Refer to &#8220;Non-GAAP Financial Measures&#8221; section below for a reconciliation of each of Non-GAAP financial measures to its most comparable GAAP financial measure.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Net income: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net income was $39.1 million and $80.9 million, or $3.42 and $7.01 per diluted share, for the three and six months ended June&#160;30, 2022 as compared to $47.0 million and $88.0 million, or $3.96 and $7.42 per diluted share, for the three and six months ended June&#160;30, 2021. The period-over-period changes were driven by the factors described above in the section titled "Income from operations."</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-GAAP adjusted net income was $44.3&#160;million or $3.87 per diluted share for the three months ended June 30, 2022 as compared to $3.96 per diluted share for the corresponding period in 2021. Non-GAAP adjusted net income was $86.1&#160;million or $7.46 per diluted share for the six months ended June 30, 2022 as compared to $7.42 per diluted share for the corresponding period in 2021.  Refer to &#8220;Non-GAAP Financial Measures&#8221; section below for a reconciliation of each of Non-GAAP financial measures to its most comparable GAAP financial measure.</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_307"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In an effort to provide investors with additional information regarding our results as determined by GAAP, we disclose various non-GAAP financial measures in this quarterly report, our quarterly earnings press release and other public disclosures. The following GAAP financial measures have been presented on an as-adjusted basis: SG&amp;A expenses, income from operations, provision for income taxes, net income and diluted earnings per share. Each of these as-adjusted financial measures excludes the impact of certain amounts related to our donations to Ukrainian refugees as further identified below and have not been calculated in accordance with GAAP. A reconciliation of each of these non-GAAP financial measures to its most comparable GAAP financial measure is included below. These non-GAAP financial measures are not intended to replace GAAP financial measures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We use these non-GAAP financial measures internally to evaluate and manage the Company&#8217;s operations because we believe they provide useful supplemental information regarding the Company&#8217;s on-going economic performance. We have chosen to provide this information to investors to enable them to perform more meaningful comparisons of operating results and as a means to emphasize the results of on-going operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables reconcile the non-GAAP financial measures included in this report (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Donation<br/>Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Donation<br/>Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzItMS0xLTEtMzgzNzY_b1ea6d3b-aa5e-4ad3-ab9b-99926dc2d0f7">272,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,426)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzItNy0xLTEtMzgzNzY_19fc4a52-f2a6-42a8-a4a6-b06c56390639">232,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzMtMS0xLTEtMzgzNzY_a1de639a-8c03-4913-ba39-e4b79fe15911">48,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzMtNy0xLTEtMzgzNzY_b4886215-aa16-42d0-b957-58bab16af696">61,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzQtMS0xLTEtMzg0NDQ_c7200ce5-064e-4c39-9fde-bc79a983082e">9,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzQtNy0xLTEtMzg0NDQ_efc1ef98-7de9-46cd-944f-6bdc4cbf91f7">14,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzQtMS0xLTEtMzgzNzY_ac1091bf-f657-4115-be12-bd07aa6f65bb">39,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzQtNy0xLTEtMzgzNzY_988d66a8-44ca-4efa-8793-00597d9c8ff8">46,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Donation<br/>Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Donation<br/>Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzItMS0xLTEtMzk0MTk_eccf9f6f-568d-4696-83c4-335f1662907c">519,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,426)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">510,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzItNy0xLTEtMzk0MTk_4470d690-df5b-47f3-bafa-554e45dcdc69">428,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzMtMS0xLTEtMzk0MTk_71f7c00d-dea5-4341-811b-c9f4b79fd58d">104,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzMtNy0xLTEtMzk0MTk_c56c8b94-c7b7-4825-b6c8-683b7929c62d">114,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzQtMS0xLTEtMzk0MTk_66ae6e31-ea5f-46a7-a956-1bcd56fe6a81">22,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzQtNy0xLTEtMzk0MTk_8962c99a-8705-4499-acde-e1e213610253">26,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzUtMS0xLTEtMzk0MTk_8b57b49d-9ddb-49f2-b2c3-c95c943599dd">80,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzUtNy0xLTEtMzk0MTk_a0eba421-492d-439c-a3fb-de31ff66611f">88,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The weighted-average diluted shares outstanding used in the calculation of these non-GAAP financial measures are the same as the weighted-average shares outstanding used in the calculation of the reported per share amounts.</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_76"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company had stockholders&#8217; equity of $129.5&#160;million and working capital of $55.1&#160;million at June&#160;30, 2022 as compared with $202.5&#160;million and $137.0&#160;million at December&#160;31, 2021, respectively. The $73.0&#160;million net decrease in stockholders&#8217; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">equity reflects $80.9&#160;million in net income for the six months ended June 30, 2022 offset by $120.0 million in repurchases of the Company&#8217;s common stock and $37.7&#160;million for declared dividends paid to holders of the Company&#8217;s common stock as well as the other equity transactions described in the &#8220;Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity&#8221; included in this report. The Company declared a quarterly dividend of $1.64 per share on June 16, 2022, to stockholders of record as of June 28, 2022 that will be paid in the third quarter of 2022. While we intend to continue the dividend program and believe we will have sufficient liquidity to do so, we can provide no assurance that we will be able to continue to declare and pay dividends. The Company&#8217;s cash, cash equivalents and investment securities decreased from $109.5 million at December&#160;31, 2021 to $61.1 million at June&#160;30, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash provided by operating activities increased by $1.2&#160;million to $87.4&#160;million for the six months ended June 30, 2022 from $86.2&#160;million for the six months ended June 30, 2021 primarily driven by a $65.5 million increase related to changes in  inventory balances offset by a reduction in net income, as well as decreases related to changes in certain balance sheet accounts, including prepaid income taxes $7.6&#160;million, other assets $7.4&#160;million and accounts payable and accrued expenses $50.9&#160;million. We continued to expand our cloud computing technology capabilities to support our planned growth during the six months ended June 30, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash used in investing activities was $0.6&#160;million for the six months ended June 30, 2022 as compared to $7.1&#160;million for the six months ended June 30, 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash used in financing activities increased by $79.2&#160;million to $130.1&#160;million for the six months ended June 30, 2022 from $51.0&#160;million for the six months ended June 30, 2021. This increase was primarily due to the $100&#160;million accelerated share repurchase ("ASR") program and $5.5&#160;million increase in cash dividends paid to stockholders, partially offset by borrowings under the revolving credit facility in the amount of $27.0&#160;million. Under the terms of the ASR agreement, approximately 480 thousand shares were delivered in the second quarter of 2022, with the remainder to be delivered at termination of the agreement, on or before October 3, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In pursuing its business strategy, the Company may require additional cash for operating and investing activities. The Company expects future cash requirements, if any, to be funded from operating cash flow and financing activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time the Company evaluates potential acquisitions that complement our business. If consummated, any such transactions may use a portion of our working capital or require the issuance of equity or debt. We have no present understandings, commitments or agreements with respect to any material acquisitions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#8220;Guarantors&#8221;) entered into a credit agreement among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on SOFR, from LIBOR (the &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement provides for a $225.0&#160;million senior secured revolving credit facility with a $20.0&#160;million letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to $100.0&#160;million. The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to credit facilities. As of June&#160;30, 2022, the Company had outstanding borrowings of $27.0&#160;million under the credit facility and was in compliance with all of its debt covenants.</span></div><div><span><br/></span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Market risk is the potential loss arising from adverse changes in market rates and prices, such as interest rates and a decline in the stock market. The Company does not enter into derivatives, foreign exchange transactions or other financial instruments for trading or speculative purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is exposed to market risk related to changes in interest rates and market pricing impacting our credit facility.  If market interest rates were to increase and market pricing were to decrease immediately and uniformly by 10% from levels at June&#160;30, 2022, the Company estimates that the fair value of its borrowings under its credit facility would decline by an immaterial amount and therefore it would not expect its operating results or cash flows to be affected to any significant degree by the effect of a change in market conditions on our investments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no material changes to our market risk exposure since December&#160;31, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Management, including our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of June&#160;30, 2022. Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported accurately and on a timely basis. Based on this evaluation performed in accordance with the criteria established in the 2013 Internal Control &#8211; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, our management concluded that the Company&#8217;s disclosure controls and procedures are effective at the reasonable assurance level as of the end of the period covered by this report.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no material changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Act) during the fiscal quarter ended June&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:21.6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Part II Other Information</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_88"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is, from time to time, subject to a variety of litigation and similar proceedings that arise out of the ordinary course of its business. Based upon the Company&#8217;s experience, current information and applicable law, it does not believe that these proceedings and claims will have a material adverse effect on its results of operations, financial position or liquidity. However, the results of legal actions cannot be predicted with certainty. Therefore, it is possible that the Company&#8217;s results of operations, financial condition or cash flows could be materially adversely affected in any particular period by the unfavorable resolution of one or more legal actions.</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_91"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no material changes to the risk factors set forth in Part I, Item 1A of the 2021 Form 10-K.</span></div><div id="i4563bf4792014469bdc8cd3ee0a97965_94"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:19.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.790%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.488%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total Number of Shares Purchased<br/>as Part of a Publicly Announced<br/>Plan or Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Maximum Number of Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Yet Be Purchased Under the Plans or Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">April 1 - April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,986,034</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">May 1 - May 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,978,957</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">June 1 - June 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499,197</span></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Also included are shares of common stock surrendered by employees and directors to the Company to cover minimum tax liability withholding obligations upon the exercise of stock options or the vesting of shares of restricted stock previously granted to such employees and directors.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At the outset of the quarter ended June&#160;30, 2022, there were 2,034,016 shares of the Company's common stock eligible for repurchase under the stock repurchase authorization dated September 16, 2014 (the "Stock Repurchase Plan").</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In the second quarter of fiscal 2022, the Company paid $100 million under an Accelerated Share Repurchase (&#8220;ASR&#8221;) agreement and received an initial delivery of approximately 480 thousand shares with the remainder to be delivered at termination of the agreement, on or before October 3, 2022.&#8217;See Note 9 to the Consolidated Financial Statements included in this report for further description of the ASR.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of June&#160;30, 2022, there were 1,499,197 shares of the Company&#8217;s common stock eligible for repurchase under the Stock Repurchase Plan. There can be no assurances as to the amount, timing or prices of repurchases, which may vary based on market conditions and other factors. The Stock Repurchase Plan does not have an expiration date and can be modified or terminated by the Board of Directors at any time.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Description of Exhibit</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/910329/000114420415012727/v402962_ex3-1.htm">Restated and Amended Certificate of Incorporation of Medifast, Inc. (incorporated by reference to Exhibit 3.1 of the Company&#8217;s Current Report on Form 8-K (File No. 001-31573) filed February 27, 2015).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/910329/000110465919069652/tm1923867d1_ex3-1.htm">Amended and Restated Bylaws of Medifast, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Amendment No. 1 Current Report on Form 8-K (File No. 001-31573) filed on December 4, 2019).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex-101medifastformpsuagree.htm">First</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex-101medifastformpsuagree.htm"> Amendment to Credit Agreement, dated May 31, 2022 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-31573) filed on June 3, 2022).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex-102amendmentno2tomedifa.htm">Amendment No. 2 to Medifast, Inc. Executive Severance Plan (filed herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20220331xexx3111.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20220331xexx3121.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20220331xexx3211.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The following financial statements from Medifast, Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 filed August 4, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Income, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Cash Flows, (v) Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity, and (vi) Notes to the Condensed Consolidated Financial Statements (filed herewith).</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC Release No. 33-8238, Exhibit 32.1 is being furnished and not filed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><div id="i4563bf4792014469bdc8cd3ee0a97965_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i4563bf4792014469bdc8cd3ee0a97965_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medifast, Inc.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ DANIEL R. CHARD</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Daniel R. Chard</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Dated:</span></td><td colspan="3" style="background-color:#ffde0f;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">August 3, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ JAMES P. MALONEY</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">James P. Maloney</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Dated:</span></td><td colspan="3" style="background-color:#ffde0f;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex-101medifastformpsuagree.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i235b71c65ee44010aa825da4e120a545_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">MEDIFAST, INC. AMENDED AND RESTATED 2012 SHARE INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GRANT NOTICE PERFORMANCE SHARE UNITS </font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medifast, Inc. (the &#8220;Company&#8221;) hereby grants to the Participant named below performance-based Deferred Shares (&#8220;Performance Share Units&#8221; or &#8220;PSUs&#8221;) pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan (the &#8220;Plan&#8221;) in the number specified below (the &#8220;Target Award Opportunity&#8221;) covering the three-year Performance Period specified below and subject to the achievement of Performance Goals, which relate to the Performance Measures specified below. Each PSU relates to and corresponds in value to a single share of Company common stock (&#8220;Share&#8221;) and represents the right to receive one Share for each vested PSU. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The PSUs are subject to all of the terms and conditions as set forth in this Grant Notice, the Performance Share Units Award Agreement (the &#8220;Award Agreement&#8221;) and the Plan, all of which are attached hereto and incorporated herein in their entirety. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan or the Award Agreement.</font></div><div><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Participant Name&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Grant Date&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Target Award Opportunity&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Performance Period&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Vesting Schedule (other than in connection with a Change in Control as provided in Section 8 of the Plan)</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Terms&#47;Acknowledgements&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The undersigned Participant acknowledges receipt of, and understands and agrees to the terms set forth in this Grant Notice, the Award Agreement and the Plan (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">by accepting this Grant Notice and attached Award Agreement electronically, you agree to the terms and conditions in the Grant Notice, Award Agreement and Plan).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant further acknowledges that as of the Grant Date, this Grant Notice, the Award Agreement, the Plan, and any employment or change in control agreement between you and the Company set forth the entire understanding between Participant and the Company regarding the acquisition of Shares in accordance with this Grant Notice, the Award Agreement and the Plan and supersede all prior oral and written Award Agreements on that subject.  </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">MEDIFAST, INC. AMENDED AND RESTATED 2012 SHARE INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PERFORMANCE SHARE UNITS AWARD AGREEMENT</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to your Performance Share Units Grant Notice (&#8220;Grant Notice&#8221;) and this Award Agreement, Medifast, Inc. (the &#8220;Company&#8221;) has granted to you performance-based Deferred Shares (&#8220;Performance Share Units&#8221;, &#8220;PSUs&#8221; or &#8220;Award&#8221;) under the Plan covering the number of PSUs indicated in your Grant Notice, which vest in accordance with the Vesting Schedule indicated in your Grant Notice and this Award Agreement. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan or your Grant Notice.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:153%">The details of your Performance Share Units are as follows&#58;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Eligibility for Payment or Distribution of Vested PSUs.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> You must be continuously employed by the Company or any of its subsidiaries from the Grant Date through and up to the last day of the Performance Period specified in your Grant Notice to be eligible for a payment or distribution of your PSUs that vest and become nonforfeitable in accordance with Section 2 of this Award Agreement. If you incur a Termination of Service for any reason other than Retirement prior the last day of the Performance Period, you will forfeit any nonvested PSUs that you then hold and you shall not be entitled to any distribution or payout with respect to such forfeited PSUs, except as otherwise provided in Section 3 of this Award Agreement. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Retirement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> If your employment with the Company is terminated by virtue of a Retirement, the PSUs shall continue to vest and be settled as they would have absent an employment termination and shall be eligible to vest at the conclusion of the Performance Period on a pro-rata basis, as set forth in Section 2 below. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Retirement&#8221; means your termination of employment from the Company and its subsidiaries other than for cause, provided that you (i) have attained age 55, (ii) the numerical sum of your age and years of service with the Company or its subsidiaries is equal to at least 70, (iii) you are performing your job duties to the Company&#8217;s satisfaction at the time of notice and until your termination of employment, and (iv) you have given notice to the Company, in form satisfactory to the Company, of your intent to retire specifying the exact intended date of retirement to the Company that is at least 12 months following such notice date (provided that prior to such notice the Company had not already given you notice that you would be terminated), and remained employed by the Company until the earlier of (a) the one year anniversary of the date of such notice or (b) the date on which you are terminated by the Company without Cause. The Chief Executive Officer of the Company (or the Compensation Committee of the Board of Directors of the Company, in the event that you are at the time of notice either of the Chief Executive Officer (&#8220;CEO&#8221;), or the CEO&#8217;s direct report at the Executive Vice President-level or above, or one of the Company&#8217;s &#8220;Named Executive Officers&#8221; in the Company&#8217;s most recent Proxy filing pursuant to Item 402 of Regulation S-K) may, in his or her discretion, waive the requirement that you remain employed until the one year anniversary of the date of such notice.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Determination of Number of Vested PSUs.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Subject to the requirements of Section 1 of this Agreement, at the conclusion of the Performance Period the Committee shall determine whether and to what extent you have become vested in your Award in accordance with Appendix A to this Agreement. In the event of your Retirement prior to the conclusion of the Performance Period, you shall be eligible to vest in a number of PSUs equal to the number of PSUs that would have vested if you had remained employed until the end of the Performance Period times a fraction, the numerator of which is the number of full months during the Performance Period that you were employed prior to your Retirement and the denominator of which is the number of months during the Performance Period.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Effect of a Change in Control Prior to a Vesting Date. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The treatment of any nonvested PSUs that you hold upon or after a Change in Control will be determined under Section 8 of the Plan. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Form and Timing of Settlement of PSUs. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As provided for under Section 6(e)(ii) of the Plan, within  two and one-half months after the close of the calendar year in which your shares vest, the Company will issue and deliver to you (at the Company&#8217;s sole discretion) the number of shares of Stock equal to the number of your PSUs that vested on such Vesting Date, subject to satisfaction of applicable tax and&#47;or other obligations as described in Section 9 of this Award Agreement. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Dividend Equivalents.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> In the event that the Company declares and pays a dividend in respect of its outstanding Shares and, on the record date for such dividend, you hold PSUs granted pursuant to this Award Agreement that have not been settled, the Company shall credit to an account maintained by the Company for your benefit an amount equal to the cash dividends you would have received if you were the holder of record, as of such record date, of the number of Shares related to the portion of the PSUs that have not been settled or forfeited as of such record date (the &#8220;Dividend Equivalent&#8221; or &#8220;DER&#8221;). Such account is intended to constitute an &#8220;unfunded&#8221; account, and neither this Section 5 nor any action taken pursuant to or in accordance with this Section 5 shall be construed to create a trust of any kind. Amounts credited to such account with respect to PSUs that vest in accordance with Sections 2 or 3 of this Award Agreement will become vested DERs and will be paid to you in cash, Shares, or a combination thereof, as determined by the Committee in its sole discretion, at the same time as your vested PSUs are settled. You shall not be entitled to receive any interest with respect to the timing of payment of DERs. In the event all or any portion of the PSUs granted to you pursuant to this Award Agreement fail to become vested under Sections 2 or 3 of this Award Agreement, the unvested DERs accumulated in your account with respect to such PSUs shall be forfeited.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Delivery of Shares.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The Company shall deliver Shares in settlement of your vested PSUs to you in accordance with this Section 6&#59; provided, however, the Company shall not be obligated to deliver Shares to you if (i) you have not satisfied all applicable tax withholding obligations, (ii) Shares are not properly registered or subject to an applicable exemption therefrom, (iii) Shares are not listed on the stock exchanges on which Company Shares are otherwise listed, or (iv) the Company determines that the delivery of Shares would violate any federal or state securities or other applicable laws. At the discretion of the Company, Shares may be delivered to you by book-entry credit to an account in your name established by the Company with the Company&#8217;s transfer agent, or upon written request</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">from you (or your personal representative, beneficiary or estate, as the case may be) in certificates in your name (or your personal representative, beneficiary or estate).You shall not acquire or have any rights as a shareholder of the Company until Shares issuable hereunder are actually issued and delivered to you in accordance with the Award Agreement.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Restrictive Covenants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Without limiting any other&#160;non-competition,&#160;non-solicitation,&#160;non-disparagement&#160;or&#160;non-disclosure&#160;or other similar agreement to which you may be a party, you shall be subject to the confidentiality and restrictive covenants set forth on&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;attached hereto, which&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;is incorporated herein and forms part of this Award Agreement. In the event that you violate any of the restrictive covenants referred to in this Section&#160;8, in addition to any other remedy that may be available at law or in equity, the PSUs shall be automatically forfeited effective as of the date on which such violation first occurs and any payment or delivery with respect to the PSUs during the &#91;6 months&#93; prior to such violation shall be rescinded. The Company shall notify you in writing of any such rescission within two years after such payment or delivery. Within ten days after receiving such a notice from the Company, you shall return the Shares to the Company or pay to the Company any profit or gain your realized in connection with sale of such Shares. The foregoing rights and remedies are in addition to any other rights and remedies that may be available to the Company and shall not prevent (and you shall not assert that they shall prevent) the Company from bringing one or more actions in any applicable jurisdiction to recover damages as a result of your breach of such restrictive covenants.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Forfeiture and Recoupment.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Notwithstanding any provision of this Award Agreement or the Plan to the contrary, you agree that your right to retain your Award, to retain any amount received pursuant to your Award and to retain any profit or gain your realized in connection with sale of such Shares, shall be subject to any recoupment or &#8220;clawback&#8221; policy or forfeiture policy adopted by the Company.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">Restrictions on Resales of Shares.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The Company may impose such restrictions, conditions, and limitations as it determines appropriate as to the timing and manner of any resales by you or other subsequent transfers by you of any Shares issued as a result of the settlement of your PSUs, including (i) restrictions under an insider trading policy, (ii) restrictions designed to delay and&#47;or coordinate the timing and manner of sales by you and other PSU holders, and (iii) restrictions as to the use of a specified brokerage firm for such resales or other transfers.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">Tax Withholding Obligations.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">At the time your PSUs are settled, you hereby authorize withholding from payroll and any other amounts payable to you by the Company, and otherwise agree to make adequate provision for, any sums required to satisfy the federal, state, local and foreign tax withholding obligations </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(&#8220;Withholding Obligations&#8221;) of the Company, if any, which arise in connection with the settlement of your PSUs. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">Upon your request and subject to approval by the Company, in its sole discretion, and compliance with any applicable legal conditions or restrictions, the Company may withhold from fully vested Shares otherwise issuable to you upon the settlement of your PSUs a number of whole Shares having a Fair Market Value, determined by the Company as of the date of settlement, at least equal to the minimum statutory amount of tax required to be withheld by law but in no event in excess of the maximum statutory amount of tax that is permitted to be withheld by law. </font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">Tax Consequences.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> You hereby agree that the Company does not have a duty to design or administer the Plan or its other compensation programs in a manner that minimizes your tax liabilities. You shall not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from your PSUs or your other compensation. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">Applicability of Section&#160;409A of the Internal Revenue Code.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">Your PSUs granted hereunder are not intended to provide for a &#8220;deferral of compensation&#8221; within the meaning of Section 409A of the U.S. Internal Revenue Code (&#8220;Section 409A&#8221;) and shall be interpreted and construed in a manner consistent with that intent. If any provision of this Award Agreement, your Grant Notice or the Plan causes your PSUs to be subject to the requirements of Section 409A, or could otherwise cause you to recognize income or be subject to the interest and penalties under Section 409A, then the provision shall have no effect or, to the extent practicable, the Committee may, in its sole discretion and without the Participant&#8217;s consent, modify the provision to (i) comply with, or avoid being subject to Section 409A, or to avoid the incurrence of any taxes, interest and penalties under Section 409A, and&#47;or (ii) maintain, to the maximum extent practicable, the original intent and economic benefit to you of the applicable provision without materially increasing the cost to the Company or contravening the provisions of Section 409A. This Section 12 does not create an obligation of the Company to modify this Award Agreement, your Grant Notice or the Plan and does not guarantee that your PSUs will not be subject to taxes, interest and penalties under Section 409A.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">If you are a &#8220;specified employee&#8221; as defined under Code Section 409A and your PSUs are to be settled on account of your separation from service (for reasons other than death) and such PSUs constitutes &#8220;deferred compensation&#8221; as defined under Code Section 409A, then any portion of your PSUs that would otherwise be settled during the six-month period commencing on your separation from service shall be settled as soon as practicable following the conclusion of the six-month period (or following your death if it occurs during such six-month period). </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.23pt">Your Termination of Service shall not be deemed to have occurred for purposes of any provision of the Award Agreement providing for the payment of any amounts or benefits that are considered nonqualified deferred compensation under Section 409A upon or following a Termination of Service, unless such termination is also a &#8220;separation from service&#8221; within the meaning of Section 409A and the payment thereof prior to a &#8220;separation from service&#8221; could otherwise cause you to recognize income or be subject to the interest and penalties under Section 409A.  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">Restrictions on Transferability.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Your PSUs may not be sold, transferred, pledged, assigned, exchanged, encumbered, or otherwise alienated or hypothecated, except (i) by will or by the laws of descent and distribution&#59; (ii) to the extent permitted by the Plan and allowed under applicable law and approved by the Committee in its sole discretion&#59; or (iii) pursuant to a domestic relations order.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">Beneficiary Designation.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> You may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Award Agreement is to be paid in case of your death before you receive any or all of such benefit. Each such designation shall revoke all prior designations by you, shall be in a form prescribed by the Company, and will be effective only when filed by you in writing with the Secretary of the Company during your lifetime. In the absence of any such designation, benefits remaining unpaid at the time of your death shall be paid to your estate.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">Securities Laws.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> This Award Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required, or the Committee determines are advisable. You agree to take all steps that the Company determines are necessary to comply with all applicable provisions of federal and state </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">securities law in exercising your rights under this Award Agreement. The Committee may impose such restrictions on any Shares acquired by you under the Award Agreement as it may deem necessary or advisable, under applicable federal securities laws, the requirements of any stock exchange or market upon which such Shares are then listed or traded or any blue sky or state securities laws applicable to such Shares. In addition, the Shares shall be subject to any trading restrictions, stock holding requirements or other policies in effect from time to time as determined by the Committee.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">Data Privacy.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> To administer the Plan, the Company may process personal data about you. Such data includes the information provided in this Award Agreement, other appropriate personal and financial data about you such as home address and business addresses and other contact information, payroll information and any other information deemed appropriate by the Company to facilitate the administration of the Plan. By accepting this award, you consent to the Company&#8217;s processing of such personal data and the transfer of such data outside the country in which you work or are employed, including, with respect to non-U.S. residents, to the United States, to transferees who shall include the Company and other persons designated by the Company to administer the Plan.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">No Right to Continued Employment or Further Awards.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">Neither the Plan nor this Award Agreement shall (i) alter your status as an &#8220;at-will&#8221; employee of the Company&#59; (ii) be construed as giving you any right to continue in the employ of the Company&#59; or (iii) be construed as giving you any right to be reemployed by the Company following any Termination of Service. The Termination of Service provisions in this Award Agreement shall solely apply to the treatment of your PSUs as specified herein and shall not otherwise affect your employment relationship with the Company.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Company has granted your PSUs in its sole discretion. Your Grant Notice, this Award Agreement and the Plan do not confer to you any right or entitlement to receive another grant of PSUs, or any other similar award at any time in the future or in respect of any future period. Your PSU grant does not confer on you any right or entitlement to receive compensation in any specific amount for any future fiscal year, and does not diminish in any way the Company&#8217;s discretion to determine the amount, if any, of your compensation.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">Notices.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Any notice required or permitted to be given under this Award Agreement, or Grant Notice or the Plan shall be in writing and shall be deemed to have been given when delivered personally or by courier, or sent by certified or registered United States mail, postage prepaid, return receipt requested, duly addressed to the party concerned at the address indicated below or to such changed address as such party may subsequently by similar process give notice of&#58;</font></div><div><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">If to the Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medifast, Inc.<br>100 International Drive</font></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18th Floor</font></div><div style="margin-bottom:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baltimore, Maryland 21202<br>Attn.&#58; General Counsel</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">If to the Employee&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To the last address delivered to the Company by the <br>Employee in the manner set forth herein.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.11pt">General Provisions.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Headings.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The headings preceding the text of the sections in this Award Agreement are inserted solely for convenience of reference, and shall not constitute a part of this Award Agreement, nor shall they affect its meaning, construction, or effect. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Severability.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> If any provision of this Award Agreement is declared to be illegal, invalid, or otherwise unenforceable by a court of competent jurisdiction, such provision shall be reformed, if possible, to the extent necessary to render it legal, valid, and enforceable, or otherwise deleted, and the remainder of the provisions of this Award Agreement shall not be affected except to the extent necessary to reform or delete such illegal, invalid, or unenforceable provision.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:10.23pt">Governing Documents.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> This Award Agreement is subject to all of the terms and conditions as set forth in your Grant Notice and the Plan, all of which are incorporated herein in their entirety. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Your Grant Notice, this Award Agreement, the Plan, and any employment or change in control agreement between you and the Company constitute the entire understanding between you and the Company regarding the PSUs. Any prior Award Agreements, commitments or negotiations concerning the PSUs are superseded. In the event of any conflict between the provisions of your Grant Notice and this Award Agreement and those of the Plan, the provisions of the Plan shall control. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Binding on Parties.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The provisions of this Award Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Applicable Law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Your Grant Notice and this Award Agreement shall be governed, construed, interpreted, and administered solely in accordance with the laws of the state of Delaware, without regard to principles of conflicts of law, with consent of jurisdiction by you in the State of Maryland.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:12.46pt">Rescission of Award Agreement and PSU Grant.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Your PSUs granted under this Award Agreement may be rescinded if necessary to ensure compliance with federal, state or other applicable laws. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">Administration of PSUs.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> All questions arising under your Grant Notice, this Award Agreement and the Plan shall be decided by the Committee in its total and absolute discretion. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of your Grant Notice, this Award Agreement and the Plan&#59; all such determinations shall be binding upon you and your successors.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.67pt">No Shareholder Rights.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The PSUs granted to you under pursuant this Award Agreement do not and shall not entitle you to any rights of a holder of a Share of Company common stock prior to the date Shares are issued to you in settlement of the PSUs, if at all (or an appropriate book entry has been made). Except as described in the Plan, no adjustments are made for dividends or other rights if the applicable record date occurs prior to the date Shares are issued to you in settlement of the PSUs (or an appropriate book entry has been made).</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.01pt">Unfunded Arrangement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The PSUs create a contractual obligation on the part of the Company to distribute to you Shares in connection with the vesting of the PSUs at the time provided for in this Award Agreement. Neither you nor any other party claiming an interest under this Agreement shall have any interest whatsoever in any specific assets of the Company. Your right to receive Shares under this Agreement is that of an unsecured general creditor of Company.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">j.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:13.01pt">Consent to Electronic Delivery.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Certain statutory materials relating to the Plan may be delivered to you in electronic form. By accepting this grant, you consent to electronic delivery and acknowledge receipt of these materials, including the Plan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:136%">This Award Agreement is not a stock certificate or a negotiable instrument. </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:124%">Appendix A</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:136%">Unless otherwise provided in the Award Agreement or Plan, set forth below are the Performance Goals applicable to your Award and the method for calculating the number of your PSUs that vest at the conclusion of the Performance Period ending on ________________, 20__.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:124%"> </font></div><div style="padding-left:54pt;text-indent:-18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex-102amendmentno2tomedifa.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if0d21cba3d48443486e1a1705e9eecb4_38"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MEDIFAST, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTIVE SEVERANCE PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Medifast, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), has adopted this Medifast, Inc. Executive Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to provide key employees of the Company and its affiliates and subsidiaries with severance protection under covered circumstances.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 1.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DEFINITIONS AND INTERPRETATIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.7pt">Definitions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Capitalized terms used in this Plan shall have the following respective meanings, except as otherwise provided or as the context shall otherwise require&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Annual Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the base salary paid to a Participant on an annual basis exclusive of any bonus payments, commission payments or additional payments under any benefit plan of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean be the Compensation Committee.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean (a) indictment or conviction for, or a please of guilty or nolo contendere to, a felony or of a criminal act involving moral turpitude&#59; (b) gross misconduct or willful and continued failure to substantially perform employment duties reasonably requested by the Company or an affiliate, after thirty (30) days&#8217; written notice by certified mail of such conduct or failure, and the failure of the Participant to remedy such conduct or failure&#59; (c) fraud,  embezzlement, or misappropriation of any amounts of money or other assets or property of the Company&#59; (d) misconduct or negligence in connection with the business of the Company or an affiliate which has a substantial adverse effect on the Company or the affiliate&#59; or (e) violation of any material policy of the Company, including the Company&#8217;s Code of Conduct and Business Ethics. Determination of Cause shall be made by the Compensation Committee in its sole discretion.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Amended and Restated 2012 Share Incentive Plan or any successor to such plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Control Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the 24 month period beginning on the date of a Change in Control. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Internal Revenue Code of 1986, as amended. Reference in this Plan to any section of the Code shall be deemed to include any amendments or successor provisions to such section and any regulations under such section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Compensation Committee of the Company&#8217;s Board of Directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean September 12, 2019.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean a Participant&#8217;s resignation of employment upon the occurrence (without the Participant&#8217;s prior written consent) of (a) a material reduction in the Participant&#8217;s Annual Base Salary or Target Bonus, (b) a material diminution in the Participant&#8217;s authority, duties or responsibilities, (c) a relocation of the Participant&#8217;s principal work location by more than 50 miles, or (d) any other action or inaction that constitutes a material breach by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company of any written agreement under which the Participant provides services&#59; provided, however, that, notwithstanding the foregoing, the Participant may not resign his or her employment for Good Reason unless (i) the Participant has provided the Company with at least thirty (30) days prior written notice of his or her intent to resign for Good Reason (which notice must be provided within ninety (90) days following the occurrence of the event(s) purported to constitute Good Reason)&#59; and (ii) the Company has not remedied the alleged violation(s) within the thirty (30) day period following its receipt of such notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean those employees of the Company or any of its subsidiaries who are from time to time designated as Participants in accordance with Section 2.01.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean this Medifast, Inc. Executive Severance Plan, as amended, supplemented or modified from time to time in accordance with its terms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean a Participant&#8217;s Termination of Employment (a) by the Company and its subsidiaries without Cause or (b) by the Participant for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Target Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Participant&#8217;s target annual incentive bonus.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Participant, the actual date of the Participant&#8217;s Termination of Employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the time when the employee-employer relationship between the Participant and the Company or any subsidiary of the Company is terminated for any reason, with or without Cause, including, but not by way of limitation, a termination by resignation, discharge, death, permanent disability or retirement&#59; provided, that such &#8220;Termination of Employment&#8221; constitutes a &#8220;separation from service&#8221; within the meaning of Treasury Regulation Section 1.409A-1(h).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.03pt">Interpretation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> In this Plan, unless a clear contrary intention appears, (a) the words &#8220;herein,&#8221; &#8220;hereof&#8221; and &#8220;hereunder&#8221; refer to this Plan as a whole and not to any particular Article, Section or other subdivision, (b) reference to any Article or Section, means such Article or Section hereof and (c) the words &#8220;including&#8221; (and with correlative meaning &#8220;include&#8221;) means including, without limiting the generality of any description preceding such term. The Article and Section headings herein are for convenience only and shall not affect the construction hereof.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 2.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ELIGIBILITY AND BENEFITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:11.38pt">Eligible Employees.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Plan is only for the benefit of the following Participants, and no other employees, personnel, consultants or independent contractors shall be eligible to participate in this Plan or to receive any rights or benefits hereunder&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-32.91pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">Chief Executive Officer&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36.24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">Chief Financial Officer&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-39.57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">All other executive officers of the Company who are direct reports of the Chief Executive Officer and are at the Executive Vice President-level or above (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Other Executives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 3.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SEVERANCE AND RELATED TERMINATION BENEFITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.7pt">Qualifying Termination. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as set forth in Section 3.02, in the event that a Participant incurs a Qualifying Termination, then, subject to Section 3.03, such Participant shall be entitled to receive the severance benefits set forth on Exhibit A attached hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.03pt">Qualifying Termination Following Change in Control. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event that, during the Change in Control Period, a Participant incurs a Qualifying Termination, then in lieu of the benefits payable pursuant to Section 3.01 and subject to Section 3.03, the Participant will be entitled to receive the severance benefits set forth on Exhibit B attached hereto. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:11.38pt">Conditions to Receipt of Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. A Participant&#8217;s receipt of any payment or benefits under this Article III shall be conditioned on and subject to such Participant&#8217;s execution and non-revocation of a general waiver and release of claims in favor of the Company, within the applicable time periods for execution following the Termination Date, as set forth in such agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.03pt">Other Terminations of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For the avoidance of doubt, in no event shall the Participant be entitled to any benefit under this Plan in the event that the Participant resigns without Good Reason or otherwise terminates employment due to death, permanent disability, or retirement, or is terminated by the Company for Cause.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:11.38pt">No Duplication of Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Plan, in the event that a Participant is entitled to severance benefits under any other employment agreement, severance agreement or similar agreement between the Participant and the Company, no benefits shall be payable under this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0f</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12.71pt">Plan Unfunded&#59; Participant's Rights Unsecured</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company shall not be required to establish any special or separate fund or make any other segregation of funds or assets to assure the payment of any benefit hereunder.  The right of any Participant to receive the benefits provided for herein shall be an unsecured claim against the general assets of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 4.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CLAIMS PROCEDURES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.7pt">Initial Claims. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A Participant who believes he or she is entitled to a payment under the Plan that has not been received may submit a written claim for benefits to the Plan within 60 days after the Participant's Qualifying Termination. Claims should be addressed and sent to&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Medifast, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chair of the Compensation Committee</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100 International Drive</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Baltimore, MD 21202</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant's claim is denied, in whole or in part, the Participant will be furnished with written notice of the denial within 90 days after the Administrator's receipt of the Participant's written claim, unless special circumstances require an extension of time for processing the claim, in which case a period not to exceed 180 days will apply. If such an extension of time is required, written notice of the extension will be furnished to the Participant before the termination of the initial 90-day period and will describe the special circumstances requiring the extension, and the date on which a decision is expected to be rendered. Written notice of the denial of the Participant's claim will contain the following information&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-32.91pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">the specific reason or reasons for the denial of the Participant's claim&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36.24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">references to the specific Plan provisions on which the denial of the Participant's claim was based&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-39.57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">a description of any additional information or material required by the Administrator to reconsider the Participant's claim (to the extent applicable) and an explanation of why such material or information is necessary&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-38.91pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">a description of the Plan's review procedures and time limits applicable to such procedures, including a statement of the Participant's right to bring a civil action under Section 502(a) of ERISA following a benefit claim denial on review.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.7pt">Appeal of Denied Claims. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Participant's claim is denied and he or she wishes to submit a request for a review of the denied claim, the Participant or his or her authorized representative must follow the procedures described below&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-35.58pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">Upon receipt of the denied claim, the Participant (or his or her authorized representative) may file a request for review of the claim in writing with the Administrator. This request for review must be filed no later than 60 days after the Participant has received written notification of the denial.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-38.91pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">The Participant has the right to submit in writing to the Administrator any comments, documents, records or other information relating to his or her claim for benefits.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-42.24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">The Participant has the right to be provided with, upon request and free of charge, reasonable access to and copies of all pertinent documents, records and other information that is relevant to his or her claim for benefits.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-45.57pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">The review of the denied claim will take into account all comments, documents, records and other information that the Participant submitted relating to his or her claim, without regard to whether such information was submitted or considered in the initial denial of his or her claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.03pt">Administrator's Response to Appeal. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrator will provide the Participant with written notice of its decision within 60 days after the Administrator's receipt of the Participant's written claim for review. There may be special circumstances which require an extension of this 60-day period. In any such case, the Administrator will notify the Participant in writing within the 60-day period and the final decision will be made no later than 120 days after the Administrator's receipt of the Participant's written claim for review. The Administrator's decision on the Participant's claim for review will be communicated to the Participant in writing and will clearly state&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-38.91pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">the specific reason or reasons for the denial of the Participant's claim&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-35.58pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">reference to the specific Plan provisions on which the denial of the Participant's claim is based&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-38.91pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">a statement that the Participant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, the Plan and all documents, records, and other information relevant to his or her claim for benefits&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-42.24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">a statement describing the Participant's right to bring an action under Section 502(a) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.7pt">Exhaustion of Administrative Remedies. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The exhaustion of these claims procedures is mandatory for resolving every claim and dispute arising under the Plan. As to such claims and disputes&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">no claimant shall be permitted to commence any legal action to recover benefits or to enforce or clarify rights under the Plan under Section 502 or Section 510 of ERISA or under any other provision of law, whether or not statutory, until these claims procedures have been exhausted in their entirety&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">in any such legal action, all explicit and implicit determinations by the Administrator (including, but not limited to, determinations as to whether the claim, or a request for a review of a denied claim, was timely filed) shall be afforded the maximum deference permitted by law.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Article 5.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MISCELLANEOUS PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:11.38pt">No Mitigation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Participant shall be required to mitigate the amount of any payment provided for in this Plan by seeking or accepting other employment following a termination of his or her employment with the Company or otherwise.  The amount of any cash payment provided for in this Plan shall not be reduced by any cash compensation earned by a Participant as the result of employment by another employer or by retirement benefits.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.03pt">Amendment or Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Board may amend or terminate the Plan at any time&#59; provided, however, that no such termination or amendment may materially and adversely affect any rights of any Participant who has incurred a Qualifying Termination prior to the date of such termination or amendment&#59; and provided, further, that the Plan cannot be terminated or materially amended during the Change in Control Period.  Notwithstanding the foregoing, the Plan shall terminate when all of the obligations to Participants hereunder have been satisfied in full.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:11.38pt">Enforceability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The failure of a Participant or the Company or any of its subsidiaries to insist upon strict adherence to any term of the Plan on any occasion shall not be considered a waiver of such party's rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0f</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12.71pt">Governing Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Plan shall be governed by and construed in accordance with the laws of the State of Maryland, without giving effect to its conflict of laws rules, and applicable federal law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.7pt">Tax Withholding. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company shall have the right to deduct from any payment or benefit hereunder all federal, state and local taxes which are required to be withheld therefrom.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0h</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.03pt">Plan Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Compensation Committee shall have full and final authority to make determinations with respect to the administration of this Plan, to construe and interpret its provisions and to take all other actions deemed necessary or advisable for the proper administration of this Plan, but such authority shall be subject to the provisions of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0i</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:13.37pt">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Plan shall be binding upon and inure to the benefit of the Company and its successors and assigns. This Plan and all rights of each Participant shall inure to the benefit of and be enforceable by each such Participant and his or her personal or legal representatives, executors, administrators, heirs and permitted assigns.  If any Participant should die while any amounts are due and payable to such Participant hereunder, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Plan to such Participant&#8217;s devisees, legatees or other designees or, if there be no such devisees, legatees or other designees, to such Participant&#8217;s estate.  No payments, benefits or rights arising under this Plan may be assigned or pledged by any Participant, except under the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0j</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12.71pt">Notices.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> All notices and other communications provided for in this Plan shall be in writing and shall be sent, delivered or mailed, addressed as follows&#58; (a) if to the Company, at the Company&#8217;s principal office address or such other address as the Company may have designated by written notice to all Participants for purposes hereof, directed to the attention of the Chief Financial Officer of the Company (or such other officer as may be designated by the Company), and (b) if to any Participant, at his or her residence address on the records of the Company or to such other address as he or she may have designated to the Company in writing for purposes hereof.  Each such notice or other communication shall be deemed to have been duly given or mailed by United States certified or registered mail, return receipt requested, postage prepaid, except that any change of notice address shall be effective only upon receipt.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.0k</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:10.03pt">No Employment Rights Conferred</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan does not alter the status of each Participant as an at-will employee of the Company. This Plan shall not be deemed to create a contract of employment between any Participant and the Company and&#47;or any of its subsidiaries.  Nothing contained in this Plan shall (a) confer upon any Participant any right with respect to continuation of employment with the Company or any of its subsidiaries or (b) subject to the rights and benefits of any Participant hereunder, interfere in any way with the right of the Company or any of its subsidiaries to terminate such Participant's employment at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.j</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18.71pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If any provision of the Plan is, becomes, or is deemed to be invalid, illegal, or unenforceable in any respect, the validity, legality, and enforceability of the remaining provisions of this Plan shall not be affected thereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 1.k</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:16.03pt">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">The Plan is intended to comply with Section 409A of the Code or an exemption thereunder and shall be construed and administered in accordance with Section 409A of the Code. Notwithstanding any other provision of the Plan, payments provided under the Plan may only be made upon an event and in a manner that complies with Section 409A of the Code or an applicable exemption. Any payments under the Plan that may be excluded from Section 409A of the Code either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A of the Code to the maximum extent possible. For purposes of Section 409A of the Code, each installment payment provided under the Plan shall be treated as a separate payment. Any payments to be made under the Plan upon a termination of employment shall only be made upon a &#34;separation from service&#34; under Section </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">409A of the Code. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under the Plan comply with Section 409A of the Code and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by a Participant on account of non-compliance with Section 409A of the Code.</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">Notwithstanding any other provision of the Plan, if any payment or benefit provided to a Participant in connection with his or her Qualifying Termination is determined to constitute &#34;nonqualified deferred compensation&#34; within the meaning of Section 409A of the Code and the Participant is determined to be a &#34;specified employee&#34; as defined in Section 409A(a)(2)(b)(i) of the Code, then such payment or benefit shall not be paid until the first payroll date to occur following the six-month anniversary of the Qualifying Termination or, if earlier, on the Participant's death (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Specified Employee Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;). The aggregate of any payments that would otherwise have been paid before the Specified Employee Payment Date shall be paid to the Participant in a lump sum on the Specified Employee Payment Date and thereafter, any remaining payments shall be paid without delay in accordance with their original schedule. Notwithstanding any other provision of the Plan, if any payment or benefit is conditioned on the Participant's execution of a Release&#47;Severance Agreement, the first payment shall include all amounts that would otherwise have been paid to the Participant during the period beginning on the date of the Qualifying Termination and ending on the payment date if no delay had been imposed.</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:4.02pt">To the extent required by Section 409A of the Code, each reimbursement or in-kind benefit provided under the Plan shall be provided in accordance with the following&#58; (i) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year&#59; and (ii) any right to reimbursements or in-kind benefits under the Plan shall not be subject to liquidation or exchange for another benefit. </font></div><div style="margin-bottom:12pt;margin-top:6pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, and as conclusive evidence of the adoption of this Plan, Medifast, Inc. has caused this Plan to be duly executed in its name and behalf by its proper officer thereunto duly authorized as of the Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">__&#47;s&#47; DANIEL R. CHARD______________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">___November 7, 2019__________________&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Daniel R. Chard,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Executive Officer,</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Medifast, Inc.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amended on September 10, 2020</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Qualifying Termination (General)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Cash Severance</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Annual Bonus &#8211; Year of Termination</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stock Options</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Time-Based Restricted Shares or Deferred Shares</font></td><td colspan="3" style="border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Performance-Based Restricted Shares or Deferred Shares</font></td></tr><tr style="height:99pt"><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5 times the sum of the Annual Base Salary and the Target Bonus</font></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pro-rated annual bonus for year of termination, based on the number of full months during the year the Participant was employed, paid at the end of the year based on actual Company performance</font></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Fully vest and remain exercisable for 90 days</font></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vest on a pro-rata basis, based on the number of full months during the vesting period the Participant was employed</font></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vest on a pro-rata basis, based on the number of full months during the performance period the Participant was employed, paid out at the end of the performance period based on actual performance</font></td></tr><tr style="height:154pt"><td colspan="3" style="border-bottom:1pt solid #999999;border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Other Executives</font></td><td colspan="3" style="border-bottom:1pt solid #999999;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1 times the sum of the Annual Base Salary and the Target Bonus</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Cash Severance shall be paid in a lump sum, no later than 30 days following the Termination Date, subject to Section 3.03.&#160;The Annual Bonus &#8211; Year of Termination will be paid at the same time the annual bonus is paid to active employees, subject to Section 3.03.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Amended on June 16, 2022</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Qualifying Termination Following Change in Control</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Cash Severance</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Annual Bonus &#8211; Year of Termination</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stock Options</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Time-Based Restricted Shares or Deferred Shares</font></td><td colspan="3" style="border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Performance-Based Restricted Shares or Deferred Shares</font></td></tr><tr style="height:111pt"><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5 times the sum of the Annual Base Salary and the Target Bonus</font></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1.5pt solid #666666;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Bonus for year of termination, pro-rated based on the number of full months during the year the Participant was employed, based on the greater of (i) target level performance OR (ii) actual Company performance as determined by the most recent forecast as of the date of termination</font></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1.5pt solid #666666;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Fully vest and remain exercisable for 90 days</font></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1.5pt solid #666666;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Fully vest</font></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1.5pt solid #666666;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vest on a pro-rata basis, based on the number of full months during the performance period the Participant was employed, at the greater of (i) target level performance OR (ii) actual Company performance as determined by the most recent financial projections&#47;forecast used for accrual purposes as of the date of termination. For those PSU grants that may contain a PSU kicker, the kicker shall be calculated based on the Company&#8217;s most current projection of performance</font></td></tr><tr style="height:294pt"><td colspan="3" style="border-bottom:1pt solid #999999;border-left:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Other Executives</font></td><td colspan="3" style="border-bottom:1pt solid #999999;border-left:1pt solid #999999;border-right:1pt solid #999999;border-top:1pt solid #999999;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5 times the sum of the Annual Base Salary and the Target Bonus</font></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cash Severance and Annual Bonus &#8211; Year of Termination shall be paid in a lump sum, no later than 30 days following the Termination Date, subject to Section 3.03.&#160;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;11</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>med-20220331xexx3111.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7d61968eb26f496e8de6981bfdd6549f_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel R. Chard, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this report on Form 10-Q of Medifast, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Daniel R. Chard</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel R. Chard</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>med-20220331xexx3121.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i155bd15980974046988073255549c268_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James P. Maloney, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this report on Form 10-Q of Medifast, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;James P. Maloney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>med-20220331xexx3211.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1ffa2490ff3b4d5fb8cad60b6d084786_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q (the &#8220;Report&#8221;) for the quarter ended March 31, 2022 of Medifast, Inc. (the &#8220;Company&#8221;), as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Daniel R. Chard, Chief Executive Officer and I, James P. Maloney, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of the operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DANIEL R. CHARD</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel R. Chard</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JAMES P. MALONEY</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>med-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cb14b1a-882e-4c5a-abba-92937aa2b6a2,g:d04941c9-f1d8-4931-a062-5edb28a6369a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:med="http://www.medifast1.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medifast1.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.medifast1.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.medifast1.com/role/INVENTORIES">
        <link:definition>2103102 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.medifast1.com/role/INVENTORIESTables">
        <link:definition>2304301 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.medifast1.com/role/INVENTORIESDetails">
        <link:definition>2405401 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.medifast1.com/role/EARNINGSPERSHARE">
        <link:definition>2106103 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.medifast1.com/role/EARNINGSPERSHARETables">
        <link:definition>2307302 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails">
        <link:definition>2408402 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARENarrativeDetails" roleURI="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails">
        <link:definition>2409403 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATION" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATION">
        <link:definition>2110104 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>2311303 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>2412404 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails">
        <link:definition>2413405 - Disclosure - SHARE-BASED COMPENSATION - Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails">
        <link:definition>2414406 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails">
        <link:definition>2415407 - Disclosure - SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.medifast1.com/role/LEASES">
        <link:definition>2116105 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.medifast1.com/role/LEASESTables">
        <link:definition>2317304 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://www.medifast1.com/role/LEASESNarrativeDetails">
        <link:definition>2418408 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSupplementalCashFlowInformationDetails" roleURI="http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails">
        <link:definition>2419409 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESFutureMinimumLeaseCommitmentsDetails" roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails">
        <link:definition>2420410 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESFutureMinimumLeaseCommitmentsDetails_1" roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1">
        <link:definition>2420410 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOME" roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME">
        <link:definition>2121106 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables">
        <link:definition>2322305 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>2423411 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2124107 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2325306 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSNarrativeDetails" roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails">
        <link:definition>2426412 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails">
        <link:definition>2427413 - Disclosure - FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.medifast1.com/role/DEBT">
        <link:definition>2128108 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://www.medifast1.com/role/DEBTNarrativeDetails">
        <link:definition>2429414 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASEASR" roleURI="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASR">
        <link:definition>2130109 - Disclosure - ACCELERATED SHARE REPURCHASE ("ASR")</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASEASRDetails" roleURI="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRDetails">
        <link:definition>2431415 - Disclosure - ACCELERATED SHARE REPURCHASE ("ASR") (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="med_NumeratorAbstract" abstract="true" name="NumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="med_GrantedIn2020Member" abstract="true" name="GrantedIn2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" abstract="false" name="AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_OperatingLeaseArrangementForEquipmentMember" abstract="true" name="OperatingLeaseArrangementForEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_GovernmentAgencySecuritiesMember" abstract="true" name="GovernmentAgencySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_OperatingLeaseArrangementForRealEstateMember" abstract="true" name="OperatingLeaseArrangementForRealEstateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_MinimumInterestCoverageRatio" abstract="false" name="MinimumInterestCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="med_DenominatorAbstract" abstract="true" name="DenominatorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="med_GrantedIn2022Member" abstract="true" name="GrantedIn2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_GrantedIn2019Member" abstract="true" name="GrantedIn2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_PaymentsForRepurchaseOfCommonStockNotYetSettled" abstract="false" name="PaymentsForRepurchaseOfCommonStockNotYetSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_CashAndCashEquivalentsAndMarketableSecuritiesTable" abstract="true" name="CashAndCashEquivalentsAndMarketableSecuritiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_MarketAndPerformanceSharesMember" abstract="true" name="MarketAndPerformanceSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_GrantedIn2021Member" abstract="true" name="GrantedIn2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_AmortizationOfPremiumOnInvestmentSecurities" abstract="false" name="AmortizationOfPremiumOnInvestmentSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="med_InventoryNonFoodFinishedGoods" abstract="false" name="InventoryNonFoodFinishedGoods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_OptionsAndRestrictedStockMember" abstract="true" name="OptionsAndRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_MaximumTotalNetLeverageRatio" abstract="false" name="MaximumTotalNetLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" abstract="true" name="CashAndCashEquivalentsAndMarketableSecuritiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="med_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_OperatingLeaseExpenseNonCash" abstract="false" name="OperatingLeaseExpenseNonCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>med-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cb14b1a-882e-4c5a-abba-92937aa2b6a2,g:d04941c9-f1d8-4931-a062-5edb28a6369a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e5228c72-272f-4a55-84a2-b9e42c95fd73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9058d329-ecad-4c97-bc66-4b2f37b5e0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e5228c72-272f-4a55-84a2-b9e42c95fd73" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9058d329-ecad-4c97-bc66-4b2f37b5e0c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dc0ab13d-baa1-4d43-a0ed-4389cbc43320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e5228c72-272f-4a55-84a2-b9e42c95fd73" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dc0ab13d-baa1-4d43-a0ed-4389cbc43320" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9bba6cd8-c817-4da1-8798-56991602209b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_f13c3552-5aad-4f32-95ef-8cf0336b5fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_9bba6cd8-c817-4da1-8798-56991602209b" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_f13c3552-5aad-4f32-95ef-8cf0336b5fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1353d211-d144-464c-b6c3-752469bb2196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_9bba6cd8-c817-4da1-8798-56991602209b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1353d211-d144-464c-b6c3-752469bb2196" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9751abb4-b555-4591-a75d-1df4eb41ac99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_670f2e4a-672f-4ef3-83e3-21f545896139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9751abb4-b555-4591-a75d-1df4eb41ac99" xlink:to="loc_us-gaap_OperatingIncomeLoss_670f2e4a-672f-4ef3-83e3-21f545896139" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9e77bcd9-bb5d-4b67-b28d-00a03db87c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9751abb4-b555-4591-a75d-1df4eb41ac99" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9e77bcd9-bb5d-4b67-b28d-00a03db87c1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fa59720b-f834-4469-b206-b976105021ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5902277c-f8f6-43cc-82b9-5da8b6e4e0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fa59720b-f834-4469-b206-b976105021ae" xlink:to="loc_us-gaap_GrossProfit_5902277c-f8f6-43cc-82b9-5da8b6e4e0d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2b9f2e1-9a27-4d54-b14d-6f74dbefc9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fa59720b-f834-4469-b206-b976105021ae" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2b9f2e1-9a27-4d54-b14d-6f74dbefc9d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f82f93a6-5af0-4b8d-9794-99508f8ced8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a2117ce0-64de-4200-89a1-e812098b98c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_f82f93a6-5af0-4b8d-9794-99508f8ced8c" xlink:to="loc_us-gaap_Revenues_a2117ce0-64de-4200-89a1-e812098b98c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_dddaaa72-1cce-424d-a25e-c589e78d5bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_f82f93a6-5af0-4b8d-9794-99508f8ced8c" xlink:to="loc_us-gaap_CostOfRevenue_dddaaa72-1cce-424d-a25e-c589e78d5bc5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4bf80189-0a18-44b6-aa70-639faf02d270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_79401b2c-f28a-43f8-b412-54fc365ee3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4bf80189-0a18-44b6-aa70-639faf02d270" xlink:to="loc_us-gaap_NetIncomeLoss_79401b2c-f28a-43f8-b412-54fc365ee3ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1b905cc5-cf4d-4a9f-856f-1d8709020ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4bf80189-0a18-44b6-aa70-639faf02d270" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1b905cc5-cf4d-4a9f-856f-1d8709020ae9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6f69b6c7-1d7e-46af-b0cb-5fa597cbb5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6352557a-20ad-4ac8-b816-ac7b86ab0989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6f69b6c7-1d7e-46af-b0cb-5fa597cbb5ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6352557a-20ad-4ac8-b816-ac7b86ab0989" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9c462cd4-eac2-44fa-85ae-1cb168d96174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6f69b6c7-1d7e-46af-b0cb-5fa597cbb5ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9c462cd4-eac2-44fa-85ae-1cb168d96174" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2c0549be-6bcb-4bd7-b7d6-7f0cb9b92f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_663daa24-4e59-4fa3-8864-d0884005e205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c0549be-6bcb-4bd7-b7d6-7f0cb9b92f81" xlink:to="loc_us-gaap_ShortTermInvestments_663daa24-4e59-4fa3-8864-d0884005e205" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5a4c7cfb-194f-44c5-a7b1-ae0745f92040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c0549be-6bcb-4bd7-b7d6-7f0cb9b92f81" xlink:to="loc_us-gaap_InventoryNet_5a4c7cfb-194f-44c5-a7b1-ae0745f92040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_f7c3f849-297f-4a14-971f-31b2548cf19a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c0549be-6bcb-4bd7-b7d6-7f0cb9b92f81" xlink:to="loc_us-gaap_PrepaidTaxes_f7c3f849-297f-4a14-971f-31b2548cf19a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f822e732-7c7d-43d1-a292-74604e4dd97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c0549be-6bcb-4bd7-b7d6-7f0cb9b92f81" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f822e732-7c7d-43d1-a292-74604e4dd97c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23b4b04a-b4be-43f1-9c6d-f58af268c510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2c0549be-6bcb-4bd7-b7d6-7f0cb9b92f81" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23b4b04a-b4be-43f1-9c6d-f58af268c510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_da2cc2a1-a072-4783-8541-53237c081ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d86e92cb-beae-4443-ab13-88bd34dd08f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da2cc2a1-a072-4783-8541-53237c081ae4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d86e92cb-beae-4443-ab13-88bd34dd08f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_76206ffb-ddea-41a0-a523-9ccdda0107f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da2cc2a1-a072-4783-8541-53237c081ae4" xlink:to="loc_us-gaap_LiabilitiesCurrent_76206ffb-ddea-41a0-a523-9ccdda0107f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4f273b6b-8a3c-4d91-a660-1e49c29e517b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3ca4d403-b6dd-4089-8ac8-22a8ca39ad66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4f273b6b-8a3c-4d91-a660-1e49c29e517b" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3ca4d403-b6dd-4089-8ac8-22a8ca39ad66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_4e4638d7-2918-46a8-bdf7-70b28528e224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4f273b6b-8a3c-4d91-a660-1e49c29e517b" xlink:to="loc_us-gaap_LinesOfCreditCurrent_4e4638d7-2918-46a8-bdf7-70b28528e224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a0e779d-e440-4db6-b107-c0282f9cabb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4f273b6b-8a3c-4d91-a660-1e49c29e517b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a0e779d-e440-4db6-b107-c0282f9cabb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_90af08b6-aa2c-448e-9933-f6b333617f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9a9e84ad-2999-4452-83b6-94183f585c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90af08b6-aa2c-448e-9933-f6b333617f37" xlink:to="loc_us-gaap_Liabilities_9a9e84ad-2999-4452-83b6-94183f585c38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b3c2050f-16f3-4353-bff9-d4944acfe4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_90af08b6-aa2c-448e-9933-f6b333617f37" xlink:to="loc_us-gaap_StockholdersEquity_b3c2050f-16f3-4353-bff9-d4944acfe4b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2da43123-784c-4b57-82af-78e1fef420d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9984df02-fc8b-4211-8979-2939947e36dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2da43123-784c-4b57-82af-78e1fef420d9" xlink:to="loc_us-gaap_AssetsCurrent_9984df02-fc8b-4211-8979-2939947e36dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fc56e56a-c306-4e04-afdd-5423e21c4995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2da43123-784c-4b57-82af-78e1fef420d9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fc56e56a-c306-4e04-afdd-5423e21c4995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_45aa16e9-2988-4eaf-a21c-acb7851f4072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2da43123-784c-4b57-82af-78e1fef420d9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_45aa16e9-2988-4eaf-a21c-acb7851f4072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_00f99029-8227-42b0-82a5-1169040ff3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2da43123-784c-4b57-82af-78e1fef420d9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_00f99029-8227-42b0-82a5-1169040ff3c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_400c522a-e2d1-40dc-b5f8-d5cab302e257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2da43123-784c-4b57-82af-78e1fef420d9" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_400c522a-e2d1-40dc-b5f8-d5cab302e257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e7e69f2c-79e3-4928-acea-34e344bbddda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4ad96725-6d24-43ad-8d17-79d71674423d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e7e69f2c-79e3-4928-acea-34e344bbddda" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4ad96725-6d24-43ad-8d17-79d71674423d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7e6ba7d4-1ebb-4e84-84b2-e209fc2f9449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e7e69f2c-79e3-4928-acea-34e344bbddda" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7e6ba7d4-1ebb-4e84-84b2-e209fc2f9449" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c17d86aa-ddea-4dfb-bbc0-fc4d11f8561c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e7e69f2c-79e3-4928-acea-34e344bbddda" xlink:to="loc_us-gaap_CommonStockValue_c17d86aa-ddea-4dfb-bbc0-fc4d11f8561c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_20dad990-0743-49cb-99bd-40bfe9ebc0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e7e69f2c-79e3-4928-acea-34e344bbddda" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_20dad990-0743-49cb-99bd-40bfe9ebc0bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84b1a785-58fd-4923-b464-f385d0d2c45b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28264091-b2cc-41af-aabe-b59e72e705ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84b1a785-58fd-4923-b464-f385d0d2c45b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28264091-b2cc-41af-aabe-b59e72e705ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c56e863-faa7-4ccc-8019-3631c6af617a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84b1a785-58fd-4923-b464-f385d0d2c45b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c56e863-faa7-4ccc-8019-3631c6af617a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3396e2bb-dbf0-4c55-a53a-d2717b66c128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84b1a785-58fd-4923-b464-f385d0d2c45b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3396e2bb-dbf0-4c55-a53a-d2717b66c128" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19a6afd7-ae5e-4647-8678-8563d04a9ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84b1a785-58fd-4923-b464-f385d0d2c45b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19a6afd7-ae5e-4647-8678-8563d04a9ec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d249a05a-bcd4-41dd-a04c-87721da34470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_72401543-d506-4a1e-8693-2b4a5f23c2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d249a05a-bcd4-41dd-a04c-87721da34470" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_72401543-d506-4a1e-8693-2b4a5f23c2f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_PaymentsForRepurchaseOfCommonStockNotYetSettled_478f45cb-0d5f-43e0-a0d5-05bb58c38a14" xlink:href="med-20220630.xsd#med_PaymentsForRepurchaseOfCommonStockNotYetSettled"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d249a05a-bcd4-41dd-a04c-87721da34470" xlink:to="loc_med_PaymentsForRepurchaseOfCommonStockNotYetSettled_478f45cb-0d5f-43e0-a0d5-05bb58c38a14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_a2f0bf2d-e905-4804-aa92-1c70d058897f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d249a05a-bcd4-41dd-a04c-87721da34470" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_a2f0bf2d-e905-4804-aa92-1c70d058897f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_7ef6a7e5-b71d-4a72-ba4e-c04cc7135cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d249a05a-bcd4-41dd-a04c-87721da34470" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_7ef6a7e5-b71d-4a72-ba4e-c04cc7135cad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f2a67647-645a-4390-b764-cbf80cb5e71a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d249a05a-bcd4-41dd-a04c-87721da34470" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f2a67647-645a-4390-b764-cbf80cb5e71a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_bf12c860-dfa8-4fb4-bf72-6da3f7ee93f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d249a05a-bcd4-41dd-a04c-87721da34470" xlink:to="loc_us-gaap_PaymentsOfDividends_bf12c860-dfa8-4fb4-bf72-6da3f7ee93f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b1385df3-b761-42c8-86ef-dcd26c9811a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_us-gaap_NetIncomeLoss_b1385df3-b761-42c8-86ef-dcd26c9811a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5567a373-63b8-43e9-8586-67f14048f873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5567a373-63b8-43e9-8586-67f14048f873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash_c7c75dd7-3a8d-401d-aad8-c21687315da2" xlink:href="med-20220630.xsd#med_OperatingLeaseExpenseNonCash"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_med_OperatingLeaseExpenseNonCash_c7c75dd7-3a8d-401d-aad8-c21687315da2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d42861d6-07ee-4534-a615-bcadcf8e9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_us-gaap_ShareBasedCompensation_d42861d6-07ee-4534-a615-bcadcf8e9ab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_AmortizationOfPremiumOnInvestmentSecurities_e5d0293f-ca48-489d-8e0c-6738a4569d0f" xlink:href="med-20220630.xsd#med_AmortizationOfPremiumOnInvestmentSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_med_AmortizationOfPremiumOnInvestmentSecurities_e5d0293f-ca48-489d-8e0c-6738a4569d0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b8622bdd-4a04-4d26-b657-979dc66b1f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b8622bdd-4a04-4d26-b657-979dc66b1f11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_4a43f423-e1dc-48b0-a891-a6d6cb3d5514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_4a43f423-e1dc-48b0-a891-a6d6cb3d5514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_701d97d2-5332-4922-b58d-9a01d60ddf1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_701d97d2-5332-4922-b58d-9a01d60ddf1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7cbd52c4-3ce7-4e53-b854-8a0fcf09cc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7cbd52c4-3ce7-4e53-b854-8a0fcf09cc8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_19acade7-2b53-41a2-ac3a-cca6e05c2213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a3d1218-b58a-48af-88df-2c47ece97433" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_19acade7-2b53-41a2-ac3a-cca6e05c2213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9eab39aa-c286-483b-b87a-e2a88d07ad7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_d09e7746-9484-480f-ba0d-9179e3de8a79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9eab39aa-c286-483b-b87a-e2a88d07ad7d" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_d09e7746-9484-480f-ba0d-9179e3de8a79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_04c581df-66d6-47ef-9515-0b3d539fd09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9eab39aa-c286-483b-b87a-e2a88d07ad7d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_04c581df-66d6-47ef-9515-0b3d539fd09c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="med-20220630.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d10ef878-6d50-405f-82c1-3c0d097e1a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_61e3ca70-9c29-4c09-8fae-3b5f6068c1af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d10ef878-6d50-405f-82c1-3c0d097e1a46" xlink:to="loc_us-gaap_InventoryRawMaterials_61e3ca70-9c29-4c09-8fae-3b5f6068c1af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_4ce22901-b233-4cb0-b66c-970a97db806c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d10ef878-6d50-405f-82c1-3c0d097e1a46" xlink:to="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_4ce22901-b233-4cb0-b66c-970a97db806c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods_8523342c-fec7-49fc-a1b4-4bee05f63200" xlink:href="med-20220630.xsd#med_InventoryNonFoodFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d10ef878-6d50-405f-82c1-3c0d097e1a46" xlink:to="loc_med_InventoryNonFoodFinishedGoods_8523342c-fec7-49fc-a1b4-4bee05f63200" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_360a9384-3dce-451b-8516-f9d26aa41470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d10ef878-6d50-405f-82c1-3c0d097e1a46" xlink:to="loc_us-gaap_InventoryFinishedGoods_360a9384-3dce-451b-8516-f9d26aa41470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_b3f28a36-f00d-436c-a9bb-75e1abd53ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d10ef878-6d50-405f-82c1-3c0d097e1a46" xlink:to="loc_us-gaap_InventoryValuationReserves_b3f28a36-f00d-436c-a9bb-75e1abd53ca4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="med-20220630.xsd#EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e14afbe7-00b6-4e10-837d-01eb65723986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a5ca3982-a58e-4b99-9ca5-8fd397dd22f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e14afbe7-00b6-4e10-837d-01eb65723986" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a5ca3982-a58e-4b99-9ca5-8fd397dd22f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_05721f46-fd2e-45de-b291-3fce7471b437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e14afbe7-00b6-4e10-837d-01eb65723986" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_05721f46-fd2e-45de-b291-3fce7471b437" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="med-20220630.xsd#LEASESFutureMinimumLeaseCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5106f565-7657-4fef-b6cb-f023e4910a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_eabc22b8-e332-4ff2-a77d-969b6362a6db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5106f565-7657-4fef-b6cb-f023e4910a51" xlink:to="loc_us-gaap_OperatingLeaseLiability_eabc22b8-e332-4ff2-a77d-969b6362a6db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b2148552-9d53-4601-94f0-45f46f7847d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5106f565-7657-4fef-b6cb-f023e4910a51" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b2148552-9d53-4601-94f0-45f46f7847d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="med-20220630.xsd#LEASESFutureMinimumLeaseCommitmentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c8b2eae-4d1f-4400-a7a5-4f5257964987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_53653e8a-f3fb-49cf-afb6-fec440861a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c8b2eae-4d1f-4400-a7a5-4f5257964987" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_53653e8a-f3fb-49cf-afb6-fec440861a2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a1d37ced-cca2-4366-b4e1-ca40f38065ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c8b2eae-4d1f-4400-a7a5-4f5257964987" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a1d37ced-cca2-4366-b4e1-ca40f38065ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8901e7af-29d7-43c4-8473-b3ae5129433f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c8b2eae-4d1f-4400-a7a5-4f5257964987" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8901e7af-29d7-43c4-8473-b3ae5129433f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2a8f26cb-1732-4a0d-b7be-c896276c3cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c8b2eae-4d1f-4400-a7a5-4f5257964987" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2a8f26cb-1732-4a0d-b7be-c896276c3cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8a99c6a5-eb8a-4a6c-ba4d-99170746da1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c8b2eae-4d1f-4400-a7a5-4f5257964987" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8a99c6a5-eb8a-4a6c-ba4d-99170746da1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_62cdb32c-741a-41c6-8349-3b7b7f8158e1" xlink:href="med-20220630.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c8b2eae-4d1f-4400-a7a5-4f5257964987" xlink:to="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_62cdb32c-741a-41c6-8349-3b7b7f8158e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0667b40a-59e7-45c9-b90b-4fc56ebae9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4d3c511d-4fe7-4d14-bf77-c78d04f991f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0667b40a-59e7-45c9-b90b-4fc56ebae9f4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4d3c511d-4fe7-4d14-bf77-c78d04f991f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_85307608-5dd1-4dbf-b494-582dc805604f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0667b40a-59e7-45c9-b90b-4fc56ebae9f4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_85307608-5dd1-4dbf-b494-582dc805604f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>med-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cb14b1a-882e-4c5a-abba-92937aa2b6a2,g:d04941c9-f1d8-4931-a062-5edb28a6369a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="extended" id="i85dff8789ca249fea77f341b952d7ad4_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8d637d02-4c0e-4f46-a9a8-ca40bce8e688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_SharesIssued_8d637d02-4c0e-4f46-a9a8-ca40bce8e688" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5a0aeb9f-eee2-4bf2-92d2-9e60ffc81700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_StockholdersEquity_5a0aeb9f-eee2-4bf2-92d2-9e60ffc81700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b078844b-9a7d-4922-a1d0-2424d4ea1b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_NetIncomeLoss_b078844b-9a7d-4922-a1d0-2424d4ea1b91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_78d1d5da-fdee-4a73-b3ec-35e731fe7fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_78d1d5da-fdee-4a73-b3ec-35e731fe7fd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_26257a34-20e0-4de6-bfb7-0db1fe7c162f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_26257a34-20e0-4de6-bfb7-0db1fe7c162f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_803b5eff-339e-4f0e-b404-fd7c4a2cb334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_803b5eff-339e-4f0e-b404-fd7c4a2cb334" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_760f2775-2441-46fa-aa3b-78a58b55e8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_760f2775-2441-46fa-aa3b-78a58b55e8df" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_ae6ec770-6661-4843-968d-271f8a2b8749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_ae6ec770-6661-4843-968d-271f8a2b8749" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_613fbe8c-628d-4bfb-bc59-494ddd2e1742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_613fbe8c-628d-4bfb-bc59-494ddd2e1742" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bb5a3157-73d4-4f67-b615-7e6ef7dced57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bb5a3157-73d4-4f67-b615-7e6ef7dced57" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_bb8ea771-5a57-4c09-8f7b-5aaffe0a9fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_bb8ea771-5a57-4c09-8f7b-5aaffe0a9fbc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_da003657-955d-4cd9-a3cd-c03a496f3140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_da003657-955d-4cd9-a3cd-c03a496f3140" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_6d565f8e-2082-49e7-b40b-9ae2e6df5c76" xlink:href="med-20220630.xsd#med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_6d565f8e-2082-49e7-b40b-9ae2e6df5c76" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f0a8a95f-ee9c-4018-bb50-ac9557edf0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f0a8a95f-ee9c-4018-bb50-ac9557edf0d8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_500183dc-8de3-4fa0-965c-33aca4b12e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_DividendsCommonStockCash_500183dc-8de3-4fa0-965c-33aca4b12e76" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_56eb7d56-916e-4f4a-bdae-2a6ddbf9aa07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84bc387f-e217-4cb1-b3db-8a219cf429d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f510eab-b8a5-4bf6-b960-242260014162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_StatementTable_1f510eab-b8a5-4bf6-b960-242260014162" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3f5d971-99a7-4773-9bb7-7fbeb01703af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1f510eab-b8a5-4bf6-b960-242260014162" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3f5d971-99a7-4773-9bb7-7fbeb01703af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b3f5d971-99a7-4773-9bb7-7fbeb01703af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3f5d971-99a7-4773-9bb7-7fbeb01703af" xlink:to="loc_us-gaap_EquityComponentDomain_b3f5d971-99a7-4773-9bb7-7fbeb01703af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3f5d971-99a7-4773-9bb7-7fbeb01703af" xlink:to="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6d23fc86-5c14-4cd1-8dbe-72644a3fcb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_CommonStockMember_6d23fc86-5c14-4cd1-8dbe-72644a3fcb2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1be4562d-ecf2-4676-974f-e6a52b086dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1be4562d-ecf2-4676-974f-e6a52b086dbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e4c7cc5f-2128-44cc-9371-69552183db5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e4c7cc5f-2128-44cc-9371-69552183db5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6eaa3204-4623-4ed7-8998-36da4475007f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_RetainedEarningsMember_6eaa3204-4623-4ed7-8998-36da4475007f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_53d636d4-ca57-4daf-ae97-8e2165848b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_TreasuryStockCommonMember_53d636d4-ca57-4daf-ae97-8e2165848b16" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended" id="idbc6e914be6744ecb7649037a24bed9d_EARNINGSPERSHARENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8c9793e0-e30a-470c-af36-7235f866a0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_63a7d36c-9df8-4ba5-b475-a2958575e191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8c9793e0-e30a-470c-af36-7235f866a0da" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_63a7d36c-9df8-4ba5-b475-a2958575e191" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7ec9190c-4e67-46cc-8472-55b57d505b92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8c9793e0-e30a-470c-af36-7235f866a0da" xlink:to="loc_us-gaap_StatementTable_7ec9190c-4e67-46cc-8472-55b57d505b92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0fd01883-45bc-462c-bed1-aa95991cb97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7ec9190c-4e67-46cc-8472-55b57d505b92" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0fd01883-45bc-462c-bed1-aa95991cb97f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0fd01883-45bc-462c-bed1-aa95991cb97f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0fd01883-45bc-462c-bed1-aa95991cb97f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0fd01883-45bc-462c-bed1-aa95991cb97f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d7d6597-ec91-42d9-b48c-6d3ed77a16a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0fd01883-45bc-462c-bed1-aa95991cb97f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d7d6597-ec91-42d9-b48c-6d3ed77a16a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_5a63abdd-bf37-445c-9f04-7ecec18953dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d7d6597-ec91-42d9-b48c-6d3ed77a16a1" xlink:to="loc_us-gaap_RestrictedStockMember_5a63abdd-bf37-445c-9f04-7ecec18953dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="i99217f2d10c246fe9ec6344cf18c61ad_SHAREBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cf26d35b-99d1-4537-8482-fb1e55997e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cf26d35b-99d1-4537-8482-fb1e55997e55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0840ca7a-7113-4a78-928e-87cb1be4ab23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0840ca7a-7113-4a78-928e-87cb1be4ab23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_206e5825-563a-4f8e-9a53-63864de4d267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_206e5825-563a-4f8e-9a53-63864de4d267" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_870f9f65-ea55-4287-8020-88e045492199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_870f9f65-ea55-4287-8020-88e045492199" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39c852e8-bff3-440a-a2b6-f70c2542ee67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39c852e8-bff3-440a-a2b6-f70c2542ee67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_89b6757f-e955-4d1a-8bb4-d210ac26f592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_89b6757f-e955-4d1a-8bb4-d210ac26f592" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2d8de65-e14f-4d01-ab8e-5b7dae203395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2d8de65-e14f-4d01-ab8e-5b7dae203395" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_bc9478bc-6449-4144-823d-1f7ef34e9b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_bc9478bc-6449-4144-823d-1f7ef34e9b6f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_45c33938-71db-46aa-8301-80f7e4b02efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_45c33938-71db-46aa-8301-80f7e4b02efa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_00ebf83d-75c6-49f9-9511-3b505b0f765e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_00ebf83d-75c6-49f9-9511-3b505b0f765e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d406e3f3-358d-4a6a-a27e-b5c8a41b00a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d406e3f3-358d-4a6a-a27e-b5c8a41b00a7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1a37e762-6931-4e27-923e-0b04765372e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1a37e762-6931-4e27-923e-0b04765372e2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3cc4457b-3ea1-437a-b251-16c9eb362414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3cc4457b-3ea1-437a-b251-16c9eb362414" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_60932433-a719-473a-80f9-850044673eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_60932433-a719-473a-80f9-850044673eb3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_786aa42b-a713-4cce-a09e-52acb34e89e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_786aa42b-a713-4cce-a09e-52acb34e89e0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_5850fcc5-d43a-4846-93a9-553b1db8e06d" xlink:href="med-20220630.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_5850fcc5-d43a-4846-93a9-553b1db8e06d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_ffd3ebfd-017e-4855-8109-b8d36a3d019e" xlink:href="med-20220630.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_ffd3ebfd-017e-4855-8109-b8d36a3d019e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2a0fada7-c875-4f79-9ef3-090b0df11a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2a0fada7-c875-4f79-9ef3-090b0df11a10" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_00a7369d-2201-4a7b-b155-6238094d50e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_00a7369d-2201-4a7b-b155-6238094d50e8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_876e12e1-f385-4596-a869-09014a86cb02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_876e12e1-f385-4596-a869-09014a86cb02" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b37a5751-a098-4bba-a6c1-9695f66c97d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b37a5751-a098-4bba-a6c1-9695f66c97d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5d1d8af2-3126-43aa-a399-26b0648f7ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b37a5751-a098-4bba-a6c1-9695f66c97d0" xlink:to="loc_us-gaap_AwardTypeAxis_5d1d8af2-3126-43aa-a399-26b0648f7ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d1d8af2-3126-43aa-a399-26b0648f7ff1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5d1d8af2-3126-43aa-a399-26b0648f7ff1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d1d8af2-3126-43aa-a399-26b0648f7ff1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5d1d8af2-3126-43aa-a399-26b0648f7ff1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a6d25b18-f568-40a6-a007-eafaf8c89af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:to="loc_us-gaap_RestrictedStockMember_a6d25b18-f568-40a6-a007-eafaf8c89af5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9fd4bd51-e16d-427a-9304-a9a5b88f48b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9fd4bd51-e16d-427a-9304-a9a5b88f48b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_91e778e8-38d4-47dc-a309-7040228d0142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:to="loc_us-gaap_PerformanceSharesMember_91e778e8-38d4-47dc-a309-7040228d0142" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_eee2600b-eed4-455c-aaae-5ce98fc590cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b37a5751-a098-4bba-a6c1-9695f66c97d0" xlink:to="loc_srt_RangeAxis_eee2600b-eed4-455c-aaae-5ce98fc590cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eee2600b-eed4-455c-aaae-5ce98fc590cd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_eee2600b-eed4-455c-aaae-5ce98fc590cd" xlink:to="loc_srt_RangeMember_eee2600b-eed4-455c-aaae-5ce98fc590cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dc8b768c-79ad-47b4-be18-e36cb566002b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_eee2600b-eed4-455c-aaae-5ce98fc590cd" xlink:to="loc_srt_RangeMember_dc8b768c-79ad-47b4-be18-e36cb566002b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cc11f4ca-2333-4f7d-9979-14fd97ebdda0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dc8b768c-79ad-47b4-be18-e36cb566002b" xlink:to="loc_srt_MinimumMember_cc11f4ca-2333-4f7d-9979-14fd97ebdda0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1dd2fec4-8bdf-484e-9aa1-8612e01d9e89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dc8b768c-79ad-47b4-be18-e36cb566002b" xlink:to="loc_srt_MaximumMember_1dd2fec4-8bdf-484e-9aa1-8612e01d9e89" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" xlink:type="extended" id="i3aa82ad96327438ba9be4e37ae7c7eb1_SHAREBASEDCOMPENSATIONStockOptionsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2ee95144-68b8-458f-8f69-73eb6ddafc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2ee95144-68b8-458f-8f69-73eb6ddafc72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61b09c59-5c82-47ac-a68d-9189a106949f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61b09c59-5c82-47ac-a68d-9189a106949f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c04269d9-329a-44ef-baac-92c9f8957fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9ffc18aa-b9e1-4019-869b-a7e4b9f8ee3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9ffc18aa-b9e1-4019-869b-a7e4b9f8ee3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f902d8e2-cb41-4eaa-b5eb-8407f1849c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f902d8e2-cb41-4eaa-b5eb-8407f1849c86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_51ddfdc2-834d-4567-ada2-d5e5a082bf88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_51ddfdc2-834d-4567-ada2-d5e5a082bf88" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_599fc9ed-9cf5-4c35-b622-99f383885edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_74ef309a-c455-43f6-ac76-2b535df17911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_74ef309a-c455-43f6-ac76-2b535df17911" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d028527d-9970-4f72-be05-dc12df77f254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d028527d-9970-4f72-be05-dc12df77f254" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_56246af6-1420-47ac-8e4d-a12cc6ab25be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d028527d-9970-4f72-be05-dc12df77f254" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_56246af6-1420-47ac-8e4d-a12cc6ab25be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_56246af6-1420-47ac-8e4d-a12cc6ab25be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_56246af6-1420-47ac-8e4d-a12cc6ab25be" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_56246af6-1420-47ac-8e4d-a12cc6ab25be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_8e24c148-ddbf-49fe-9576-b3825e255a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_56246af6-1420-47ac-8e4d-a12cc6ab25be" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_8e24c148-ddbf-49fe-9576-b3825e255a24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_35365dbd-5818-441c-9ec5-c06b2858fc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_8e24c148-ddbf-49fe-9576-b3825e255a24" xlink:to="loc_us-gaap_EmployeeStockOptionMember_35365dbd-5818-441c-9ec5-c06b2858fc83" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="extended" id="i948ae90f5e5a461193b4bf965e5cfca2_SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2de0929-76ce-4db8-9ff5-8f7c6f996c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2de0929-76ce-4db8-9ff5-8f7c6f996c78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_98af01f2-8745-48e4-a912-99338d1028a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_98af01f2-8745-48e4-a912-99338d1028a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_84946d6d-f298-42b4-af7c-3c2d13481315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_84946d6d-f298-42b4-af7c-3c2d13481315" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e63e3b35-308a-41f5-9e58-9f1d29ea309d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e63e3b35-308a-41f5-9e58-9f1d29ea309d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1dcc0338-64f6-45c1-94c3-5b368e515916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1dcc0338-64f6-45c1-94c3-5b368e515916" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64ec2815-502c-4870-b494-9f3a4d06f83c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2de0929-76ce-4db8-9ff5-8f7c6f996c78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f883f900-d612-4e47-8a0e-2d137c3303fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f883f900-d612-4e47-8a0e-2d137c3303fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_084c4057-ba3c-4fca-8f06-424ba99f5f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_084c4057-ba3c-4fca-8f06-424ba99f5f03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f7fb8f0a-b0ff-4544-8aeb-045ddcd86fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f7fb8f0a-b0ff-4544-8aeb-045ddcd86fe8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d88cf947-1fa8-4050-91ac-4307466128ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d88cf947-1fa8-4050-91ac-4307466128ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7bc8e5bf-a8ee-453d-8fbe-c8c9523a6434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5cc05cc7-5efe-4cb7-a41d-0517abd393d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2de0929-76ce-4db8-9ff5-8f7c6f996c78" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5cc05cc7-5efe-4cb7-a41d-0517abd393d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7c7f8950-171a-4fd9-bfda-17615e367838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5cc05cc7-5efe-4cb7-a41d-0517abd393d2" xlink:to="loc_us-gaap_AwardTypeAxis_7c7f8950-171a-4fd9-bfda-17615e367838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7f8950-171a-4fd9-bfda-17615e367838_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7c7f8950-171a-4fd9-bfda-17615e367838" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7f8950-171a-4fd9-bfda-17615e367838_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_282afdcb-db77-4d04-933d-10613658ad2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7c7f8950-171a-4fd9-bfda-17615e367838" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_282afdcb-db77-4d04-933d-10613658ad2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_f590aaf2-cb44-45e5-9979-b6cbade69f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_282afdcb-db77-4d04-933d-10613658ad2f" xlink:to="loc_us-gaap_RestrictedStockMember_f590aaf2-cb44-45e5-9979-b6cbade69f28" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="extended" id="i7ddb67679ec443ddbdf42681b06c5ace_SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a3cd14c-eff6-4ffc-b4ea-22206fbb0b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5902340b-68a4-45a1-b9a8-f84779272b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a3cd14c-eff6-4ffc-b4ea-22206fbb0b31" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5902340b-68a4-45a1-b9a8-f84779272b05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2c2b51c4-afea-4ab9-938e-eb16eac793ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a3cd14c-eff6-4ffc-b4ea-22206fbb0b31" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2c2b51c4-afea-4ab9-938e-eb16eac793ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10e26611-d1c3-4769-8192-5ca2b15696ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a3cd14c-eff6-4ffc-b4ea-22206fbb0b31" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10e26611-d1c3-4769-8192-5ca2b15696ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_26394226-fb90-4d16-9bb5-f97ed82f079c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10e26611-d1c3-4769-8192-5ca2b15696ff" xlink:to="loc_us-gaap_AwardTypeAxis_26394226-fb90-4d16-9bb5-f97ed82f079c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26394226-fb90-4d16-9bb5-f97ed82f079c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_26394226-fb90-4d16-9bb5-f97ed82f079c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26394226-fb90-4d16-9bb5-f97ed82f079c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_26394226-fb90-4d16-9bb5-f97ed82f079c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OptionsAndRestrictedStockMember_7d401522-48af-46d0-8825-a6631ef0c729" xlink:href="med-20220630.xsd#med_OptionsAndRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:to="loc_med_OptionsAndRestrictedStockMember_7d401522-48af-46d0-8825-a6631ef0c729" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceSharesMember_b6ea66b7-2ee4-4a46-9853-3b74df68a8ac" xlink:href="med-20220630.xsd#med_MarketAndPerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:to="loc_med_MarketAndPerformanceSharesMember_b6ea66b7-2ee4-4a46-9853-3b74df68a8ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_7e8605fe-b481-4fa8-8c52-afc5e961b798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:to="loc_us-gaap_PerformanceSharesMember_7e8605fe-b481-4fa8-8c52-afc5e961b798" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_51eb8c0c-f955-4fc5-bfe8-665ef2dc71b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10e26611-d1c3-4769-8192-5ca2b15696ff" xlink:to="loc_us-gaap_AwardDateAxis_51eb8c0c-f955-4fc5-bfe8-665ef2dc71b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_51eb8c0c-f955-4fc5-bfe8-665ef2dc71b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_51eb8c0c-f955-4fc5-bfe8-665ef2dc71b2" xlink:to="loc_us-gaap_AwardDateDomain_51eb8c0c-f955-4fc5-bfe8-665ef2dc71b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_51eb8c0c-f955-4fc5-bfe8-665ef2dc71b2" xlink:to="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member_9ce93933-9b38-4bba-9283-3d0e1aa1fa86" xlink:href="med-20220630.xsd#med_GrantedIn2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:to="loc_med_GrantedIn2022Member_9ce93933-9b38-4bba-9283-3d0e1aa1fa86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2021Member_d6b51d5f-ba70-4a46-82b2-36c10b2b28a4" xlink:href="med-20220630.xsd#med_GrantedIn2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:to="loc_med_GrantedIn2021Member_d6b51d5f-ba70-4a46-82b2-36c10b2b28a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2020Member_ee66e465-fd6c-42e6-845e-18b7b2ba93f1" xlink:href="med-20220630.xsd#med_GrantedIn2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:to="loc_med_GrantedIn2020Member_ee66e465-fd6c-42e6-845e-18b7b2ba93f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2019Member_80c8318a-1a2b-4704-a5b6-76a07d08eafa" xlink:href="med-20220630.xsd#med_GrantedIn2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:to="loc_med_GrantedIn2019Member_80c8318a-1a2b-4704-a5b6-76a07d08eafa" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="extended" id="i59db5785515e41d890a51c7d7d5cb133_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_0cde99ef-e463-49a7-a2a9-31d52515d806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_aa9892ec-516f-4ea7-8ce0-e3bca3ddd81d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0cde99ef-e463-49a7-a2a9-31d52515d806" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_aa9892ec-516f-4ea7-8ce0-e3bca3ddd81d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_b653f4db-37e2-441e-999f-5b070666e31f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0cde99ef-e463-49a7-a2a9-31d52515d806" xlink:to="loc_us-gaap_OperatingLeaseExpense_b653f4db-37e2-441e-999f-5b070666e31f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b90fa5a3-5e6d-4df5-9c27-7af80a642d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0cde99ef-e463-49a7-a2a9-31d52515d806" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b90fa5a3-5e6d-4df5-9c27-7af80a642d45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_17d97a6e-ef09-4a32-84b0-a2e9c12988a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b90fa5a3-5e6d-4df5-9c27-7af80a642d45" xlink:to="loc_srt_RangeAxis_17d97a6e-ef09-4a32-84b0-a2e9c12988a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17d97a6e-ef09-4a32-84b0-a2e9c12988a4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_17d97a6e-ef09-4a32-84b0-a2e9c12988a4" xlink:to="loc_srt_RangeMember_17d97a6e-ef09-4a32-84b0-a2e9c12988a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b72f3cd-1726-4d00-b6c5-80fbf11cc355" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_17d97a6e-ef09-4a32-84b0-a2e9c12988a4" xlink:to="loc_srt_RangeMember_1b72f3cd-1726-4d00-b6c5-80fbf11cc355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_486d01c9-77f9-409d-9d16-22c335a5def6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1b72f3cd-1726-4d00-b6c5-80fbf11cc355" xlink:to="loc_srt_MinimumMember_486d01c9-77f9-409d-9d16-22c335a5def6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7094fc11-a868-42b7-aa43-f2d7757a9845" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1b72f3cd-1726-4d00-b6c5-80fbf11cc355" xlink:to="loc_srt_MaximumMember_7094fc11-a868-42b7-aa43-f2d7757a9845" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_28e74198-2b61-4f5a-a28f-f145f8b53737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b90fa5a3-5e6d-4df5-9c27-7af80a642d45" xlink:to="loc_us-gaap_TypeOfArrangementAxis_28e74198-2b61-4f5a-a28f-f145f8b53737" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_28e74198-2b61-4f5a-a28f-f145f8b53737_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_28e74198-2b61-4f5a-a28f-f145f8b53737" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_28e74198-2b61-4f5a-a28f-f145f8b53737_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b2b1d7c-87a2-47c4-a8d1-e93b4f5ec792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_28e74198-2b61-4f5a-a28f-f145f8b53737" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b2b1d7c-87a2-47c4-a8d1-e93b4f5ec792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForRealEstateMember_25133b6e-08a0-4682-9289-f814b5889b84" xlink:href="med-20220630.xsd#med_OperatingLeaseArrangementForRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b2b1d7c-87a2-47c4-a8d1-e93b4f5ec792" xlink:to="loc_med_OperatingLeaseArrangementForRealEstateMember_25133b6e-08a0-4682-9289-f814b5889b84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForEquipmentMember_b86d7311-9e81-4909-ab4e-6885dc385b9b" xlink:href="med-20220630.xsd#med_OperatingLeaseArrangementForEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b2b1d7c-87a2-47c4-a8d1-e93b4f5ec792" xlink:to="loc_med_OperatingLeaseArrangementForEquipmentMember_b86d7311-9e81-4909-ab4e-6885dc385b9b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" xlink:type="simple" xlink:href="med-20220630.xsd#FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" xlink:type="extended" id="i1fedafb74e4d4d1e82498ae7dfc7746c_FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:href="med-20220630.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_58f552bd-5c3a-4907-bd06-d159b3b7fea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_MarketableSecurities_58f552bd-5c3a-4907-bd06-d159b3b7fea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_bd188fa0-08d4-4dd2-80db-15a1c0b32124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_bd188fa0-08d4-4dd2-80db-15a1c0b32124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_d877e224-cae8-4204-917f-e1d722afe853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_InterestReceivable_d877e224-cae8-4204-917f-e1d722afe853" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7b3f1183-62d3-4f8f-a86b-50ac8a20c1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7b3f1183-62d3-4f8f-a86b-50ac8a20c1a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_79a6541f-37bf-4284-a6e2-992d8e27dc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_79a6541f-37bf-4284-a6e2-992d8e27dc3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_6908a2a6-54fd-49fd-8f47-938d345391bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_6908a2a6-54fd-49fd-8f47-938d345391bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:href="med-20220630.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec3dee43-b7aa-4ec9-8940-dc8311b55179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec3dee43-b7aa-4ec9-8940-dc8311b55179" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ec3dee43-b7aa-4ec9-8940-dc8311b55179_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec3dee43-b7aa-4ec9-8940-dc8311b55179" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ec3dee43-b7aa-4ec9-8940-dc8311b55179_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fca6cc9e-ca56-4d19-8361-dfea1756f52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec3dee43-b7aa-4ec9-8940-dc8311b55179" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fca6cc9e-ca56-4d19-8361-dfea1756f52b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3e1b42f3-ac19-4c09-bc08-3e80affd381b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fca6cc9e-ca56-4d19-8361-dfea1756f52b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3e1b42f3-ac19-4c09-bc08-3e80affd381b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_215a3ced-a0fe-4dfb-8505-49ff5adeb673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fca6cc9e-ca56-4d19-8361-dfea1756f52b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_215a3ced-a0fe-4dfb-8505-49ff5adeb673" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_ab160769-4d94-4eaa-bcd1-14200343765a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_ab160769-4d94-4eaa-bcd1-14200343765a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ab160769-4d94-4eaa-bcd1-14200343765a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_ab160769-4d94-4eaa-bcd1-14200343765a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_ab160769-4d94-4eaa-bcd1-14200343765a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_ab160769-4d94-4eaa-bcd1-14200343765a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_63202c0e-4cd2-433a-b270-1c1cfd80ac17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:to="loc_us-gaap_CashMember_63202c0e-4cd2-433a-b270-1c1cfd80ac17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a686113d-fdd8-402d-8dd6-19149f4ec365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a686113d-fdd8-402d-8dd6-19149f4ec365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GovernmentAgencySecuritiesMember_424bd536-e80d-41e3-b9e4-be7b93bb008f" xlink:href="med-20220630.xsd#med_GovernmentAgencySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:to="loc_med_GovernmentAgencySecuritiesMember_424bd536-e80d-41e3-b9e4-be7b93bb008f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7a1b0ecd-f849-4dba-a326-0585bd98680b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:to="loc_us-gaap_InvestmentTypeAxis_7a1b0ecd-f849-4dba-a326-0585bd98680b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7a1b0ecd-f849-4dba-a326-0585bd98680b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_7a1b0ecd-f849-4dba-a326-0585bd98680b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7a1b0ecd-f849-4dba-a326-0585bd98680b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c3f2092f-f9f8-41ab-bfbe-0faac475deae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_7a1b0ecd-f849-4dba-a326-0585bd98680b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c3f2092f-f9f8-41ab-bfbe-0faac475deae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_2e4a10d8-5ad9-4e96-af44-45304a3a99bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c3f2092f-f9f8-41ab-bfbe-0faac475deae" xlink:to="loc_us-gaap_MunicipalBondsMember_2e4a10d8-5ad9-4e96-af44-45304a3a99bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/DEBTNarrativeDetails" xlink:type="extended" id="i8f73733da40642b691e3b72b8ad985f2_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0055b685-1136-4e19-b0f7-3d8126637bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0055b685-1136-4e19-b0f7-3d8126637bc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_84984a6b-d3ac-48c2-8d2f-16fe98975bb6" xlink:href="med-20220630.xsd#med_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_84984a6b-d3ac-48c2-8d2f-16fe98975bb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_2ad72a44-68cc-428d-a925-c228e22211ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_2ad72a44-68cc-428d-a925-c228e22211ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2baad536-2eeb-4761-a975-8fcf89c1bfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2baad536-2eeb-4761-a975-8fcf89c1bfd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MaximumTotalNetLeverageRatio_d1734998-eacb-493f-80a2-405823dbc041" xlink:href="med-20220630.xsd#med_MaximumTotalNetLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_med_MaximumTotalNetLeverageRatio_d1734998-eacb-493f-80a2-405823dbc041" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MinimumInterestCoverageRatio_c8abb3cf-9c9c-426f-9093-b7f781633684" xlink:href="med-20220630.xsd#med_MinimumInterestCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_med_MinimumInterestCoverageRatio_c8abb3cf-9c9c-426f-9093-b7f781633684" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_716f285e-d6c3-4129-852f-5d1a2b875a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_716f285e-d6c3-4129-852f-5d1a2b875a6a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7b3d9226-d722-43a9-be6e-3712c409dd20" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:to="loc_srt_RangeAxis_7b3d9226-d722-43a9-be6e-3712c409dd20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b3d9226-d722-43a9-be6e-3712c409dd20_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7b3d9226-d722-43a9-be6e-3712c409dd20" xlink:to="loc_srt_RangeMember_7b3d9226-d722-43a9-be6e-3712c409dd20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b94f7e3-3136-499e-9462-38c987982955" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7b3d9226-d722-43a9-be6e-3712c409dd20" xlink:to="loc_srt_RangeMember_7b94f7e3-3136-499e-9462-38c987982955" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6daa0927-5630-432a-b523-6a7b0088f5e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7b94f7e3-3136-499e-9462-38c987982955" xlink:to="loc_srt_MinimumMember_6daa0927-5630-432a-b523-6a7b0088f5e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4b1cc566-3178-4580-bc14-32fe8ea53150" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7b94f7e3-3136-499e-9462-38c987982955" xlink:to="loc_srt_MaximumMember_4b1cc566-3178-4580-bc14-32fe8ea53150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a4acd087-d58c-4d35-8dc0-7454d8ff57e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:to="loc_us-gaap_DebtInstrumentAxis_a4acd087-d58c-4d35-8dc0-7454d8ff57e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a4acd087-d58c-4d35-8dc0-7454d8ff57e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a4acd087-d58c-4d35-8dc0-7454d8ff57e8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a4acd087-d58c-4d35-8dc0-7454d8ff57e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c443add4-ab15-4c61-bedc-3214c6fda0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a4acd087-d58c-4d35-8dc0-7454d8ff57e8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c443add4-ab15-4c61-bedc-3214c6fda0ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CreditAgreementMember_6cf8b9db-1203-483c-807e-4e93d581b8f2" xlink:href="med-20220630.xsd#med_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c443add4-ab15-4c61-bedc-3214c6fda0ab" xlink:to="loc_med_CreditAgreementMember_6cf8b9db-1203-483c-807e-4e93d581b8f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1e7a72fd-4b77-43a8-a143-c85bad16789d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:to="loc_us-gaap_CreditFacilityAxis_1e7a72fd-4b77-43a8-a143-c85bad16789d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1e7a72fd-4b77-43a8-a143-c85bad16789d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1e7a72fd-4b77-43a8-a143-c85bad16789d" xlink:to="loc_us-gaap_CreditFacilityDomain_1e7a72fd-4b77-43a8-a143-c85bad16789d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_450e8b48-e1d5-4f7a-89a9-163e4c86b7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1e7a72fd-4b77-43a8-a143-c85bad16789d" xlink:to="loc_us-gaap_CreditFacilityDomain_450e8b48-e1d5-4f7a-89a9-163e4c86b7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1fdafe9f-b772-4b34-b77e-a4e0857adb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_450e8b48-e1d5-4f7a-89a9-163e4c86b7e6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1fdafe9f-b772-4b34-b77e-a4e0857adb9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_f30f55a7-436a-449d-bc2b-7d1ff671f74a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_1fdafe9f-b772-4b34-b77e-a4e0857adb9d" xlink:to="loc_us-gaap_LetterOfCreditMember_f30f55a7-436a-449d-bc2b-7d1ff671f74a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a8b69a0a-5a4e-4984-8663-a6c8ca85f42e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:to="loc_us-gaap_VariableRateAxis_a8b69a0a-5a4e-4984-8663-a6c8ca85f42e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a8b69a0a-5a4e-4984-8663-a6c8ca85f42e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_a8b69a0a-5a4e-4984-8663-a6c8ca85f42e" xlink:to="loc_us-gaap_VariableRateDomain_a8b69a0a-5a4e-4984-8663-a6c8ca85f42e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b1ccf2e7-b896-4160-ae81-dc0f5404bc86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_a8b69a0a-5a4e-4984-8663-a6c8ca85f42e" xlink:to="loc_us-gaap_VariableRateDomain_b1ccf2e7-b896-4160-ae81-dc0f5404bc86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_5b139455-2ec5-4a64-8683-4d2ab9cf3b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b1ccf2e7-b896-4160-ae81-dc0f5404bc86" xlink:to="loc_us-gaap_EurodollarMember_5b139455-2ec5-4a64-8683-4d2ab9cf3b7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_bd94b0be-7d3c-4ee2-917f-306e67f42bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b1ccf2e7-b896-4160-ae81-dc0f5404bc86" xlink:to="loc_us-gaap_BaseRateMember_bd94b0be-7d3c-4ee2-917f-306e67f42bde" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>med-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cb14b1a-882e-4c5a-abba-92937aa2b6a2,g:d04941c9-f1d8-4931-a062-5edb28a6369a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ada50a6f-4233-44a9-8d50-1f0d8b711a1c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_d33060b2-36dc-448d-ab2e-7a7023d4d346_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_f393ab7f-861d-4481-8b95-9fc35b7128ec_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_efa61ed9-d73c-4d45-8734-42666aa10856_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations, net of current lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_92afcc9b-4e5c-482c-8a9e-9e6d9339baab_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_33cfc6ba-c0bc-41e0-8482-7007579031f3_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c1e05b40-cfcd-4eaf-b794-4b33b3808fd3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_01d08046-3fb7-4e83-b64e-a98e6fc3dd09_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6df8d9fa-a1c0-49e5-b2bd-9ab92bae5f14_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_7c42d6db-ad9d-4284-934a-bbbceaaf7379_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_bcb80812-627f-42f6-8057-3c195fcf8f54_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_med_MaximumTotalNetLeverageRatio_60395cb2-e5d0-4364-8b57-b1c1acd1b191_terseLabel_en-US" xlink:label="lab_med_MaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Total Net Leverage Ratio</link:label>
    <link:label id="lab_med_MaximumTotalNetLeverageRatio_label_en-US" xlink:label="lab_med_MaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Total Net Leverage Ratio</link:label>
    <link:label id="lab_med_MaximumTotalNetLeverageRatio_documentation_en-US" xlink:label="lab_med_MaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum ratio as of any date, of (a) Total Net Funded Indebtedness on such date to (b) Consolidated EBITDA for the Reference Period ended on such date under credit facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_MaximumTotalNetLeverageRatio" xlink:href="med-20220630.xsd#med_MaximumTotalNetLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_MaximumTotalNetLeverageRatio" xlink:to="lab_med_MaximumTotalNetLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_38ceda4c-2487-48a9-b1d4-faed952f32f1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1a578ddb-061f-434c-a0bb-2109c52844b0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit recognized related to restricted stock awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_3cb9a51b-cb50-4516-9bb2-a451a207be63_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_716d4611-b632-45e9-87e9-69bb2e57ffc7_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_2ba7e4aa-c49c-415f-85cd-e40cf7deae6e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6058436a-ec52-4306-ae30-90138f935138_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_f483c0ef-1746-44d1-9d6f-606c2ab17388_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7765219b-1966-412d-9cca-af0af668a933_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_1581c969-e647-4258-96f4-ac2fc5882673_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared to stockholders</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f09174fd-1065-4617-9b7a-866585190392_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b69a89d5-6440-437a-91df-2df44b48739a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OperatingLeaseArrangementForEquipmentMember_8ac7149b-0098-4d8a-bcd1-97d7874d93ef_terseLabel_en-US" xlink:label="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement for Equipment</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForEquipmentMember_label_en-US" xlink:label="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement For Equipment [Member]</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForEquipmentMember_documentation_en-US" xlink:label="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the operating lease arrangement for equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForEquipmentMember" xlink:href="med-20220630.xsd#med_OperatingLeaseArrangementForEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OperatingLeaseArrangementForEquipmentMember" xlink:to="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3d59349d-e49e-4e69-bba7-73bfc8ea947f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_3a435500-9fb7-4464-a180-d6634a1be2b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1280aede-7f7c-4355-8104-44ba31e6d1c9_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6be4e438-12f2-4b5a-93be-cf16c06d83da_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_737663c8-a139-4f9a-a21d-00f1ce876146_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_d62b6c85-dcb0-4c49-bf2f-4ba9596e85a7_terseLabel_en-US" xlink:label="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accordion feature, increase limit</link:label>
    <link:label id="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, accordion feature, increase limit, subject to certain conditions by obtaining additional commitments from existing and/or new lenders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="med-20220630.xsd#med_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OptionsAndRestrictedStockMember_5c37842d-0385-427a-a16f-d65a2a0ceaea_terseLabel_en-US" xlink:label="lab_med_OptionsAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock</link:label>
    <link:label id="lab_med_OptionsAndRestrictedStockMember_label_en-US" xlink:label="lab_med_OptionsAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock [Member]</link:label>
    <link:label id="lab_med_OptionsAndRestrictedStockMember_documentation_en-US" xlink:label="lab_med_OptionsAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OptionsAndRestrictedStockMember" xlink:href="med-20220630.xsd#med_OptionsAndRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OptionsAndRestrictedStockMember" xlink:to="lab_med_OptionsAndRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_fe6cd743-19db-434d-88f7-c7e12ed13454_negatedTerseLabel_en-US" xlink:label="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases, not yet settled</link:label>
    <link:label id="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_label_en-US" xlink:label="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Paid In Capital, Share Repurchases Not Yet Settled</link:label>
    <link:label id="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_documentation_en-US" xlink:label="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Paid In Capital, Share Repurchases Not Yet Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:href="med-20220630.xsd#med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:to="lab_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity_a370ba55-1813-432b-b23b-b148eee778c9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net shares repurchased for taxes</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Other Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7d2508eb-8363-4bf5-803b-a309d699232a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_01f70ee6-afb2-4ecd-9035-31be6935c3c6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_cf91bfc7-8681-4b94-a149-369025108b78_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by executives and directors</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_84630704-7d43-43f8-915b-02bef11d3495_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_fab398b6-8859-453d-939d-897e0bb8801b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_269b3aac-d5ee-4866-95e4-962309e91f64_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) Increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7f330c98-d06e-432a-9acf-fb32184a4921_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f481ec0b-4e17-47bf-9caa-1840f7598c8f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_dafd085f-acd7-44b7-9d4b-3dbb24bf870e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8f83fdb2-6696-4a4c-adea-9000be9341b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6f9aed8a-3fb8-4e05-8024-3fca7ba80577_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b04bdf41-89ef-453a-a696-0deccc14bd46_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_med_AmortizationOfPremiumOnInvestmentSecurities_90ac5a96-88d2-431c-a354-9404fd58fcb1_terseLabel_en-US" xlink:label="lab_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investment securities</link:label>
    <link:label id="lab_med_AmortizationOfPremiumOnInvestmentSecurities_label_en-US" xlink:label="lab_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Premium on Investment Securities</link:label>
    <link:label id="lab_med_AmortizationOfPremiumOnInvestmentSecurities_documentation_en-US" xlink:label="lab_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The expense charged against amortization of premium on investment securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:href="med-20220630.xsd#med_AmortizationOfPremiumOnInvestmentSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:to="lab_med_AmortizationOfPremiumOnInvestmentSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_2fa4b92d-bd04-4666-8b76-e04449cfad0b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b07d38af-4522-4494-a248-c262896ed753_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_111b7796-03e1-4d0e-a4b9-d081993fae1e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_cc9a27ee-a5a2-4154-a50a-39f9d8f89ae0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2020Member_77a6afb5-4d11-4ba3-91b7-79eff0d1f8c0_terseLabel_en-US" xlink:label="lab_med_GrantedIn2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2020</link:label>
    <link:label id="lab_med_GrantedIn2020Member_label_en-US" xlink:label="lab_med_GrantedIn2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2020 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2020Member_documentation_en-US" xlink:label="lab_med_GrantedIn2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2020Member" xlink:href="med-20220630.xsd#med_GrantedIn2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2020Member" xlink:to="lab_med_GrantedIn2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_6b5ef6fd-e52d-4309-96e4-d76fb6c391b0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f28a2187-9cf1-447b-b08a-d7945935c519_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_5948f26f-1677-4737-8d72-98ec604c05cb_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, shares authorized under stock option plans, exercise price range, lower range limit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_49ea4b1f-1c35-4a73-9ff9-9396a08fbb93_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_86f5a5a3-961a-46d2-a366-2a01b49183d8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_6458ce04-75f6-4e06-bcf6-9107c384d0bc_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_f2087fe1-bfd2-48f2-9f79-314a27d3e992_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b84c1bb3-dc38-4f97-b740-685e288a586b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_278bda5c-b0ac-471b-9d58-9aa81564e22f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0767d6c3-bc0c-4148-9369-924be4df53a1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4d87e454-5def-4abd-90b6-10d1d9a8aae6_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive awards</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3caf479b-db8a-4374-8d4d-2c4ecf52c560_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_195aa5d5-e9ce-4393-8348-c0475fc2ca89_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, prepaid</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_2c8f778b-e9b9-4a2c-80aa-fe75e3dd4ce3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_be577f68-4fc4-4814-8962-48652fccb859_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dc459840-6362-41e2-bb04-d314ea65131a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8ee229d8-c592-4369-929e-09f71d72a4a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement, fair value of awards vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_0a12199d-26ea-4763-a42a-b408e1f16be3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_med_CreditAgreementMember_29db7b36-a383-4b50-b229-e98e654f157f_terseLabel_en-US" xlink:label="lab_med_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_med_CreditAgreementMember_label_en-US" xlink:label="lab_med_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_med_CreditAgreementMember_documentation_en-US" xlink:label="lab_med_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_CreditAgreementMember" xlink:href="med-20220630.xsd#med_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_CreditAgreementMember" xlink:to="lab_med_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock_f732a3d5-77bd-4140-a7aa-e5a03eaca563_terseLabel_en-US" xlink:label="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCELERATED SHARE REPURCHASE ("ASR")</link:label>
    <link:label id="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Agreements, Resale Agreements, Securities Borrowed, and Securities Loaned Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:to="lab_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_6460832d-e189-43f4-a364-b313a944bb8c_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal bonds</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_23607ea4-37fe-4ae9-b029-9e3b18e70a17_terseLabel_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents And Marketable securities [Line Items]</link:label>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_label_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents And Marketable securities [Line Items]</link:label>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_documentation_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">N/A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:href="med-20220630.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c5a53786-86ab-461f-9002-ec2f411d035a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options and restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_21120b91-76d8-4873-b8b8-08fbfbaab76f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2e773f61-8b24-4003-9d5a-2ae74b4c6a46_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9e19118a-4fbf-4f61-8bb0-d02a5661bd87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_097d4388-347f-45ab-8b95-5f9958d06dae_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b536d47a-ef30-4e98-8e96-57b09713a633_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_fb3dec63-c367-4af1-aad7-e465c8b3ea80_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_dbfeffda-6e0c-4ba6-955b-2ab7f82c520e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_f9b75d5a-ceca-4c4b-a14e-ab995445796f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_171b0e44-bed1-4df3-a8e3-05ca06d4c374_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercisable at end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_e0c1b548-cc52-4182-91db-abf1b693d921_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2149bdfc-7715-4efc-a821-5ab5050d9cfb_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_15575760-f009-496f-be51-69950e1d14c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_a5e8f84f-3d2e-44cb-9cde-8a91ebb9105b_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared included in accounts payable</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_67723573-69f6-4d95-8bb0-93986be7579f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1aa156a4-6ebb-4e61-a5b5-a8c3e12343ce_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0390b920-e27b-4426-8c74-790e4d87ca0b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7cdb8675-d066-4861-90c1-17a9bb46fa5d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d046269b-2ef5-4df5-b6c6-40cb2e0190c2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_53f3b0d5-58a4-4161-8e88-d13f3be7791e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retired from stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8f29aa4f-9dff-4687-99ca-b12e94779f01_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_ea1c390d-1f87-4886-b5a6-abdd9c4efe41_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_671d5ea0-ef85-4571-b785-98ce1f4bed19_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f312c155-e720-423b-ac1f-b8ac49af3e0e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_9a926dc9-249b-4c6c-89f4-bf856fcb3233_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2:</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_med_PaymentsForRepurchaseOfCommonStockNotYetSettled_6371cc12-bf20-4e7c-9678-fc5450bce0d8_negatedTerseLabel_en-US" xlink:label="lab_med_PaymentsForRepurchaseOfCommonStockNotYetSettled" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases, not yet settled</link:label>
    <link:label id="lab_med_PaymentsForRepurchaseOfCommonStockNotYetSettled_label_en-US" xlink:label="lab_med_PaymentsForRepurchaseOfCommonStockNotYetSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock, Not Yet Settled</link:label>
    <link:label id="lab_med_PaymentsForRepurchaseOfCommonStockNotYetSettled_documentation_en-US" xlink:label="lab_med_PaymentsForRepurchaseOfCommonStockNotYetSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock, Not Yet Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_PaymentsForRepurchaseOfCommonStockNotYetSettled" xlink:href="med-20220630.xsd#med_PaymentsForRepurchaseOfCommonStockNotYetSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_PaymentsForRepurchaseOfCommonStockNotYetSettled" xlink:to="lab_med_PaymentsForRepurchaseOfCommonStockNotYetSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashContributionExpense_6264590f-ed06-4f25-9a6c-0c594cafbb72_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashContributionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Donated inventory</link:label>
    <link:label id="lab_us-gaap_NoncashContributionExpense_label_en-US" xlink:label="lab_us-gaap_NoncashContributionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Contribution Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashContributionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashContributionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashContributionExpense" xlink:to="lab_us-gaap_NoncashContributionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_236bba86-72d1-4e9c-86ad-17e2e6091f6b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_32a13b3b-6bcb-4639-bbef-25c277d0c113_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4f85f1b0-685d-4906-88a9-a317968607d4_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations - Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_ffb83975-1c63-43b4-99e6-e4966b999dc3_verboseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_61d4ee94-e192-4c84-a179-baf4608c5886_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, options, grants in period, gross</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_660781d5-c604-4d3c-9cd4-089eebe96027_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the Table Sets Forth the Computation of Basic and Diluted EPS</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_15250d3e-1fce-4694-a243-02cdb85f280a_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net shares repurchased for taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_05e97a40-0ed9-4f0a-af23-71f1612d79ff_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_056fb084-469a-43ca-8de0-6112df559f58_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2019Member_3ad50a90-65f0-4e8d-ae14-9ade8161d18f_terseLabel_en-US" xlink:label="lab_med_GrantedIn2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2019</link:label>
    <link:label id="lab_med_GrantedIn2019Member_label_en-US" xlink:label="lab_med_GrantedIn2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2019 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2019Member_documentation_en-US" xlink:label="lab_med_GrantedIn2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2019Member" xlink:href="med-20220630.xsd#med_GrantedIn2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2019Member" xlink:to="lab_med_GrantedIn2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ed93ec81-41ad-4777-bb77-473efb40a7b9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_592594f2-d046-4b52-ae0e-cc50f0a48f47_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_med_NumeratorAbstract_3f9c59a6-dc98-49f5-95d5-a9ca486f31a0_verboseLabel_en-US" xlink:label="lab_med_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_med_NumeratorAbstract_label_en-US" xlink:label="lab_med_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:label id="lab_med_NumeratorAbstract_documentation_en-US" xlink:label="lab_med_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_NumeratorAbstract" xlink:href="med-20220630.xsd#med_NumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_NumeratorAbstract" xlink:to="lab_med_NumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5f1e0ef2-e766-4b4c-8d15-8c82e8ad787f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OperatingLeaseExpenseNonCash_f91f7714-3539-49ab-95df-8c45ec67534b_terseLabel_en-US" xlink:label="lab_med_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_med_OperatingLeaseExpenseNonCash_label_en-US" xlink:label="lab_med_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense, Non-Cash</link:label>
    <link:label id="lab_med_OperatingLeaseExpenseNonCash_documentation_en-US" xlink:label="lab_med_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash" xlink:href="med-20220630.xsd#med_OperatingLeaseExpenseNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OperatingLeaseExpenseNonCash" xlink:to="lab_med_OperatingLeaseExpenseNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_f5ef75b7-b2bf-45c4-a8cb-845bbceaf881_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f10ec6fb-d614-438c-ad26-5fbe0fb3df4d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ba404601-f99e-471c-bca8-db8b64970618_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f600adf1-f784-42af-8bb4-230efababcb0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cdda0712-041a-471d-90f5-ffdc59ab9a22_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_80530825-68c4-4ef8-8a5c-991fc72c0511_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_7c8cc419-2cd9-454e-a4d3-3635ec15ce1a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a34a2cd6-48c5-4704-9ad9-8b3ce88a9d1d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_8f9a5cbe-91e1-4b58-8c19-5b26ab51ea36_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b78bb19-6186-4965-bb76-1a4d2a2175f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_dedab4a4-61ab-4ec3-8b45-27adcd1e2405_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_16b3b2a2-2bdb-4cc2-8c7e-8d5e5a0d9a32_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_9adab575-adde-4cd4-a10d-6af7c956095b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_e24e2031-7679-4a67-a6e1-0583b1b98e8a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OperatingLeaseArrangementForRealEstateMember_c75fe5fd-9181-45aa-8a17-22c62934ec6e_terseLabel_en-US" xlink:label="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement for Real Estate</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForRealEstateMember_label_en-US" xlink:label="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement For Real Estate [Member]</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForRealEstateMember_documentation_en-US" xlink:label="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the operating lease arrangement for real estate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForRealEstateMember" xlink:href="med-20220630.xsd#med_OperatingLeaseArrangementForRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OperatingLeaseArrangementForRealEstateMember" xlink:to="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_308d8ee4-ca6a-4758-a689-c18d6d077e76_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_f24259a6-a4c2-456a-9abe-7042898ba232_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_803946de-c72b-4b7a-af1c-f34177949b8c_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net shares repurchased for taxes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_c7b2b10a-1b94-4536-9e1d-531495a6a9bf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurements of lease liabilities - Operating cash flow used in operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_8a5c8ca2-fa85-4e53-86df-6bf08751dc07_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e6203654-9800-45bd-9177-d043a5c78184_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0834e7de-0cae-450a-a654-dc9614595321_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2afcb576-b22e-48c2-a859-2763a6934760_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e1d83e61-1dbf-4c31-ba2b-6813827359e5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_9a0d8e2a-26a3-479e-8d4c-56f89b3178ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_c9da7164-5e5f-45ef-b1ad-4727d93edac1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_med_MinimumInterestCoverageRatio_995eb1b1-4f94-4ef0-ba21-3a871f8096b8_terseLabel_en-US" xlink:label="lab_med_MinimumInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Interest Coverage Ratio</link:label>
    <link:label id="lab_med_MinimumInterestCoverageRatio_label_en-US" xlink:label="lab_med_MinimumInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Interest Coverage Ratio</link:label>
    <link:label id="lab_med_MinimumInterestCoverageRatio_documentation_en-US" xlink:label="lab_med_MinimumInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Interest Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_MinimumInterestCoverageRatio" xlink:href="med-20220630.xsd#med_MinimumInterestCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_MinimumInterestCoverageRatio" xlink:to="lab_med_MinimumInterestCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_bf69998b-d923-447f-9244-57d562100fa7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_8813eb90-7520-4e8c-9d01-141b81cac4b4_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GovernmentAgencySecuritiesMember_4ec5da6a-b204-4496-bbc9-083e35a5fb5d_terseLabel_en-US" xlink:label="lab_med_GovernmentAgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government &amp; agency securities</link:label>
    <link:label id="lab_med_GovernmentAgencySecuritiesMember_label_en-US" xlink:label="lab_med_GovernmentAgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Agency Securities [Member]</link:label>
    <link:label id="lab_med_GovernmentAgencySecuritiesMember_documentation_en-US" xlink:label="lab_med_GovernmentAgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Agency Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GovernmentAgencySecuritiesMember" xlink:href="med-20220630.xsd#med_GovernmentAgencySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GovernmentAgencySecuritiesMember" xlink:to="lab_med_GovernmentAgencySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_fcbfe922-5bc0-45b4-b437-2ed31f598fce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1:</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9e6ad9df-1825-4573-bc8a-24ce861a6194_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ad15ab31-1f5c-420d-870c-580a90b95be0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_489c6935-01f5-4f91-a720-dafeb37fae90_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f3af33b1-39eb-46f7-a125-0bb9deb2a685_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding -</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_22d0efe9-ea3e-4c09-a6bb-567aea2162fc_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_fe157d4e-569d-4d89-ada2-5b1e55f57733_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fb1f67aa-a333-4392-a0ef-75d9fcab48cf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_6ff5ad71-7fee-4a36-a2d2-03ba5d84e0af_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_med_MarketAndPerformanceSharesMember_8a2ee287-cdd9-47fe-ab02-2308ac2793ba_terseLabel_en-US" xlink:label="lab_med_MarketAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market and Performance-Based Shares</link:label>
    <link:label id="lab_med_MarketAndPerformanceSharesMember_label_en-US" xlink:label="lab_med_MarketAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market And Performance Shares [Member]</link:label>
    <link:label id="lab_med_MarketAndPerformanceSharesMember_documentation_en-US" xlink:label="lab_med_MarketAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market And Performance Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceSharesMember" xlink:href="med-20220630.xsd#med_MarketAndPerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_MarketAndPerformanceSharesMember" xlink:to="lab_med_MarketAndPerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_bff70338-14a2-43c5-a29a-ad35065ae895_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ca299e6a-5382-4fbb-94a3-87f58ad01486_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ee2f95f1-41a0-4cb7-b3b6-bd081dd87274_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_2d4f5f8e-561b-4954-ad8e-ec70e39b9bfe_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_fae7ad06-331f-4439-80b8-348b0d248623_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3e54d94a-e867-470e-88e1-6e591abf0927_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04ed9048-3035-4705-83a6-ad3547cefaf9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_511606c2-b665-4c0a-a050-f98f30a67450_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_397303ba-a651-4e55-b35b-c45d54afe334_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_1020327f-bf9e-4c6e-9be6-ffdb3fdb7333_terseLabel_en-US" xlink:label="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Packaging</link:label>
    <link:label id="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_label_en-US" xlink:label="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Related Inventory, Packaging and Other Supplies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:to="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_bed4dead-d5fb-4746-a487-c16851276773_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_7ebf19b5-acfa-48b6-a608-2538cc9b4708_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_4075dd46-6ec8-4141-9ea1-d53f103c307b_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock from stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_5455afc5-1a44-47e5-915c-274455856511_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retire from stock repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_229dc4a3-aba3-4fd1-b2a2-6589029676b2_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_adc46bd3-478d-4bb1-8561-142fc170d4ba_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_3f0108bf-2e9c-47fa-be7b-8fb8c9ede77b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fc56a8b0-91e6-41f7-a4df-429eb5c991c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by executives and directors</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d83b177f-9453-4feb-97ad-38aba6e830c5_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d5b62177-6822-4400-bd34-d837744b2f3b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_02d28c81-28bb-4f23-a2c6-39345d71df1c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7de43a5b-11eb-4491-ab55-befda93855f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on investment securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_af43c23c-6f59-4943-bc9c-9a3b4ab16b9b_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9c3471f3-5e0f-4f0c-8976-61ceff18fab7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_78d14a2e-dbf0-40a7-bfb0-7b8ead508259_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency impact</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_867cb789-8258-4001-b199-f58f79a05149_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_d36a4bf6-af41-42ed-b9b5-976fa84c40d5_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_33f88dc3-76cd-4a27-b790-3f72105d6c82_verboseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_ed82b52b-ee19-416e-a521-0174b92dcc3d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_693fbc7f-0326-43e2-aa0c-a8d3d2ef3e17_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3f51fa7c-e8df-4ddb-9fd1-12ae21789c30_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_2c15b062-5c1d-4ae6-a5fe-a1f22994f38f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_0b3f39aa-5089-449f-bf7a-fae4ce4d3fc8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment - net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_173237e1-dcbc-4415-af24-808b9b6d1ac1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_6936002c-63a6-41dc-a56e-b74b1017b7f6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b97e445f-6241-4f61-aa8f-f286bb8a4374_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial amount received (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_2dfac63f-c6c6-4112-9249-3c5263cf916f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_16a6a031-0548-417e-b237-4cf620b3b849_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_8ac43629-4ff4-4867-a4f1-ec805673f47e_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_745bc5b6-e62f-4aa9-9b10-c51f5e053aa4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f32b4db9-9bc8-4211-a3d6-c93d1bfcffb1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_268bbd84-0230-4385-88ec-346c07dd5852_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Exercisable at end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2ab0ccec-c226-4cd8-9592-7b99766efc36_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_afa12751-c332-4026-ae29-b9b8bcba7154_terseLabel_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional performance-based shares, percentage</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_label_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_documentation_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:href="med-20220630.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:to="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_a6f0f1dc-c6cf-45c8-8059-10071b633086_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_4484661d-eab9-4828-8f9c-c6ef3c6a0438_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b1cba8f4-7895-4296-b452-c47c284594ec_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_3e071835-2178-4a25-ae44-4bcb6e41d516_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1d50b3ce-2d0a-4411-89e8-b22c27707807_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains on investment securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f4594955-57b8-43f9-b946-6b6e8c6a548f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_7804ef50-5c23-4a95-91d6-d91222a46829_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_f7afe99f-4d22-4b84-9220-77a5ccb63a86_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3a8d4620-7f49-4ea2-8a6f-58bb6b5b5a35_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8e6ea6ae-36de-42ce-bd22-d447af7dddfe_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5c29ad18-a32f-430d-8ea6-274fd930f558_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding at end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_29d79901-aa44-4de6-8c05-0c85c6300d3e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $.001 per share: 20,000 shares authorized; 11,594 and 11,594 issued and 11,593 and 11,593 outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_732dfc7f-b641-4800-91cf-b4f4257d4986_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other (expense) income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1975f058-e6b6-4c9f-b19e-34faa4db35a7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation cost recognition weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_f69bd69b-9652-477d-a82c-6f6ae49abeb1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6c23ae8d-4e81-4e70-bef0-22a72f87554e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5d451068-ff37-45dc-b0dd-2a242ab0b3b7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_39cd41bc-5ab6-4cd8-8777-3cebcaa2291e_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_bb677e19-07ce-402d-b42c-0ab3fe149532_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_1f929d37-b059-431d-a9fc-e00560396f13_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b2d7cb29-f33c-4944-ab5a-01130f4ca85b_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment arrangement, expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9c865a99-d1cd-4ea6-9043-8ebcd369be88_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3977b2a0-4eff-4b05-b8dc-0f1310ae19a9_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c7f824ca-0185-4048-a86f-9b9e5c1cdf65_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4c435671-3aa8-4be6-81e8-993299ce0f95_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_0bcf71f9-fa2d-4ad6-a4b1-bc3659f1aa3f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_bc995189-d643-49a0-bb0d-a74621ab954c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:to="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1ef60aa1-6f5b-4244-8780-ffd5bb5cde4d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 (excluding the six months ended June&#160;30, 2022)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0fc51f5-1b0e-41af-9995-6361482f090b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_3f4e9bae-f9d2-4605-8820-776c60b2a0d1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_med_InventoryNonFoodFinishedGoods_5ecdef62-ac2e-4536-8cc9-8062c01f9706_verboseLabel_en-US" xlink:label="lab_med_InventoryNonFoodFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-food finished goods</link:label>
    <link:label id="lab_med_InventoryNonFoodFinishedGoods_label_en-US" xlink:label="lab_med_InventoryNonFoodFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Non Food Finished Goods</link:label>
    <link:label id="lab_med_InventoryNonFoodFinishedGoods_documentation_en-US" xlink:label="lab_med_InventoryNonFoodFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before last-in first-out (LIFO) and valuation reserves of (Non-food) merchandise or goods held by the entity that are readily available for sale.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods" xlink:href="med-20220630.xsd#med_InventoryNonFoodFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_InventoryNonFoodFinishedGoods" xlink:to="lab_med_InventoryNonFoodFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_39801d36-536e-4e1f-89a4-37107a8a931d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_e4cb2c23-db2e-4b9c-9e21-d54b93b38752_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, prepaid</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2022Member_d41c75f4-4d53-489a-bc3d-bdbb31341507_terseLabel_en-US" xlink:label="lab_med_GrantedIn2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2022</link:label>
    <link:label id="lab_med_GrantedIn2022Member_label_en-US" xlink:label="lab_med_GrantedIn2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2022 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2022Member_documentation_en-US" xlink:label="lab_med_GrantedIn2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member" xlink:href="med-20220630.xsd#med_GrantedIn2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2022Member" xlink:to="lab_med_GrantedIn2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_8c13d2b0-fd63-42ff-ab31-0429d1b5684b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_52543827-4133-47c1-9f95-8948f02b4853_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_c5fd6305-b4cb-4c6e-8d59-ab76933dbdf4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2fa3a4f7-8ad6-4bf6-a5c2-66a741ce63d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e61c9d38-5b0f-4ce9-a46a-3e8fc5a0976a_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_9ce0b158-5ce9-4175-9cfd-3c0c6fca9d13_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_7e1b3201-712e-4c4f-8acd-b0b44132bf24_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_a0680eb5-c558-423c-8650-fef1c50b1bb7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_676c2da1-b96c-4bfb-90e5-1e58ad37f703_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b85f8807-7160-4a87-a7fc-1ad3bebdb062_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6c7539f1-40d2-4144-a4c7-cf50725b126b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_40ab2c1f-6f33-4d8a-be62-29e63a015b33_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_ec3647a7-8892-4cf5-83cd-d2be4e4163b0_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_985987af-5175-4860-bcde-303e72463ff9_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_4674fa23-86be-4446-a54d-41c2e09e64b5_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e43ef6a2-443c-4d7b-bfd6-b4ee4f5d653f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d074a72d-8017-466e-a5ea-29c95c0372e0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by executives and directors (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ef98a4fd-7a81-4ead-85f2-fccdd2963372_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_54b491a5-1eb7-492a-a113-0dc95957b1bb_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3d9f6111-9e7f-4309-ac20-50aeadc01f55_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_817ad69f-5bf5-4434-b58d-2a14f6f564db_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_13ef046f-9d47-4689-80e7-7289ea91611d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7bde1862-9415-493e-b94a-97a28105490f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_d5a97ad1-cd56-4090-9ea7-cfa6cbf5e69c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_71216247-d76f-4ea1-babb-86a4b5cf606d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized loss or gains</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_med_DenominatorAbstract_ab072c9b-1ecc-4b5b-9241-351060366b45_verboseLabel_en-US" xlink:label="lab_med_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_med_DenominatorAbstract_label_en-US" xlink:label="lab_med_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:label id="lab_med_DenominatorAbstract_documentation_en-US" xlink:label="lab_med_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_DenominatorAbstract" xlink:href="med-20220630.xsd#med_DenominatorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_DenominatorAbstract" xlink:to="lab_med_DenominatorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6a44da2e-7aa3-4cb9-8b56-4e6be1142ed0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_8168f30f-9fd3-4eb7-8b8b-919b346f0bec_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid to stockholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3069be90-ccb3-4e7b-9f94-8b74c3d0461b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_1a2d258a-3a97-4bc1-b1bf-f8a4e779a77a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2021Member_e5670d63-58a4-4812-9ce7-68bc7d61684e_terseLabel_en-US" xlink:label="lab_med_GrantedIn2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2021</link:label>
    <link:label id="lab_med_GrantedIn2021Member_label_en-US" xlink:label="lab_med_GrantedIn2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2021 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2021Member_documentation_en-US" xlink:label="lab_med_GrantedIn2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2021Member" xlink:href="med-20220630.xsd#med_GrantedIn2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2021Member" xlink:to="lab_med_GrantedIn2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_d6da7ec9-14ee-4d7d-996c-113d2bff6572_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c746bcaf-15b0-4055-a5d8-4cda297aaec8_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c3071d3d-7d3f-44c2-bec1-52ec70005fab_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_11e32559-c25f-48cd-8c9a-7c43c78c0254_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_1a167314-3346-4e34-918e-b719d49b4e48_terseLabel_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents And Marketable securities [Table]</link:label>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_label_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents And Marketable securities [Table]</link:label>
    <link:label id="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_documentation_en-US" xlink:label="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">N/A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:href="med-20220630.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:to="lab_med_CashAndCashEquivalentsAndMarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_f010723c-4d3b-451d-9520-93fecbc03148_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and maturities of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_b890bbf6-b84d-4bfa-ba7c-6ca3ed569102_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_dca5b3fb-0ea6-4d0b-9da6-921a6e36458a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4e450c4b-a876-48a9-b00e-bf15649e5d96_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4acd2efa-2fdf-405c-9619-fd31a5ede500_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis_100d0a54-9ee1-4dd3-a6b7-8a9b54d2e012_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_4d28a460-cdfa-49d7-9191-9c7e9e1ff6b7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2514950f-66d2-4c76-b42e-ed6e5f9def64_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_60ad428d-bd56-4b63-8ebc-6b8db8ceb7dc_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3b7de77c-074e-4128-a746-eefd0593655d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_64813e7c-7744-472b-a5e9-70af944eedb3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b2f87e7c-d88c-4ca8-8f16-b8cf2750df56_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_7390078b-0fa3-4648-9489-b110d1cd1b39_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_1fdb698a-187c-4b1c-acd2-f3937bc3a8f6_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Presentation of Financial Statements</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ed310efe-f239-42a1-863d-47a6b247d7f0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_371bcd12-1583-4678-b919-fbd5b4ee443d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_cee3bc04-c70f-4f21-b1cb-379bde681368_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_2e02a820-8f08-4607-9ba7-bb34cb9d5ae4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Recognition and Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2add8662-5e41-4689-813e-4b1ec23cb518_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_c9ea1770-90d7-4a0c-b4e3-eff400238630_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_0cb2b6cd-6eca-43dd-982f-0ad21a09f5a3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6f471362-8b8e-48db-b925-139dfc9146a1_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_47750f04-3e5a-46f4-8cdc-f4092595941b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash &amp; Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_09197e7f-2952-4911-b84d-85b382fb27db_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_025af10a-d537-4119-a42a-654ed75e6ea5_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market accounts</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d220dbec-47cb-4e4c-86ff-cf43a30dadac_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_a8e60f94-a54b-4e8e-ae6d-38bbe4ddcd12_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_84abe735-e2c9-48d1-b147-414efb334f49_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_df9d0d58-8831-4b51-8668-63b5c4006f77_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing under revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_9c2173f2-4996-4413-90c7-24ef4027f031_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5f30c634-95be-40f1-8a00-56a57cf04182_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8eebf124-13cb-4de4-887f-b008a7825b6f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_7df02859-e831-45e7-b140-d925654252db_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e7dc524b-fe3b-4c86-8e20-6aa9857a254c_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements Adopted in 2022</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a0578517-e8c3-4f12-aaf7-5af3e034919b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_60c4f930-6f30-4ce4-9f63-67a75bbb80d1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee service share based compensation nonvested awards total compensation cost not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_7e151092-e218-4559-9705-f4cec3eef6f3_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1752d3a9-3d9c-4feb-b389-246e73104cd0_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_7c07a530-235f-495e-a93e-917f2f3cbd65_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_2ad89783-04b9-4eee-897b-a928e197f423_terseLabel_en-US" xlink:label="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_label_en-US" xlink:label="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Payments Due Year Five And After Year Five</link:label>
    <link:label id="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_documentation_en-US" xlink:label="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Payments Due Year Five And After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:href="med-20220630.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:to="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_6b7afcba-ef20-4550-be51-1a6118374a8b_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_9b148ddd-6d5f-40e5-b0f7-9288c71e8c30_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c576cbcb-71d6-45c1-9911-1b5b7a4c1eeb_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_98e0de9c-8873-4152-96eb-62c32cfa3d6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b2684c7c-d16e-43e2-8318-3155add6f88b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Maturity of the Company's Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_9a21d946-99c1-48e9-8ecc-afd46bab6f6f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5157a7f1-f2fc-4629-ad3d-3ff9e326b30b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ca03fbce-8757-4dc4-aacb-36320d48f5a0_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_a334146b-dd7b-4a7b-9cf8-964afd375ea3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6554df01-2010-45c5-9cd2-7f36ad241d08_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_d6687260-9e8f-4b93-8df5-bc0f3fcbeeda_terseLabel_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_label_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_documentation_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:href="med-20220630.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:to="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_94d3ea94-a3a3-4350-bc12-49fd6309a321_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_4ce69099-e1ef-4996-b7ae-11dd80b0647d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_611c90fa-7b4b-4f0e-ae69-ab651aa0be33_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d6689c0b-1738-48b8-8da4-bf98682bf8cb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_176accca-43df-4604-a307-968c0e124af4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_c6bf58d7-d77b-4686-b709-2cfd99df77a1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases, settled</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_e43bed4e-49e4-4bba-a090-26dbe66df583_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_203b16e4-54f4-435e-a791-29094cff49a6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_02a77e95-14bc-4da6-b985-f2548db59673_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>med-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cb14b1a-882e-4c5a-abba-92937aa2b6a2,g:d04941c9-f1d8-4931-a062-5edb28a6369a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20220630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6db115aa-af2b-4af8-8940-f47f20fb8509" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_DocumentType_6db115aa-af2b-4af8-8940-f47f20fb8509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_58d297cd-fc60-4053-abb5-bd86f7eb30e4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_DocumentQuarterlyReport_58d297cd-fc60-4053-abb5-bd86f7eb30e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2b357910-89c9-4871-bf43-daee8fef2688" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_DocumentPeriodEndDate_2b357910-89c9-4871-bf43-daee8fef2688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_4e88c87e-6c5b-4b9c-86ad-2384354faa43" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_DocumentTransitionReport_4e88c87e-6c5b-4b9c-86ad-2384354faa43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8f6218c5-7a4e-4ceb-be70-ef0419c0c957" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityFileNumber_8f6218c5-7a4e-4ceb-be70-ef0419c0c957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d66fd90c-c244-4e97-840f-4f6c09ecd4f0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityRegistrantName_d66fd90c-c244-4e97-840f-4f6c09ecd4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_242bb924-3cdc-4263-aab0-2cf534db2fc7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_242bb924-3cdc-4263-aab0-2cf534db2fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a423acf5-16ed-42f5-b650-fdf48185cf6d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityTaxIdentificationNumber_a423acf5-16ed-42f5-b650-fdf48185cf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_da0d8384-d8eb-496b-91ae-e555d5a5f9a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityAddressAddressLine1_da0d8384-d8eb-496b-91ae-e555d5a5f9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f0cbdc6a-7cf4-4b6a-92da-35e551da8865" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityAddressCityOrTown_f0cbdc6a-7cf4-4b6a-92da-35e551da8865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f4ae21e3-3f47-4d7c-806e-896c0f6cb8b4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityAddressStateOrProvince_f4ae21e3-3f47-4d7c-806e-896c0f6cb8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8974ad6c-3e17-47e9-aaab-2260c8a51a32" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityAddressPostalZipCode_8974ad6c-3e17-47e9-aaab-2260c8a51a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_32e9b457-c21a-46d7-91b9-a7c30298dff9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_CityAreaCode_32e9b457-c21a-46d7-91b9-a7c30298dff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4162cc6a-3077-4cab-b302-a05962de679d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_LocalPhoneNumber_4162cc6a-3077-4cab-b302-a05962de679d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0566a757-9983-458c-b793-79da540b2254" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_Security12bTitle_0566a757-9983-458c-b793-79da540b2254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ae5daa3e-463e-42b8-ac5f-b53590161d3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_TradingSymbol_ae5daa3e-463e-42b8-ac5f-b53590161d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a22de129-3cc8-42f6-8ce7-0bed8cd7ac90" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_SecurityExchangeName_a22de129-3cc8-42f6-8ce7-0bed8cd7ac90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_218b169f-e6df-4137-93f7-4aca4ebd35e0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityCurrentReportingStatus_218b169f-e6df-4137-93f7-4aca4ebd35e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_52c05d17-5a97-4cf0-95ac-edefa597afd9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityInteractiveDataCurrent_52c05d17-5a97-4cf0-95ac-edefa597afd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_0a4ed986-c959-4035-853f-3fc1a41ce58f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityFilerCategory_0a4ed986-c959-4035-853f-3fc1a41ce58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_20f3e8bf-29b4-4f6d-bae9-2c73c1e94189" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntitySmallBusiness_20f3e8bf-29b4-4f6d-bae9-2c73c1e94189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9e6343eb-2913-477a-9582-2396d0f106c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityEmergingGrowthCompany_9e6343eb-2913-477a-9582-2396d0f106c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4db569ad-3fdc-45fe-a541-c1abc2ec0a2f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityShellCompany_4db569ad-3fdc-45fe-a541-c1abc2ec0a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_03f077ec-414b-4b12-8d4d-70ec3086e1ec" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_03f077ec-414b-4b12-8d4d-70ec3086e1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_27eedcd6-b6dc-4c58-9bdc-fcf44c99a0cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_EntityCentralIndexKey_27eedcd6-b6dc-4c58-9bdc-fcf44c99a0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e4394d91-fde7-43b2-8e2c-1de8e0171b7d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_CurrentFiscalYearEndDate_e4394d91-fde7-43b2-8e2c-1de8e0171b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4badc5f4-abfa-4de4-8560-16c8e86e0e36" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_DocumentFiscalYearFocus_4badc5f4-abfa-4de4-8560-16c8e86e0e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0c669322-510f-4a2a-87cd-0867219ae539" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0c669322-510f-4a2a-87cd-0867219ae539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d889a2cd-a770-4efc-b3c6-d0888250b741" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_385d0a39-8b8a-4450-b394-016ab80cad4b" xlink:to="loc_dei_AmendmentFlag_d889a2cd-a770-4efc-b3c6-d0888250b741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e284285d-4a85-4e8b-96a5-5e33b5c730c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9b3cbf7d-84ce-4cd2-bc8a-f2ea89399cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e284285d-4a85-4e8b-96a5-5e33b5c730c5" xlink:to="loc_us-gaap_Revenues_9b3cbf7d-84ce-4cd2-bc8a-f2ea89399cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_e0c034cc-2907-4397-a7c8-0de0e8afed84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e284285d-4a85-4e8b-96a5-5e33b5c730c5" xlink:to="loc_us-gaap_CostOfRevenue_e0c034cc-2907-4397-a7c8-0de0e8afed84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_729349b4-8971-42a0-871d-c9e8e2533dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e284285d-4a85-4e8b-96a5-5e33b5c730c5" xlink:to="loc_us-gaap_GrossProfit_729349b4-8971-42a0-871d-c9e8e2533dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e22268af-d91d-4913-aed3-f29ab068d078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e284285d-4a85-4e8b-96a5-5e33b5c730c5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e22268af-d91d-4913-aed3-f29ab068d078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ba5a8de5-7a89-4a0a-884f-a8afa0dafbec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e284285d-4a85-4e8b-96a5-5e33b5c730c5" xlink:to="loc_us-gaap_OperatingIncomeLoss_ba5a8de5-7a89-4a0a-884f-a8afa0dafbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e284285d-4a85-4e8b-96a5-5e33b5c730c5" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_1d12d06a-ae9f-4c04-9f54-25d893df643e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_1d12d06a-ae9f-4c04-9f54-25d893df643e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d994a377-0367-4078-b8fa-59943c7e457c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d994a377-0367-4078-b8fa-59943c7e457c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4cd22f6c-cd2f-413a-915a-7957870f28e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4cd22f6c-cd2f-413a-915a-7957870f28e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b219d557-aec9-492d-8387-0ff75089eded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b219d557-aec9-492d-8387-0ff75089eded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f82bf87a-5a1d-4f93-a423-6aaa8c439441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f82bf87a-5a1d-4f93-a423-6aaa8c439441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ed56e276-ce54-4e90-9b51-02c2da5d7d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:to="loc_us-gaap_NetIncomeLoss_ed56e276-ce54-4e90-9b51-02c2da5d7d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_3912ea1d-c779-46cd-84f4-14162771cf06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_3912ea1d-c779-46cd-84f4-14162771cf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_52d43b79-9023-4846-9c6a-763b1105f35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_3912ea1d-c779-46cd-84f4-14162771cf06" xlink:to="loc_us-gaap_EarningsPerShareBasic_52d43b79-9023-4846-9c6a-763b1105f35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_e775b2aa-acad-4f0f-8b55-0dbb9f3804c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e97e4ecc-c4e2-4876-8fa4-6adba7013e53" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_e775b2aa-acad-4f0f-8b55-0dbb9f3804c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_25ad075b-3f20-46e9-902b-03e96c6591ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_e775b2aa-acad-4f0f-8b55-0dbb9f3804c8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_25ad075b-3f20-46e9-902b-03e96c6591ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_01c2926b-8826-4aa1-8fff-4388946804ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e284285d-4a85-4e8b-96a5-5e33b5c730c5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_01c2926b-8826-4aa1-8fff-4388946804ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0e15f23f-cb76-4df4-a18d-3a144e5e1edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_01c2926b-8826-4aa1-8fff-4388946804ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0e15f23f-cb76-4df4-a18d-3a144e5e1edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3e46d8c6-c09b-4510-ac9c-f85410b54c56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_01c2926b-8826-4aa1-8fff-4388946804ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3e46d8c6-c09b-4510-ac9c-f85410b54c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_2b155fc0-98ca-4ed9-96ee-ee98258e6bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e284285d-4a85-4e8b-96a5-5e33b5c730c5" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_2b155fc0-98ca-4ed9-96ee-ee98258e6bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a59c2525-672d-4789-b5ea-b3801d492bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f2865761-f32e-4b84-9162-61f2aec4570d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a59c2525-672d-4789-b5ea-b3801d492bc1" xlink:to="loc_us-gaap_NetIncomeLoss_f2865761-f32e-4b84-9162-61f2aec4570d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c05016a1-6d0e-48af-b71d-420b5ebde789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a59c2525-672d-4789-b5ea-b3801d492bc1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c05016a1-6d0e-48af-b71d-420b5ebde789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8ffaafa9-3e06-49b6-b3e2-f3a6888beaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c05016a1-6d0e-48af-b71d-420b5ebde789" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8ffaafa9-3e06-49b6-b3e2-f3a6888beaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_68368127-0aa1-4f8d-80e0-5553af1c684d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c05016a1-6d0e-48af-b71d-420b5ebde789" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_68368127-0aa1-4f8d-80e0-5553af1c684d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f425b760-c177-4fba-a10e-13ebccc587b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c05016a1-6d0e-48af-b71d-420b5ebde789" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f425b760-c177-4fba-a10e-13ebccc587b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0bd924b7-7573-4ccb-a861-f0008362235b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c05016a1-6d0e-48af-b71d-420b5ebde789" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0bd924b7-7573-4ccb-a861-f0008362235b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bdc62906-1685-4450-a341-b8c7dd3d5b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_bb3b9337-40d9-4bc5-b41c-41e832e11782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bdc62906-1685-4450-a341-b8c7dd3d5b1a" xlink:to="loc_us-gaap_AssetsAbstract_bb3b9337-40d9-4bc5-b41c-41e832e11782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d362e8ed-1ccb-4a5a-ba44-9fe0d84275e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb3b9337-40d9-4bc5-b41c-41e832e11782" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d362e8ed-1ccb-4a5a-ba44-9fe0d84275e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3807af77-7c18-42a6-868d-3e87c9bab4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d362e8ed-1ccb-4a5a-ba44-9fe0d84275e9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3807af77-7c18-42a6-868d-3e87c9bab4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1b9cef31-b6f6-4720-bb41-4e11a49ce1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d362e8ed-1ccb-4a5a-ba44-9fe0d84275e9" xlink:to="loc_us-gaap_InventoryNet_1b9cef31-b6f6-4720-bb41-4e11a49ce1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_21e119f0-2507-459e-b3ad-a9bff3003ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d362e8ed-1ccb-4a5a-ba44-9fe0d84275e9" xlink:to="loc_us-gaap_ShortTermInvestments_21e119f0-2507-459e-b3ad-a9bff3003ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_9be06df6-e1fa-4007-95a5-25a16168e94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d362e8ed-1ccb-4a5a-ba44-9fe0d84275e9" xlink:to="loc_us-gaap_PrepaidTaxes_9be06df6-e1fa-4007-95a5-25a16168e94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f5118a7d-4b0e-4972-93e1-6d59a1bf3ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d362e8ed-1ccb-4a5a-ba44-9fe0d84275e9" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f5118a7d-4b0e-4972-93e1-6d59a1bf3ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_69336509-04de-422e-b546-45586c1ac445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb3b9337-40d9-4bc5-b41c-41e832e11782" xlink:to="loc_us-gaap_AssetsCurrent_69336509-04de-422e-b546-45586c1ac445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3fc049f7-4daf-46a5-a794-85d8e8a0061f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb3b9337-40d9-4bc5-b41c-41e832e11782" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3fc049f7-4daf-46a5-a794-85d8e8a0061f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5c67b3c2-d84f-4c7b-9929-ba5cada5c960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb3b9337-40d9-4bc5-b41c-41e832e11782" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5c67b3c2-d84f-4c7b-9929-ba5cada5c960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_73aeae38-cb69-4476-9d6e-b7024edf86e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb3b9337-40d9-4bc5-b41c-41e832e11782" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_73aeae38-cb69-4476-9d6e-b7024edf86e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ea443cc3-efc0-4124-a241-3ebf8ad49ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb3b9337-40d9-4bc5-b41c-41e832e11782" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ea443cc3-efc0-4124-a241-3ebf8ad49ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e0524203-3dbd-4bc9-bb8a-ac8134f1dcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bb3b9337-40d9-4bc5-b41c-41e832e11782" xlink:to="loc_us-gaap_Assets_e0524203-3dbd-4bc9-bb8a-ac8134f1dcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b26e3759-171e-4d86-8df4-fa4b2c8620b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bdc62906-1685-4450-a341-b8c7dd3d5b1a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b26e3759-171e-4d86-8df4-fa4b2c8620b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_96fb45e1-9c34-4d37-8cd7-564f11286809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b26e3759-171e-4d86-8df4-fa4b2c8620b7" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_96fb45e1-9c34-4d37-8cd7-564f11286809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3a473e71-0211-4984-a87a-a48409294502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_96fb45e1-9c34-4d37-8cd7-564f11286809" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3a473e71-0211-4984-a87a-a48409294502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_33bb66ca-3c48-43c3-8a10-d602d4ef8bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_96fb45e1-9c34-4d37-8cd7-564f11286809" xlink:to="loc_us-gaap_LinesOfCreditCurrent_33bb66ca-3c48-43c3-8a10-d602d4ef8bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8f90eb9e-db83-418a-9b7b-82a4958bd608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_96fb45e1-9c34-4d37-8cd7-564f11286809" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8f90eb9e-db83-418a-9b7b-82a4958bd608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e4c97a65-0a8e-4981-9662-7f92711286bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_96fb45e1-9c34-4d37-8cd7-564f11286809" xlink:to="loc_us-gaap_LiabilitiesCurrent_e4c97a65-0a8e-4981-9662-7f92711286bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5339e5ff-a58a-44a8-bada-9c0800c99d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b26e3759-171e-4d86-8df4-fa4b2c8620b7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5339e5ff-a58a-44a8-bada-9c0800c99d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f765c385-8415-4fab-85be-617e0936250e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b26e3759-171e-4d86-8df4-fa4b2c8620b7" xlink:to="loc_us-gaap_Liabilities_f765c385-8415-4fab-85be-617e0936250e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3ec1a1d4-5850-4b30-a65a-7081f2d5ae40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b26e3759-171e-4d86-8df4-fa4b2c8620b7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3ec1a1d4-5850-4b30-a65a-7081f2d5ae40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0f57bed1-faff-4b76-ac64-81d01e2735df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3ec1a1d4-5850-4b30-a65a-7081f2d5ae40" xlink:to="loc_us-gaap_CommonStockValue_0f57bed1-faff-4b76-ac64-81d01e2735df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_23f37f14-08b9-4b79-802a-b7f87a8f57da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3ec1a1d4-5850-4b30-a65a-7081f2d5ae40" xlink:to="loc_us-gaap_AdditionalPaidInCapital_23f37f14-08b9-4b79-802a-b7f87a8f57da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e1f3fa5c-66c2-413a-8a11-0475e3364822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3ec1a1d4-5850-4b30-a65a-7081f2d5ae40" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e1f3fa5c-66c2-413a-8a11-0475e3364822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_207c7ec5-45b3-4b6e-a4cf-c5cdf9f0a4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3ec1a1d4-5850-4b30-a65a-7081f2d5ae40" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_207c7ec5-45b3-4b6e-a4cf-c5cdf9f0a4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_67885d77-8ac4-4e1b-ad3f-cf3d5aac3189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3ec1a1d4-5850-4b30-a65a-7081f2d5ae40" xlink:to="loc_us-gaap_StockholdersEquity_67885d77-8ac4-4e1b-ad3f-cf3d5aac3189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c94bf60-b878-4f3e-bbfe-0229c68d4588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b26e3759-171e-4d86-8df4-fa4b2c8620b7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5c94bf60-b878-4f3e-bbfe-0229c68d4588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bea04ab9-1ae2-42f6-bf55-b65e72f6db58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2b2597d0-7663-4a99-94c3-132103e6e8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bea04ab9-1ae2-42f6-bf55-b65e72f6db58" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2b2597d0-7663-4a99-94c3-132103e6e8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2f892d78-d82c-4abd-a055-f71dc5709aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bea04ab9-1ae2-42f6-bf55-b65e72f6db58" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2f892d78-d82c-4abd-a055-f71dc5709aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a2bf39b7-60e2-417b-9d5b-63ef387a849d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bea04ab9-1ae2-42f6-bf55-b65e72f6db58" xlink:to="loc_us-gaap_CommonStockSharesIssued_a2bf39b7-60e2-417b-9d5b-63ef387a849d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_84f1ab0a-6ae1-4651-8ea5-cfb1177ca100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bea04ab9-1ae2-42f6-bf55-b65e72f6db58" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_84f1ab0a-6ae1-4651-8ea5-cfb1177ca100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_bb034955-3473-4043-b88b-ac9019508cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ef45db1-3924-46f2-a148-5f42c6f6ae65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb034955-3473-4043-b88b-ac9019508cc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ef45db1-3924-46f2-a148-5f42c6f6ae65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a192a580-78fe-458b-803c-aadf05ac31b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ef45db1-3924-46f2-a148-5f42c6f6ae65" xlink:to="loc_us-gaap_NetIncomeLoss_a192a580-78fe-458b-803c-aadf05ac31b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e22662de-b447-4623-a09f-17366ddebdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8ef45db1-3924-46f2-a148-5f42c6f6ae65" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e22662de-b447-4623-a09f-17366ddebdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c04f0f5b-7862-4c23-bc85-a9845f42a444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e22662de-b447-4623-a09f-17366ddebdf2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c04f0f5b-7862-4c23-bc85-a9845f42a444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash_b2d531b3-6e0b-4353-94bc-165d9adca5b3" xlink:href="med-20220630.xsd#med_OperatingLeaseExpenseNonCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e22662de-b447-4623-a09f-17366ddebdf2" xlink:to="loc_med_OperatingLeaseExpenseNonCash_b2d531b3-6e0b-4353-94bc-165d9adca5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_30a722e8-8f52-4839-b357-7d792973cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e22662de-b447-4623-a09f-17366ddebdf2" xlink:to="loc_us-gaap_ShareBasedCompensation_30a722e8-8f52-4839-b357-7d792973cad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_AmortizationOfPremiumOnInvestmentSecurities_32072b9d-3fb8-4a45-92ba-c780cedf84d2" xlink:href="med-20220630.xsd#med_AmortizationOfPremiumOnInvestmentSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e22662de-b447-4623-a09f-17366ddebdf2" xlink:to="loc_med_AmortizationOfPremiumOnInvestmentSecurities_32072b9d-3fb8-4a45-92ba-c780cedf84d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e27500f3-5cc1-4f7f-bacd-9f5d3d32a1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e22662de-b447-4623-a09f-17366ddebdf2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e27500f3-5cc1-4f7f-bacd-9f5d3d32a1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_cc8912a1-db96-46be-9bf2-6545082a63ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e27500f3-5cc1-4f7f-bacd-9f5d3d32a1f4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_cc8912a1-db96-46be-9bf2-6545082a63ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_4c2b76d9-59ea-4719-a6b9-c782dc7991d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e27500f3-5cc1-4f7f-bacd-9f5d3d32a1f4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_4c2b76d9-59ea-4719-a6b9-c782dc7991d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5c016595-2250-4147-a15b-de754dd16633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e27500f3-5cc1-4f7f-bacd-9f5d3d32a1f4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5c016595-2250-4147-a15b-de754dd16633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_68879a47-8e5f-4357-92e8-8937daebbf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e27500f3-5cc1-4f7f-bacd-9f5d3d32a1f4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_68879a47-8e5f-4357-92e8-8937daebbf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8f3a167d-1703-4025-87fc-7fe3f156f954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e27500f3-5cc1-4f7f-bacd-9f5d3d32a1f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8f3a167d-1703-4025-87fc-7fe3f156f954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6301b49-5799-4b08-a40d-baf9d056554a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e27500f3-5cc1-4f7f-bacd-9f5d3d32a1f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6301b49-5799-4b08-a40d-baf9d056554a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_64bf5ca3-4617-4d90-980c-3ef613e068f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb034955-3473-4043-b88b-ac9019508cc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_64bf5ca3-4617-4d90-980c-3ef613e068f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_bada08c0-88c8-406a-9f4a-fb835750ce1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_64bf5ca3-4617-4d90-980c-3ef613e068f2" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_bada08c0-88c8-406a-9f4a-fb835750ce1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4c088683-f691-4667-8d1d-96c8a16c2b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_64bf5ca3-4617-4d90-980c-3ef613e068f2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4c088683-f691-4667-8d1d-96c8a16c2b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e6c4903-c571-4254-9e0d-d7b46d81f82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_64bf5ca3-4617-4d90-980c-3ef613e068f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e6c4903-c571-4254-9e0d-d7b46d81f82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_26aa469c-59c5-4b63-b569-ac3972bfb47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb034955-3473-4043-b88b-ac9019508cc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_26aa469c-59c5-4b63-b569-ac3972bfb47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_edd40c7f-43c0-4cc2-95ea-55b948385529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_26aa469c-59c5-4b63-b569-ac3972bfb47c" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_edd40c7f-43c0-4cc2-95ea-55b948385529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_4f564af4-003c-4109-98c0-89d863d2a8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_26aa469c-59c5-4b63-b569-ac3972bfb47c" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_4f564af4-003c-4109-98c0-89d863d2a8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_289c518b-6b30-45fe-bb0c-e4af8f87197a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_26aa469c-59c5-4b63-b569-ac3972bfb47c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_289c518b-6b30-45fe-bb0c-e4af8f87197a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_84416934-e015-4451-b95f-f185aca28a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_26aa469c-59c5-4b63-b569-ac3972bfb47c" xlink:to="loc_us-gaap_PaymentsOfDividends_84416934-e015-4451-b95f-f185aca28a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c58c538e-0369-4483-8c40-1b1ac4a61ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_26aa469c-59c5-4b63-b569-ac3972bfb47c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c58c538e-0369-4483-8c40-1b1ac4a61ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_PaymentsForRepurchaseOfCommonStockNotYetSettled_7aef1e05-e393-4c80-b2cb-6f43f47b85c4" xlink:href="med-20220630.xsd#med_PaymentsForRepurchaseOfCommonStockNotYetSettled"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_26aa469c-59c5-4b63-b569-ac3972bfb47c" xlink:to="loc_med_PaymentsForRepurchaseOfCommonStockNotYetSettled_7aef1e05-e393-4c80-b2cb-6f43f47b85c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_61c08314-714d-4347-8aea-e77f5cfb2c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_26aa469c-59c5-4b63-b569-ac3972bfb47c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_61c08314-714d-4347-8aea-e77f5cfb2c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9279137c-7570-46a9-8845-3cdfc8f68cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb034955-3473-4043-b88b-ac9019508cc8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9279137c-7570-46a9-8845-3cdfc8f68cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d62937f3-a6e6-40dc-a53d-de41f1fe1986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb034955-3473-4043-b88b-ac9019508cc8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d62937f3-a6e6-40dc-a53d-de41f1fe1986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e45a0636-c9d9-48d5-88e8-9e2a00dca10e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb034955-3473-4043-b88b-ac9019508cc8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e45a0636-c9d9-48d5-88e8-9e2a00dca10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_93355eef-fa15-4fc2-a547-6eff4124fd80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb034955-3473-4043-b88b-ac9019508cc8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_93355eef-fa15-4fc2-a547-6eff4124fd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_71e2f4da-0555-4cb0-8e43-344d4ac98c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb034955-3473-4043-b88b-ac9019508cc8" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_71e2f4da-0555-4cb0-8e43-344d4ac98c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_ef1d518b-cc37-457e-a2d2-46b71161e4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_71e2f4da-0555-4cb0-8e43-344d4ac98c1b" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_ef1d518b-cc37-457e-a2d2-46b71161e4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_36653851-42e7-417e-8dec-ff5e6d637024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_71e2f4da-0555-4cb0-8e43-344d4ac98c1b" xlink:to="loc_us-gaap_DividendsCash_36653851-42e7-417e-8dec-ff5e6d637024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="med-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_cd4ce118-a087-4d72-9845-e28bcdf92dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f510eab-b8a5-4bf6-b960-242260014162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_cd4ce118-a087-4d72-9845-e28bcdf92dce" xlink:to="loc_us-gaap_StatementTable_1f510eab-b8a5-4bf6-b960-242260014162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3f5d971-99a7-4773-9bb7-7fbeb01703af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f510eab-b8a5-4bf6-b960-242260014162" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3f5d971-99a7-4773-9bb7-7fbeb01703af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3f5d971-99a7-4773-9bb7-7fbeb01703af" xlink:to="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6d23fc86-5c14-4cd1-8dbe-72644a3fcb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_CommonStockMember_6d23fc86-5c14-4cd1-8dbe-72644a3fcb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_1be4562d-ecf2-4676-974f-e6a52b086dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_1be4562d-ecf2-4676-974f-e6a52b086dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e4c7cc5f-2128-44cc-9371-69552183db5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e4c7cc5f-2128-44cc-9371-69552183db5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6eaa3204-4623-4ed7-8998-36da4475007f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_RetainedEarningsMember_6eaa3204-4623-4ed7-8998-36da4475007f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_53d636d4-ca57-4daf-ae97-8e2165848b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fc7c87d-3ac9-4af9-a0d8-4c7ac866d39f" xlink:to="loc_us-gaap_TreasuryStockCommonMember_53d636d4-ca57-4daf-ae97-8e2165848b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f510eab-b8a5-4bf6-b960-242260014162" xlink:to="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8d637d02-4c0e-4f46-a9a8-ca40bce8e688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_SharesIssued_8d637d02-4c0e-4f46-a9a8-ca40bce8e688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5a0aeb9f-eee2-4bf2-92d2-9e60ffc81700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_StockholdersEquity_5a0aeb9f-eee2-4bf2-92d2-9e60ffc81700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b078844b-9a7d-4922-a1d0-2424d4ea1b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_NetIncomeLoss_b078844b-9a7d-4922-a1d0-2424d4ea1b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_78d1d5da-fdee-4a73-b3ec-35e731fe7fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_78d1d5da-fdee-4a73-b3ec-35e731fe7fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_26257a34-20e0-4de6-bfb7-0db1fe7c162f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_26257a34-20e0-4de6-bfb7-0db1fe7c162f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_803b5eff-339e-4f0e-b404-fd7c4a2cb334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_803b5eff-339e-4f0e-b404-fd7c4a2cb334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_760f2775-2441-46fa-aa3b-78a58b55e8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_760f2775-2441-46fa-aa3b-78a58b55e8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_ae6ec770-6661-4843-968d-271f8a2b8749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_ae6ec770-6661-4843-968d-271f8a2b8749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_613fbe8c-628d-4bfb-bc59-494ddd2e1742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_613fbe8c-628d-4bfb-bc59-494ddd2e1742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bb5a3157-73d4-4f67-b615-7e6ef7dced57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bb5a3157-73d4-4f67-b615-7e6ef7dced57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_bb8ea771-5a57-4c09-8f7b-5aaffe0a9fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_bb8ea771-5a57-4c09-8f7b-5aaffe0a9fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_da003657-955d-4cd9-a3cd-c03a496f3140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_da003657-955d-4cd9-a3cd-c03a496f3140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_6d565f8e-2082-49e7-b40b-9ae2e6df5c76" xlink:href="med-20220630.xsd#med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled_6d565f8e-2082-49e7-b40b-9ae2e6df5c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f0a8a95f-ee9c-4018-bb50-ac9557edf0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f0a8a95f-ee9c-4018-bb50-ac9557edf0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_500183dc-8de3-4fa0-965c-33aca4b12e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_DividendsCommonStockCash_500183dc-8de3-4fa0-965c-33aca4b12e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_56eb7d56-916e-4f4a-bdae-2a6ddbf9aa07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_SharesIssued_56eb7d56-916e-4f4a-bdae-2a6ddbf9aa07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84bc387f-e217-4cb1-b3db-8a219cf429d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_56985207-9a0f-4da4-ab33-4ef89fefb235" xlink:to="loc_us-gaap_StockholdersEquity_84bc387f-e217-4cb1-b3db-8a219cf429d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="med-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bf17c3eb-17bd-4ff7-bccc-eb202dd159d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e42969bb-3ec6-43d9-82df-a33ca24f8f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf17c3eb-17bd-4ff7-bccc-eb202dd159d7" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e42969bb-3ec6-43d9-82df-a33ca24f8f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="med-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8e14d6c3-5559-4c1c-bd70-ebd684bcdcb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8bb1b04d-18e6-4f08-8c2c-42f780699e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8e14d6c3-5559-4c1c-bd70-ebd684bcdcb4" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8bb1b04d-18e6-4f08-8c2c-42f780699e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_4615826c-b186-44a4-9534-d63110ceed2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8e14d6c3-5559-4c1c-bd70-ebd684bcdcb4" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_4615826c-b186-44a4-9534-d63110ceed2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_21cdcadc-21eb-4856-9644-586f27449d13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8e14d6c3-5559-4c1c-bd70-ebd684bcdcb4" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_21cdcadc-21eb-4856-9644-586f27449d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_c0507acf-b0b4-4aaa-9f72-9c52b003431d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8e14d6c3-5559-4c1c-bd70-ebd684bcdcb4" xlink:to="loc_us-gaap_UseOfEstimates_c0507acf-b0b4-4aaa-9f72-9c52b003431d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_38be00da-166d-427e-842c-ad7519f76e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8e14d6c3-5559-4c1c-bd70-ebd684bcdcb4" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_38be00da-166d-427e-842c-ad7519f76e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIES" xlink:type="simple" xlink:href="med-20220630.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_bcdc55a7-031b-4306-ade4-d336865ad54b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_b3e9f7e1-dc22-41fe-bb2d-5a7eece89d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_bcdc55a7-031b-4306-ade4-d336865ad54b" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_b3e9f7e1-dc22-41fe-bb2d-5a7eece89d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="med-20220630.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_f2578db9-7ce6-4611-830e-f9b8113ed12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7a0557f5-f3b1-46a3-aba9-8ddf6b2950ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_f2578db9-7ce6-4611-830e-f9b8113ed12f" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7a0557f5-f3b1-46a3-aba9-8ddf6b2950ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="med-20220630.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_927fa66b-d94d-4e20-9a3e-1046a2ec7bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashContributionExpense_f1c06d52-cb96-4e0f-8f4b-455fff297554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashContributionExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_927fa66b-d94d-4e20-9a3e-1046a2ec7bda" xlink:to="loc_us-gaap_NoncashContributionExpense_f1c06d52-cb96-4e0f-8f4b-455fff297554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_6e2ac9f0-5886-464d-9eb1-fe3aa6c63756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_927fa66b-d94d-4e20-9a3e-1046a2ec7bda" xlink:to="loc_us-gaap_InventoryRawMaterials_6e2ac9f0-5886-464d-9eb1-fe3aa6c63756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_01d001f4-c102-4428-b07d-5e9f70111adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_927fa66b-d94d-4e20-9a3e-1046a2ec7bda" xlink:to="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_01d001f4-c102-4428-b07d-5e9f70111adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods_8d9696cf-499b-4618-b66a-8c80b650b791" xlink:href="med-20220630.xsd#med_InventoryNonFoodFinishedGoods"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_927fa66b-d94d-4e20-9a3e-1046a2ec7bda" xlink:to="loc_med_InventoryNonFoodFinishedGoods_8d9696cf-499b-4618-b66a-8c80b650b791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_f7881a8b-c89e-4220-9e39-76660c7dcd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_927fa66b-d94d-4e20-9a3e-1046a2ec7bda" xlink:to="loc_us-gaap_InventoryFinishedGoods_f7881a8b-c89e-4220-9e39-76660c7dcd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_aeab7015-1793-4ebb-96f1-346bc11bd376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_927fa66b-d94d-4e20-9a3e-1046a2ec7bda" xlink:to="loc_us-gaap_InventoryValuationReserves_aeab7015-1793-4ebb-96f1-346bc11bd376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0302ec12-50e4-4159-b489-e38786689898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_927fa66b-d94d-4e20-9a3e-1046a2ec7bda" xlink:to="loc_us-gaap_InventoryNet_0302ec12-50e4-4159-b489-e38786689898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="med-20220630.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_24d1c81d-fe14-471e-8697-c3c16ac94c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_e49cc0e5-2426-4f56-9f5d-dc62bb59daea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_24d1c81d-fe14-471e-8697-c3c16ac94c67" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_e49cc0e5-2426-4f56-9f5d-dc62bb59daea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="med-20220630.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_21e1600f-7684-45c1-ae12-a4216f70701b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8d563fc2-50df-4752-aefa-218e373d9f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_21e1600f-7684-45c1-ae12-a4216f70701b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8d563fc2-50df-4752-aefa-218e373d9f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="med-20220630.xsd#EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3380d198-8db0-4dd6-8e9a-59bacb755242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_NumeratorAbstract_3c204057-8521-4e03-9873-5797fbf71f06" xlink:href="med-20220630.xsd#med_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3380d198-8db0-4dd6-8e9a-59bacb755242" xlink:to="loc_med_NumeratorAbstract_3c204057-8521-4e03-9873-5797fbf71f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_daa43a14-73d5-47fb-ad23-1cc664cb769e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_NumeratorAbstract_3c204057-8521-4e03-9873-5797fbf71f06" xlink:to="loc_us-gaap_NetIncomeLoss_daa43a14-73d5-47fb-ad23-1cc664cb769e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_DenominatorAbstract_474c7250-3b8c-41f0-baf0-d9e0402b8c4b" xlink:href="med-20220630.xsd#med_DenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3380d198-8db0-4dd6-8e9a-59bacb755242" xlink:to="loc_med_DenominatorAbstract_474c7250-3b8c-41f0-baf0-d9e0402b8c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_15b4b22d-7086-4dd0-b248-412cefb6df8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_474c7250-3b8c-41f0-baf0-d9e0402b8c4b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_15b4b22d-7086-4dd0-b248-412cefb6df8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_85db088e-06a2-4ec1-9d17-7f5e40c9d9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_474c7250-3b8c-41f0-baf0-d9e0402b8c4b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_85db088e-06a2-4ec1-9d17-7f5e40c9d9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8c23942b-8b29-4266-b444-e0a921bb228a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_474c7250-3b8c-41f0-baf0-d9e0402b8c4b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8c23942b-8b29-4266-b444-e0a921bb228a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_2ff5ba79-51dd-4e5f-8772-af467178a159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_474c7250-3b8c-41f0-baf0-d9e0402b8c4b" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_2ff5ba79-51dd-4e5f-8772-af467178a159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_11e37681-664f-4fd8-ac0a-ef054ea8818e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_2ff5ba79-51dd-4e5f-8772-af467178a159" xlink:to="loc_us-gaap_EarningsPerShareBasic_11e37681-664f-4fd8-ac0a-ef054ea8818e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_0cdb62f6-d888-4adf-912b-d0dd58251cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_474c7250-3b8c-41f0-baf0-d9e0402b8c4b" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_0cdb62f6-d888-4adf-912b-d0dd58251cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8d36b5dd-c9e2-4c31-8025-6d72e54a2410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_0cdb62f6-d888-4adf-912b-d0dd58251cc3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8d36b5dd-c9e2-4c31-8025-6d72e54a2410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_26f86eac-aead-4022-989a-e79cc0e5f128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7ec9190c-4e67-46cc-8472-55b57d505b92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_26f86eac-aead-4022-989a-e79cc0e5f128" xlink:to="loc_us-gaap_StatementTable_7ec9190c-4e67-46cc-8472-55b57d505b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0fd01883-45bc-462c-bed1-aa95991cb97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7ec9190c-4e67-46cc-8472-55b57d505b92" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0fd01883-45bc-462c-bed1-aa95991cb97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d7d6597-ec91-42d9-b48c-6d3ed77a16a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0fd01883-45bc-462c-bed1-aa95991cb97f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d7d6597-ec91-42d9-b48c-6d3ed77a16a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_5a63abdd-bf37-445c-9f04-7ecec18953dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d7d6597-ec91-42d9-b48c-6d3ed77a16a1" xlink:to="loc_us-gaap_RestrictedStockMember_5a63abdd-bf37-445c-9f04-7ecec18953dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8c9793e0-e30a-470c-af36-7235f866a0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7ec9190c-4e67-46cc-8472-55b57d505b92" xlink:to="loc_us-gaap_StatementLineItems_8c9793e0-e30a-470c-af36-7235f866a0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_63a7d36c-9df8-4ba5-b475-a2958575e191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8c9793e0-e30a-470c-af36-7235f866a0da" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_63a7d36c-9df8-4ba5-b475-a2958575e191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATION" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f21d9bb2-2456-45b0-9935-d5f594d9cebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b34e4469-2f30-40bc-9278-872b066d230b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f21d9bb2-2456-45b0-9935-d5f594d9cebd" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b34e4469-2f30-40bc-9278-872b066d230b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5d71492-47e5-4829-9371-d8d74bfd8495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8923d7ce-e671-49f6-924e-2642fbbaf1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5d71492-47e5-4829-9371-d8d74bfd8495" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8923d7ce-e671-49f6-924e-2642fbbaf1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_2ebc18f8-8da3-4a0c-b03f-12f57ecba830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5d71492-47e5-4829-9371-d8d74bfd8495" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_2ebc18f8-8da3-4a0c-b03f-12f57ecba830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_fa68921f-6b61-40ab-b8bf-42f303406b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5d71492-47e5-4829-9371-d8d74bfd8495" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_fa68921f-6b61-40ab-b8bf-42f303406b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c8ceab18-3704-459a-8f2f-d6a0d1e223e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b37a5751-a098-4bba-a6c1-9695f66c97d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c8ceab18-3704-459a-8f2f-d6a0d1e223e1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b37a5751-a098-4bba-a6c1-9695f66c97d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5d1d8af2-3126-43aa-a399-26b0648f7ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b37a5751-a098-4bba-a6c1-9695f66c97d0" xlink:to="loc_us-gaap_AwardTypeAxis_5d1d8af2-3126-43aa-a399-26b0648f7ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5d1d8af2-3126-43aa-a399-26b0648f7ff1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a6d25b18-f568-40a6-a007-eafaf8c89af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:to="loc_us-gaap_RestrictedStockMember_a6d25b18-f568-40a6-a007-eafaf8c89af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9fd4bd51-e16d-427a-9304-a9a5b88f48b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9fd4bd51-e16d-427a-9304-a9a5b88f48b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_91e778e8-38d4-47dc-a309-7040228d0142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d480e578-7249-4fea-a787-38d81523fce6" xlink:to="loc_us-gaap_PerformanceSharesMember_91e778e8-38d4-47dc-a309-7040228d0142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_eee2600b-eed4-455c-aaae-5ce98fc590cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b37a5751-a098-4bba-a6c1-9695f66c97d0" xlink:to="loc_srt_RangeAxis_eee2600b-eed4-455c-aaae-5ce98fc590cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dc8b768c-79ad-47b4-be18-e36cb566002b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_eee2600b-eed4-455c-aaae-5ce98fc590cd" xlink:to="loc_srt_RangeMember_dc8b768c-79ad-47b4-be18-e36cb566002b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cc11f4ca-2333-4f7d-9979-14fd97ebdda0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dc8b768c-79ad-47b4-be18-e36cb566002b" xlink:to="loc_srt_MinimumMember_cc11f4ca-2333-4f7d-9979-14fd97ebdda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1dd2fec4-8bdf-484e-9aa1-8612e01d9e89" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dc8b768c-79ad-47b4-be18-e36cb566002b" xlink:to="loc_srt_MaximumMember_1dd2fec4-8bdf-484e-9aa1-8612e01d9e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b37a5751-a098-4bba-a6c1-9695f66c97d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cf26d35b-99d1-4537-8482-fb1e55997e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_cf26d35b-99d1-4537-8482-fb1e55997e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0840ca7a-7113-4a78-928e-87cb1be4ab23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0840ca7a-7113-4a78-928e-87cb1be4ab23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_206e5825-563a-4f8e-9a53-63864de4d267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_206e5825-563a-4f8e-9a53-63864de4d267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_870f9f65-ea55-4287-8020-88e045492199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_870f9f65-ea55-4287-8020-88e045492199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39c852e8-bff3-440a-a2b6-f70c2542ee67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39c852e8-bff3-440a-a2b6-f70c2542ee67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_89b6757f-e955-4d1a-8bb4-d210ac26f592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_89b6757f-e955-4d1a-8bb4-d210ac26f592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2d8de65-e14f-4d01-ab8e-5b7dae203395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c2d8de65-e14f-4d01-ab8e-5b7dae203395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_bc9478bc-6449-4144-823d-1f7ef34e9b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_bc9478bc-6449-4144-823d-1f7ef34e9b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_45c33938-71db-46aa-8301-80f7e4b02efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_45c33938-71db-46aa-8301-80f7e4b02efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_00ebf83d-75c6-49f9-9511-3b505b0f765e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_00ebf83d-75c6-49f9-9511-3b505b0f765e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d406e3f3-358d-4a6a-a27e-b5c8a41b00a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d406e3f3-358d-4a6a-a27e-b5c8a41b00a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1a37e762-6931-4e27-923e-0b04765372e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1a37e762-6931-4e27-923e-0b04765372e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3cc4457b-3ea1-437a-b251-16c9eb362414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3cc4457b-3ea1-437a-b251-16c9eb362414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_60932433-a719-473a-80f9-850044673eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_60932433-a719-473a-80f9-850044673eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_786aa42b-a713-4cce-a09e-52acb34e89e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_786aa42b-a713-4cce-a09e-52acb34e89e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_5850fcc5-d43a-4846-93a9-553b1db8e06d" xlink:href="med-20220630.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_5850fcc5-d43a-4846-93a9-553b1db8e06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_ffd3ebfd-017e-4855-8109-b8d36a3d019e" xlink:href="med-20220630.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_ffd3ebfd-017e-4855-8109-b8d36a3d019e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2a0fada7-c875-4f79-9ef3-090b0df11a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2a0fada7-c875-4f79-9ef3-090b0df11a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_00a7369d-2201-4a7b-b155-6238094d50e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_00a7369d-2201-4a7b-b155-6238094d50e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_876e12e1-f385-4596-a869-09014a86cb02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcbd6bc8-aa57-4cc7-a761-02bf1edbf9fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_876e12e1-f385-4596-a869-09014a86cb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a97d4788-d229-48a0-81d5-59f606c83cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d028527d-9970-4f72-be05-dc12df77f254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a97d4788-d229-48a0-81d5-59f606c83cc9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d028527d-9970-4f72-be05-dc12df77f254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_56246af6-1420-47ac-8e4d-a12cc6ab25be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d028527d-9970-4f72-be05-dc12df77f254" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_56246af6-1420-47ac-8e4d-a12cc6ab25be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_8e24c148-ddbf-49fe-9576-b3825e255a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_56246af6-1420-47ac-8e4d-a12cc6ab25be" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_8e24c148-ddbf-49fe-9576-b3825e255a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_35365dbd-5818-441c-9ec5-c06b2858fc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_8e24c148-ddbf-49fe-9576-b3825e255a24" xlink:to="loc_us-gaap_EmployeeStockOptionMember_35365dbd-5818-441c-9ec5-c06b2858fc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d028527d-9970-4f72-be05-dc12df77f254" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2ee95144-68b8-458f-8f69-73eb6ddafc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2ee95144-68b8-458f-8f69-73eb6ddafc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61b09c59-5c82-47ac-a68d-9189a106949f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61b09c59-5c82-47ac-a68d-9189a106949f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c04269d9-329a-44ef-baac-92c9f8957fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c04269d9-329a-44ef-baac-92c9f8957fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9ffc18aa-b9e1-4019-869b-a7e4b9f8ee3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9ffc18aa-b9e1-4019-869b-a7e4b9f8ee3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f902d8e2-cb41-4eaa-b5eb-8407f1849c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f902d8e2-cb41-4eaa-b5eb-8407f1849c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_51ddfdc2-834d-4567-ada2-d5e5a082bf88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_51ddfdc2-834d-4567-ada2-d5e5a082bf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_599fc9ed-9cf5-4c35-b622-99f383885edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_599fc9ed-9cf5-4c35-b622-99f383885edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_74ef309a-c455-43f6-ac76-2b535df17911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_20ad2035-df15-4324-a4ec-9d22b9296950" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_74ef309a-c455-43f6-ac76-2b535df17911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_85c9086e-9bbd-472f-883c-7a9d243eecaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5cc05cc7-5efe-4cb7-a41d-0517abd393d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_85c9086e-9bbd-472f-883c-7a9d243eecaf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5cc05cc7-5efe-4cb7-a41d-0517abd393d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7c7f8950-171a-4fd9-bfda-17615e367838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5cc05cc7-5efe-4cb7-a41d-0517abd393d2" xlink:to="loc_us-gaap_AwardTypeAxis_7c7f8950-171a-4fd9-bfda-17615e367838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_282afdcb-db77-4d04-933d-10613658ad2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7c7f8950-171a-4fd9-bfda-17615e367838" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_282afdcb-db77-4d04-933d-10613658ad2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_f590aaf2-cb44-45e5-9979-b6cbade69f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_282afdcb-db77-4d04-933d-10613658ad2f" xlink:to="loc_us-gaap_RestrictedStockMember_f590aaf2-cb44-45e5-9979-b6cbade69f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2de0929-76ce-4db8-9ff5-8f7c6f996c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5cc05cc7-5efe-4cb7-a41d-0517abd393d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2de0929-76ce-4db8-9ff5-8f7c6f996c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2de0929-76ce-4db8-9ff5-8f7c6f996c78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_98af01f2-8745-48e4-a912-99338d1028a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_98af01f2-8745-48e4-a912-99338d1028a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_84946d6d-f298-42b4-af7c-3c2d13481315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_84946d6d-f298-42b4-af7c-3c2d13481315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e63e3b35-308a-41f5-9e58-9f1d29ea309d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e63e3b35-308a-41f5-9e58-9f1d29ea309d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1dcc0338-64f6-45c1-94c3-5b368e515916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1dcc0338-64f6-45c1-94c3-5b368e515916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64ec2815-502c-4870-b494-9f3a4d06f83c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7e8080d4-78cb-4bba-976e-327d37c5c8b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64ec2815-502c-4870-b494-9f3a4d06f83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a2de0929-76ce-4db8-9ff5-8f7c6f996c78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f883f900-d612-4e47-8a0e-2d137c3303fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f883f900-d612-4e47-8a0e-2d137c3303fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_084c4057-ba3c-4fca-8f06-424ba99f5f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_084c4057-ba3c-4fca-8f06-424ba99f5f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f7fb8f0a-b0ff-4544-8aeb-045ddcd86fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f7fb8f0a-b0ff-4544-8aeb-045ddcd86fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d88cf947-1fa8-4050-91ac-4307466128ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d88cf947-1fa8-4050-91ac-4307466128ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7bc8e5bf-a8ee-453d-8fbe-c8c9523a6434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc34ddc-1f86-49a6-9109-6ac20ec2e239" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7bc8e5bf-a8ee-453d-8fbe-c8c9523a6434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="simple" xlink:href="med-20220630.xsd#SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dfa73023-e1a5-4e44-b895-36a6b438d210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10e26611-d1c3-4769-8192-5ca2b15696ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dfa73023-e1a5-4e44-b895-36a6b438d210" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10e26611-d1c3-4769-8192-5ca2b15696ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_26394226-fb90-4d16-9bb5-f97ed82f079c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10e26611-d1c3-4769-8192-5ca2b15696ff" xlink:to="loc_us-gaap_AwardTypeAxis_26394226-fb90-4d16-9bb5-f97ed82f079c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_26394226-fb90-4d16-9bb5-f97ed82f079c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OptionsAndRestrictedStockMember_7d401522-48af-46d0-8825-a6631ef0c729" xlink:href="med-20220630.xsd#med_OptionsAndRestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:to="loc_med_OptionsAndRestrictedStockMember_7d401522-48af-46d0-8825-a6631ef0c729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceSharesMember_b6ea66b7-2ee4-4a46-9853-3b74df68a8ac" xlink:href="med-20220630.xsd#med_MarketAndPerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:to="loc_med_MarketAndPerformanceSharesMember_b6ea66b7-2ee4-4a46-9853-3b74df68a8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_7e8605fe-b481-4fa8-8c52-afc5e961b798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1fc95fe2-1401-4a9f-821f-86a9b88706af" xlink:to="loc_us-gaap_PerformanceSharesMember_7e8605fe-b481-4fa8-8c52-afc5e961b798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_51eb8c0c-f955-4fc5-bfe8-665ef2dc71b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10e26611-d1c3-4769-8192-5ca2b15696ff" xlink:to="loc_us-gaap_AwardDateAxis_51eb8c0c-f955-4fc5-bfe8-665ef2dc71b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_51eb8c0c-f955-4fc5-bfe8-665ef2dc71b2" xlink:to="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member_9ce93933-9b38-4bba-9283-3d0e1aa1fa86" xlink:href="med-20220630.xsd#med_GrantedIn2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:to="loc_med_GrantedIn2022Member_9ce93933-9b38-4bba-9283-3d0e1aa1fa86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2021Member_d6b51d5f-ba70-4a46-82b2-36c10b2b28a4" xlink:href="med-20220630.xsd#med_GrantedIn2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:to="loc_med_GrantedIn2021Member_d6b51d5f-ba70-4a46-82b2-36c10b2b28a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2020Member_ee66e465-fd6c-42e6-845e-18b7b2ba93f1" xlink:href="med-20220630.xsd#med_GrantedIn2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:to="loc_med_GrantedIn2020Member_ee66e465-fd6c-42e6-845e-18b7b2ba93f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2019Member_80c8318a-1a2b-4704-a5b6-76a07d08eafa" xlink:href="med-20220630.xsd#med_GrantedIn2019Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_dd8ba0ba-7fa0-4042-98e9-ba98038822dc" xlink:to="loc_med_GrantedIn2019Member_80c8318a-1a2b-4704-a5b6-76a07d08eafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a3cd14c-eff6-4ffc-b4ea-22206fbb0b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_10e26611-d1c3-4769-8192-5ca2b15696ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a3cd14c-eff6-4ffc-b4ea-22206fbb0b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5902340b-68a4-45a1-b9a8-f84779272b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a3cd14c-eff6-4ffc-b4ea-22206fbb0b31" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5902340b-68a4-45a1-b9a8-f84779272b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2c2b51c4-afea-4ab9-938e-eb16eac793ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3a3cd14c-eff6-4ffc-b4ea-22206fbb0b31" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2c2b51c4-afea-4ab9-938e-eb16eac793ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASES" xlink:type="simple" xlink:href="med-20220630.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c1771318-33a0-4c34-b418-26637f75e50c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_3b146f1c-6323-4b9d-9276-915c075748a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c1771318-33a0-4c34-b418-26637f75e50c" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_3b146f1c-6323-4b9d-9276-915c075748a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESTables" xlink:type="simple" xlink:href="med-20220630.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_be405550-122f-4ace-8c7f-2f4c616eabcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_656b03ab-f88c-4e71-b8a2-45462d2c7ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_be405550-122f-4ace-8c7f-2f4c616eabcb" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_656b03ab-f88c-4e71-b8a2-45462d2c7ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_86efa82c-5805-4475-a234-2f6565196d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_be405550-122f-4ace-8c7f-2f4c616eabcb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_86efa82c-5805-4475-a234-2f6565196d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a560449e-6f03-4004-aa82-5878ba8ee7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b90fa5a3-5e6d-4df5-9c27-7af80a642d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a560449e-6f03-4004-aa82-5878ba8ee7d2" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b90fa5a3-5e6d-4df5-9c27-7af80a642d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_17d97a6e-ef09-4a32-84b0-a2e9c12988a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b90fa5a3-5e6d-4df5-9c27-7af80a642d45" xlink:to="loc_srt_RangeAxis_17d97a6e-ef09-4a32-84b0-a2e9c12988a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b72f3cd-1726-4d00-b6c5-80fbf11cc355" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_17d97a6e-ef09-4a32-84b0-a2e9c12988a4" xlink:to="loc_srt_RangeMember_1b72f3cd-1726-4d00-b6c5-80fbf11cc355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_486d01c9-77f9-409d-9d16-22c335a5def6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1b72f3cd-1726-4d00-b6c5-80fbf11cc355" xlink:to="loc_srt_MinimumMember_486d01c9-77f9-409d-9d16-22c335a5def6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7094fc11-a868-42b7-aa43-f2d7757a9845" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1b72f3cd-1726-4d00-b6c5-80fbf11cc355" xlink:to="loc_srt_MaximumMember_7094fc11-a868-42b7-aa43-f2d7757a9845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_28e74198-2b61-4f5a-a28f-f145f8b53737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b90fa5a3-5e6d-4df5-9c27-7af80a642d45" xlink:to="loc_us-gaap_TypeOfArrangementAxis_28e74198-2b61-4f5a-a28f-f145f8b53737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b2b1d7c-87a2-47c4-a8d1-e93b4f5ec792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_28e74198-2b61-4f5a-a28f-f145f8b53737" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b2b1d7c-87a2-47c4-a8d1-e93b4f5ec792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForRealEstateMember_25133b6e-08a0-4682-9289-f814b5889b84" xlink:href="med-20220630.xsd#med_OperatingLeaseArrangementForRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b2b1d7c-87a2-47c4-a8d1-e93b4f5ec792" xlink:to="loc_med_OperatingLeaseArrangementForRealEstateMember_25133b6e-08a0-4682-9289-f814b5889b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForEquipmentMember_b86d7311-9e81-4909-ab4e-6885dc385b9b" xlink:href="med-20220630.xsd#med_OperatingLeaseArrangementForEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b2b1d7c-87a2-47c4-a8d1-e93b4f5ec792" xlink:to="loc_med_OperatingLeaseArrangementForEquipmentMember_b86d7311-9e81-4909-ab4e-6885dc385b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_0cde99ef-e463-49a7-a2a9-31d52515d806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b90fa5a3-5e6d-4df5-9c27-7af80a642d45" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_0cde99ef-e463-49a7-a2a9-31d52515d806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_aa9892ec-516f-4ea7-8ce0-e3bca3ddd81d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0cde99ef-e463-49a7-a2a9-31d52515d806" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_aa9892ec-516f-4ea7-8ce0-e3bca3ddd81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_b653f4db-37e2-441e-999f-5b070666e31f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0cde99ef-e463-49a7-a2a9-31d52515d806" xlink:to="loc_us-gaap_OperatingLeaseExpense_b653f4db-37e2-441e-999f-5b070666e31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="med-20220630.xsd#LEASESSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5cc01a95-dc5d-4e5f-9c1d-0452b399378d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_a07c15a9-1b0f-4a22-a4a0-ebc28c630553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5cc01a95-dc5d-4e5f-9c1d-0452b399378d" xlink:to="loc_us-gaap_OperatingLeasePayments_a07c15a9-1b0f-4a22-a4a0-ebc28c630553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bad83952-f1bc-4ea4-92c2-ca9834101102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5cc01a95-dc5d-4e5f-9c1d-0452b399378d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bad83952-f1bc-4ea4-92c2-ca9834101102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5a736454-4c04-4564-852b-61bbc57adb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5cc01a95-dc5d-4e5f-9c1d-0452b399378d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5a736454-4c04-4564-852b-61bbc57adb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9c9de07e-ed70-43b8-bd4e-5b9e3d8a91ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5cc01a95-dc5d-4e5f-9c1d-0452b399378d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9c9de07e-ed70-43b8-bd4e-5b9e3d8a91ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="med-20220630.xsd#LEASESFutureMinimumLeaseCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f63a81d5-3fac-492f-83ed-220b407598b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f63a81d5-3fac-492f-83ed-220b407598b8" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_986eaed2-c209-4b3b-a634-c933fa3862d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_986eaed2-c209-4b3b-a634-c933fa3862d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7b968744-789f-4d99-967b-a234f702cf6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7b968744-789f-4d99-967b-a234f702cf6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_243743c1-d872-45ca-bbe9-5a45356e76a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_243743c1-d872-45ca-bbe9-5a45356e76a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_56732a35-958e-44d9-8809-043fa21053c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_56732a35-958e-44d9-8809-043fa21053c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_92402bb9-aef5-4600-8742-718f4b37930a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_92402bb9-aef5-4600-8742-718f4b37930a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_c91823bd-1cf7-4437-a047-bc79205883b1" xlink:href="med-20220630.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:to="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive_c91823bd-1cf7-4437-a047-bc79205883b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_62bc5f83-57bd-45d8-b10c-e9c14351d8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_62bc5f83-57bd-45d8-b10c-e9c14351d8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_74073122-cec5-4924-91b6-13f586ce4640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_74073122-cec5-4924-91b6-13f586ce4640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d63e887f-b071-49b4-b1d2-6e3a2f4d6717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5aa1621c-62e1-49aa-bcbb-ff557490ffb9" xlink:to="loc_us-gaap_OperatingLeaseLiability_d63e887f-b071-49b4-b1d2-6e3a2f4d6717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="med-20220630.xsd#LEASESFutureMinimumLeaseCommitmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="med-20220630.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_639b2e92-b6eb-41e3-acc8-8e7834e833de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_30b24300-646e-49dd-91b2-d200997548e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_639b2e92-b6eb-41e3-acc8-8e7834e833de" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_30b24300-646e-49dd-91b2-d200997548e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" xlink:type="simple" xlink:href="med-20220630.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7fe54048-6519-4d90-9fbb-f081255bd0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2f2f5abe-2304-4534-ba24-56031673e234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7fe54048-6519-4d90-9fbb-f081255bd0d0" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2f2f5abe-2304-4534-ba24-56031673e234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7258d011-daf9-4a0a-abc4-6f08ffe913a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d7633d58-799f-414f-9dd4-40b187002835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7258d011-daf9-4a0a-abc4-6f08ffe913a9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d7633d58-799f-414f-9dd4-40b187002835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_943022f5-34cd-4f4b-b2b9-ca97bad4241e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7258d011-daf9-4a0a-abc4-6f08ffe913a9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_943022f5-34cd-4f4b-b2b9-ca97bad4241e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aede1f0b-aae7-4e3a-9792-75ce0cd94934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7258d011-daf9-4a0a-abc4-6f08ffe913a9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aede1f0b-aae7-4e3a-9792-75ce0cd94934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="med-20220630.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_213e8fe9-c02e-4f7c-beaf-54ee04c10628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_262b16e2-a438-4646-b3d4-2922f750ec7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_213e8fe9-c02e-4f7c-beaf-54ee04c10628" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_262b16e2-a438-4646-b3d4-2922f750ec7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="med-20220630.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_e563c71d-27df-40f5-901a-576ecd954baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_0ab15647-a500-4922-b7c8-d055ccc674be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_e563c71d-27df-40f5-901a-576ecd954baa" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_0ab15647-a500-4922-b7c8-d055ccc674be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_a87f9de0-ebe2-43d4-abec-db3b6f8bf687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_e7a01505-d543-4508-8bdd-96e1422c3c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndEquitySecuritiesRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_a87f9de0-ebe2-43d4-abec-db3b6f8bf687" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss_e7a01505-d543-4508-8bdd-96e1422c3c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" xlink:type="simple" xlink:href="med-20220630.xsd#FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_eef978a3-35a0-44bc-b2d4-fa63f6d1a072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:href="med-20220630.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_eef978a3-35a0-44bc-b2d4-fa63f6d1a072" xlink:to="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec3dee43-b7aa-4ec9-8940-dc8311b55179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec3dee43-b7aa-4ec9-8940-dc8311b55179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fca6cc9e-ca56-4d19-8361-dfea1756f52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec3dee43-b7aa-4ec9-8940-dc8311b55179" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fca6cc9e-ca56-4d19-8361-dfea1756f52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3e1b42f3-ac19-4c09-bc08-3e80affd381b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fca6cc9e-ca56-4d19-8361-dfea1756f52b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3e1b42f3-ac19-4c09-bc08-3e80affd381b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_215a3ced-a0fe-4dfb-8505-49ff5adeb673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fca6cc9e-ca56-4d19-8361-dfea1756f52b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_215a3ced-a0fe-4dfb-8505-49ff5adeb673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_ab160769-4d94-4eaa-bcd1-14200343765a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_ab160769-4d94-4eaa-bcd1-14200343765a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_ab160769-4d94-4eaa-bcd1-14200343765a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_63202c0e-4cd2-433a-b270-1c1cfd80ac17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:to="loc_us-gaap_CashMember_63202c0e-4cd2-433a-b270-1c1cfd80ac17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a686113d-fdd8-402d-8dd6-19149f4ec365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a686113d-fdd8-402d-8dd6-19149f4ec365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GovernmentAgencySecuritiesMember_424bd536-e80d-41e3-b9e4-be7b93bb008f" xlink:href="med-20220630.xsd#med_GovernmentAgencySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1e8bc629-de47-43bf-bc5e-c66d6d6f7a88" xlink:to="loc_med_GovernmentAgencySecuritiesMember_424bd536-e80d-41e3-b9e4-be7b93bb008f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7a1b0ecd-f849-4dba-a326-0585bd98680b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:to="loc_us-gaap_InvestmentTypeAxis_7a1b0ecd-f849-4dba-a326-0585bd98680b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_c3f2092f-f9f8-41ab-bfbe-0faac475deae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_7a1b0ecd-f849-4dba-a326-0585bd98680b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_c3f2092f-f9f8-41ab-bfbe-0faac475deae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_2e4a10d8-5ad9-4e96-af44-45304a3a99bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_c3f2092f-f9f8-41ab-bfbe-0faac475deae" xlink:to="loc_us-gaap_MunicipalBondsMember_2e4a10d8-5ad9-4e96-af44-45304a3a99bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:href="med-20220630.xsd#med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesTable_ea3ea664-cdfd-4e81-987a-119eec65ef0d" xlink:to="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_58f552bd-5c3a-4907-bd06-d159b3b7fea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_MarketableSecurities_58f552bd-5c3a-4907-bd06-d159b3b7fea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_bd188fa0-08d4-4dd2-80db-15a1c0b32124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_bd188fa0-08d4-4dd2-80db-15a1c0b32124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_d877e224-cae8-4204-917f-e1d722afe853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_InterestReceivable_d877e224-cae8-4204-917f-e1d722afe853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7b3f1183-62d3-4f8f-a86b-50ac8a20c1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_7b3f1183-62d3-4f8f-a86b-50ac8a20c1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_79a6541f-37bf-4284-a6e2-992d8e27dc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_79a6541f-37bf-4284-a6e2-992d8e27dc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_6908a2a6-54fd-49fd-8f47-938d345391bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems_91227ef2-29cd-487e-b91e-1cd8e5969a0b" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_6908a2a6-54fd-49fd-8f47-938d345391bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/DEBT" xlink:type="simple" xlink:href="med-20220630.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6d5c7228-3ba6-4623-9a53-c9bf6feb2061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_77970c7e-3922-4988-8147-bd750eb61c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6d5c7228-3ba6-4623-9a53-c9bf6feb2061" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_77970c7e-3922-4988-8147-bd750eb61c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="med-20220630.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ae9b91e0-068e-4d62-886f-98c4d946b705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ae9b91e0-068e-4d62-886f-98c4d946b705" xlink:to="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7b3d9226-d722-43a9-be6e-3712c409dd20" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:to="loc_srt_RangeAxis_7b3d9226-d722-43a9-be6e-3712c409dd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b94f7e3-3136-499e-9462-38c987982955" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7b3d9226-d722-43a9-be6e-3712c409dd20" xlink:to="loc_srt_RangeMember_7b94f7e3-3136-499e-9462-38c987982955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6daa0927-5630-432a-b523-6a7b0088f5e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b94f7e3-3136-499e-9462-38c987982955" xlink:to="loc_srt_MinimumMember_6daa0927-5630-432a-b523-6a7b0088f5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4b1cc566-3178-4580-bc14-32fe8ea53150" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b94f7e3-3136-499e-9462-38c987982955" xlink:to="loc_srt_MaximumMember_4b1cc566-3178-4580-bc14-32fe8ea53150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a4acd087-d58c-4d35-8dc0-7454d8ff57e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:to="loc_us-gaap_DebtInstrumentAxis_a4acd087-d58c-4d35-8dc0-7454d8ff57e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c443add4-ab15-4c61-bedc-3214c6fda0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a4acd087-d58c-4d35-8dc0-7454d8ff57e8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c443add4-ab15-4c61-bedc-3214c6fda0ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CreditAgreementMember_6cf8b9db-1203-483c-807e-4e93d581b8f2" xlink:href="med-20220630.xsd#med_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c443add4-ab15-4c61-bedc-3214c6fda0ab" xlink:to="loc_med_CreditAgreementMember_6cf8b9db-1203-483c-807e-4e93d581b8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1e7a72fd-4b77-43a8-a143-c85bad16789d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:to="loc_us-gaap_CreditFacilityAxis_1e7a72fd-4b77-43a8-a143-c85bad16789d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_450e8b48-e1d5-4f7a-89a9-163e4c86b7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1e7a72fd-4b77-43a8-a143-c85bad16789d" xlink:to="loc_us-gaap_CreditFacilityDomain_450e8b48-e1d5-4f7a-89a9-163e4c86b7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1fdafe9f-b772-4b34-b77e-a4e0857adb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_450e8b48-e1d5-4f7a-89a9-163e4c86b7e6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1fdafe9f-b772-4b34-b77e-a4e0857adb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_f30f55a7-436a-449d-bc2b-7d1ff671f74a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_1fdafe9f-b772-4b34-b77e-a4e0857adb9d" xlink:to="loc_us-gaap_LetterOfCreditMember_f30f55a7-436a-449d-bc2b-7d1ff671f74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a8b69a0a-5a4e-4984-8663-a6c8ca85f42e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:to="loc_us-gaap_VariableRateAxis_a8b69a0a-5a4e-4984-8663-a6c8ca85f42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b1ccf2e7-b896-4160-ae81-dc0f5404bc86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_a8b69a0a-5a4e-4984-8663-a6c8ca85f42e" xlink:to="loc_us-gaap_VariableRateDomain_b1ccf2e7-b896-4160-ae81-dc0f5404bc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_5b139455-2ec5-4a64-8683-4d2ab9cf3b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b1ccf2e7-b896-4160-ae81-dc0f5404bc86" xlink:to="loc_us-gaap_EurodollarMember_5b139455-2ec5-4a64-8683-4d2ab9cf3b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_bd94b0be-7d3c-4ee2-917f-306e67f42bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b1ccf2e7-b896-4160-ae81-dc0f5404bc86" xlink:to="loc_us-gaap_BaseRateMember_bd94b0be-7d3c-4ee2-917f-306e67f42bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c53236de-2038-4346-9e4b-f3d93f209bd6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0055b685-1136-4e19-b0f7-3d8126637bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0055b685-1136-4e19-b0f7-3d8126637bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_84984a6b-d3ac-48c2-8d2f-16fe98975bb6" xlink:href="med-20220630.xsd#med_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit_84984a6b-d3ac-48c2-8d2f-16fe98975bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_2ad72a44-68cc-428d-a925-c228e22211ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_2ad72a44-68cc-428d-a925-c228e22211ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2baad536-2eeb-4761-a975-8fcf89c1bfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2baad536-2eeb-4761-a975-8fcf89c1bfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MaximumTotalNetLeverageRatio_d1734998-eacb-493f-80a2-405823dbc041" xlink:href="med-20220630.xsd#med_MaximumTotalNetLeverageRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_med_MaximumTotalNetLeverageRatio_d1734998-eacb-493f-80a2-405823dbc041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MinimumInterestCoverageRatio_c8abb3cf-9c9c-426f-9093-b7f781633684" xlink:href="med-20220630.xsd#med_MinimumInterestCoverageRatio"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_med_MinimumInterestCoverageRatio_c8abb3cf-9c9c-426f-9093-b7f781633684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_716f285e-d6c3-4129-852f-5d1a2b875a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6bdeb533-5751-4e4c-a566-bc32e1ad7892" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_716f285e-d6c3-4129-852f-5d1a2b875a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASR" xlink:type="simple" xlink:href="med-20220630.xsd#ACCELERATEDSHAREREPURCHASEASR"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASR" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c1625736-f3ad-47ca-81dc-489e94669ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock_5e0b7e39-30cb-4077-9c6c-d8009e29357b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c1625736-f3ad-47ca-81dc-489e94669ebb" xlink:to="loc_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock_5e0b7e39-30cb-4077-9c6c-d8009e29357b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRDetails" xlink:type="simple" xlink:href="med-20220630.xsd#ACCELERATEDSHAREREPURCHASEASRDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_bf0811cd-9184-4da3-b990-f617ccb37305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_12f73330-4866-4f4a-870b-67c62a36eefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bf0811cd-9184-4da3-b990-f617ccb37305" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_12f73330-4866-4f4a-870b-67c62a36eefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_31550107-4658-4c3b-809b-d5333a8bfc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bf0811cd-9184-4da3-b990-f617ccb37305" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_31550107-4658-4c3b-809b-d5333a8bfc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_23c3cc9f-ac99-46f3-9a82-48288307d4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bf0811cd-9184-4da3-b990-f617ccb37305" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_23c3cc9f-ac99-46f3-9a82-48288307d4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334981050848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 25, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Medifast, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3714405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 International Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Baltimore<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">581-8042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,017,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000910329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334978596832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 453,333<span></span>
</td>
<td class="nump">$ 394,189<span></span>
</td>
<td class="nump">$ 870,933<span></span>
</td>
<td class="nump">$ 734,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">131,651<span></span>
</td>
<td class="nump">100,482<span></span>
</td>
<td class="nump">246,965<span></span>
</td>
<td class="nump">192,604<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">321,682<span></span>
</td>
<td class="nump">293,707<span></span>
</td>
<td class="nump">623,968<span></span>
</td>
<td class="nump">542,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative</a></td>
<td class="nump">272,718<span></span>
</td>
<td class="nump">232,273<span></span>
</td>
<td class="nump">519,917<span></span>
</td>
<td class="nump">428,021<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">48,964<span></span>
</td>
<td class="nump">61,434<span></span>
</td>
<td class="nump">104,051<span></span>
</td>
<td class="nump">114,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense</a></td>
<td class="num">(164)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income</a></td>
<td class="num">(168)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
<td class="num">(279)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from operations before income taxes</a></td>
<td class="nump">48,796<span></span>
</td>
<td class="nump">61,345<span></span>
</td>
<td class="nump">103,772<span></span>
</td>
<td class="nump">114,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">9,683<span></span>
</td>
<td class="nump">14,382<span></span>
</td>
<td class="nump">22,878<span></span>
</td>
<td class="nump">26,160<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 39,113<span></span>
</td>
<td class="nump">$ 46,963<span></span>
</td>
<td class="nump">$ 80,894<span></span>
</td>
<td class="nump">$ 88,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share - basic (in dollars per share)</a></td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="nump">$ 7.06<span></span>
</td>
<td class="nump">$ 7.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share - diluted (in dollars per share)</a></td>
<td class="nump">$ 3.42<span></span>
</td>
<td class="nump">$ 3.96<span></span>
</td>
<td class="nump">$ 7.01<span></span>
</td>
<td class="nump">$ 7.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding -</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">11,354<span></span>
</td>
<td class="nump">11,753<span></span>
</td>
<td class="nump">11,455<span></span>
</td>
<td class="nump">11,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">11,435<span></span>
</td>
<td class="nump">11,858<span></span>
</td>
<td class="nump">11,534<span></span>
</td>
<td class="nump">11,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 1.64<span></span>
</td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="nump">$ 2.84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334981039296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 39,113<span></span>
</td>
<td class="nump">$ 46,963<span></span>
</td>
<td class="nump">$ 80,894<span></span>
</td>
<td class="nump">$ 88,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">148<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized losses on investment securities</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">141<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 39,254<span></span>
</td>
<td class="nump">$ 46,935<span></span>
</td>
<td class="nump">$ 81,050<span></span>
</td>
<td class="nump">$ 88,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334981063552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 61,069<span></span>
</td>
<td class="nump">$ 104,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">156,974<span></span>
</td>
<td class="nump">180,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Income taxes, prepaid</a></td>
<td class="nump">8,547<span></span>
</td>
<td class="nump">945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">16,710<span></span>
</td>
<td class="nump">16,334<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">243,300<span></span>
</td>
<td class="nump">306,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment - net of accumulated depreciation</a></td>
<td class="nump">58,544<span></span>
</td>
<td class="nump">56,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">21,347<span></span>
</td>
<td class="nump">24,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">12,955<span></span>
</td>
<td class="nump">6,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">4,404<span></span>
</td>
<td class="nump">4,404<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">340,550<span></span>
</td>
<td class="nump">398,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">154,782<span></span>
</td>
<td class="nump">163,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Revolving credit facility</a></td>
<td class="nump">27,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease obligations</a></td>
<td class="nump">6,378<span></span>
</td>
<td class="nump">6,523<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">188,160<span></span>
</td>
<td class="nump">169,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease obligations, net of current lease obligations</a></td>
<td class="nump">22,914<span></span>
</td>
<td class="nump">26,020<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">211,074<span></span>
</td>
<td class="nump">195,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $.001 per share: 20,000 shares authorized; 11,594 and 11,594 issued and 11,593 and 11,593 outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">129,197<span></span>
</td>
<td class="nump">190,333<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">129,476<span></span>
</td>
<td class="nump">202,474<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 340,550<span></span>
</td>
<td class="nump">$ 398,326<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334980917520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">11,019<span></span>
</td>
<td class="nump">11,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">11,018<span></span>
</td>
<td class="nump">11,593<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334981102272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 80,894<span></span>
</td>
<td class="nump">$ 88,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to cash provided by operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">5,176<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_OperatingLeaseExpenseNonCash', window );">Non-cash lease expense</a></td>
<td class="nump">3,211<span></span>
</td>
<td class="nump">2,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">5,140<span></span>
</td>
<td class="nump">4,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_AmortizationOfPremiumOnInvestmentSecurities', window );">Amortization of premium on investment securities</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">23,069<span></span>
</td>
<td class="num">(42,398)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Income taxes, prepaid</a></td>
<td class="num">(7,602)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(376)<span></span>
</td>
<td class="num">(4,657)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(8,169)<span></span>
</td>
<td class="num">(762)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(13,922)<span></span>
</td>
<td class="nump">36,962<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flow provided by operating activities</a></td>
<td class="nump">87,435<span></span>
</td>
<td class="nump">86,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Sale and maturities of investment securities</a></td>
<td class="nump">5,267<span></span>
</td>
<td class="nump">5,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(5,849)<span></span>
</td>
<td class="num">(12,196)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flow used in investing activities</a></td>
<td class="num">(582)<span></span>
</td>
<td class="num">(7,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowing under revolving credit facility</a></td>
<td class="nump">27,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Options exercised by executives and directors</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfOtherEquity', window );">Net shares repurchased for taxes</a></td>
<td class="num">(1,479)<span></span>
</td>
<td class="num">(1,833)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid to stockholders</a></td>
<td class="num">(35,617)<span></span>
</td>
<td class="num">(30,095)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Stock repurchases, settled</a></td>
<td class="num">(100,038)<span></span>
</td>
<td class="num">(19,730)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_PaymentsForRepurchaseOfCommonStockNotYetSettled', window );">Stock repurchases, not yet settled</a></td>
<td class="num">(20,010)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flow used in financing activities</a></td>
<td class="num">(130,144)<span></span>
</td>
<td class="num">(50,956)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Foreign currency impact</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) Increase in cash and cash equivalents</a></td>
<td class="num">(43,114)<span></span>
</td>
<td class="nump">28,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning of the period</a></td>
<td class="nump">104,183<span></span>
</td>
<td class="nump">163,723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">61,069<span></span>
</td>
<td class="nump">191,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">30,283<span></span>
</td>
<td class="nump">26,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends declared included in accounts payable</a></td>
<td class="nump">$ 19,305<span></span>
</td>
<td class="nump">$ 17,531<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_AmortizationOfPremiumOnInvestmentSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense charged against amortization of premium on investment securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_AmortizationOfPremiumOnInvestmentSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_OperatingLeaseExpenseNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Expense, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_OperatingLeaseExpenseNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_PaymentsForRepurchaseOfCommonStockNotYetSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Repurchase of Common Stock, Not Yet Settled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_PaymentsForRepurchaseOfCommonStockNotYetSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to reacquire equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334973537376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 157,246<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 7,842<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 154,351<span></span>
</td>
<td class="num">$ (5,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">41,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">2,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by executives and directors (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised by executives and directors</a></td>
<td class="nump">481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(1,807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,807)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(7,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(16,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">174,891<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">8,714<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">178,562<span></span>
</td>
<td class="num">(12,500)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">157,246<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">7,842<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">154,351<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 88,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes (in shares)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">194,689<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">10,606<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">185,343<span></span>
</td>
<td class="num">(1,347)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">174,891<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">8,714<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">178,562<span></span>
</td>
<td class="num">(12,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">46,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">1,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by executives and directors (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised by executives and directors</a></td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">$ (12,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retire from stock repurchases (in shares)</a></td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,383)<span></span>
</td>
<td class="nump">23,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(16,941)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,941)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">194,689<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">10,606<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">185,343<span></span>
</td>
<td class="num">(1,347)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">202,474<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,018<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">190,333<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">41,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">2,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(1,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(10,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retire from stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(19,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">216,024<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,834<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">203,051<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">202,474<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,018<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">190,333<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 80,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes (in shares)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">$ 156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">129,476<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="nump">129,197<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">216,024<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,834<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">203,051<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">39,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">2,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for taxes</a></td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">$ (90,038)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90,038)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retire from stock repurchases (in shares)</a></td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90,038)<span></span>
</td>
<td class="nump">90,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled', window );">Stock repurchases, not yet settled</a></td>
<td class="num">(20,010)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,679)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(18,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">$ 129,476<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
<td class="nump">$ 129,197<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Paid In Capital, Share Repurchases Not Yet Settled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334979664544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#8220;Medifast,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#8220;2021 Form 10-K&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the 2021 audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Statements -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update ("ASU") 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span>, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334983088752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">INVENTORIESInventories consist principally of raw materials, non-food finished goods and packaged meal replacements held in the Company&#8217;s warehouses and outsourced distribution centers. Inventories are stated at the lower of cost or net realizable value, utilizing the first-in, first-out method. The cost of finished goods includes the cost of raw materials, packaging supplies, direct <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and indirect labor and other indirect manufacturing costs. On a quarterly basis, management reviews inventories for unsalable or obsolete inventories.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company donated inventory with an aggregate cost of $9.4&#160;million to Ukrainian refugees and those in need in Ukraine, increasing SG&amp;A during the three months ended June 30, 2022. The donations were made to two 501(c)(3) organizations that are coordinating the distribution throughout refugee camps in Europe and in Ukraine.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12,942</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15,196</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,987</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,641</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-food finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12,810</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15,991</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">131,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">152,687</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Reserve for obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(7,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">156,974</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">180,043</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140335153766400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) computations are calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding during the periods presented. Diluted EPS is calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding adjusted for the effect of dilutive common stock equivalents.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted EPS excluded 3 and 0 antidilutive restricted stock awards for the three months ended June 30, 2022 and 2021, respectively, and 1 and 0 antidilutive restricted stock awards for the six months ended June 30, 2022 and 2021, respectively. EPS is computed independently for each of the periods presented above, and accordingly, the sum of the quarterly earnings per common share may not equal the year-to-date total computed.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334980154800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">SHARE-BASED COMPENSATION<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued non-qualified and incentive stock options to employees and non-employee directors. The fair value of these options are estimated on the date of grant using the Black-Scholes option pricing model, which requires estimates of the expected term of the option, the risk-free interest rate, the expected volatility of the price of the Company&#8217;s common stock, and </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividend yield. Options outstanding as of June&#160;30, 2022 generally vest over a period of three years and expire ten years from the date of grant. The exercise price of these options ranges from $26.52 to $66.68. Due to the Company&#8217;s lack of option exercise history on the date of grant, the expected term is calculated using the simplified method defined as the midpoint between the vesting period and the contractual term of each option. The risk free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant that most closely corresponds to the expected term of the option. The expected volatility is based on the historical volatility of the Company&#8217;s common stock over the period of time equivalent to the expected term for each award. The dividend yield is computed as the annualized dividend rate at the grant date divided by the strike price of the stock option. For the six months ended June 30, 2022 and 2021, the Company did not grant stock options. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our stock option activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at end of the period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.76&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.18&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the weighted-average remaining contractual life for outstanding stock options was 4.8 years with an aggregate intrinsic value of $4.2 million and the weighted-average remaining contractual life for exercisable stock options was 4.7 years with an aggregate intrinsic value of $3.6 million. The unrecognized compensation expense calculated under the fair value method for stock options expected to vest as of June&#160;30, 2022 was $0.1 million and is expected to be recognized over a weighted-average period of 0.6 year. For the six months ended June 30, 2022, there was no exercise activity of stock options. For the six months ended June 30, 2021, the Company received $0.7 million in cash proceeds from the exercise of stock options. The total intrinsic value for stock options exercised during the six months ended June 30, 2021 was $2.3 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued restricted stock to employees and non-employee directors generally with vesting terms up to five years after the date of grant. The fair value of the restricted stock is equal to the market price of the Company&#8217;s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our restricted stock activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.617%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.80&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company withheld approximately 8,000 and 7,000 shares of the Company&#8217;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of restricted stock for the six months ended June 30, 2022 and 2021, respectively. The total fair value of restricted stock awards vested during the six months ended June 30, 2022 and 2021 was $3.3&#160;million and $6.7&#160;million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Performance-based Share Awards</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued market and performance-based share awards to certain key executives who were granted deferred shares and may earn between 0% and 250% of the target number depending upon both the Company's total stockholder return and the Company's performance against predetermined performance goals over a three-year performance period after the date of grant. Market and performance-based share awards that are tied to the Company&#8217;s total stockholder return are valued using the Monte Carlo method and are recognized ratably as expense over the award&#8217;s performance period. The fair value of the performance-based share awards is equal to the market price of the Company&#8217;s common stock on the date of grant adjusted by expected level of achievement over the performance period. Expense for performance-based share awards is amortized ratably over the performance period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is recorded in selling, general, and administrative expense in the accompanying Condensed Consolidated Statements of Income. The total expenses during the three months ended June 30, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total expenses during the six months ended June 30, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total income tax benefit recognized in the accompanying Condensed Consolidated Statements of Income for restricted stock awards was $0.4 million and $0.9 million for the three months ended June 30, 2022 and 2021, respectively, and $0.9&#160;million and $2.1&#160;million for the six months ended June 30, 2022 and 2021, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was $8.9 million of total unrecognized compensation cost related to restricted stock awards as of June&#160;30, 2022, which is expected to be recognized over a weighted-average period of 2.0 years. There was $9.4 million of unrecognized compensation costs related to the 65,477 performance-based shares discussed above as of June&#160;30, 2022, which is expected to be recognized over a weighted-average period of 2.1 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140335073039824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for office and warehouse space and certain equipment. In certain of the Company&#8217;s lease agreements, the rental payments are adjusted periodically based on defined terms within the lease. The Company did not have any finance leases as of June&#160;30, 2022 and 2021, respectively, or for the six-month periods then ended, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases relating to office and warehouse space have lease terms of 18 months to 126 months. Our leases relating to equipment have lease terms of 24 months to 203 months, with certain of them having automatic renewal clauses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s warehouse agreements also contain non-lease components, in the form of payments towards variable logistics services and labor charges, which the Company is obligated to pay based on the services consumed by it. Such amounts are not included in the measurement of the lease liability but are recognized as expenses when they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease expense was $1.7&#160;million and $1.4&#160;million for the three months ended June 30, 2022 and 2021, respectively, and $3.5 million and $2.4 million for the six months ended June 30, 2022 and 2021, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company&#8217;s operating leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:63.780%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurements of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flow used in operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,745&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the weighted average remaining lease term was 5.3 years and the weighted average discount rate was 2.1%.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company&#8217;s operating lease liabilities as of June&#160;30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:81.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2022 (excluding the six months ended June&#160;30, 2022)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334979577568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:64.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized gains on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334980718976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain financial assets and liabilities are accounted for at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy prioritizes the inputs used to measure fair value:</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8211; Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#8217;s best estimate of fair value from the perspective of a market participant.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,069&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,069&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,069&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Government &amp; agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Municipal bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div>The Company had a realized loss of $0.2&#160;million for the three and six months ended June&#160;30, 2022 and no realized gain or losses for the three and six months ended June&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334983269312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#8220;Guarantors&#8221;) entered into a credit agreement (the &#8220;Credit Agreement&#8221;) among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on Secured Overnight Financing Rate (SOFR), from London Inter-Bank Offered Rate (LIBOR) (the &#8220;Amended Credit Agreement&#8221;).  The Amended Credit Agreement provides for a $225.0 million senior secured revolving credit facility with a $20.0 million letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to $100.0 million. The Amended Credit Agreement matures on April&#160;13, 2026.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the Amended Credit Agreement are guaranteed by the Guarantors. The obligations of the Company and the Guarantors are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the Company will pay to the administrative agent for the account of each revolving lender a commitment fee on a quarterly basis based on amounts committed but unused under the revolving facility from 0.20% to 0.40% per annum depending on the Company&#8217;s Total Net Leverage Ratio (as defined in the Amended Credit Agreement). The Company is also obligated to pay the administrative agent customary fees for credit facilities of this size and type.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving borrowings under the Amended Credit Agreement bear interest at a rate per annum equal to (i) the Term SOFR Rate for the interest period plus the Applicable Rate (as defined in the Amended Credit Agreement) based on the Company&#8217;s Total Net Leverage Ratio or (ii) the Alternate Base Rate (as defined in the Amended Credit Agreement) as in effect from time to time plus the Applicable Rate based on the Company&#8217;s Total Net Leverage Ratio. As of June&#160;30, 2022, the Applicable Rate for Term SOFR Loans is 1.25% per annum and the Applicable Rate for ABR Loans is 0.25% per annum. SOFR based loans also include a Credit Spread Adjustment based on the duration of the borrowing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants that, among other things, limit or restrict the ability of the Company and its subsidiaries, subject to negotiated exceptions, to incur additional indebtedness and additional liens on their assets, engage in mergers or acquisitions or dispose of assets, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments and change the nature of their businesses. The Amended Credit Agreement also contains customary events of default, subject to thresholds and grace periods, including, among others, payment default, covenant default, cross default to other material indebtedness and judgment default. In addition, the Amended Credit Agreement requires the Company to maintain a Total Net Leverage Ratio of no more than 2.75 to 1.00 and an Interest Coverage Ratio of at least 3.50 to 1.00.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $27.0 million of borrowings outstanding under the Amended Credit Agreement as of June&#160;30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334980154800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE ("ASR")<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock', window );">ACCELERATED SHARE REPURCHASE ("ASR")</a></td>
<td class="text">ACCELERATED SHARE REPURCHASE (&#8220;ASR&#8221;) PROGRAMIn the second quarter of fiscal 2022, the Company entered into an ASR agreement with JPMorgan Chase, National Association ("JPMorgan Chase") to purchase shares of its common stock from JPMorgan Chase for an aggregate purchase price of $100.0&#160;million. Pursuant to the ASR program, the Company received an initial delivery of approximately 480&#160;thousand shares of common stock based on the closing price of the common stock on May 31, 2022. As a result, approximately $20.0&#160;million remains at JPMorgan Chase for additional repurchases until the completion of the ASR program.  The final number of shares that will be delivered to the Company under the ASR agreement will be based on the average of the daily volume-weighted average trading prices of the Company&#8217;s common stock during the term of the ASR program, less a discount. The Company expects to receive the remaining shares no later than October 3, 2022. The effect of the potential share settlement is excluded in the diluted EPS calculation as the effect is anti-dilutive.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for repurchase agreements (also known as repos), resale agreements (also known as reverse repurchase agreements or reverse repos), securities borrowed transactions, and securities loaned transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -URI http://asc.fasb.org/topic&amp;trid=2197590<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334978728912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#8220;Medifast,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#8220;2021 Form 10-K&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the 2021 audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Presentation of Financial Statements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Statements -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Adopted in 2022</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Adopted in 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update ("ASU") 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span>, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334979560464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12,942</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15,196</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,987</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,641</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-food finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12,810</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15,991</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">131,435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">152,687</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Reserve for obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(7,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">156,974</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">180,043</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334981509984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of the Table Sets Forth the Computation of Basic and Diluted EPS</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334978808352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our stock option activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at end of the period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.76&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.18&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our restricted stock activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.617%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.80&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</a></td>
<td class="text">The total expenses during the three months ended June 30, 2022 and 2021 are as follows (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total expenses during the six months ended June 30, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,344&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334983125616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company&#8217;s operating leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:63.780%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurements of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flow used in operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,745&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Maturity of the Company's Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company&#8217;s operating lease liabilities as of June&#160;30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:81.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2022 (excluding the six months ended June&#160;30, 2022)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334979520368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:64.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized gains on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334979495280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,069&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,069&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,069&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Accrued Interest</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Estimated Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash &amp; Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investment<br/>Securities</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Money market accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Government &amp; agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Municipal bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334981140752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashContributionExpense', window );">Donated inventory</a></td>
<td class="nump">$ 9,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">12,942<span></span>
</td>
<td class="nump">$ 15,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies', window );">Packaging</a></td>
<td class="nump">2,987<span></span>
</td>
<td class="nump">3,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_InventoryNonFoodFinishedGoods', window );">Non-food finished goods</a></td>
<td class="nump">12,810<span></span>
</td>
<td class="nump">15,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">131,435<span></span>
</td>
<td class="nump">152,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Reserve for obsolete inventory</a></td>
<td class="num">(3,200)<span></span>
</td>
<td class="num">(7,472)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 156,974<span></span>
</td>
<td class="nump">$ 180,043<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_InventoryNonFoodFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before last-in first-out (LIFO) and valuation reserves of (Non-food) merchandise or goods held by the entity that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_InventoryNonFoodFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashContributionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash charitable contributions made by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashContributionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of items used in storage, presentation or transportation of physical goods that are targeted for sale to end users.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334973229984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 39,113<span></span>
</td>
<td class="nump">$ 41,781<span></span>
</td>
<td class="nump">$ 46,963<span></span>
</td>
<td class="nump">$ 41,063<span></span>
</td>
<td class="nump">$ 80,894<span></span>
</td>
<td class="nump">$ 88,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding (in shares)</a></td>
<td class="nump">11,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,455<span></span>
</td>
<td class="nump">11,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive common stock equivalents (in shares)</a></td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding (in shares)</a></td>
<td class="nump">11,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,534<span></span>
</td>
<td class="nump">11,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share - basic (in dollars per share)</a></td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.06<span></span>
</td>
<td class="nump">$ 7.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share - diluted (in dollars per share)</a></td>
<td class="nump">$ 3.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.01<span></span>
</td>
<td class="nump">$ 7.42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140335142585824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive awards</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334977166448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based compensation arrangement by share-based payment award, options, grants in period, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost recognition weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based compensation arrangement, fair value of awards vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">$ 6,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Total income tax benefit recognized related to restricted stock awards</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs</a></td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based compensation, shares authorized under stock option plans, exercise price range, lower range limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="nump">4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual life of options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of options exercisable</a></td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee service share based compensation nonvested awards total compensation cost not yet recognized</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost recognition weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost recognition weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod', window );">Performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs</a></td>
<td class="nump">$ 9,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage', window );">Additional performance-based shares, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage', window );">Additional performance-based shares, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334981107040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Stock Options Activity (Details) - Stock Options<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares, Exercised (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at end of the period (in shares) | shares</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares, Exercisable at end of the period (in shares) | shares</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 54.98<span></span>
</td>
<td class="nump">$ 48.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding at end of the period (in dollars per share) | $ / shares</a></td>
<td class="nump">54.98<span></span>
</td>
<td class="nump">47.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercisable at end of the period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 52.76<span></span>
</td>
<td class="nump">$ 42.18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334977857904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Restricted Stock Activity (Details) - Restricted Stock - $ / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 183.51<span></span>
</td>
<td class="nump">$ 116.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">176.81<span></span>
</td>
<td class="nump">267.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">155.57<span></span>
</td>
<td class="nump">113.91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">186.53<span></span>
</td>
<td class="nump">154.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (in dollars per share)</a></td>
<td class="nump">$ 187.80<span></span>
</td>
<td class="nump">$ 182.96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334973481184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Options and restricted stock (in shares)</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">$ 2,865<span></span>
</td>
<td class="nump">$ 2,198<span></span>
</td>
<td class="nump">$ 5,140<span></span>
</td>
<td class="nump">$ 4,344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=med_OptionsAndRestrictedStockMember', window );">Options And Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Options and restricted stock (in shares)</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">$ 1,311<span></span>
</td>
<td class="nump">$ 938<span></span>
</td>
<td class="nump">$ 2,398<span></span>
</td>
<td class="nump">$ 2,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceSharesMember', window );">Market and Performance-Based Shares | Granted In 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Options and restricted stock (in shares)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 512<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Granted In 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Options and restricted stock (in shares)</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">$ 1,287<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Granted In 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Options and restricted stock (in shares)</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">$ 943<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Granted In 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Options and restricted stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment arrangement, expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 711<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,078<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=med_OptionsAndRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=med_OptionsAndRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=med_MarketAndPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334973444256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Operating Lease Arrangement for Real Estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Operating Lease Arrangement for Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Operating Lease Arrangement for Real Estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">126 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">126 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Operating Lease Arrangement for Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">203 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">203 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334979826480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurements of lease liabilities - Operating cash flow used in operating leases</a></td>
<td class="nump">$ 3,674<span></span>
</td>
<td class="nump">$ 2,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations - Operating leases</a></td>
<td class="nump">$ 103<span></span>
</td>
<td class="nump">$ 9,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334977153968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Future Minimum Lease Commitments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022 (excluding the six months ended June&#160;30, 2022)</a></td>
<td class="nump">$ 3,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">6,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">5,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">5,825<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">4,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive', window );">Thereafter</a></td>
<td class="nump">5,412<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">30,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(1,564)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 29,292<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Liability Payments Due Year Five And After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334977150016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">$ 268<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gains on investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">$ 268<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140335072697472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss', window );">Realized loss or gains</a></td>
<td class="num">$ (200,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (200,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334973340704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="nump">$ 61,069<span></span>
</td>
<td class="nump">$ 109,464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Accrued Interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="nump">61,069<span></span>
</td>
<td class="nump">109,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &amp; Cash Equivalents</a></td>
<td class="nump">61,069<span></span>
</td>
<td class="nump">104,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="nump">60,277<span></span>
</td>
<td class="nump">94,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="nump">60,277<span></span>
</td>
<td class="nump">94,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &amp; Cash Equivalents</a></td>
<td class="nump">60,277<span></span>
</td>
<td class="nump">94,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &amp; Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1: | Money market accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="nump">792<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="nump">792<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash &amp; Cash Equivalents</a></td>
<td class="nump">$ 792<span></span>
</td>
<td class="nump">9,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1: | Government &amp; agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2: | Municipal bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash And Cash Equivalents And Marketable securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,948<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>N/A</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=med_GovernmentAgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=med_GovernmentAgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334978674384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Narrative (Details) - Credit Agreement<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 13, 2021</div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_MaximumTotalNetLeverageRatio', window );">Maximum Total Net Leverage Ratio</a></td>
<td class="nump">2.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_MinimumInterestCoverageRatio', window );">Minimum Interest Coverage Ratio</a></td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable Rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Senior Secured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Accordion feature, increase limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility, accordion feature, increase limit, subject to certain conditions by obtaining additional commitments from existing and/or new lenders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_MaximumTotalNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum ratio as of any date, of (a) Total Net Funded Indebtedness on such date to (b) Consolidated EBITDA for the Reference Period ended on such date under credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_MaximumTotalNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_MinimumInterestCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum Interest Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_MinimumInterestCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=med_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140334980027744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE ("ASR") (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Initial amount received (in shares)</a></td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>med-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:med="http://www.medifast1.com/20220630"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="med-20220630.xsd" xlink:type="simple"/>
    <context id="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1c83b2d6bd3c4cee96349c87ec14ea1b_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i18c77be8472d4605bfa303d562fd60b2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib948ed90768e446fa2a7da19901058c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2cb2cb83f1f4e5db44b278f12bea8b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib717e1074bde42e0901aeb7e954bcbd3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib007aabffb2f44fe8073ab3215a03eb5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i70994f711ef24ed1b554ae05170a0beb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8d42d0328604314b103add648897899_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idddb1d1de99c4ffb96425d0fb0935d42_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if19addb8cd514cfab707066c1d48a8b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i81a10d1a3ea1444f9c9554929870ed73_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7eb1b28eb5c740d291bf7d672b2ecc4b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3f614cfb222b45358fd4a8d8202d5a51_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1329ce8de55b48caa47ae30f8e7f1fdd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6c17c93c4db5400dbad4c963bf804dcc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3323f77d983c40708d7df03f365955c7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia51614e2d87f471b9611cdd907dfd3b9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie0989ccad19040f5b5d63fd9ed61ec3b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic011d96c5d0e44b897ab88e6c880715d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4d77050a9aad4a668e670082595a0872_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i94cfceef1c49443a98b3eccf024ccd8c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie77b0f4c612645f4b5db58aa9f5feb14_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia7d57531d9c1486fa7935451b76cc244_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4f1ba3aafeb246248eb2f5d8d106e124_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i330f682e6d384eddbd2ad742ee94e292_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iadacc573ef8c41f4b06a98194c3c83bb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4ee4cc608c6743ce9b79d053c9413fd0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7926d7c8beee47bb8f67125936a7efb8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6b12b911b3be4af1927784cfc0ea5a2f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic153d5cbf75b48c8801f45f3ff6868aa_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i420f82e6dd774834a5ff44c9e9ab77df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9eae09b33bec4a8a86534172345a885f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if15858c6593a4308a5b4a5f453163253_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0f6f8991b244fb491b90bb6cd39d68f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iabdffcc0da434db48bba66473c5942b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf8fcce8f57b4164b5fd496a4762fb6c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i29d77b83c536442c87946833f8aa3fd5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id87de8628b754ed199047a89c561a717_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie2cd41ad8c1f47a58b8e56c0545a424f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4084eaf131484e538b813c92b9a8808a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic9cd5e00468f4c31a6ad35b46dc5f678_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3603223f943940e8bb0e20a4b0812f09_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i64da106a0256487891ae3679ee954695_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i994c40f6e8264eb9846533b735f22532_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i95794c49258c433a90e7170fa1e44931_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6420c7cef69b48e4a74f0ced80372d52_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i339725a880774411bbaef2b210a31022_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i854bc7faa0594c56b36981f871a1e7bd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8ceaf5d8702b4db0b4f91c3787bd2a76_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5e0a3cd16fbf42e3a67ec29910bd258d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i32eb764f079c4b1d8469239466030d0a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i68ef1256755c4d0f8435ea934548d592_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i75fbb52e386d4f8a9bcf066f87b0150f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia7698f0af5074b91b7c210b87f471501_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id3c6300a2f004db38274d065e4c9bac3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if7841ac501214a4ea7e05c285cf32e72_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icd64b09ae9b9490f9048feed73ccf44e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i12734edec8f6435d8dd9b0e550bf268d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibf47d02920404be79f49c2edef3bd952_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id55dd95aa3bc470e9e56ec5f8723d097_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1602479b512c4de9830dc7270e25407f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i58a4c9c4abd041de9a9bf0f6ab581c1b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b570ba8f30648dfacf09a049d1a4224_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0372fb43e9d841769683ae47a2e205e0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idf143fc967754c9285fe98b52326ac85_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id508aa7830c34993b9ba67211a0443ef_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i50220b2625794fccbe511347ebb66670_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i829d85fe933a4eda921636a7a3a375d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib21e0e3f9ad94913bf93467edc85ce06_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia759f6e591be41e886afe18c17d6e776_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i21b609542b4c460580805a1e4f761438_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib5f1116c90194300a342749eb3892747_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i791f345fa7fe442d9a480bb5934ca24a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id10455ed7a30470c8ce16fd0347a1491_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id36d21034a864432b8162b094357f768_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9ee521e8f7844c1f94e09336bcfd86db_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibf790b22c1264d739149650b115efb43_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iea89962a06654099aa9ce6020660ce2c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9b6e347e922e48cf858c12fd486caacd_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i61d036694b67452fbbdb85aea52976a0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i236cdbac8a54499bae6a9b834bcc1d9b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib227523b7a72441886b57ff4d5975e64_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id089f7cb3778424d85b3c0a0ba3abe64_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1dc76c8e56a84d50b6f056f5427ad729_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icec11bcf6e124a15853dea3f1b683cbc_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie16284d30a4743a2bbed4a4f253b25b4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i054b770bfe6145718c8c3e0c92dd66d4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3ec22b44a1b94e7db889140b0beb2981_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4060674f7e11431e987e42f39d8bd999_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i73edf9ea6315403eb92729cc50508941_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i064f238b1a2c484cae33fd7a5814ff0f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i452fd630b64a4bebb247b038e9162298_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icc759c3471364896ad8b5e7747af27bd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1a55b7020a694cb9930ecf0c3056192a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if49b585270844361a9f23ee1a6dd8b32_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i28c9596a0f004e71bab401ece8aceb03_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i24907f08c3c549f2a30017b51b01cb28_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8acefb9e79bd4ae1a22dc956c10939ee_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i39f1cb1cd2be465aa4baf8f6ad80e124_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i666df92b88214be186d1a29032aab0cb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0b46dfbb84c942a2876f386c170b5410_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iee065151388c4c8cbe6affcd09c55b2b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i332a69d5d4c54c2094cc9048eb80a99c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i57509a5816a14b6e9f710cd2a1430d7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89eed6193bce41109d7fcaa6ca2460a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0cac6b725df74e8ea420f955e6941daa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">med:GovernmentAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icea4ee9f85da4ed49ceb9bda111639c6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">med:GovernmentAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d5f95ffbfb34e22af63161d1bed6f55_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8938f1db545249db980bb8fc24aee80f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibad7c8db12bd42e2809f2f8c2ced2539_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9333a141fdf6464bb3ce95b9dd9b08ea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i49b6f09335094cb2b7b85ec6ae9e598c_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="ib6945a9410a34cf18dd01065cbc232f2_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="ia2123a6dc9f841d696b311320dc700c8_D20210413-20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-13</startDate>
            <endDate>2021-04-13</endDate>
        </period>
    </context>
    <context id="i247bb176b7b847c4ab8a1f139e0b0856_D20210413-20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-13</startDate>
            <endDate>2021-04-13</endDate>
        </period>
    </context>
    <context id="ie6f63e1a4da2439cb942d7e717740fd6_D20210413-20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-13</startDate>
            <endDate>2021-04-13</endDate>
        </period>
    </context>
    <context id="i8b76567e652341a8bc33402177cf2fb8_D20210413-20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-13</startDate>
            <endDate>2021-04-13</endDate>
        </period>
    </context>
    <context id="i88c992e95e9b4995a92a40903056360e_I20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-13</instant>
        </period>
    </context>
    <context id="ib4e372b4b4424facb12f398698cc062e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0923735811e44b48bfa510c4594688c6_D20220531-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-05-31</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8yNi0xLTEtMS0zMDc1Ng_076c13f4-81a9-41ce-8942-5382f0954280">0000910329</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8yNy0xLTEtMS0zMDc1Ng_b584a943-b47f-433f-b20d-106c33bed797">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8yOC0xLTEtMS0zMDc1Ng_885b7f81-ba3e-4612-afb9-402fe9f8f5b7">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8yOS0xLTEtMS0zMDc1Ng_bda44bd0-072d-49ab-8f50-7ae38b28bb57">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80L2ZyYWc6NzgzNWFhNmQyOTg3NDkzYWEzYjhhZjA5NWVlNGE5ZWUvdGFibGU6MTQyOGU1ODI0ZmJjNGEyMGI2YWE2ZmRkNWU3ZTVhMzAvdGFibGVyYW5nZToxNDI4ZTU4MjRmYmM0YTIwYjZhYTZmZGQ1ZTdlNWEzMF8zMC0xLTEtMS0zMDc1Ng_c384b40f-952d-4f49-affb-59bc7422039c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzIy_12c6f0c8-6c9b-4dd9-ae5e-f3a17b2280a8">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzIz_09b899a4-6f9f-4f1c-a01a-59fc98e47e22">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF80OTQ3ODAyMzI3MzQ1_72edb8b4-a4cd-4ffe-beae-3daaac4a87ea">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI4_e4f99fb4-3e9c-4dc6-b395-80200662087d">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE3_2266de62-1e50-454c-aad5-f08f3870f9ec">001-31573</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI5_9100d065-f359-44d4-8a54-c2b91f784c64">Medifast, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6MjAxNDlkMzdkNGU4NDA2NmEzNDk5MzdiYjFiZTljY2IvdGFibGVyYW5nZToyMDE0OWQzN2Q0ZTg0MDY2YTM0OTkzN2JiMWJlOWNjYl8wLTAtMS0xLTMwNzU2_5ed25742-6e4f-48be-9bd4-557263f6c5a5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6MjAxNDlkMzdkNGU4NDA2NmEzNDk5MzdiYjFiZTljY2IvdGFibGVyYW5nZToyMDE0OWQzN2Q0ZTg0MDY2YTM0OTkzN2JiMWJlOWNjYl8wLTItMS0xLTMwNzU2_3c57994c-c459-4aaf-abb3-359caccbcf15">13-3714405</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE4_fcfe60ef-c5b9-4761-b94c-ab2e507e793a">100 International Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI3_f723fdca-e3a7-43b6-b619-eea3c2997a64">Baltimore</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE5_43455566-615d-42bb-ba39-b4746d89d718">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI1_72831519-b9d1-49ff-a524-e3da9f1d8168">21202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE1_01ce5ce3-daae-426c-9492-d49ab50638da">410</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzI2_9da9b16e-c748-4311-a19a-a09e8b102add">581-8042</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6YzE3MzdhOTAxZjQ3NDkwOWEwMTIxMjExZmQzNjliZjcvdGFibGVyYW5nZTpjMTczN2E5MDFmNDc0OTA5YTAxMjEyMTFmZDM2OWJmN18xLTAtMS0xLTMwNzU2_afeba404-4a05-4dea-8bf1-8380ff3bdf3c">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6YzE3MzdhOTAxZjQ3NDkwOWEwMTIxMjExZmQzNjliZjcvdGFibGVyYW5nZTpjMTczN2E5MDFmNDc0OTA5YTAxMjEyMTFmZDM2OWJmN18xLTItMS0xLTMwNzU2_d4f77a46-6cf7-4146-bc7d-907f48a689ba">MED</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6YzE3MzdhOTAxZjQ3NDkwOWEwMTIxMjExZmQzNjliZjcvdGFibGVyYW5nZTpjMTczN2E5MDFmNDc0OTA5YTAxMjEyMTFmZDM2OWJmN18xLTQtMS0xLTMwNzU2_3e62b640-8f03-4c81-b376-9ad931c5c0f5">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzIw_6bc8665f-e198-431a-8183-348f992a09bc">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzE2_eb10bde4-fa13-4ed3-8231-5bc258a94280">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6OWU2YjMxMWM4NzQ2NDM3MTg0OGY3OWZkNzM3OTYxOTcvdGFibGVyYW5nZTo5ZTZiMzExYzg3NDY0MzcxODQ4Zjc5ZmQ3Mzc5NjE5N18wLTAtMS0xLTMwNzU2_d8731aa8-abb8-4305-94ff-fde43e519ecb">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6OWU2YjMxMWM4NzQ2NDM3MTg0OGY3OWZkNzM3OTYxOTcvdGFibGVyYW5nZTo5ZTZiMzExYzg3NDY0MzcxODQ4Zjc5ZmQ3Mzc5NjE5N18xLTMtMS0xLTMwNzU2_2f852c38-6113-4aea-a468-86ed44081d14">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGFibGU6OWU2YjMxMWM4NzQ2NDM3MTg0OGY3OWZkNzM3OTYxOTcvdGFibGVyYW5nZTo5ZTZiMzExYzg3NDY0MzcxODQ4Zjc5ZmQ3Mzc5NjE5N18yLTEtMS0xLTMwNzU2_b174d6c2-e4d8-46fb-a13a-d7159af08472">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzIx_3afa8000-1266-4c71-b339-470d1eac7c78">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1c83b2d6bd3c4cee96349c87ec14ea1b_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xL2ZyYWc6MjdmYjJlYTJlZTIyNDJmNGFjY2Y5MDI1ZmU4NGY4MWQvdGV4dHJlZ2lvbjoyN2ZiMmVhMmVlMjI0MmY0YWNjZjkwMjVmZTg0ZjgxZF8yMzEx_55fbdb38-50ca-4111-be98-488723a135fa"
      unitRef="shares">11017899</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMy0xLTEtMS0zMDc1Ng_f5d9f8d4-9e7d-4f64-9e8d-4cff6add4a31"
      unitRef="usd">453333000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMy0zLTEtMS0zMDc1Ng_5bea65d6-0282-4929-ac93-0543248b28fd"
      unitRef="usd">394189000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMy01LTEtMS0zMTEzNg_b8acb137-791f-4bab-b877-0cc7c80284f0"
      unitRef="usd">870933000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMy03LTEtMS0zMTEzNg_38594dcf-9cb9-48ab-95d9-743f7e021e3f"
      unitRef="usd">734858000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNC0xLTEtMS0zMDc1Ng_f5d7c48b-0a7e-497b-9be5-c6fc1e814ca0"
      unitRef="usd">131651000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNC0zLTEtMS0zMDc1Ng_0d9a704c-293c-4189-b736-ef324e614661"
      unitRef="usd">100482000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNC01LTEtMS0zMTEzNg_633002d7-65ad-4b50-ac0e-845b3b72f0af"
      unitRef="usd">246965000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNC03LTEtMS0zMTEzNg_3bae00ce-3d58-4e99-b3e5-0c152142fbb7"
      unitRef="usd">192604000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNS0xLTEtMS0zMDc1Ng_02bcef5a-579e-42a2-921e-b6c921a640b9"
      unitRef="usd">321682000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNS0zLTEtMS0zMDc1Ng_c237720c-d3fb-4ffc-8ea0-5abfb2c735d9"
      unitRef="usd">293707000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNS01LTEtMS0zMTEzNg_15e1626e-5e04-4a17-92b1-135da3cb8f2f"
      unitRef="usd">623968000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNS03LTEtMS0zMTEzNg_bc532b32-4ab7-409f-a7eb-99afe9add4c1"
      unitRef="usd">542254000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNy0xLTEtMS0zMDc1Ng_b1ea6d3b-aa5e-4ad3-ab9b-99926dc2d0f7"
      unitRef="usd">272718000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNy0zLTEtMS0zMDc1Ng_19fc4a52-f2a6-42a8-a4a6-b06c56390639"
      unitRef="usd">232273000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNy01LTEtMS0zMTEzOQ_eccf9f6f-568d-4696-83c4-335f1662907c"
      unitRef="usd">519917000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfNy03LTEtMS0zMTEzOQ_4470d690-df5b-47f3-bafa-554e45dcdc69"
      unitRef="usd">428021000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfOS0xLTEtMS0zMDc1Ng_a1de639a-8c03-4913-ba39-e4b79fe15911"
      unitRef="usd">48964000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfOS0zLTEtMS0zMDc1Ng_b4886215-aa16-42d0-b957-58bab16af696"
      unitRef="usd">61434000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfOS01LTEtMS0zMTEzOQ_71f7c00d-dea5-4341-811b-c9f4b79fd58d"
      unitRef="usd">104051000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfOS03LTEtMS0zMTEzOQ_c56c8b94-c7b7-4825-b6c8-683b7929c62d"
      unitRef="usd">114233000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTItMS0xLTEtMzA3NTY_c648a873-aafb-4a85-8cda-80badd308459"
      unitRef="usd">-164000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTItMy0xLTEtMzA3NTY_8f4e9eea-41e7-44a5-b0a2-f3b8417c1be4"
      unitRef="usd">-67000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTItNS0xLTEtMzExNDI_c53b2c88-d89b-465d-af6a-1284a912b8d6"
      unitRef="usd">-259000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTItNy0xLTEtMzExNDI_2395fde4-ed73-4434-b3b8-74c9763aee2c"
      unitRef="usd">-44000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTMtMS0xLTEtMzA3NTY_7441fa6f-0d9c-4477-a39a-8bca708283d2"
      unitRef="usd">-4000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTMtMy0xLTEtMzA3NTY_2a5e043a-9200-4c54-86cf-2c9721da60d6"
      unitRef="usd">-22000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTMtNS0xLTEtMzExNDI_83b16a2f-6fe2-4b51-be87-181b203c04a3"
      unitRef="usd">-20000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTMtNy0xLTEtMzExNDI_ed47c4bf-9e08-47e4-92cc-87595fecbeb1"
      unitRef="usd">-3000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTQtMS0xLTEtMzA3NTY_2fbdc9c9-9f19-48c3-9ff7-cb3caa945633"
      unitRef="usd">-168000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTQtMy0xLTEtMzA3NTY_622a630b-38f1-460d-bf33-5717b61273b9"
      unitRef="usd">-89000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTQtNS0xLTEtMzExNDI_c1839abe-9c23-425d-9975-c4b6320dbae3"
      unitRef="usd">-279000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTQtNy0xLTEtMzExNDI_8f81bb12-c112-462e-9a76-f52bcd9f6480"
      unitRef="usd">-47000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTYtMS0xLTEtMzA3NTY_f219aaea-585d-441b-925a-53cdf3f0ff3d"
      unitRef="usd">48796000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTYtMy0xLTEtMzA3NTY_9ec9fe2e-4953-4753-811b-f0746dbe66f0"
      unitRef="usd">61345000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTYtNS0xLTEtMzExNDU_2d250b50-e11e-4712-a4ca-57fa6fe2a4f6"
      unitRef="usd">103772000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTYtNy0xLTEtMzExNDU_e16f46ea-d0f8-464d-bec9-88f67cd5fd39"
      unitRef="usd">114186000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTgtMS0xLTEtMzA3NTY_c7200ce5-064e-4c39-9fde-bc79a983082e"
      unitRef="usd">9683000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTgtMy0xLTEtMzA3NTY_efc1ef98-7de9-46cd-944f-6bdc4cbf91f7"
      unitRef="usd">14382000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTgtNS0xLTEtMzExNDU_66ae6e31-ea5f-46a7-a956-1bcd56fe6a81"
      unitRef="usd">22878000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMTgtNy0xLTEtMzExNDU_8962c99a-8705-4499-acde-e1e213610253"
      unitRef="usd">26160000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjAtMS0xLTEtMzA3NTY_ac1091bf-f657-4115-be12-bd07aa6f65bb"
      unitRef="usd">39113000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjAtMy0xLTEtMzA3NTY_988d66a8-44ca-4efa-8793-00597d9c8ff8"
      unitRef="usd">46963000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjAtNS0xLTEtMzExNDU_8b57b49d-9ddb-49f2-b2c3-c95c943599dd"
      unitRef="usd">80894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjAtNy0xLTEtMzExNDU_a0eba421-492d-439c-a3fb-de31ff66611f"
      unitRef="usd">88026000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjItMS0xLTEtMzA3NTY_1125cbc7-7539-4a01-8c3f-efed7e8a83fd"
      unitRef="usdPerShare">3.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjItMy0xLTEtMzA3NTY_d8be4a57-9336-4d17-8b93-345e29e479c4"
      unitRef="usdPerShare">4.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjItNS0xLTEtMzExNDU_ad05fbad-b60d-40d8-b29f-f45bf9661b3e"
      unitRef="usdPerShare">7.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjItNy0xLTEtMzExNDU_c4d6a7e4-cc88-422d-b561-ae8ffe38eb59"
      unitRef="usdPerShare">7.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjQtMS0xLTEtMzA3NTY_df99ef0b-ede2-47a3-be41-a1212cefc9d6"
      unitRef="usdPerShare">3.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjQtMy0xLTEtMzA3NTY_ec6f4c1a-d7f4-40d6-8de6-f019d056b1ba"
      unitRef="usdPerShare">3.96</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjQtNS0xLTEtMzExNDU_a100e2ef-017e-4687-a01b-fbc2d37140ee"
      unitRef="usdPerShare">7.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjQtNy0xLTEtMzExNDU_49e3ebd1-f8fb-4447-88be-9478b4e9e3e6"
      unitRef="usdPerShare">7.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjctMS0xLTEtMzA3NTY_7577dc15-d983-4736-a571-35518363c7ed"
      unitRef="shares">11354000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjctMy0xLTEtMzA3NTY_9e4ef948-df41-4da5-82c7-47c871ff630c"
      unitRef="shares">11753000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjctNS0xLTEtMzExNDU_55fcac73-586a-4cd3-8c48-599f93bc1f75"
      unitRef="shares">11455000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjctNy0xLTEtMzExNDU_c80c8806-8fce-45e0-b3a4-95bdcb106475"
      unitRef="shares">11762000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjgtMS0xLTEtMzA3NTY_cc4903ff-fdbc-4732-9ff1-6ca118cf3712"
      unitRef="shares">11435000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjgtMy0xLTEtMzA3NTY_a9eaa7f3-d4db-472d-bc2b-7259f782892f"
      unitRef="shares">11858000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjgtNS0xLTEtMzM1NzE_f4eb82e1-592a-446a-ba7c-dbe79d0ab33d"
      unitRef="shares">11534000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMjgtNy0xLTEtMzM1NzM_8e3574a2-492c-4ed2-9f91-670f26468fb0"
      unitRef="shares">11869000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMzAtMS0xLTEtMzA3NTY_e9d11463-10d0-4cbb-a120-7eb1e1c33122"
      unitRef="usdPerShare">1.64</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMzAtMy0xLTEtMzA3NTY_de7d3e9b-2513-4ef9-81c1-f3efb50c2adc"
      unitRef="usdPerShare">1.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMzAtNS0xLTEtMzExNDU_59cffb36-1ccc-4782-9443-7ae21d1b0ae7"
      unitRef="usdPerShare">3.28</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xNi9mcmFnOmVlYjY0MmFmN2UzMDRlZDNhZDA1MGQxNjQ2ZmFlYmVkL3RhYmxlOmUxZDVkNjQ3NTZlOTQyMDU4Yzk2YjQzODBhMjFlZTk5L3RhYmxlcmFuZ2U6ZTFkNWQ2NDc1NmU5NDIwNThjOTZiNDM4MGEyMWVlOTlfMzAtNy0xLTEtMzExNDU_80ee417c-231f-4915-a8b4-2949d4d5f0ae"
      unitRef="usdPerShare">2.84</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:NetIncomeLoss
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMy0xLTEtMS0zMDc1Ng_43be901c-982c-4d9d-9a59-af564ebbdb25"
      unitRef="usd">39113000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMy0zLTEtMS0zMDc1Ng_5a5dc5b5-bf3a-4add-86c7-feb4998e23b4"
      unitRef="usd">46963000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMy01LTEtMS0zMDc1Ng_153be390-2bc9-4fd9-8cb4-b78820607c49"
      unitRef="usd">80894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMy03LTEtMS0zMDc1Ng_de3e4db0-88c7-44c5-afa5-0f89ffa924a2"
      unitRef="usd">88026000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNi0xLTEtMS0zMDc1Ng_734a67c2-d1aa-45f8-bf19-83c6b00da786"
      unitRef="usd">148000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNi0zLTEtMS0zMDc1Ng_613be27f-9655-43b6-9ddd-9ac2edb41269"
      unitRef="usd">-11000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNi01LTEtMS0zMDc1Ng_441bb869-68d5-4f83-9303-5458d0754f56"
      unitRef="usd">177000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNi03LTEtMS0zMDc1Ng_ea60d116-72ae-4e39-ace0-12179c19f533"
      unitRef="usd">67000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNy0xLTEtMS0zMDc1Ng_200b7fe8-e2a5-45ff-9a91-88ddc9206148"
      unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNy0zLTEtMS0zMDc1Ng_5540c180-4b52-44c4-be86-77c2a12c597a"
      unitRef="usd">-17000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNy01LTEtMS0zMDc1Ng_1db2a7ab-c9d4-4052-ab52-18bdc18bbfbb"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfNy03LTEtMS0zMDc1Ng_8944a9b5-afe4-48d5-9d59-5b8fbce6aa30"
      unitRef="usd">-33000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfOC0xLTEtMS0zMDc1Ng_e6b4107f-044f-496b-8163-39a36de24370"
      unitRef="usd">141000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfOC0zLTEtMS0zMDc1Ng_6083f97b-323a-4e68-a558-30b462f77ec0"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfOC01LTEtMS0zMDc1Ng_4aa7815d-ee6a-4518-bed5-0055bc3e95d2"
      unitRef="usd">156000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfOC03LTEtMS0zMDc1Ng_cf4c7401-94b7-4f33-a07f-53ac2bb4f0f4"
      unitRef="usd">34000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMTAtMS0xLTEtMzA3NTY_7cb88e86-5ce1-43a8-82b7-96f1156e1cc1"
      unitRef="usd">39254000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMTAtMy0xLTEtMzA3NTY_9f0679f6-2a89-493c-ab43-863cb83309bd"
      unitRef="usd">46935000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMTAtNS0xLTEtMzA3NTY_b7bf31cc-c0eb-4355-b321-78940aaaf73d"
      unitRef="usd">81050000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8xOS9mcmFnOjc3MjkzOWZkNTE5MzQxYmE5M2JmNmJhZDRkNTg2ZjlhL3RhYmxlOjVhY2NmMjg2YmRlNTQ0MWY5MjY3MDNmODQ3OWYzNDA1L3RhYmxlcmFuZ2U6NWFjY2YyODZiZGU1NDQxZjkyNjcwM2Y4NDc5ZjM0MDVfMTAtNy0xLTEtMzA3NTY_5ce7f16f-56fa-4ac8-9c34-9059c4200f49"
      unitRef="usd">88060000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNC0xLTEtMS0zMDc1Ng_344e9ec3-1dad-40aa-b975-ac1f1d2abe4e"
      unitRef="usd">61069000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNC0zLTEtMS0zMDc1Ng_f671faaa-4e70-4c51-9bb3-60ec878377d9"
      unitRef="usd">104183000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InventoryNet
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNS0xLTEtMS0zMDc1Ng_ac0fd3b4-01a0-46d1-be5c-e34d6a53dfce"
      unitRef="usd">156974000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNS0zLTEtMS0zMDc1Ng_ba0e63eb-ac36-4845-9330-10889c958112"
      unitRef="usd">180043000</us-gaap:InventoryNet>
    <us-gaap:ShortTermInvestments
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNi0xLTEtMS0zMDc1Ng_5d4ac63b-633a-4509-9ac1-075cb7368f00"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNi0zLTEtMS0zMDc1Ng_dd8185e8-8140-4e52-ab25-06c9f5eb60a5"
      unitRef="usd">5361000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidTaxes
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNy0xLTEtMS0zMDc1Ng_05ba8309-8874-4d3a-896c-84ebeab4fba5"
      unitRef="usd">8547000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfNy0zLTEtMS0zMDc1Ng_4000768b-ca82-4128-8188-2975647c01e9"
      unitRef="usd">945000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfOC0xLTEtMS0zMDc1Ng_2dca4482-fb37-40f5-8e31-458d1a71371b"
      unitRef="usd">16710000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfOC0zLTEtMS0zMDc1Ng_78b3d75f-2f4f-47a4-8ca6-5d3f927f8e23"
      unitRef="usd">16334000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfOS0xLTEtMS0zMDc1Ng_a99a8352-514d-46ea-8db8-069ce2f79c36"
      unitRef="usd">243300000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfOS0zLTEtMS0zMDc1Ng_6aef4fbb-d1df-4084-aa14-d785be89fb88"
      unitRef="usd">306866000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTEtMS0xLTEtMzA3NTY_a7cf5ab2-5783-409f-bd2f-7a49b0dd7826"
      unitRef="usd">58544000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTEtMy0xLTEtMzA3NTY_a904c53e-70e5-4558-9a01-b3b2dda9574b"
      unitRef="usd">56131000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTItMS0xLTEtMzA3NTY_8a97f341-a276-4a06-924b-adb1904ac10f"
      unitRef="usd">21347000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTItMy0xLTEtMzA3NTY_50a7f352-27f1-4dd6-8f64-91b240e39f57"
      unitRef="usd">24457000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTMtMS0xLTEtMzA3NTY_6b829787-54f2-48f6-bbd4-1012622fe9ec"
      unitRef="usd">12955000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTMtMy0xLTEtMzA3NTY_5bd4f04b-2964-4a47-b07d-7b4d9c9f4116"
      unitRef="usd">6468000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTQtMS0xLTEtMzA3NTY_e7e48a92-2607-4ae3-be9a-a5852ad299cd"
      unitRef="usd">4404000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTQtMy0xLTEtMzA3NTY_ca1791ac-3f0f-4b50-9abf-f7ec3e58f4f0"
      unitRef="usd">4404000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:Assets
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTctMS0xLTEtMzA3NTY_ae9635db-6b85-4df5-a3ad-faa1cc69bc2b"
      unitRef="usd">340550000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMTctMy0xLTEtMzA3NTY_d018efe7-140f-4d0a-ae2b-da662f2ece62"
      unitRef="usd">398326000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjEtMS0xLTEtMzA3NTY_7175d666-8795-4a3f-bb10-37ec9097a261"
      unitRef="usd">154782000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjEtMy0xLTEtMzA3NTY_cd463718-5efa-40e0-b09e-a6d6a616e63a"
      unitRef="usd">163309000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjItMS0xLTEtMzUzMDE_6ba09c68-6ca0-4747-961c-68467f0d592e"
      unitRef="usd">27000000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjItMy0xLTEtMzUzMDE_2440af42-0c53-47a0-a917-985c5b392e6b"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjItMS0xLTEtMzA3NTY_c65139bb-801d-4683-a2d2-cfd09acee46e"
      unitRef="usd">6378000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjItMy0xLTEtMzA3NTY_93e16ab0-21d6-4d3c-8370-eec595ed5759"
      unitRef="usd">6523000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjMtMS0xLTEtMzA3NTY_51eb1611-0fd6-4ec5-b14f-218305954c45"
      unitRef="usd">188160000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjMtMy0xLTEtMzA3NTY_b64c2b88-b265-42a7-b6de-d1d9f81779d0"
      unitRef="usd">169832000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjUtMS0xLTEtMzA3NTY_6811be2b-9273-45ab-9c57-6109c122e621"
      unitRef="usd">22914000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjUtMy0xLTEtMzA3NTY_8f2ce670-3e3c-48f2-877f-283f8977bb80"
      unitRef="usd">26020000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjYtMS0xLTEtMzA3NTY_2903247a-32df-4800-9bfc-72b84cd41dff"
      unitRef="usd">211074000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjYtMy0xLTEtMzA3NTY_4d964602-9314-42ab-aeaa-59e74b0bf890"
      unitRef="usd">195852000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjktMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjo3MzcyNDNmNWQ1NmQ0MTE4ODY3YzI2NTVmMTNlNzUyY18yOA_8331eee4-a2d6-4b27-8a30-741d1fe73658"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjktMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjo3MzcyNDNmNWQ1NmQ0MTE4ODY3YzI2NTVmMTNlNzUyY18yOA_c36b5f57-37ba-401f-a5d9-b81549042825"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjktMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjo3MzcyNDNmNWQ1NmQ0MTE4ODY3YzI2NTVmMTNlNzUyY180Mg_01de1bca-2778-48a9-9715-1b64b19d2d00"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMjktMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjo3MzcyNDNmNWQ1NmQ0MTE4ODY3YzI2NTVmMTNlNzUyY180Mg_7dc1e2ea-1b2a-48e1-8309-83d389be2781"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzAtMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjozNzdkYmY1MjQ2ZmI0ZGY1YTZiODA5NzA0ZDgwNmU0Zl80_7637d3dd-d881-45a5-85e3-399f848f0d29"
      unitRef="shares">11019000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzAtMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjozNzdkYmY1MjQ2ZmI0ZGY1YTZiODA5NzA0ZDgwNmU0Zl8xMQ_7c85eb18-0777-4eeb-a4f1-2809b0ca0988"
      unitRef="shares">11594000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzAtMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjozNzdkYmY1MjQ2ZmI0ZGY1YTZiODA5NzA0ZDgwNmU0Zl8yNQ_ff489509-c490-4cdf-aed0-59c115092214"
      unitRef="shares">11018000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzAtMC0xLTEtMzA3NTYvdGV4dHJlZ2lvbjozNzdkYmY1MjQ2ZmI0ZGY1YTZiODA5NzA0ZDgwNmU0Zl8zMg_fab48a62-5d30-44f0-87f6-717f31ada7d4"
      unitRef="shares">11593000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzEtMS0xLTEtMzA3NTY_1d616c6e-2814-4e2b-b068-8789258cb44b"
      unitRef="usd">11000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzEtMy0xLTEtMzA3NTY_46e74d38-3db4-40c8-b6e3-40fdfd97b3be"
      unitRef="usd">12000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzItMS0xLTEtMzA3NTY_12d91404-5820-4c93-9421-5ca55a9f2ed7"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzItMy0xLTEtMzA3NTY_6c47324d-c706-445c-965e-c3cd421d3cb9"
      unitRef="usd">12018000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzMtMS0xLTEtMzA3NTY_d3b0e5ca-d87e-476d-a283-41bb417bf9ca"
      unitRef="usd">268000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzMtMy0xLTEtMzA3NTY_f8b41a3b-880a-45da-b026-ec3f468cddcf"
      unitRef="usd">111000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzQtMS0xLTEtMzA3NTY_ea0f33d0-ecb0-4020-96db-377ee05aa3a5"
      unitRef="usd">129197000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzQtMy0xLTEtMzA3NTY_2d3e251a-54f0-46c4-a7cb-0228288ea590"
      unitRef="usd">190333000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzYtMS0xLTEtMzA3NTY_54c862d3-13e9-4c0b-b933-2d7b7b9968b7"
      unitRef="usd">129476000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzYtMy0xLTEtMzA3NTY_ff412b08-b00a-4bdf-bbbb-769854aa16cc"
      unitRef="usd">202474000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzgtMS0xLTEtMzA3NTY_5e036933-0e8f-47f5-9530-1b010e019014"
      unitRef="usd">340550000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yMi9mcmFnOjc2MDEzYzhiNjA3NzRlZGE5ZWFmZTAzODhkYWFkZjQ1L3RhYmxlOjMxNzBlMGE4ZThhODRhZWQ5ZWVhODNkZjQ5MTZiNGFkL3RhYmxlcmFuZ2U6MzE3MGUwYThlOGE4NGFlZDllZWE4M2RmNDkxNmI0YWRfMzgtMy0xLTEtMzA3NTY_a59d6488-ac33-4184-a616-54ab9671d2c9"
      unitRef="usd">398326000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNC0xLTEtMS0zMDc1Ng_448977c6-7459-4a67-8f57-80a953e0075b"
      unitRef="usd">80894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNC0zLTEtMS0zMDc1Ng_802eca88-954d-4793-b6e4-fecdeb36b8d9"
      unitRef="usd">88026000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNi0xLTEtMS0zMDc1Ng_a23d4a51-9564-487f-beb4-337b8d3ce298"
      unitRef="usd">5176000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNi0zLTEtMS0zMDc1Ng_09b39989-e1c1-4110-a2f7-e0f9f24aa08f"
      unitRef="usd">2453000</us-gaap:DepreciationDepletionAndAmortization>
    <med:OperatingLeaseExpenseNonCash
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNy0xLTEtMS0zMDc1Ng_8dfe6967-3209-41df-92f9-a1fdb4559582"
      unitRef="usd">3211000</med:OperatingLeaseExpenseNonCash>
    <med:OperatingLeaseExpenseNonCash
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfNy0zLTEtMS0zMDc1Ng_8556fc0d-1ad9-44e5-bc05-f8349e7f750a"
      unitRef="usd">2187000</med:OperatingLeaseExpenseNonCash>
    <us-gaap:ShareBasedCompensation
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfOC0xLTEtMS0zMDc1Ng_41795b20-aeb1-4a45-9bad-ae64d5826847"
      unitRef="usd">5140000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfOC0zLTEtMS0zMDc1Ng_7b5ac22c-c502-49cf-8772-adc71d144eae"
      unitRef="usd">4344000</us-gaap:ShareBasedCompensation>
    <med:AmortizationOfPremiumOnInvestmentSecurities
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfOS0xLTEtMS0zMDc1Ng_47048525-0f37-4f48-a47e-a29003b3a6f8"
      unitRef="usd">14000</med:AmortizationOfPremiumOnInvestmentSecurities>
    <med:AmortizationOfPremiumOnInvestmentSecurities
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfOS0zLTEtMS0zMDc1Ng_76d763e5-bb89-4e9e-b83f-573e4a7bd8d9"
      unitRef="usd">49000</med:AmortizationOfPremiumOnInvestmentSecurities>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTItMS0xLTEtMzA3NTY_116b969f-2146-4966-83f9-825d9cfe6246"
      unitRef="usd">-23069000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTItMy0xLTEtMzA3NTY_a439b3b0-1e2c-4151-8c7d-493ae668375a"
      unitRef="usd">42398000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTMtMS0xLTEtMzA3NTY_0976208c-17e3-464f-9e70-5bcf65817968"
      unitRef="usd">7602000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTMtMy0xLTEtMzA3NTY_05cb16c7-2755-4003-aae6-c24b7c55ade2"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTQtMS0xLTEtMzA3NTY_cef186d4-d5c5-4af0-92b5-9501a5cfdd2c"
      unitRef="usd">376000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTQtMy0xLTEtMzA3NTY_ca308c6a-88fa-4a06-96ad-9f4053138519"
      unitRef="usd">4657000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTUtMS0xLTEtMzA3NTY_c807946a-cc97-436f-ace5-1464809192ee"
      unitRef="usd">8169000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTUtMy0xLTEtMzA3NTY_13616498-7ce2-45cf-9b90-33c92632e707"
      unitRef="usd">762000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTYtMS0xLTEtMzA3NTY_4b44f396-a422-401c-832a-ff4ed51abee2"
      unitRef="usd">-13922000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTYtMy0xLTEtMzA3NTY_2510ac26-2ef3-4866-bad1-28650f1ec971"
      unitRef="usd">36962000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTctMS0xLTEtMzA3NTY_705df01a-19c0-4782-bd0e-762187c1d69b"
      unitRef="usd">87435000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMTctMy0xLTEtMzA3NTY_be5aeecc-a368-4353-bd26-771dbafd0967"
      unitRef="usd">86204000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjAtMS0xLTEtMzA3NTY_5fd11d89-b46f-41cf-956c-3c0c168f03c5"
      unitRef="usd">5267000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjAtMy0xLTEtMzA3NTY_8034c4cd-faf6-4fbc-abf1-7f723c204b69"
      unitRef="usd">5145000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjEtMS0xLTEtMzA3NTY_7d49b30f-4c50-494f-82b3-d5c319977061"
      unitRef="usd">5849000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjEtMy0xLTEtMzA3NTY_55408650-314d-41b4-ab0d-80e1e37a5bca"
      unitRef="usd">12196000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjItMS0xLTEtMzA3NTY_8acea6f4-fdfd-4b0a-8b11-9280312cbda2"
      unitRef="usd">-582000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjItMy0xLTEtMzA3NTY_dbf46708-b879-463a-958a-27908ffaca2d"
      unitRef="usd">-7051000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjYtMS0xLTEtMzc1ODk_4d5df550-e783-4e67-a5ab-61f131331686"
      unitRef="usd">27000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjYtMy0xLTEtMzc1OTY_cf825c5c-58da-44a1-a5ad-00ca6c288cd0"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjUtMS0xLTEtMzA3NTY_ed6488b9-f724-41cd-8ba2-259072ad9081"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjUtMy0xLTEtMzA3NTY_6ce5e4a3-ad90-451d-87cb-046d421455be"
      unitRef="usd">702000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjYtMS0xLTEtMzA3NTY_4c4550c2-7210-40ff-a98b-93cc7721dc3c"
      unitRef="usd">1479000</us-gaap:PaymentsForRepurchaseOfOtherEquity>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjYtMy0xLTEtMzA3NTY_c6db1741-d366-4d25-b794-6a406e2ee695"
      unitRef="usd">1833000</us-gaap:PaymentsForRepurchaseOfOtherEquity>
    <us-gaap:PaymentsOfDividends
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjctMS0xLTEtMzA3NTY_50d9ae27-67dc-4e4d-9009-d87ec874b523"
      unitRef="usd">35617000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjctMy0xLTEtMzA3NTY_6eb73888-72dd-4a53-a8e3-b44a87fcff6b"
      unitRef="usd">30095000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjgtMS0xLTEtMzA3NTY_ff68494f-576e-4e6d-af97-ad900e989032"
      unitRef="usd">100038000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjgtMy0xLTEtMzA3NTY_3d294e73-9335-4526-9bd4-28e466f8d35a"
      unitRef="usd">19730000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <med:PaymentsForRepurchaseOfCommonStockNotYetSettled
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzEtMS0xLTEtMzc2MzQ_6f53d4b0-9f07-4262-a526-1836966f93d7"
      unitRef="usd">20010000</med:PaymentsForRepurchaseOfCommonStockNotYetSettled>
    <med:PaymentsForRepurchaseOfCommonStockNotYetSettled
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzEtMy0xLTEtMzc2NDI_008551cf-210b-4ad0-8c58-bd82c078f84b"
      unitRef="usd">0</med:PaymentsForRepurchaseOfCommonStockNotYetSettled>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjktMS0xLTEtMzA3NTY_db354316-a951-437e-a11a-89cb11ef92db"
      unitRef="usd">-130144000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMjktMy0xLTEtMzA3NTY_653fa3e5-7d4b-4e22-a150-8f1662984ccb"
      unitRef="usd">-50956000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzEtMS0xLTEtMzA3NTY_ff860433-bbf6-4583-a454-4dfe2efa0d45"
      unitRef="usd">177000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzEtMy0xLTEtMzA3NTY_e9e72e93-af12-44bd-b04d-7e9afe96ea5e"
      unitRef="usd">67000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzMtMS0xLTEtMzA3NTY_0a9286e3-b4a7-4a77-b1c9-eaad7dd59de6"
      unitRef="usd">-43114000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzMtMy0xLTEtMzA3NTY_f0f73365-5723-4c39-b62c-abe67ef48b9d"
      unitRef="usd">28264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzQtMS0xLTEtMzA3NTY_7d6a3f93-9d68-4ca2-b813-adadd164189a"
      unitRef="usd">104183000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie2cb2cb83f1f4e5db44b278f12bea8b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzQtMy0xLTEtMzA3NTY_491e21f9-9d28-4e3c-817d-e8a18f2cb63a"
      unitRef="usd">163723000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzUtMS0xLTEtMzA3NTY_1bc986fd-98de-479b-91d4-a11d97667210"
      unitRef="usd">61069000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib717e1074bde42e0901aeb7e954bcbd3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzUtMy0xLTEtMzA3NTY_deaef80b-8ba9-43be-a010-b06d750f6503"
      unitRef="usd">191987000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzgtMS0xLTEtMzA3NTY_8131b882-b533-4fde-b4e4-1e62bb868a75"
      unitRef="usd">30283000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzgtMy0xLTEtMzA3NTY_c328d38c-f31e-40d0-ba6e-5cbdb53a74b2"
      unitRef="usd">26751000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:DividendsCash
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzktMS0xLTEtMzA3NTY_b9c605f4-85aa-40fa-896b-c12f910397b2"
      unitRef="usd">19305000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yNS9mcmFnOjU4ZWFiZGE0MmRkOTRlYmQ5MGIxMjM5NjVhMGZkNDdhL3RhYmxlOjU4OTJkMTJjYWYwMTQ3MzA4YzRlMGEwMmY1MWRmZWEwL3RhYmxlcmFuZ2U6NTg5MmQxMmNhZjAxNDczMDhjNGUwYTAyZjUxZGZlYTBfMzktMy0xLTEtMzA3NTY_98ae2bfd-19f4-46d9-b31a-fe84d14c0461"
      unitRef="usd">17531000</us-gaap:DividendsCash>
    <us-gaap:SharesIssued
      contextRef="ib007aabffb2f44fe8073ab3215a03eb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy0xLTEtMS0zMDc1Ng_a60c1946-bd2a-4590-8e9c-8e4c4cdbaa1a"
      unitRef="shares">11594000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib007aabffb2f44fe8073ab3215a03eb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy0zLTEtMS0zMDc1Ng_ee659ff3-c713-4edb-8c81-25f33f3f3811"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70994f711ef24ed1b554ae05170a0beb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy01LTEtMS0zMDc1Ng_1042e2b9-bc36-488c-bfd4-541e855c040a"
      unitRef="usd">12018000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia8d42d0328604314b103add648897899_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy03LTEtMS0zMDc1Ng_9e6d66cc-2782-4bff-b66b-000838acb4f7"
      unitRef="usd">111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idddb1d1de99c4ffb96425d0fb0935d42_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy05LTEtMS0zMDc1Ng_4c685f37-44e0-4905-89ed-23aa401f85dc"
      unitRef="usd">190333000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if19addb8cd514cfab707066c1d48a8b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy0xMS0xLTEtMzA3NTY_7f948859-fdbe-4cff-80f5-4cb9f9391334"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMy0xMy0xLTEtMzA3NTY_0fb2448c-210f-4dc4-8109-e4e646d88118"
      unitRef="usd">202474000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i81a10d1a3ea1444f9c9554929870ed73_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNC05LTEtMS0zMDc1Ng_e0720ff3-a401-42f1-b2db-04a8e49ce9ad"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNC0xMy0xLTEtMzA3NTY_67a31252-6731-4f21-8ac7-42dd5b672bb7"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i7eb1b28eb5c740d291bf7d672b2ecc4b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNS0xLTEtMS0zMDc1Ng_73ad3095-b019-4bdf-a68b-913a207eb841"
      unitRef="shares">18000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i3f614cfb222b45358fd4a8d8202d5a51_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNS01LTEtMS0zMDc1Ng_173445f3-da3d-430b-9fbd-ae4a12c14301"
      unitRef="usd">2275000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNS0xMy0xLTEtMzA3NTY_b2e4d3f8-fb91-4b28-9b22-ac3470a1bbaf"
      unitRef="usd">2275000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i7eb1b28eb5c740d291bf7d672b2ecc4b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNi0xLTEtMS0zMDc1Ng_43037913-78b7-4ed0-8597-c542e2c06c39"
      unitRef="shares">8000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3f614cfb222b45358fd4a8d8202d5a51_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNi01LTEtMS0zMDc1Ng_8d4544f9-2456-4197-829c-2c28277501ce"
      unitRef="usd">1459000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNi0xMy0xLTEtMzA3NTY_cfb7a5ef-dc33-447a-a7a3-49b0b25fbe45"
      unitRef="usd">1459000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1329ce8de55b48caa47ae30f8e7f1fdd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNy0xMS0xLTEtMzA3NTY_1f33f802-30f7-47bf-a617-b297442c64dc"
      unitRef="usd">10000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfNy0xMy0xLTEtMzA3NTY_49e5bb93-ce32-4e18-8dd6-4b7a7e804283"
      unitRef="usd">10000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i7eb1b28eb5c740d291bf7d672b2ecc4b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOC0xLTEtMS0zMDc1Ng_7c9554dc-969a-4360-85cd-438c3ce5dbf6"
      unitRef="shares">51000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i81a10d1a3ea1444f9c9554929870ed73_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOC05LTEtMS0zMDc1Ng_33f4c50f-1bc8-45db-b99c-0c9d66c3ea0b"
      unitRef="usd">10000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i1329ce8de55b48caa47ae30f8e7f1fdd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOC0xMS0xLTEtMzA3NTY_ed13b251-b56e-497b-9ce6-992c57baf1c3"
      unitRef="usd">-10000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOC0xMy0xLTEtMzA3NTY_1bf91224-4b0a-4154-995d-1d1b45557aa1"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c17c93c4db5400dbad4c963bf804dcc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOS03LTEtMS0zMDc1Ng_c820e39e-06a5-4a27-aa12-e6c4f35bb6fd"
      unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfOS0xMy0xLTEtMzA3NTY_4209b7b9-bfbb-4472-ac16-69f2ce896af4"
      unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i81a10d1a3ea1444f9c9554929870ed73_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTAtOS0xLTEtMzA3NTY_17a80fe8-acb5-4c35-b9c3-f6856d7e5847"
      unitRef="usd">19063000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="idb5793adfb764dd8a9b007fc4c5fd154_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTAtMTMtMS0xLTMwNzU2_492cd0e7-38bf-4264-a081-4b38a624aea8"
      unitRef="usd">19063000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesIssued
      contextRef="i3323f77d983c40708d7df03f365955c7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItMS0xLTEtMzA3NTY_11063fd5-26fd-447f-82b2-4dd4db5df119"
      unitRef="shares">11553000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3323f77d983c40708d7df03f365955c7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItMy0xLTEtMzA3NTY_a7da8077-72d0-4ab9-a2e7-6adf062c342d"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia51614e2d87f471b9611cdd907dfd3b9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItNS0xLTEtMzA3NTY_fbdf8230-91e6-442e-809c-b153dcb3980a"
      unitRef="usd">12834000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie0989ccad19040f5b5d63fd9ed61ec3b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItNy0xLTEtMzA3NTY_1d23116b-81ca-43bb-b091-0d3e5daf60bb"
      unitRef="usd">127000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic011d96c5d0e44b897ab88e6c880715d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItOS0xLTEtMzA3NTY_5986b2a9-fd83-40f7-92cb-568eb8d3dcfa"
      unitRef="usd">203051000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4d77050a9aad4a668e670082595a0872_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItMTEtMS0xLTMwNzU2_3f75e30e-38e7-4063-a276-961d0c4c289b"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94cfceef1c49443a98b3eccf024ccd8c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTItMTMtMS0xLTMwNzU2_fa2a4c9e-e09b-4d07-80a1-2662d0e7252c"
      unitRef="usd">216024000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTMtOS0xLTEtMzI3NTQ_565cac9e-beb9-4e8a-a4a1-a4148fcb57f1"
      unitRef="usd">39113000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTMtMTMtMS0xLTMyNzU0_020e74d8-d6dc-4ff7-85b6-1f1e0640240b"
      unitRef="usd">39113000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ie77b0f4c612645f4b5db58aa9f5feb14_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTQtMS0xLTEtMzI3MzI_1d2469cb-c565-47a4-b169-8614ba225110"
      unitRef="shares">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="ia7d57531d9c1486fa7935451b76cc244_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTQtNS0xLTEtMzI3NTQ_8b06f245-22ee-4e7b-9b2b-a371ba62f8c7"
      unitRef="usd">2865000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTQtMTMtMS0xLTMyNzU0_4d44b8ef-d108-46f8-8854-a4a75cada59d"
      unitRef="usd">2865000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia7d57531d9c1486fa7935451b76cc244_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTUtNS0xLTEtMzI3NTQ_4bb7e012-e37c-467a-8679-c46c3d2936fc"
      unitRef="usd">20000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTUtMTMtMS0xLTMyNzU0_0d9f3a68-8aee-4490-9603-ffd1f97f9061"
      unitRef="usd">20000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4f1ba3aafeb246248eb2f5d8d106e124_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTYtMTEtMS0xLTMyNzU0_285edbe0-d3e5-4e41-8f33-83790a7cb6a5"
      unitRef="usd">90038000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTYtMTMtMS0xLTMyNzU0_b3c25d90-6ac0-44e6-aef8-8ec83f7aa101"
      unitRef="usd">90038000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctMS0xLTEtMzI3MzI_581288a8-7ad4-454f-bbba-12e3288b5c37"
      unitRef="shares">535000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctMy0xLTEtMzI3NTQ_32758bb7-2feb-4517-b281-2d2d7a19c0fa"
      unitRef="usd">1000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctOS0xLTEtMzI3NTQ_2b1ff62a-55ad-442b-864e-8801fc782240"
      unitRef="usd">90038000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i4f1ba3aafeb246248eb2f5d8d106e124_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctMTEtMS0xLTMyNzU0_89a2d208-84e8-4b43-a2b6-da812cadb8e9"
      unitRef="usd">-90038000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTctMTMtMS0xLTMyNzU0_18fcbde0-9146-4e07-a556-9b550845afc3"
      unitRef="usd">1000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled
      contextRef="ia7d57531d9c1486fa7935451b76cc244_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtNS0xLTEtMzk1MDk_4ce506d0-cee7-4858-9032-775ee4165b0a"
      unitRef="usd">15679000</med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled>
    <med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled
      contextRef="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtOS0xLTEtMzk1MDk_27d45925-f762-4db3-9120-23b2ef793819"
      unitRef="usd">4331000</med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled>
    <med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtMTMtMS0xLTM5NTA5_77dd12e5-a540-4f28-9250-328ec3c817dd"
      unitRef="usd">20010000</med:AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i330f682e6d384eddbd2ad742ee94e292_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtNy0xLTEtMzI3NTQ_ef509cf1-775e-462f-8fe5-1a3e50890ff0"
      unitRef="usd">141000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTgtMTMtMS0xLTMyNzU0_5e238aa9-a143-4277-8037-61e12efebb60"
      unitRef="usd">141000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i25431649c6b44ea6aa839a144ca7a011_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTktOS0xLTEtMzI3NTQ_b915f597-6fde-4f2a-a281-c8e1b583f3c0"
      unitRef="usd">18598000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMTktMTMtMS0xLTMyNzU0_d95fbfcc-be3c-4d31-9575-c2ed20cdddb0"
      unitRef="usd">18598000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesIssued
      contextRef="iadacc573ef8c41f4b06a98194c3c83bb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtMS0xLTEtMzI3MzI_7dd149ca-c541-42b8-81f0-3b1cccee6784"
      unitRef="shares">11019000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iadacc573ef8c41f4b06a98194c3c83bb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtMy0xLTEtMzI3NTQ_34292c56-9763-41b9-99fa-541dbdf4a88f"
      unitRef="usd">11000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4ee4cc608c6743ce9b79d053c9413fd0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtNS0xLTEtMzI3NTQ_54a02abc-d4b0-4444-b156-9241e40b8512"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7926d7c8beee47bb8f67125936a7efb8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtNy0xLTEtMzI3NTQ_42c81d7e-86a3-4bb8-a677-62bdc31ee7ba"
      unitRef="usd">268000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b12b911b3be4af1927784cfc0ea5a2f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtOS0xLTEtMzI3NTQ_2b4cc646-1752-42af-a24b-e380d6595377"
      unitRef="usd">129197000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic153d5cbf75b48c8801f45f3ff6868aa_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtMTEtMS0xLTMyNzU0_70297616-e0a1-44d2-92e4-e96dc43f72ba"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOjUxNjEwNTg5NjQwOTQ5YzI4YzZiMjY5MTk0NTg0MzUwL3RhYmxlcmFuZ2U6NTE2MTA1ODk2NDA5NDljMjhjNmIyNjkxOTQ1ODQzNTBfMjEtMTMtMS0xLTMyNzU0_afe0e533-b6d8-4702-9ace-4650c0a7125a"
      unitRef="usd">129476000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i420f82e6dd774834a5ff44c9e9ab77df_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy0xLTEtMS0zMDc1Ng_408b23e9-d3b6-4668-bb6e-14130cba83fe"
      unitRef="shares">11822000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i420f82e6dd774834a5ff44c9e9ab77df_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy0zLTEtMS0zMDc1Ng_36b075d2-bd3f-48d8-8371-03dcca72f461"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9eae09b33bec4a8a86534172345a885f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy01LTEtMS0zMDc1Ng_7598e125-a54b-4937-8f2c-35ea73806987"
      unitRef="usd">7842000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if15858c6593a4308a5b4a5f453163253_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy03LTEtMS0zMDc1Ng_09a36856-73bf-42e0-963c-a77f2c401e19"
      unitRef="usd">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0f6f8991b244fb491b90bb6cd39d68f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy05LTEtMS0zMDc1Ng_fecc32c3-9048-43b7-8e19-7504070527e9"
      unitRef="usd">154351000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iabdffcc0da434db48bba66473c5942b8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy0xMS0xLTEtMzA3NTY_4244607d-f1f6-4018-9b78-712bb4e3fa5f"
      unitRef="usd">-5000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie2cb2cb83f1f4e5db44b278f12bea8b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMy0xMy0xLTEtMzA3NTY_0bc6c696-ddec-480e-94aa-5d6d15295aa5"
      unitRef="usd">157246000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ibf8fcce8f57b4164b5fd496a4762fb6c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNC05LTEtMS0zMDc1Ng_0f5d5622-50e1-45a3-9d22-414f073655a3"
      unitRef="usd">41063000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNC0xMy0xLTEtMzA3NTY_d5ffb22e-1154-487d-bdb6-c1a2c08ace0d"
      unitRef="usd">41063000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i29d77b83c536442c87946833f8aa3fd5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNS0xLTEtMS0zMDc1Ng_465cb609-e73b-4de2-817b-0f533b7fb691"
      unitRef="shares">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="id87de8628b754ed199047a89c561a717_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNS01LTEtMS0zMDc1Ng_b73cc774-0ae2-4744-930e-78fe08708016"
      unitRef="usd">2198000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNS0xMy0xLTEtMzA3NTY_05f930c0-dbd7-4901-aa55-6726c64c568d"
      unitRef="usd">2198000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i29d77b83c536442c87946833f8aa3fd5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNi0xLTEtMS0zMDc1Ng_96abd861-5270-4506-835a-40025c4cc195"
      unitRef="shares">11000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id87de8628b754ed199047a89c561a717_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNi01LTEtMS0zMDc1Ng_c6b1510a-f220-4361-bef3-f69e60265036"
      unitRef="usd">481000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNi0xMy0xLTEtMzA3NTY_164e618f-5530-4a64-8716-65e8d23e97d5"
      unitRef="usd">481000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i29d77b83c536442c87946833f8aa3fd5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNy0xLTEtMS0zMDc1Ng_71220028-3e83-40bc-81e4-a24c757ea0ad"
      unitRef="shares">7000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id87de8628b754ed199047a89c561a717_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNy01LTEtMS0zMDc1Ng_556cc287-1a94-4c3a-862f-f35de2bac122"
      unitRef="usd">1807000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4f1ba3aafeb246248eb2f5d8d106e124_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNy0xMS0xLTEtMzA3NTY_dfede826-b3c3-40e0-aa5c-da981444a3d0"
      unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfNy0xMy0xLTEtMzA3NTY_bf826bcb-01e0-42dd-b3c1-25b420b30f15"
      unitRef="usd">1807000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie2cd41ad8c1f47a58b8e56c0545a424f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfOC0xMS0xLTEtMzA3NTY_a7d0ab82-ae0d-4510-b6f7-283c5ab76195"
      unitRef="usd">7500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfOC0xMy0xLTEtMzA3NTY_6ea83858-7360-4f41-bd67-91c4b3cd191f"
      unitRef="usd">7500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4084eaf131484e538b813c92b9a8808a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfOS03LTEtMS0zMDc1Ng_e7f53be4-294b-4fed-b1cd-d3e5f2dad1ff"
      unitRef="usd">62000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfOS0xMy0xLTEtMzA3NTY_03a1e54f-517a-492c-989c-ecb9eae2756d"
      unitRef="usd">62000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibf8fcce8f57b4164b5fd496a4762fb6c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTAtOS0xLTEtMzA3NTY_32aeacc1-e814-46a0-a7e9-527c846e4bec"
      unitRef="usd">16852000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="iec87ca2b6ed24aec96c1c4bc29f91ae2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTAtMTMtMS0xLTMwNzU2_cf359dd0-cecb-40df-b751-865d1990b377"
      unitRef="usd">16852000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesIssued
      contextRef="ic9cd5e00468f4c31a6ad35b46dc5f678_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItMS0xLTEtMzA3NTY_ad4dc7af-e50c-44c0-91fb-480a724d3eea"
      unitRef="shares">11839000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic9cd5e00468f4c31a6ad35b46dc5f678_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItMy0xLTEtMzA3NTY_2fb690fa-1411-4023-8e46-17df37fcb45d"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3603223f943940e8bb0e20a4b0812f09_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItNS0xLTEtMzA3NTY_1e8f5369-605a-4f6c-91ba-48c808890a70"
      unitRef="usd">8714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i64da106a0256487891ae3679ee954695_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItNy0xLTEtMzA3NTY_9322f322-61a2-45d6-803c-4a2c61cbdde5"
      unitRef="usd">103000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i994c40f6e8264eb9846533b735f22532_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItOS0xLTEtMzA3NTY_084d3f18-9b71-4522-a518-0593a9a2bbca"
      unitRef="usd">178562000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i95794c49258c433a90e7170fa1e44931_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItMTEtMS0xLTMwNzU2_58ec93d5-d5c6-4046-99dc-d26a3487d898"
      unitRef="usd">-12500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6420c7cef69b48e4a74f0ced80372d52_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTItMTMtMS0xLTMwNzU2_e0bc3b9c-3a98-4785-a9a5-c1e7e7ca19ee"
      unitRef="usd">174891000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i339725a880774411bbaef2b210a31022_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTMtOS0xLTEtMzI4ODA_31947099-7a45-40aa-88e8-34af502136f5"
      unitRef="usd">46963000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTMtMTMtMS0xLTMyODgw_41c077fa-f1ee-4df7-868c-7565b0a754c1"
      unitRef="usd">46963000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i854bc7faa0594c56b36981f871a1e7bd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTQtMS0xLTEtMzI4ODA_8a9f4100-f1a6-41c9-881b-3711e298f03f"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i8ceaf5d8702b4db0b4f91c3787bd2a76_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTQtNS0xLTEtMzI4ODA_114cbda3-ef4a-407d-9818-3d7e3036815b"
      unitRef="usd">1697000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i339725a880774411bbaef2b210a31022_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTQtOS0xLTEtMzI4ODA_d151c5ed-0bd1-48ca-9202-23150ff857e3"
      unitRef="usd">142000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTQtMTMtMS0xLTMyODgw_cab6bc30-9c20-4010-b4c6-be57a2faffd0"
      unitRef="usd">1839000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i854bc7faa0594c56b36981f871a1e7bd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTUtMS0xLTEtMzI4ODA_3301c89e-3547-49ae-8d27-86c755de4598"
      unitRef="shares">3000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8ceaf5d8702b4db0b4f91c3787bd2a76_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTUtNS0xLTEtMzI4ODA_a1a7eaf1-cb38-4560-8f11-49deb12a9599"
      unitRef="usd">221000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTUtMTMtMS0xLTMyODgw_7aad5806-0411-406a-84bd-6d0afe347b78"
      unitRef="usd">221000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8ceaf5d8702b4db0b4f91c3787bd2a76_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTYtNS0xLTEtMzI4ODA_6694d8dd-33b4-4f9d-8b30-ce54740a6f7b"
      unitRef="usd">26000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTYtMTEtMS0xLTMyODgw_28089e16-6f22-4da9-8ed6-ade1ec2510b2"
      unitRef="usd">0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTYtMTMtMS0xLTMyODgw_2fc87729-bf6f-4b03-aa55-9ac9c2d922cb"
      unitRef="usd">26000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5e0a3cd16fbf42e3a67ec29910bd258d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTctNy0xLTEtMzI4ODA_7c0717bc-8e4e-49c7-9fc1-abd3583b8fc3"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTctMTEtMS0xLTMyODgw_2e41e6f0-9989-44fa-9ea9-29503961cd7e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTctMTMtMS0xLTMyODgw_af233242-5326-4f2d-b51a-82181929390a"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTgtMTEtMS0xLTMyODgw_2ff33d16-d488-4b36-b18c-1154c3f26777"
      unitRef="usd">12230000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTgtMTMtMS0xLTMyODgw_e90c46f1-ef30-49b3-9f66-e2a6859e5ebd"
      unitRef="usd">12230000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTktMS0xLTEtMzI4ODA_17a91887-614e-4a4f-aaa9-a206674de2ff"
      unitRef="shares">114000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i339725a880774411bbaef2b210a31022_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTktOS0xLTEtMzI4ODA_32488049-449a-4536-be72-85cdbe6ace0c"
      unitRef="usd">23383000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i300bced80fd7457da5f6e98b8f4b1ad4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTktMTEtMS0xLTMyODgw_5549c1a7-c8a3-452d-9426-65f1db5da92a"
      unitRef="usd">-23383000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMTktMTMtMS0xLTMyODgw_747890c8-747d-4443-a619-e582a9a0cc27"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:DividendsCommonStockCash
      contextRef="i339725a880774411bbaef2b210a31022_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjAtOS0xLTEtMzI4ODA_2610f684-e2cd-4d11-b31e-9a6433299071"
      unitRef="usd">16941000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjAtMTMtMS0xLTMyODgw_53eae9b5-c91f-401e-8df2-2897e4b49d2e"
      unitRef="usd">16941000</us-gaap:DividendsCommonStockCash>
    <us-gaap:SharesIssued
      contextRef="i32eb764f079c4b1d8469239466030d0a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItMS0xLTEtMzI4ODA_ded2cba5-b998-4039-a24f-97bdcf7912cb"
      unitRef="shares">11738000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i32eb764f079c4b1d8469239466030d0a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItMy0xLTEtMzI4ODA_787a98c3-e176-4c04-ba43-47b066fd074a"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i68ef1256755c4d0f8435ea934548d592_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItNS0xLTEtMzI4ODA_7573652b-5dfb-4b56-9f88-7643ba296d30"
      unitRef="usd">10606000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i75fbb52e386d4f8a9bcf066f87b0150f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItNy0xLTEtMzI4ODA_b95f7550-0a56-46e4-92b3-3766bbd4268d"
      unitRef="usd">75000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia7698f0af5074b91b7c210b87f471501_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItOS0xLTEtMzI4ODA_3144a93b-6912-4c03-b8a0-b0a37e214cba"
      unitRef="usd">185343000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id3c6300a2f004db38274d065e4c9bac3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItMTEtMS0xLTMyODgw_caab5e38-5c65-4fdb-9e44-fbc4a20304ac"
      unitRef="usd">-1347000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib717e1074bde42e0901aeb7e954bcbd3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOC9mcmFnOmQ0Mjk3ODgzZWRjOTQ2N2FiNzRkZjZlOWE3NWRhNjc0L3RhYmxlOmViOGVmNTY0YWY2NTRmY2ZhMTdhOGZjZWMwMDdlMDYyL3RhYmxlcmFuZ2U6ZWI4ZWY1NjRhZjY1NGZjZmExN2E4ZmNlYzAwN2UwNjJfMjItMTMtMS0xLTMyODgw_942429e2-1317-4b16-9dea-84c1fc24b038"
      unitRef="usd">194689000</us-gaap:StockholdersEquity>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5Mg_f6ac8d95-bbf2-44f4-9e48-9445bed20737">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#x201c;Medifast,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; or &#x201c;our&#x201d;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#x201c;2021 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the 2021 audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Presentation of Financial Statements -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassification -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Adopted in 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standards Update ("ASU") 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5Mw_bdf59432-45f4-4943-98e5-b03514f5d3d3">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#x201c;Medifast,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; or &#x201c;our&#x201d;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2021 has been derived from the audited consolidated financial statements at that date included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 (&#x201c;2021 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2022. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the 2021 audited consolidated financial statements and notes thereto, which are included in the 2021 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5NA_4679c47a-9b67-4ce8-9e0a-6d5818cb4e32">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Presentation of Financial Statements -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.&lt;/span&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5NQ_2eea652c-557d-474c-a188-94f85d7e66d1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassification -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.&lt;/span&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5Ng_013adb41-8a21-44be-9c24-9fdc3043901f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNC9mcmFnOmRiMDJhZjRiYWYzMDQ2NDhiYzBkNWUxODU1MGNmMjBhL3RleHRyZWdpb246ZGIwMmFmNGJhZjMwNDY0OGJjMGQ1ZTE4NTUwY2YyMGFfMzQ5Nw_a18d55c1-dcb6-4b1d-b4c3-47fc2b589fad">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Adopted in 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standards Update ("ASU") 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;, which provides optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying accounting principles under GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met and to other derivative instruments if there is a change to the interest rates used for discounting, margining or contract price alignment. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We adopted Topic 848 beginning in the first quarter of fiscal 2022 without any material impact on the Company's financial position and results of operations.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RleHRyZWdpb246YmUyMTVlZWE1ZmUzNDRiMTkwNDdmODhhNTIyM2NhOTlfNjAy_efa846c0-406a-4766-81e2-5b743783b5a5">INVENTORIESInventories consist principally of raw materials, non-food finished goods and packaged meal replacements held in the Company&#x2019;s warehouses and outsourced distribution centers. Inventories are stated at the lower of cost or net realizable value, utilizing the first-in, first-out method. The cost of finished goods includes the cost of raw materials, packaging supplies, direct &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and indirect labor and other indirect manufacturing costs. On a quarterly basis, management reviews inventories for unsalable or obsolete inventories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company donated inventory with an aggregate cost of $9.4&#160;million to Ukrainian refugees and those in need in Ukraine, increasing SG&amp;amp;A during the three months ended June 30, 2022. The donations were made to two 501(c)(3) organizations that are coordinating the distribution throughout refugee camps in Europe and in Ukraine.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12,942&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15,196&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2,987&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3,641&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Non-food finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12,810&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15,991&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;131,435&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;152,687&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Reserve for obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(7,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;156,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;180,043&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:NoncashContributionExpense
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RleHRyZWdpb246YmUyMTVlZWE1ZmUzNDRiMTkwNDdmODhhNTIyM2NhOTlfMTI2NDQzODM3MjI4MzE_39fa819f-6bd3-4dae-ba17-09f6be33b93e"
      unitRef="usd">9400000</us-gaap:NoncashContributionExpense>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RleHRyZWdpb246YmUyMTVlZWE1ZmUzNDRiMTkwNDdmODhhNTIyM2NhOTlfNjAz_f27091db-c9d6-4858-86a9-053f2b447bfb">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12,942&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15,196&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2,987&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3,641&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Non-food finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12,810&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15,991&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;131,435&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;152,687&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Reserve for obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(7,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;156,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;180,043&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfMi0xLTEtMS0zMDc1Ng_18fa88d9-331b-4add-9407-a14d5805c2de"
      unitRef="usd">12942000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfMi0zLTEtMS0zMDc1Ng_42c0b3c7-b6e6-4596-897d-22f7c9b01510"
      unitRef="usd">15196000</us-gaap:InventoryRawMaterials>
    <us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfMy0xLTEtMS0zMDc1Ng_be80b231-253c-4cf9-a55b-360f57153ea4"
      unitRef="usd">2987000</us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies>
    <us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfMy0zLTEtMS0zMDc1Ng_bd82f2d4-cdac-4ee7-b423-505ab27d13c2"
      unitRef="usd">3641000</us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies>
    <med:InventoryNonFoodFinishedGoods
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNC0xLTEtMS0zMDc1Ng_df7becbd-41d0-459d-954d-8c9a5eccc846"
      unitRef="usd">12810000</med:InventoryNonFoodFinishedGoods>
    <med:InventoryNonFoodFinishedGoods
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNC0zLTEtMS0zMDc1Ng_41f8093c-4032-45cd-a522-2bf3e52fd678"
      unitRef="usd">15991000</med:InventoryNonFoodFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNS0xLTEtMS0zMDc1Ng_7bf1eb56-098e-4592-b8ef-0ea9e2f0393d"
      unitRef="usd">131435000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNS0zLTEtMS0zMDc1Ng_ec504c3a-8d42-4f4f-9ec9-5c7b4c838462"
      unitRef="usd">152687000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryValuationReserves
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNi0xLTEtMS0zMDc1Ng_60cdaa67-68d4-43ea-9fd5-4c10e385a5b2"
      unitRef="usd">3200000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNi0zLTEtMS0zMDc1Ng_a45ae057-db8c-4e9b-96a3-d327f976be6f"
      unitRef="usd">7472000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNy0xLTEtMS0zMDc1Ng_7b6f7108-5f66-4ed7-a1f2-4e7bc3e3b0b6"
      unitRef="usd">156974000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zNy9mcmFnOmJlMjE1ZWVhNWZlMzQ0YjE5MDQ3Zjg4YTUyMjNjYTk5L3RhYmxlOmZmMzM3NjUxN2RmNDQ1ZTFiYTc0MGEyODM1MzY2NjhhL3RhYmxlcmFuZ2U6ZmYzMzc2NTE3ZGY0NDVlMWJhNzQwYTI4MzUzNjY2OGFfNy0zLTEtMS0zMDc1Ng_baa15147-ff60-4973-bd80-0493838fda0a"
      unitRef="usd">180043000</us-gaap:InventoryNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNjE4_ba7a1f3c-3810-4393-b9cc-68ae6b099402">EARNINGS PER SHARE&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) computations are calculated utilizing the weighted average number of shares of the Company&#x2019;s common stock outstanding during the periods presented. Diluted EPS is calculated utilizing the weighted average number of shares of the Company&#x2019;s common stock outstanding adjusted for the effect of dilutive common stock equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Effect of dilutive common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of diluted EPS excluded 3 and 0 antidilutive restricted stock awards for the three months ended June 30, 2022 and 2021, respectively, and 1 and 0 antidilutive restricted stock awards for the six months ended June 30, 2022 and 2021, respectively. EPS is computed independently for each of the periods presented above, and accordingly, the sum of the quarterly earnings per common share may not equal the year-to-date total computed.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNjE5_2648f4a5-44e3-4ed6-9407-11561e4d0ba2">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Effect of dilutive common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNC0xLTEtMS0zMDc1Ng_ac1091bf-f657-4115-be12-bd07aa6f65bb"
      unitRef="usd">39113000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNC0zLTEtMS0zMDc1Ng_988d66a8-44ca-4efa-8793-00597d9c8ff8"
      unitRef="usd">46963000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNC01LTEtMS0zMDc1Ng_8b57b49d-9ddb-49f2-b2c3-c95c943599dd"
      unitRef="usd">80894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNC03LTEtMS0zMDc1Ng_a0eba421-492d-439c-a3fb-de31ff66611f"
      unitRef="usd">88026000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNy0xLTEtMS0zMDc1Ng_7577dc15-d983-4736-a571-35518363c7ed"
      unitRef="shares">11354000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNy0zLTEtMS0zMDc1Ng_9e4ef948-df41-4da5-82c7-47c871ff630c"
      unitRef="shares">11753000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNy01LTEtMS0zMDc1Ng_55fcac73-586a-4cd3-8c48-599f93bc1f75"
      unitRef="shares">11455000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfNy03LTEtMS0zMDc1Ng_c80c8806-8fce-45e0-b3a4-95bdcb106475"
      unitRef="shares">11762000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOC0xLTEtMS0zMDc1Ng_2aa6a864-5ed0-4e35-9c06-7fe446426c03"
      unitRef="shares">81000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOC0zLTEtMS0zMDc1Ng_4877db27-700c-4c13-a10d-8cc60bb0cd56"
      unitRef="shares">105000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOC01LTEtMS0zMDc1Ng_bed21dbd-b3ba-4717-8697-3d02e5f6bf3e"
      unitRef="shares">79000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOC03LTEtMS0zMDc1Ng_db4b8d3a-7bae-46f0-8d2f-b6d85bae22a1"
      unitRef="shares">107000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOS0xLTEtMS0zMDc1Ng_cc4903ff-fdbc-4732-9ff1-6ca118cf3712"
      unitRef="shares">11435000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOS0zLTEtMS0zMDc1Ng_a9eaa7f3-d4db-472d-bc2b-7259f782892f"
      unitRef="shares">11858000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOS01LTEtMS0zMDc1Ng_f4eb82e1-592a-446a-ba7c-dbe79d0ab33d"
      unitRef="shares">11534000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfOS03LTEtMS0zMDc1Ng_8e3574a2-492c-4ed2-9f91-670f26468fb0"
      unitRef="shares">11869000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTEtMS0xLTEtMzA3NTY_e09acaab-c6a2-4599-8730-67aafb6a7573"
      unitRef="usdPerShare">3.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTEtMy0xLTEtMzA3NTY_e01dc267-bdd5-4d1e-aaaf-180c088e8722"
      unitRef="usdPerShare">4.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTEtNS0xLTEtMzA3NTY_015b0ca5-ddb9-4229-8712-4dd8640881b3"
      unitRef="usdPerShare">7.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTEtNy0xLTEtMzA3NTY_b64bf8aa-7f44-4d90-8ada-de2db020a00c"
      unitRef="usdPerShare">7.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTMtMS0xLTEtMzA3NTY_33c9dbd3-0dd8-44a2-8e8a-b59a81e40b12"
      unitRef="usdPerShare">3.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTMtMy0xLTEtMzA3NTY_da458125-b28a-44c9-b18a-207227188c7b"
      unitRef="usdPerShare">3.96</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTMtNS0xLTEtMzA3NTY_c89f39c0-a627-4469-9f7b-518b966ddcdc"
      unitRef="usdPerShare">7.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RhYmxlOmZjMDc4NzM4ZjU0YTRjYTJhODlkOWQxY2NiZjM0NWMwL3RhYmxlcmFuZ2U6ZmMwNzg3MzhmNTRhNGNhMmE4OWQ5ZDFjY2JmMzQ1YzBfMTMtNy0xLTEtMzA3NTY_7e249096-de08-4925-852a-28642bc080f9"
      unitRef="usdPerShare">7.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if7841ac501214a4ea7e05c285cf32e72_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNTQ5NzU1ODE0NjM2_45ebb655-3e5c-4beb-8085-01ac3a3e7f62"
      unitRef="shares">3</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icd64b09ae9b9490f9048feed73ccf44e_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNTQ5NzU1ODE0NjQw_6ef93f16-1989-4843-9a3f-b30a136c75d6"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i12734edec8f6435d8dd9b0e550bf268d_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNTM5_294dbb0f-ac9e-4b2e-9d50-127d658d73fa"
      unitRef="shares">1</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibf47d02920404be79f49c2edef3bd952_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80MC9mcmFnOmYxNzdmYzY0MDkyZTRkMTA5MmU2MDg4MjA5OWU2N2VhL3RleHRyZWdpb246ZjE3N2ZjNjQwOTJlNGQxMDkyZTYwODgyMDk5ZTY3ZWFfNTQ2_dca6e3ab-dae2-445e-832b-478f32abaa1b"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYxOQ_4f9aad88-2a93-47f0-892b-c4bd04f65414">SHARE-BASED COMPENSATION&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued non-qualified and incentive stock options to employees and non-employee directors. The fair value of these options are estimated on the date of grant using the Black-Scholes option pricing model, which requires estimates of the expected term of the option, the risk-free interest rate, the expected volatility of the price of the Company&#x2019;s common stock, and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dividend yield. Options outstanding as of June&#160;30, 2022 generally vest over a period of three years and expire ten years from the date of grant. The exercise price of these options ranges from $26.52 to $66.68. Due to the Company&#x2019;s lack of option exercise history on the date of grant, the expected term is calculated using the simplified method defined as the midpoint between the vesting period and the contractual term of each option. The risk free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant that most closely corresponds to the expected term of the option. The expected volatility is based on the historical volatility of the Company&#x2019;s common stock over the period of time equivalent to the expected term for each award. The dividend yield is computed as the annualized dividend rate at the grant date divided by the strike price of the stock option. For the six months ended June 30, 2022 and 2021, the Company did not grant stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our stock option activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the weighted-average remaining contractual life for outstanding stock options was 4.8 years with an aggregate intrinsic value of $4.2 million and the weighted-average remaining contractual life for exercisable stock options was 4.7 years with an aggregate intrinsic value of $3.6 million. The unrecognized compensation expense calculated under the fair value method for stock options expected to vest as of June&#160;30, 2022 was $0.1 million and is expected to be recognized over a weighted-average period of 0.6 year. For the six months ended June 30, 2022, there was no exercise activity of stock options. For the six months ended June 30, 2021, the Company received $0.7 million in cash proceeds from the exercise of stock options. The total intrinsic value for stock options exercised during the six months ended June 30, 2021 was $2.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued restricted stock to employees and non-employee directors generally with vesting terms up to five years after the date of grant. The fair value of the restricted stock is equal to the market price of the Company&#x2019;s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our restricted stock activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company withheld approximately 8,000 and 7,000 shares of the Company&#x2019;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of restricted stock for the six months ended June 30, 2022 and 2021, respectively. The total fair value of restricted stock awards vested during the six months ended June 30, 2022 and 2021 was $3.3&#160;million and $6.7&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Market and Performance-based Share Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued market and performance-based share awards to certain key executives who were granted deferred shares and may earn between 0% and 250% of the target number depending upon both the Company's total stockholder return and the Company's performance against predetermined performance goals over a three-year performance period after the date of grant. Market and performance-based share awards that are tied to the Company&#x2019;s total stockholder return are valued using the Monte Carlo method and are recognized ratably as expense over the award&#x2019;s performance period. The fair value of the performance-based share awards is equal to the market price of the Company&#x2019;s common stock on the date of grant adjusted by expected level of achievement over the performance period. Expense for performance-based share awards is amortized ratably over the performance period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense is recorded in selling, general, and administrative expense in the accompanying Condensed Consolidated Statements of Income. The total expenses during the three months ended June 30, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total expenses during the six months ended June 30, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total income tax benefit recognized in the accompanying Condensed Consolidated Statements of Income for restricted stock awards was $0.4 million and $0.9 million for the three months ended June 30, 2022 and 2021, respectively, and $0.9&#160;million and $2.1&#160;million for the six months ended June 30, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was $8.9 million of total unrecognized compensation cost related to restricted stock awards as of June&#160;30, 2022, which is expected to be recognized over a weighted-average period of 2.0 years. There was $9.4 million of unrecognized compensation costs related to the 65,477 performance-based shares discussed above as of June&#160;30, 2022, which is expected to be recognized over a weighted-average period of 2.1 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTA1_2876211d-efe3-4b44-a36b-5615ae1a002b">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTE5_6106d055-7624-49b1-b950-247d96a56160">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTk0_5034f2ae-ca90-4b7f-94ad-5ccf765d90d4"
      unitRef="usdPerShare">26.52</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNjAw_0ffee3b1-b1e4-4667-aa01-61ec662facef"
      unitRef="usdPerShare">66.68</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMyNw_1e03862c-1ea1-4e5a-9fd4-67cc3060d44d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMyNw_3fdbb92e-4c56-4fd1-b310-802c0443c1d8"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYyMA_8ec228fb-2b66-49d5-bf49-9694a2c8569e">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our stock option activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id55dd95aa3bc470e9e56ec5f8723d097_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNC0xLTEtMS0zMDc1Ng_62b25046-804c-473a-83d5-1343f9f89567"
      unitRef="shares">33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id55dd95aa3bc470e9e56ec5f8723d097_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNC0zLTEtMS0zMDc1Ng_63de0c4f-26db-4329-8d94-8b52696d121e"
      unitRef="usdPerShare">54.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1602479b512c4de9830dc7270e25407f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNC01LTEtMS0zMDc1Ng_510c4b76-773f-4d3f-83bf-24cd8135007d"
      unitRef="shares">61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1602479b512c4de9830dc7270e25407f_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNC03LTEtMS0zMDc1Ng_26ce48ca-9ec5-4bff-9318-c78bc9e4c63d"
      unitRef="usdPerShare">48.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i58a4c9c4abd041de9a9bf0f6ab581c1b_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNS0xLTEtMS0zMDc1Ng_9c0f8bac-f830-4a10-9d8a-18b3c8a99703"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i58a4c9c4abd041de9a9bf0f6ab581c1b_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNS0zLTEtMS0zMDc1Ng_c7668e2a-d189-46de-b225-b6cb9dcaa603"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7b570ba8f30648dfacf09a049d1a4224_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNS01LTEtMS0zMDc1Ng_3a6cc6f1-7974-44c1-a14d-e5e7b8fab8bc"
      unitRef="shares">14</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i7b570ba8f30648dfacf09a049d1a4224_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNS03LTEtMS0zMDc1Ng_7ba28dfb-7a2e-4955-b675-2d420b9de9d6"
      unitRef="usdPerShare">50.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0372fb43e9d841769683ae47a2e205e0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNy0xLTEtMS0zMDc1Ng_6e1712b0-5b83-4813-a1a7-cf0623519780"
      unitRef="shares">33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0372fb43e9d841769683ae47a2e205e0_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNy0zLTEtMS0zMDc1Ng_e5470bc5-2e2d-490e-aa45-a3d30717bde0"
      unitRef="usdPerShare">54.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="idf143fc967754c9285fe98b52326ac85_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNy01LTEtMS0zMDc1Ng_0d8ad110-07f3-4a0a-b443-4907eadfe0c6"
      unitRef="shares">47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="idf143fc967754c9285fe98b52326ac85_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfNy03LTEtMS0zMDc1Ng_49aa3dd3-0208-483d-bc6f-8bb4a5b147c2"
      unitRef="usdPerShare">47.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i0372fb43e9d841769683ae47a2e205e0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfOC0xLTEtMS0zMDc1Ng_be35c1b4-6681-4176-a4ba-d4e7062e6b45"
      unitRef="shares">28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i0372fb43e9d841769683ae47a2e205e0_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfOC0zLTEtMS0zMDc1Ng_4624b99c-deac-42a3-8378-d0387ddb08ec"
      unitRef="usdPerShare">52.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="idf143fc967754c9285fe98b52326ac85_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfOC01LTEtMS0zMDc1Ng_0d672cdf-659a-4867-966a-55b435c97e74"
      unitRef="shares">38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="idf143fc967754c9285fe98b52326ac85_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmUxZmY5ODhkNjVjMTQyZjFhM2Q4OTllYTY4NGY5YTZkL3RhYmxlcmFuZ2U6ZTFmZjk4OGQ2NWMxNDJmMWEzZDg5OWVhNjg0ZjlhNmRfOC03LTEtMS0zMDc1Ng_06b686d3-5cb3-4f37-99b2-fa0ce56a7ccd"
      unitRef="usdPerShare">42.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4Njcw_c9d338d2-9d1f-488d-9138-2485007b02cb">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="id508aa7830c34993b9ba67211a0443ef_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTU4OA_b45438fa-0242-47cb-af1d-ddd4dafce34f"
      unitRef="usd">4200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTY3Nw_a39c8a07-856a-4509-9d32-3667cac0fdfd">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="id508aa7830c34993b9ba67211a0443ef_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTcxNw_1a6e8501-82e1-4164-9342-ab488d803169"
      unitRef="usd">3600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="id508aa7830c34993b9ba67211a0443ef_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTg0Ng_844d05eb-cfb5-4cb8-973e-1fb78c49dc73"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="idb8f40f075f34f15acb194954c94fcaa_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTkxNg_550568e1-64fa-40d3-a0ca-9309db649c87">P0Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjAxNA_471b4bb0-414d-45ae-944f-0a7f8f1c5f32"
      unitRef="usd">700000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i50220b2625794fccbe511347ebb66670_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjE0Mg_f69940fb-f379-407d-9895-c1c6b0816452"
      unitRef="usd">2300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjI3OA_5c1e64b9-fb3c-4215-9454-871e15168c27">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYyMQ_92615779-8451-40d1-8409-07ca9a077bbe">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our restricted stock activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;267.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i829d85fe933a4eda921636a7a3a375d6_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNC0xLTEtMS0zMDc1Ng_9ad01a64-cd02-4343-a248-42e9f77d7ed5"
      unitRef="shares">44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i829d85fe933a4eda921636a7a3a375d6_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNC0zLTEtMS0zMDc1Ng_6d4d7f5e-7c74-4f8c-81d0-f8b4f7533e47"
      unitRef="usdPerShare">183.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib21e0e3f9ad94913bf93467edc85ce06_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNC01LTEtMS0zMDc1Ng_ba0e41d8-3d25-4ab7-9378-3cee00c41330"
      unitRef="shares">50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib21e0e3f9ad94913bf93467edc85ce06_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNC03LTEtMS0zMDc1Ng_f70a180a-40c3-4185-8786-e70ca3c24bc5"
      unitRef="usdPerShare">116.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNS0xLTEtMS0zMDc1Ng_d5ee2171-12cc-4b64-9f1b-23b7620b4476"
      unitRef="shares">38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNS0zLTEtMS0zMDc1Ng_ee46c85c-452c-410d-b14a-0e679766ec64"
      unitRef="usdPerShare">176.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNS01LTEtMS0zMDc1Ng_8e4dfff0-db3a-4f03-a562-22b218f8f8b9"
      unitRef="shares">21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNS03LTEtMS0zMDc1Ng_149e849d-9a8e-4f9c-878d-ba3a50b3ba93"
      unitRef="usdPerShare">267.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNi0xLTEtMS0zMDc1Ng_f13f9f0a-a86c-4e19-bf95-c6d6fdd2213f"
      unitRef="shares">19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNi0zLTEtMS0zMDc1Ng_354595b3-d18f-4760-a317-476e6aeef805"
      unitRef="usdPerShare">155.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNi01LTEtMS0zMDc1Ng_e820d014-e64e-47c4-a110-97a8aaf4ba48"
      unitRef="shares">25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNi03LTEtMS0zMDc1Ng_ec201394-06a8-43b5-a4ec-07109cf89707"
      unitRef="usdPerShare">113.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNy0xLTEtMS0zMDc1Ng_53724b80-60d7-4147-85d5-3c6a777ccbdf"
      unitRef="shares">1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNy0zLTEtMS0zMDc1Ng_327ee4c6-d412-48e6-9f04-c3424c59b288"
      unitRef="usdPerShare">186.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNy01LTEtMS0zMDc1Ng_5608b8d0-ea46-4f49-b7e8-75002949d3ea"
      unitRef="shares">2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfNy03LTEtMS0zMDc1Ng_f5204b1e-0a83-4f58-a205-d5825c3fcb60"
      unitRef="usdPerShare">154.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia759f6e591be41e886afe18c17d6e776_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfOC0xLTEtMS0zMDc1Ng_40b1df22-1667-4eae-b8f7-d50f85ebf524"
      unitRef="shares">62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia759f6e591be41e886afe18c17d6e776_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfOC0zLTEtMS0zMDc1Ng_04cd03a2-9dac-4652-a8be-89939df8fad7"
      unitRef="usdPerShare">187.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i21b609542b4c460580805a1e4f761438_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfOC01LTEtMS0zMDc1Ng_72930f6c-b128-40bc-b977-356afa4d70d2"
      unitRef="shares">44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i21b609542b4c460580805a1e4f761438_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjgyZTM2NjE0MGQyOTRhZTI4OTZlNmMzZjY2OGI0ZTY4L3RhYmxlcmFuZ2U6ODJlMzY2MTQwZDI5NGFlMjg5NmU2YzNmNjY4YjRlNjhfOC03LTEtMS0zMDc1Ng_2ea5be90-93f8-4a04-af95-bf688751b966"
      unitRef="usdPerShare">182.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjYzOA_cbca5ab7-1302-45ec-8165-52c2825a2c32"
      unitRef="shares">8000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMjY0NQ_b26c20a0-53f7-4666-8e45-0e3ef22629e3"
      unitRef="shares">7000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4NTcz_4e37ac6d-2c97-4746-9a78-99ebfb7ba0a6"
      unitRef="usd">3300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4NTgx_171b39db-ed99-4c95-a8a4-ee7ea6a2178c"
      unitRef="usd">6700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage
      contextRef="ib5f1116c90194300a342749eb3892747_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMxOTQxMzk1MzkwODY_eb424b2e-ca09-4099-91d3-bf0af579799e"
      unitRef="number">0</med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage>
    <med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage
      contextRef="i791f345fa7fe442d9a480bb5934ca24a_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMxOTQxMzk1MzkwOTA_bedbc448-ba63-4b1e-bdc7-2d91da9e6c4f"
      unitRef="number">2.50</med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage>
    <med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod
      contextRef="id10455ed7a30470c8ce16fd0347a1491_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfMTMxOTQxMzk1MzkxMDY_6cc0a27e-23e9-469d-a3ae-ee786278d537">P3Y</med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYxNw_d6ff10e2-5eab-41d2-a580-61c3c22dfc8f">The total expenses during the three months ended June 30, 2022 and 2021 are as follows (in thousands):&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total expenses during the six months ended June 30, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="id36d21034a864432b8162b094357f768_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfMy0xLTEtMS0zMjk2NA_8dffd47a-539f-4bdb-a288-4138be7d1001"
      unitRef="shares">86000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id36d21034a864432b8162b094357f768_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfMy0zLTEtMS0zMjk2NA_3040ce47-91f5-4302-bf4f-c6775a93cdfa"
      unitRef="usd">1311000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9ee521e8f7844c1f94e09336bcfd86db_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfMy01LTEtMS0zMjk2NA_bf4adf28-d129-4e1a-9ed8-bc2c1cf3f208"
      unitRef="shares">103000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9ee521e8f7844c1f94e09336bcfd86db_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfMy03LTEtMS0zMjk2NA_5551beea-1f6c-4577-8f9d-1a3ad0441ad9"
      unitRef="usd">938000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ibf790b22c1264d739149650b115efb43_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNC0xLTEtMS0zMjk2NA_5469257c-a1b8-470f-88db-97d30d8f0be4"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibf790b22c1264d739149650b115efb43_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNC0zLTEtMS0zMjk2NA_089fed77-5fff-404b-adc4-311f0431d059"
      unitRef="usd">433000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iea89962a06654099aa9ce6020660ce2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNC01LTEtMS0zMjk2NA_8a8b42a5-7891-4ea1-a0f2-e9e8cdce2187"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iea89962a06654099aa9ce6020660ce2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNC03LTEtMS0zMjk2NA_0be2c502-2614-4c4e-bb8c-c37ed03a08e3"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9b6e347e922e48cf858c12fd486caacd_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNS0xLTEtMS0zMjk2NA_1a5d5e94-eb3f-436f-afbe-8b2994d787ec"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9b6e347e922e48cf858c12fd486caacd_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNS0zLTEtMS0zMjk2NA_b940f008-ed2d-42d8-ac9b-65953d88367a"
      unitRef="usd">647000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i61d036694b67452fbbdb85aea52976a0_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNS01LTEtMS0zMjk2NA_895c603b-1b19-49be-beaa-c74d25e7931f"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i61d036694b67452fbbdb85aea52976a0_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNS03LTEtMS0zMjk2NA_fea73e4e-3372-4e2c-811d-144187fe3b19"
      unitRef="usd">54000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i236cdbac8a54499bae6a9b834bcc1d9b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNi0xLTEtMS0zMjk2NA_d429a3b0-8d55-4b9b-a871-e7b645e0769c"
      unitRef="shares">26000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i236cdbac8a54499bae6a9b834bcc1d9b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNi0zLTEtMS0zMjk2NA_b87592b2-9d81-462e-8405-21befe23abf3"
      unitRef="usd">474000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib227523b7a72441886b57ff4d5975e64_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNi01LTEtMS0zMjk2NA_94cf25c4-2801-44de-bd77-1febec0cb596"
      unitRef="shares">28000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib227523b7a72441886b57ff4d5975e64_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNi03LTEtMS0zMjk2NA_7bf635b3-4aaa-4e48-9635-3cc702378f85"
      unitRef="usd">495000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="id089f7cb3778424d85b3c0a0ba3abe64_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNy0xLTEtMS0zMjk2NA_0ef48cd2-167f-4107-81c7-8b07c4d838c2"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id089f7cb3778424d85b3c0a0ba3abe64_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNy0zLTEtMS0zMjk2NA_faf5023f-b3cb-465f-9f06-df3f913764c9"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i1dc76c8e56a84d50b6f056f5427ad729_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNy01LTEtMS0zMjk2NA_13150951-e48f-4745-a43a-a7b0c842d274"
      unitRef="shares">17000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1dc76c8e56a84d50b6f056f5427ad729_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfNy03LTEtMS0zMjk2NA_ab441d23-136b-4701-b46c-86be84d2baf1"
      unitRef="usd">711000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfOC0xLTEtMS0zMjk2NA_3c7806d3-bc02-4ba9-8117-57af2340bf69"
      unitRef="shares">152000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfOC0zLTEtMS0zMjk2NA_9f780352-c4d8-4361-be92-c349cfd1cdf5"
      unitRef="usd">2865000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfOC01LTEtMS0zMjk2NA_8f71da22-5c64-4e22-89d1-0f1d5a6ac3e9"
      unitRef="shares">162000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOmQyODJlMWE4YmRmYjQyNDk5ZmE4YjBiNzg5MDhlYTA5L3RhYmxlcmFuZ2U6ZDI4MmUxYThiZGZiNDI0OTlmYThiMGI3ODkwOGVhMDlfOC03LTEtMS0zMjk2NA_686011e1-ac2d-487e-a237-d9f08ae15fb2"
      unitRef="usd">2198000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="icec11bcf6e124a15853dea3f1b683cbc_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfMy0xLTEtMS0zMDc1Ng_eeb70314-0da0-401a-89be-23a4a6e55057"
      unitRef="shares">91000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icec11bcf6e124a15853dea3f1b683cbc_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfMy0zLTEtMS0zMDc1Ng_1cb534c6-da48-4ed3-8f45-2388314d10e3"
      unitRef="usd">2398000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie16284d30a4743a2bbed4a4f253b25b4_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfMy01LTEtMS0zMDc1Ng_e7a29ed5-f5bd-4168-a479-20b07f564a8a"
      unitRef="shares">91000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie16284d30a4743a2bbed4a4f253b25b4_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfMy03LTEtMS0zMDc1Ng_ad44e966-6519-464b-81d9-89dbf3be607a"
      unitRef="usd">2059000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i054b770bfe6145718c8c3e0c92dd66d4_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNC0xLTEtMS0zMDc1Ng_50dd928d-7a74-4222-bbac-fc0d4f17c566"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i054b770bfe6145718c8c3e0c92dd66d4_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNC0zLTEtMS0zMDc1Ng_18508b3e-9861-4b37-89ae-c6d8d777e745"
      unitRef="usd">512000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3ec22b44a1b94e7db889140b0beb2981_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNC01LTEtMS0zMDc1Ng_0264627b-c61a-4dac-a312-06561c7eaa75"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3ec22b44a1b94e7db889140b0beb2981_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNC03LTEtMS0zMDc1Ng_07648504-c51a-4cb1-8179-622e9a80edda"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4060674f7e11431e987e42f39d8bd999_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNS0xLTEtMS0zMDc1Ng_e3791722-5174-401c-bdb7-c349c018b75b"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4060674f7e11431e987e42f39d8bd999_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNS0zLTEtMS0zMDc1Ng_b70e1b2a-ab03-4f1a-a98f-aeb6829ce266"
      unitRef="usd">1287000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i73edf9ea6315403eb92729cc50508941_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNS01LTEtMS0zMDc1Ng_a513de35-0880-4821-b818-e7993b982144"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i73edf9ea6315403eb92729cc50508941_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNS03LTEtMS0zMDc1Ng_20ebb9be-91eb-4ced-aba7-bbc5425f4d24"
      unitRef="usd">357000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i064f238b1a2c484cae33fd7a5814ff0f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNi0xLTEtMS0zMDc1Ng_e4207d7c-87bb-49d2-adb7-6a8eb5729fc6"
      unitRef="shares">26000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i064f238b1a2c484cae33fd7a5814ff0f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNi0zLTEtMS0zMDc1Ng_624f7ab9-1002-4fa2-ac28-cc672222eb9d"
      unitRef="usd">943000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i452fd630b64a4bebb247b038e9162298_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNi01LTEtMS0zMDc1Ng_0ab95343-f661-469d-bfa7-a9d0bf22b3ac"
      unitRef="shares">28000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i452fd630b64a4bebb247b038e9162298_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNi03LTEtMS0zMDc1Ng_59a8b64e-0697-4390-9e5f-42fbb4784837"
      unitRef="usd">850000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="icc759c3471364896ad8b5e7747af27bd_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNy0xLTEtMS0zMDc1Ng_21d02b22-f524-460d-b5ad-76f687491cbf"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icc759c3471364896ad8b5e7747af27bd_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNy0zLTEtMS0zMDc1Ng_d71a8580-22d9-4031-a42f-90c230e8d1d9"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i1a55b7020a694cb9930ecf0c3056192a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNy01LTEtMS0zMDc1Ng_fa298423-5653-4fd9-98dc-a5c49d20998a"
      unitRef="shares">17000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1a55b7020a694cb9930ecf0c3056192a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfNy03LTEtMS0zMDc1Ng_9d6c5a40-002e-4b72-8095-cb770ba6e7af"
      unitRef="usd">1078000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfOC0xLTEtMS0zMDc1Ng_268a30b8-6907-4558-8c70-866c5aa58b67"
      unitRef="shares">157000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfOC0zLTEtMS0zMDc1Ng_ec9cf32b-ad4a-405b-9da0-e699415d7260"
      unitRef="usd">5140000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfOC01LTEtMS0zMDc1Ng_c14a42d8-d4f4-4b8a-95dd-1e867bcecc6f"
      unitRef="shares">150000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RhYmxlOjE4MDczMjlmODJiMzQyYWQ4YjBjNmI5MWRkZjIxMDE1L3RhYmxlcmFuZ2U6MTgwNzMyOWY4MmIzNDJhZDhiMGM2YjkxZGRmMjEwMTVfOC03LTEtMS0zMDc1Ng_8bc924e2-1b2d-49dd-8eb3-e8fa01b90e2c"
      unitRef="usd">4344000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="if49b585270844361a9f23ee1a6dd8b32_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4Nzc3_2f130e01-85e5-4916-9d9b-ca11bbf86ec6"
      unitRef="usd">400000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i28c9596a0f004e71bab401ece8aceb03_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4Nzgy_eed4914c-51d3-439e-a150-7428dbd8130b"
      unitRef="usd">900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4NTEx_bab9f347-3c8e-4b9d-a5ce-400f4d3c7990"
      unitRef="usd">900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i6b5fa5edd6914520b6608cb96d980731_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNTQ5NzU1ODE4NTQw_d04e7e1a-570a-49b9-b504-db2a8a3ba75e"
      unitRef="usd">2100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="ia759f6e591be41e886afe18c17d6e776_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDI2OA_90aa06c5-acd6-4ff4-a171-8294151a317d"
      unitRef="usd">8900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i704b615b775c48bab44c00b68e70be3c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDQyNQ_951d0456-767f-429a-99c0-484f4b00087d">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i24907f08c3c549f2a30017b51b01cb28_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDQzOQ_d6a2014f-1baf-4bdd-a867-85f98829e369"
      unitRef="usd">9400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id10455ed7a30470c8ce16fd0347a1491_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDQ5Mg_426482a0-fabc-4a28-9229-24c7a21c5f3d"
      unitRef="shares">65477</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id10455ed7a30470c8ce16fd0347a1491_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80My9mcmFnOmFjNDkyMWI4ODYwMzRhMjdiOGY2YzE3MmJjZTc4MDQ3L3RleHRyZWdpb246YWM0OTIxYjg4NjAzNGEyN2I4ZjZjMTcyYmNlNzgwNDdfNDYxNQ_d97e4a53-3b9f-44cb-8081-3f92bad2e195">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTM0OA_19e021d8-fb18-44df-9a58-24a485af2acf">LEASES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for office and warehouse space and certain equipment. In certain of the Company&#x2019;s lease agreements, the rental payments are adjusted periodically based on defined terms within the lease. The Company did not have any finance leases as of June&#160;30, 2022 and 2021, respectively, or for the six-month periods then ended, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our leases relating to office and warehouse space have lease terms of 18 months to 126 months. Our leases relating to equipment have lease terms of 24 months to 203 months, with certain of them having automatic renewal clauses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s warehouse agreements also contain non-lease components, in the form of payments towards variable logistics services and labor charges, which the Company is obligated to pay based on the services consumed by it. Such amounts are not included in the measurement of the lease liability but are recognized as expenses when they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease expense was $1.7&#160;million and $1.4&#160;million for the three months ended June 30, 2022 and 2021, respectively, and $3.5 million and $2.4 million for the six months ended June 30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to the Company&#x2019;s operating leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash paid for amounts included in the measurements of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flow used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the weighted average remaining lease term was 5.3 years and the weighted average discount rate was 2.1%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturity of the Company&#x2019;s operating lease liabilities as of June&#160;30, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2022 (excluding the six months ended June&#160;30, 2022)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i8acefb9e79bd4ae1a22dc956c10939ee_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNDQ1_e4674ae8-2d08-465f-9d3e-0948bd211f16">P18M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i39f1cb1cd2be465aa4baf8f6ad80e124_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNDUx_0d7e0261-59f8-417e-a0a9-fdae40b316aa">P126M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i666df92b88214be186d1a29032aab0cb_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNTA4_e711d512-fced-488d-8d44-f7f6a3aedb3a">P24M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i0b46dfbb84c942a2876f386c170b5410_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNTE0_6cb5f0d9-6a20-46c5-8adc-1ae8fc4b382e">P203M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseExpense
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNTQ5NzU1ODE1MzQz_4d2664d7-2fba-4542-9f2f-b1996299c251"
      unitRef="usd">1700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfNTQ5NzU1ODE1MzUx_ba201d0e-3cdc-42d3-b221-b1c935877ef8"
      unitRef="usd">1400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfOTU3_0385cac5-8cae-49fb-b4fd-ce93b65583cf"
      unitRef="usd">3500000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfOTY0_a7d0a49e-42e3-48e5-83cf-5949296b2dcd"
      unitRef="usd">2400000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTM0OQ_62c7d0e3-7abd-4011-b58c-005ed56937a4">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to the Company&#x2019;s operating leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash paid for amounts included in the measurements of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flow used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOmQ1YjAyMDM2ZmMxNTRkYTViZTMxNGEyZDg2OWQ0ZDBhL3RhYmxlcmFuZ2U6ZDViMDIwMzZmYzE1NGRhNWJlMzE0YTJkODY5ZDRkMGFfNC0xLTEtMS0zMDc1Ng_d97aa68f-66d6-420b-a0d9-c6d8dea80937"
      unitRef="usd">3674000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOmQ1YjAyMDM2ZmMxNTRkYTViZTMxNGEyZDg2OWQ0ZDBhL3RhYmxlcmFuZ2U6ZDViMDIwMzZmYzE1NGRhNWJlMzE0YTJkODY5ZDRkMGFfNC0zLTEtMS0zMDc1Ng_95ef8a53-acd8-45f3-b611-8d638056229d"
      unitRef="usd">2005000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOmQ1YjAyMDM2ZmMxNTRkYTViZTMxNGEyZDg2OWQ0ZDBhL3RhYmxlcmFuZ2U6ZDViMDIwMzZmYzE1NGRhNWJlMzE0YTJkODY5ZDRkMGFfNy0xLTEtMS0zMDc1Ng_2101f209-b5ae-4530-a38e-8906bf89527c"
      unitRef="usd">103000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOmQ1YjAyMDM2ZmMxNTRkYTViZTMxNGEyZDg2OWQ0ZDBhL3RhYmxlcmFuZ2U6ZDViMDIwMzZmYzE1NGRhNWJlMzE0YTJkODY5ZDRkMGFfNy0zLTEtMS0zMDc1Ng_fcdd699f-e2a9-4065-8aab-5a80851e7bba"
      unitRef="usd">9745000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTE4NQ_0144c544-d66d-4b5d-b0eb-eed77e82c788">P5Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTIzMg_aba506ee-b149-4add-a475-0ec8479d84b6"
      unitRef="number">0.021</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RleHRyZWdpb246ZTUzMjYzMzdmMWRlNGY1ZGE4NTliMmQzYTBmNzk4OTlfMTM1MA_7f60e5c0-7a20-45ba-b69f-f001d4a852fb">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturity of the Company&#x2019;s operating lease liabilities as of June&#160;30, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2022 (excluding the six months ended June&#160;30, 2022)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfMC0xLTEtMS0zMDc1Ng_d312c929-e7ee-45af-a2a1-f6edb93717c9"
      unitRef="usd">3525000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfMS0xLTEtMS0zMDc1Ng_d597c561-ee41-431f-a24e-ffa0d28599de"
      unitRef="usd">6241000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfMi0xLTEtMS0zMDc1Ng_28f720e8-268e-4e32-9a80-4dc470eb9b0c"
      unitRef="usd">5693000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfMy0xLTEtMS0zMDc1Ng_f29573ff-8638-414f-8504-4b75b2f722e8"
      unitRef="usd">5825000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfNC0xLTEtMS0zMDc1Ng_b72b5ac3-ee29-4f9d-b6d8-5b18bfffd7b3"
      unitRef="usd">4160000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <med:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfNS0xLTEtMS0zMDc1Ng_cca46bec-43cb-4032-957b-1f8fb8db25e4"
      unitRef="usd">5412000</med:LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfNi0xLTEtMS0zMDc1Ng_bba0edae-f1b7-41aa-a63a-b04009bf2913"
      unitRef="usd">30856000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfNy0xLTEtMS0zMDc1Ng_b2847e67-624b-49ee-9742-c9c65d5eb715"
      unitRef="usd">1564000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80Ni9mcmFnOmU1MzI2MzM3ZjFkZTRmNWRhODU5YjJkM2EwZjc5ODk5L3RhYmxlOjVjNmNmNTFhYzFlODQxMWRiZTRmOTY0ZTk1Mjc3MWQyL3RhYmxlcmFuZ2U6NWM2Y2Y1MWFjMWU4NDExZGJlNGY5NjRlOTUyNzcxZDJfOC0xLTEtMS0zMDc1Ng_f2abd7bf-ebe4-439f-9df1-0a421df29802"
      unitRef="usd">29292000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RleHRyZWdpb246NWVkYzgyZDEwMjkxNDZmY2FjMGJmNDEzOTlkOGM0Y2JfMTgx_bf51a096-20da-4c57-898e-d6bb1a6f9ce6">ACCUMULATED OTHER COMPREHENSIVE INCOME&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Unrealized gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RleHRyZWdpb246NWVkYzgyZDEwMjkxNDZmY2FjMGJmNDEzOTlkOGM0Y2JfMTgw_8f27009c-a35e-4417-ad48-aa1aa4be01bf">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of accumulated other comprehensive income, net of tax where applicable (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Unrealized gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfMi0xLTEtMS0zMDc1Ng_0aad3952-caf6-4472-ab6e-b6ccace3073d"
      unitRef="usd">268000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfMi0zLTEtMS0zMDc1Ng_bca4229e-5258-4220-937d-20d1fba24059"
      unitRef="usd">90000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfMy0xLTEtMS0zMDc1Ng_195c6740-5d86-448f-9d39-83fe6afcac17"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfMy0zLTEtMS0zMDc1Ng_7c1f41aa-36ef-400f-83c2-ef3940936e53"
      unitRef="usd">21000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfNC0xLTEtMS0zMDc1Ng_0bc3fc5c-ecdb-43ba-a6a8-dd623a3219a6"
      unitRef="usd">268000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV80OS9mcmFnOjVlZGM4MmQxMDI5MTQ2ZmNhYzBiZjQxMzk5ZDhjNGNiL3RhYmxlOmExZWQyYWQzNWU2OTQzNjNiMGEyODAyNzY5ZmY1MWFjL3RhYmxlcmFuZ2U6YTFlZDJhZDM1ZTY5NDM2M2IwYTI4MDI3NjlmZjUxYWNfNC0zLTEtMS0zMDc1Ng_09067cec-4e29-4408-9974-43e4f345adb8"
      unitRef="usd">111000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfMTYwMg_b2a33e10-a0de-4e94-8405-284e07ebdd9b">FINANCIAL INSTRUMENTS&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain financial assets and liabilities are accounted for at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy prioritizes the inputs used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2013; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 &#x2013; Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 &#x2013; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#x2019;s best estimate of fair value from the perspective of a market participant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Accrued Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash &amp;amp; Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Investment&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Accrued Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash &amp;amp; Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Investment&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Government &amp;amp; agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company had a realized loss of $0.2&#160;million for the three and six months ended June&#160;30, 2022 and no realized gain or losses for the three and six months ended June&#160;30, 2021.</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfMTYwMQ_4010b613-aa7b-46f5-a01e-93ff6d30f663">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s cash and financial assets that are measured at fair value on a recurring basis for each of the hierarchy levels (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Accrued Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash &amp;amp; Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Investment&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Accrued Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash &amp;amp; Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Investment&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Money market accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Government &amp;amp; agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Municipal bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:MarketableSecurities
      contextRef="iee065151388c4c8cbe6affcd09c55b2b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMy0xLTEtMS0zMDc1Ng_7ad986ec-b5ba-4c8e-b01a-a6b82f5f3bfa"
      unitRef="usd">60277000</us-gaap:MarketableSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iee065151388c4c8cbe6affcd09c55b2b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMy03LTEtMS0zMDc1Ng_5c7f3a9b-0ec9-4a83-a22a-79760da42fb7"
      unitRef="usd">60277000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iee065151388c4c8cbe6affcd09c55b2b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMy05LTEtMS0zMDc1Ng_fc727f82-feea-48ec-ac34-70830d791488"
      unitRef="usd">60277000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="i332a69d5d4c54c2094cc9048eb80a99c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfNi0xLTEtMS0zMDc1Ng_f8df749e-dc61-494e-80ac-93172d9c3677"
      unitRef="usd">792000</us-gaap:MarketableSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i332a69d5d4c54c2094cc9048eb80a99c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfNi03LTEtMS0zMDc1Ng_3b175fa9-6a7e-4667-989d-919569b96bea"
      unitRef="usd">792000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i332a69d5d4c54c2094cc9048eb80a99c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfNi05LTEtMS0zMDc1Ng_adec2541-e386-41fb-9f85-733d5f58b6cd"
      unitRef="usd">792000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtMS0xLTEtMzA3NTY_47d8087a-a73a-4d6a-949d-8d6f3344a3c2"
      unitRef="usd">61069000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtMy0xLTEtMzA3NTY_b953017c-781d-45c9-9e17-37a7076946d4"
      unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:InterestReceivable
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtNS0xLTEtMzA3NTY_7b28bf33-1ae6-4847-8768-9e053df2f3c3"
      unitRef="usd">0</us-gaap:InterestReceivable>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtNy0xLTEtMzA3NTY_d309f224-d701-4c0a-ac30-8e3625220500"
      unitRef="usd">61069000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtOS0xLTEtMzA3NTY_8c57074d-d736-453c-a72c-a375eec37e20"
      unitRef="usd">61069000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOmJmYTVjZDc3OGI0YzRiN2Y4Y2IyZTdkMWYxNjdhMDY4L3RhYmxlcmFuZ2U6YmZhNWNkNzc4YjRjNGI3ZjhjYjJlN2QxZjE2N2EwNjhfMTMtMTEtMS0xLTMwNzU2_dcabcf5d-34da-42fc-b3b8-0f8a272f29d4"
      unitRef="usd">0</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:MarketableSecurities
      contextRef="i57509a5816a14b6e9f710cd2a1430d7b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMy0xLTEtMS0zMDc1Ng_6259eb57-cd35-4606-8213-488f25e02985"
      unitRef="usd">94824000</us-gaap:MarketableSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i57509a5816a14b6e9f710cd2a1430d7b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMy03LTEtMS0zMDc1Ng_715821c4-aa0c-409a-a9b6-95b46e83366a"
      unitRef="usd">94824000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i57509a5816a14b6e9f710cd2a1430d7b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMy05LTEtMS0zMDc1Ng_2b71f896-4f88-4239-b039-0e45bbf65e74"
      unitRef="usd">94824000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="i89eed6193bce41109d7fcaa6ca2460a3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNi0xLTEtMS0zMDc1Ng_15ad3c13-72c8-46d0-899d-52b76eebdec1"
      unitRef="usd">9359000</us-gaap:MarketableSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i89eed6193bce41109d7fcaa6ca2460a3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNi03LTEtMS0zMDc1Ng_e0d138b6-cf77-48fd-afb7-038977407bf0"
      unitRef="usd">9359000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i89eed6193bce41109d7fcaa6ca2460a3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNi05LTEtMS0zMDc1Ng_1185b975-24fd-42c2-be7d-525348448050"
      unitRef="usd">9359000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="i0cac6b725df74e8ea420f955e6941daa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNy0xLTEtMS0zMDc1Ng_1ed9a0b7-3007-492a-b5ae-915384827bc0"
      unitRef="usd">1401000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="icea4ee9f85da4ed49ceb9bda111639c6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNy0zLTEtMS0zMDc1Ng_47fb8029-cefd-47c7-ada9-6e8b413dfa74"
      unitRef="usd">12000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i0cac6b725df74e8ea420f955e6941daa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNy03LTEtMS0zMDc1Ng_d78cb5ff-cfa4-4925-ada6-c892f2fcee8d"
      unitRef="usd">1413000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i0cac6b725df74e8ea420f955e6941daa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfNy0xMS0xLTEtMzA3NTY_080dfd9f-fde1-4001-bf96-3c8e97bb9472"
      unitRef="usd">1413000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:MarketableSecurities
      contextRef="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC0xLTEtMS0zMDc1Ng_de45c68e-2eb4-4b88-80e5-45f6d21f04b9"
      unitRef="usd">10760000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i9d5f95ffbfb34e22af63161d1bed6f55_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC0zLTEtMS0zMDc1Ng_6bceb952-56d4-4a8a-92a2-c4faaf4d1a2c"
      unitRef="usd">12000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC03LTEtMS0zMDc1Ng_d59a750b-6626-48fd-a177-f001643bbfce"
      unitRef="usd">10772000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC05LTEtMS0zMDc1Ng_8749740f-c2d3-4e51-a2fb-59086e50844e"
      unitRef="usd">9359000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="ic74e00c7e134447fb0f6c93fe36e93bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfOC0xMS0xLTEtMzA3NTY_1fcd8d37-34f1-490f-8e15-2e68f5c420fe"
      unitRef="usd">1413000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:MarketableSecurities
      contextRef="i8938f1db545249db980bb8fc24aee80f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtMS0xLTEtMzA3NTY_debba084-34b8-426c-8786-6824d56b0440"
      unitRef="usd">3880000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="ibad7c8db12bd42e2809f2f8c2ced2539_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtMy0xLTEtMzA3NTY_eafcf975-c24f-4af5-ba71-bbb701b3e231"
      unitRef="usd">9000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:InterestReceivable
      contextRef="i8938f1db545249db980bb8fc24aee80f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtNS0xLTEtMzA3NTY_7328229f-351f-4a2b-bc21-ca07188eb8c2"
      unitRef="usd">59000</us-gaap:InterestReceivable>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8938f1db545249db980bb8fc24aee80f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtNy0xLTEtMzA3NTY_8f019995-be47-456a-b7d4-ab1b9212fe7a"
      unitRef="usd">3948000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i8938f1db545249db980bb8fc24aee80f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTEtMTEtMS0xLTMwNzU2_2db53a2d-be86-43a3-a947-1de2b524f438"
      unitRef="usd">3948000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:MarketableSecurities
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtMS0xLTEtMzA3NTY_026e7bff-36c0-4076-9c3e-1e4e40bff7ca"
      unitRef="usd">109464000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i9333a141fdf6464bb3ce95b9dd9b08ea_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtMy0xLTEtMzA3NTY_16fbcbf2-01db-4a14-b86a-44313d9c533b"
      unitRef="usd">21000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:InterestReceivable
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtNS0xLTEtMzA3NTY_5518ad5a-73c1-4d08-9ce0-1a6bac96d9eb"
      unitRef="usd">59000</us-gaap:InterestReceivable>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtNy0xLTEtMzA3NTY_ae034f72-0d31-4e7c-86ff-e5e569d7e4dc"
      unitRef="usd">109544000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtOS0xLTEtMzA3NTY_86637d3f-e14e-48ea-92d4-317940b87199"
      unitRef="usd">104183000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="ib948ed90768e446fa2a7da19901058c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RhYmxlOjk3OWIzZjI0NTk3NDQzZTNhMjQ2ZTA0MmI2ODg0MTdlL3RhYmxlcmFuZ2U6OTc5YjNmMjQ1OTc0NDNlM2EyNDZlMDQyYjY4ODQxN2VfMTMtMTEtMS0xLTMwNzU2_a9e65053-6c4d-4fe2-95a2-587c1c2be0eb"
      unitRef="usd">5361000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfNjU5NzA2OTc2ODcwMg_18f77efe-3d24-42b5-be2e-0b550b84d2d1"
      unitRef="usd">-200000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfNjU5NzA2OTc2ODcwMg_93581e60-3043-4988-8ff5-9cd6276d7e20"
      unitRef="usd">-200000</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfMTI2NDQzODM3MjI0OTM_4b51966f-5f84-4cc6-a1d3-251ab7245e53"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesRealizedGainLoss
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81Mi9mcmFnOjlmMTVmZWI2MzJiOTQxZDNhOGYxOWZjYWY0NzI0MDFkL3RleHRyZWdpb246OWYxNWZlYjYzMmI5NDFkM2E4ZjE5ZmNhZjQ3MjQwMWRfMTI2NDQzODM3MjI0OTM_ab71fd19-815c-4076-8ab5-6d87f1511e58"
      unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesRealizedGainLoss>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMzEwNg_25d149c5-fd4a-4859-84e8-42995f591429">DEBT&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#x201c;Guarantors&#x201d;) entered into a credit agreement (the &#x201c;Credit Agreement&#x201d;) among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on Secured Overnight Financing Rate (SOFR), from London Inter-Bank Offered Rate (LIBOR) (the &#x201c;Amended Credit Agreement&#x201d;).  The Amended Credit Agreement provides for a $225.0 million senior secured revolving credit facility with a $20.0 million letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to $100.0 million. The Amended Credit Agreement matures on April&#160;13, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s obligations under the Amended Credit Agreement are guaranteed by the Guarantors. The obligations of the Company and the Guarantors are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Amended Credit Agreement, the Company will pay to the administrative agent for the account of each revolving lender a commitment fee on a quarterly basis based on amounts committed but unused under the revolving facility from 0.20% to 0.40% per annum depending on the Company&#x2019;s Total Net Leverage Ratio (as defined in the Amended Credit Agreement). The Company is also obligated to pay the administrative agent customary fees for credit facilities of this size and type.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving borrowings under the Amended Credit Agreement bear interest at a rate per annum equal to (i) the Term SOFR Rate for the interest period plus the Applicable Rate (as defined in the Amended Credit Agreement) based on the Company&#x2019;s Total Net Leverage Ratio or (ii) the Alternate Base Rate (as defined in the Amended Credit Agreement) as in effect from time to time plus the Applicable Rate based on the Company&#x2019;s Total Net Leverage Ratio. As of June&#160;30, 2022, the Applicable Rate for Term SOFR Loans is 1.25% per annum and the Applicable Rate for ABR Loans is 0.25% per annum. SOFR based loans also include a Credit Spread Adjustment based on the duration of the borrowing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants that, among other things, limit or restrict the ability of the Company and its subsidiaries, subject to negotiated exceptions, to incur additional indebtedness and additional liens on their assets, engage in mergers or acquisitions or dispose of assets, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments and change the nature of their businesses. The Amended Credit Agreement also contains customary events of default, subject to thresholds and grace periods, including, among others, payment default, covenant default, cross default to other material indebtedness and judgment default. In addition, the Amended Credit Agreement requires the Company to maintain a Total Net Leverage Ratio of no more than 2.75 to 1.00 and an Interest Coverage Ratio of at least 3.50 to 1.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has $27.0 million of borrowings outstanding under the Amended Credit Agreement as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i49b6f09335094cb2b7b85ec6ae9e598c_I20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfNDM5ODA0NjUyMjQ0MA_030d383e-b454-471c-8c4d-c21f20cef587"
      unitRef="usd">225000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib6945a9410a34cf18dd01065cbc232f2_I20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfNDM5ODA0NjUyMjQ2Nw_b6d38290-e443-43f2-9c6a-e77eac3495ca"
      unitRef="usd">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <med:LineOfCreditFacilityAccordionFeatureIncreaseLimit
      contextRef="ib6945a9410a34cf18dd01065cbc232f2_I20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfNDM5ODA0NjUyMjUwMw_3dc95660-3bad-46ae-a821-8f0e4e78f9d4"
      unitRef="usd">100000000</med:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ia2123a6dc9f841d696b311320dc700c8_D20210413-20210413"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMTE1MQ_fee92fd7-dcf0-4b50-aa76-255096bc6643"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i247bb176b7b847c4ab8a1f139e0b0856_D20210413-20210413"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMTE1Nw_9206df83-7fd0-49ed-ad46-54f62473e5fd"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie6f63e1a4da2439cb942d7e717740fd6_D20210413-20210413"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMTk3OQ_9d0d1e5d-8a9e-435c-a69d-49100f2d25b5"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8b76567e652341a8bc33402177cf2fb8_D20210413-20210413"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMjAzMw_0cd2a06b-0038-4fbe-a995-bc54e64d0a79"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <med:MaximumTotalNetLeverageRatio
      contextRef="i88c992e95e9b4995a92a40903056360e_I20210413"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMjk3OQ_b43ca30a-9b6c-4fb1-8851-904b1fe3d5e6"
      unitRef="number">2.75</med:MaximumTotalNetLeverageRatio>
    <med:MinimumInterestCoverageRatio
      contextRef="i88c992e95e9b4995a92a40903056360e_I20210413"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMzAzMQ_6feac291-44c8-44c7-8cc1-bdf6a6356f7d"
      unitRef="number">3.50</med:MinimumInterestCoverageRatio>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib4e372b4b4424facb12f398698cc062e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV81NS9mcmFnOjAwZjZlYzJhMzcyODRjMDI4ZTI3ODEyNWZmNjM2NWRlL3RleHRyZWdpb246MDBmNmVjMmEzNzI4NGMwMjhlMjc4MTI1ZmY2MzY1ZGVfMzA1Nw_2547173c-b858-4871-9d64-4df39dac87ed"
      unitRef="usd">27000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOTQvZnJhZzo1Y2I4NzhlOGViNzc0NjE3YTkyZDE2NDZmMGI1MmNlMi90ZXh0cmVnaW9uOjVjYjg3OGU4ZWI3NzQ2MTdhOTJkMTY0NmYwYjUyY2UyXzQ5NDc4MDIzMjgyNjA_b6599a37-8dc2-479b-9520-79e8cac52fb7">ACCELERATED SHARE REPURCHASE (&#x201c;ASR&#x201d;) PROGRAMIn the second quarter of fiscal 2022, the Company entered into an ASR agreement with JPMorgan Chase, National Association ("JPMorgan Chase") to purchase shares of its common stock from JPMorgan Chase for an aggregate purchase price of $100.0&#160;million. Pursuant to the ASR program, the Company received an initial delivery of approximately 480&#160;thousand shares of common stock based on the closing price of the common stock on May 31, 2022. As a result, approximately $20.0&#160;million remains at JPMorgan Chase for additional repurchases until the completion of the ASR program.  The final number of shares that will be delivered to the Company under the ASR agreement will be based on the average of the daily volume-weighted average trading prices of the Company&#x2019;s common stock during the term of the ASR program, less a discount. The Company expects to receive the remaining shares no later than October 3, 2022. The effect of the potential share settlement is excluded in the diluted EPS calculation as the effect is anti-dilutive.</us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOTQvZnJhZzo1Y2I4NzhlOGViNzc0NjE3YTkyZDE2NDZmMGI1MmNlMi90ZXh0cmVnaW9uOjVjYjg3OGU4ZWI3NzQ2MTdhOTJkMTY0NmYwYjUyY2UyXzQ5NDc4MDIzMzIwMTQ_9ac953f7-b097-4609-9651-cf952e46b952"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0923735811e44b48bfa510c4594688c6_D20220531-20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOTQvZnJhZzo1Y2I4NzhlOGViNzc0NjE3YTkyZDE2NDZmMGI1MmNlMi90ZXh0cmVnaW9uOjVjYjg3OGU4ZWI3NzQ2MTdhOTJkMTY0NmYwYjUyY2UyXzQ5NDc4MDIzMzIwMDA_b9ab6f88-d017-42d3-877c-25f3067e027c"
      unitRef="shares">480000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i18c77be8472d4605bfa303d562fd60b2_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8yOTQvZnJhZzo1Y2I4NzhlOGViNzc0NjE3YTkyZDE2NDZmMGI1MmNlMi90ZXh0cmVnaW9uOjVjYjg3OGU4ZWI3NzQ2MTdhOTJkMTY0NmYwYjUyY2UyXzQ5NDc4MDIzMzIwMzA_c203c2ec-1a9c-4593-ba67-5c4cebbbf179"
      unitRef="usd">20000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzItMS0xLTEtMzgzNzY_b1ea6d3b-aa5e-4ad3-ab9b-99926dc2d0f7"
      unitRef="usd">272718000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzItNy0xLTEtMzgzNzY_19fc4a52-f2a6-42a8-a4a6-b06c56390639"
      unitRef="usd">232273000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzMtMS0xLTEtMzgzNzY_a1de639a-8c03-4913-ba39-e4b79fe15911"
      unitRef="usd">48964000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzMtNy0xLTEtMzgzNzY_b4886215-aa16-42d0-b957-58bab16af696"
      unitRef="usd">61434000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzQtMS0xLTEtMzg0NDQ_c7200ce5-064e-4c39-9fde-bc79a983082e"
      unitRef="usd">9683000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzQtNy0xLTEtMzg0NDQ_efc1ef98-7de9-46cd-944f-6bdc4cbf91f7"
      unitRef="usd">14382000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzQtMS0xLTEtMzgzNzY_ac1091bf-f657-4115-be12-bd07aa6f65bb"
      unitRef="usd">39113000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99a6193487cf4ee0a251ceb8d5d5d785_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZTo3ZTUzYjQ2NzcyMWM0ODEzOWI1ZmVjZTE3OTVmMzI3NS90YWJsZXJhbmdlOjdlNTNiNDY3NzIxYzQ4MTM5YjVmZWNlMTc5NWYzMjc1XzQtNy0xLTEtMzgzNzY_988d66a8-44ca-4efa-8793-00597d9c8ff8"
      unitRef="usd">46963000</us-gaap:NetIncomeLoss>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzItMS0xLTEtMzk0MTk_eccf9f6f-568d-4696-83c4-335f1662907c"
      unitRef="usd">519917000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzItNy0xLTEtMzk0MTk_4470d690-df5b-47f3-bafa-554e45dcdc69"
      unitRef="usd">428021000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzMtMS0xLTEtMzk0MTk_71f7c00d-dea5-4341-811b-c9f4b79fd58d"
      unitRef="usd">104051000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzMtNy0xLTEtMzk0MTk_c56c8b94-c7b7-4825-b6c8-683b7929c62d"
      unitRef="usd">114233000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzQtMS0xLTEtMzk0MTk_66ae6e31-ea5f-46a7-a956-1bcd56fe6a81"
      unitRef="usd">22878000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzQtNy0xLTEtMzk0MTk_8962c99a-8705-4499-acde-e1e213610253"
      unitRef="usd">26160000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzUtMS0xLTEtMzk0MTk_8b57b49d-9ddb-49f2-b2c3-c95c943599dd"
      unitRef="usd">80894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0363deef3a3c4a53b5cfc2afe2d9d76f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1NjNiZjQ3OTIwMTQ0NjliZGM4Y2QzZWUwYTk3OTY1L3NlYzo0NTYzYmY0NzkyMDE0NDY5YmRjOGNkM2VlMGE5Nzk2NV8zMDcvZnJhZzo3YWI0NGJkOWVjNzM0NmM2YTZkYmQ2YjhjYjc4YzFkNy90YWJsZToxODEyMmU3MzZjODc0YTExYmYzMWVmYmM1OTBiMmZiOS90YWJsZXJhbmdlOjE4MTIyZTczNmM4NzRhMTFiZjMxZWZiYzU5MGIyZmI5XzUtNy0xLTEtMzk0MTk_a0eba421-492d-439c-a3fb-de31ff66611f"
      unitRef="usd">88026000</us-gaap:NetIncomeLoss>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>51
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M4=PIKHZT3_1,Y4Z:5O21B%YAU5 Y/^RIKN^H4=!A#C8M6XV##L.&Z;I$C02
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MG]#V)X)MRF]$STP(MBX/5S2*:5X Y/T%8^+MI!B@_I Y^1=02P,$%     @
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M!>#[6@CU.M!WC8>[Y<'_4$L#!!0    ( *>% U52)N(3OP(  &0'   8
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M9#^!]"?X Q/H?@*M#6V0U68M6<EF)TK>(:6E09M^J->FG@W6B%QOXZI4\*N
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MN.$,*A$M +^OI2P?!_H/VHO1V;]02P,$%     @ IX4#56@H]UIR#0  [H@
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M#0>PCT#YY20X6'W\3/X!4$L#!!0    ( *>% U7BRBX('@0  "H*   9
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;+U66V_;-A3^*X0Z%"W@6%??$MM
M+N[: 0V,>%L?ACW0TK'%12(5DHKC_?J=0UFJLR9&UX>]B!>=\YWOW$A.=TK?
MFQS LJ>RD&;FY=96Y[YOTAQ*;OJJ HE_-DJ7W.)2;WU3:>"94RH+/PJ"H5]R
M(;WYU.TM]7RJ:EL("4O-3%V67.^OH%"[F1=Z[<:=V.:6-OSYM.);6(']K5IJ
M7/D=2B9*D$8HR31L9MYE>'Z5D+P3^%W SAS-&7FR5NJ>%I^RF1<0(2@@M83
M<7B$:R@* D(:#P=,KS-)BL?S%OV#\QU]67,#UZKX(C*;S[RQQS+8\+JP=VKW
M$0[^# @O585Q7[9K9./ 8VEMK"H/RLB@%+(9^=,A#D<*X]<4HH-"Y'@WAAS+
M&V[Y?*K5CFF21C2:.%>=-I(3DI*RLAK_"M2S\\7EW>VGVY]7;+FX8ZN/EW>+
MJ6\1E_[ZZ0'CJL&(7L$8LL]*VMRPA<P@>Z[O(Y^.5-22NHI. OY2RSZ+@QZ+
M@B@Z@1=W3L8.+W[-2:ZED%O#EJ#9*N<:V!^7:V,UUL2?+_G;P"4OPU&?G)N*
MIS#SL!$,Z$?PYF_?A,/@X@39I".;G$+_SHS\5PQVQ8U(&;21J# 2QD7BW=LW
MXR@*+A;+E9N%%^]9JLJJMISZQC 22GF1U@6WD+':BD+\C2#,YL!VKNQQFS^"
MQBYFLB[7B*TV#;RA&0E>(R27>S(1CBX,F2BQ*[' TWN&IX6Q7&:$FM6Z!4>2
M0F5(EJ(LT4J?W8BB)G/(E@GS?_+BV5_8CHB()Z'3A,T&CQ;"R8@4'B[/E>&A
M%H^\0.*FSWY%A8TJ\ QT#/FZ &; &D*SN<,["CJ!KEW"T'@#?_#YG9 HK&J#
M/TR/P5,*E3W*9H:'P/MS-*<!6-FT)5!;,FPJ<$VU$D^O_*%VHT]X-+NM2PR@
M5?J<W>(=(232!/83BR>],(QQD@Q[DR%-QD%O/$EH,NX%T9#=@%1X8C6Z7_Z=
MCZ]9>#7B8=B+!PD-HT%,0S(8N-4P8HOO#SX;ARP,!FPTP6'THTR2V-D>#\8T
M#&+':SR<L,6W+75V2!Y&J9]01))^$. PZ@=#-R3CE]7:3#O%R V31B,(&\7(
M55);]H=2.2X0K(BBIJS&KG8"_%K1Q0@=M5JD)-QXR7=<9Z:K:7NB;EQ-$";5
M18^@*G!W:K'ON?WP1RR:T]7XLKU^U_^N9U!+H&Y% -(6>P<./,W;)O_F(&%\
MK1ZAH<W35&E*,_GA*-5EJ_A0<VU!(^2SD[,M%)>VDN^95)9*CA=.:X_"9U:=
M83-B2)7%[99H_Z4;PC^ZO[';MNZ50L[5TC97>;?;/80NF_O_JWCSBOK,]5;@
MH5W !E6#_FC@,=V\3)J%595[#:R5Q;>%F^;XF -- OA_HY1M%V2@>Q[._P%0
M2P,$%     @ IX4#5>Y4?H#K"0  Y1\  !D   !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&ULO5EK<]NX%?TK&*V[369DBJ2H5];VC)UDN^E,-IXXF_W0Z0>(
MA"36)*$ H&7UU_=<@*0HZV&Y:?K%!BG@XC[./?<"O%A)=:\70ACVF&>%ONPL
MC%F^Z?5TO! YUYY<B@*_S*3*N<&CFO?T4@F>V$5YU@M]?]C+>5ITKB[LNUMU
M=2%+DZ6%N%5,EWG.U?I&9')UV0DZ]8O/Z7QAZ$7OZF+)Y^).F#^6MPI/O49*
MDN:BT*DLF!*SR\YU\.8FHOEVPM=4K'1KS,B2J93W]/ AN>SXI)#(1&Q( L>_
M!_%69!D)@AK?*IF=9DM:V![7TG^UML.6*=?BK<S^3!.SN.R,.RP1,UYFYK-<
M_28J>P8D+Y:9MG_9RLV-^AT6E]K(O%H,#?*T</_Y8^6'UH*Q?V!!6"T(K=YN
M(ZOE.V[XU862*Z9H-J31P)IJ5T.YM*"@W!F%7U.L,U=WOUU_?G]^<WWW_AU[
M^^GC[?O?[ZZ_?/CT^T7/0#K-Z<65I!LG*3P@:<@^RL(L-'M?)"+97M^#5HUJ
M8:W:37A4X-_+PF-]O\M"/PR/R.LWIO:MO/XA4Q=<B7,*8<)N^1K(,NQ:*5[,
MA1W_XWJJC0),_KG/>"<[VB^;4N>-7O)87':0&UJH!]&Y^OFG8.C_<D3SJ-$\
M.B;]14'Z[R2Q.R/C>_9I2:FBV9>%8&]EON3%FBVX9JG6);Q6R.+\6\FS=);B
MB1<)2XL8KD->,6T%R$J D4SDRTRNA=!V(BVMW[ D54A*J;1G=YKQ5+$'GI6"
MR1DS"_BO$820,:%-BOS#EDAC_,P2/-#4.8)G6*G38F[?WV0\OC^_BQ<RP[9.
M!%NJ-*8)N4Q$UF6K11HO0"??2BBA&]FZVIJ)QR5TPUY&J+Q^Z41U[5BE^OY\
MIF!&6F .!# % =WMU0\RXR;-4K.N99 >M8&U<W_^:1P&HU\TBV6>0U?KQ*YU
M6)(^I(G 8)V*+/&:T(!8M<$$,HE;K9$GHLD3-A>%4#S+UNR!5),/0C'.ED*E
M,G&[D^IKP94+##2&(V!M4;V<*9GO>ME%2CP*%:=ZVYA6M&PR52+.PJ$W" D)
M9\.A-QQ[[!T"C,=]]E/@2%P5LV:?10J7J/7>P'?WQ"N%*WD6EYF%RP89.@7V
M'&QS819P!9@;N9&0#VE"GB9+B8"RJ3 K(=QVY$&24'F/W$6O8_ <\00RH4&)
MX$"5T]ZYBF#"=F%"&CH*JDSZP[O# M137<).&VSP/O@#ZYB8S6#<?MB;!3<
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MYK3G43L#^KY0RKX*+D#SYQC\!5!+ P04    " "GA0-5)58@9'@%   ;#0
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M3,4_B[8.)9&6!"O'2$$Z(.Q8>," -*-</]QA7(GC0@S*TXX7T7]<@=!?%8L
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M4B]( +Q"N=!3MSJ83L\FC05],0X.0VW^L"T2LA[-'39%"@B]%!*U86]\)KT
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M>-'K>*#K"5$;5FVKKEPJ2SU>+3<T5%&[#12G0MF#X0YHQO3D#U!+ P04
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MRYRF.FKG0.=SI>S:< 3-?Z+_%U!+ P04    " "GA0-5__[A0KT#  "^"
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MA_0:;U'!GZPPR2'CMV2MTRU!,*E >:9;AN'I.4P+;3JNQA[)=(Q+EJ4%>B2
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MXTJ73SO,=0L%81ST^I9S=9@8@;XIQW\ 4$L#!!0    ( *>% U4D!75O*P@
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MH&\,U,Z ]F=*V<>).Z#]:DE_ 5!+ P04    " "GA0-5D?B>[.H"   %"
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M<VAE970S-BYX;6R]6MMNVS@0_17"6Q0MT(TDTI;MU#'@.$GK11($N70?%OO
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MHV!8H]1FA%8U"39HDJY=L\-!M"0AL"0Y1"?"$(WW8*LZI$XG$JU""*Q"#LV
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M2P$"% ,4    " "GA0-5!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *>% U6DH1GN[@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M *>% U697)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ IX4#5>JW]3+!!0  Q!X  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M *>% U5"?@XQ( 8  -0<   8              " @00.  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " "GA0-5/>U.1;L#  !L#0  &
M            @(%:%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ IX4#57##=73W!0  9Q8  !@              ("!2Q@  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( *>% U52)N(3OP(  &0'
M   8              " @7@>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " "GA0-57S+.;@P'   D'0  &               @(%M(0
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ IX4#56@H]UIR
M#0  [H@  !@              ("!KR@  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( *>% U5$[</O9P8  -$/   8              "
M@5<V  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "GA0-5
MZWCH?TD$   ("0  &               @('T/   >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ IX4#5>+*+@@>!   *@H  !D
M     ("!<T$  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M" "GA0-5[E1^@.L)  #E'P  &0              @('(10  >&PO=V]R:W-H
M965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( *>% U4IKY%O(04  ' ,   9
M              " @>I/  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L!
M A0#%     @ IX4#52OFC>/8 @  108  !D              ("!0E4  'AL
M+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "GA0-5)58@9'@%
M   ;#0  &0              @(%16   >&PO=V]R:W-H965T<R]S:&5E=#$T
M+GAM;%!+ 0(4 Q0    ( *>% U7VX W*!P<  (T2   9              "
M@0!>  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ IX4#
M52X?.@,#!   ^0@  !D              ("!/F4  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    " "GA0-5EPP6B:H&  #9$0  &0
M        @(%X:0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( *>% U7/47'=N (  +(%   9              " @5EP  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ IX4#55[8M<I# P  +@<
M !D              ("!2',  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    " "GA0-5\>!4J;H$  !:#@  &0              @('"=@
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( *>% U68A>;G
M? ,  #D(   9              " @;-[  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ IX4#57:OWLKD @  ,P8  !D
M ("!9G\  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "G
MA0-5__[A0KT#  "^"   &0              @(&!@@  >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( *>% U5D=I6_(0,  &@)   9
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M970R."YX;6Q02P$"% ,4    " "GA0-58&K)O9,#   *#0  &0
M    @(%EG0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M *>% U4O;W06<P4  %,D   9              " @2^A  !X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ IX4#57"0T.'\ P  D!H  !D
M             ("!V:8  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    " "GA0-5MB*M]C #  #!"   &0              @($,JP  >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( *>% U61^)[LZ@(
M  4(   9              " @7.N  !X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ IX4#51^?*A>[ @  R 8  !D              ("!
ME+$  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "GA0-5
MH(];[IL"  #/!P  &0              @(&&M   >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( *>% U4F1;AFV 4  +DB   9
M      " @5BW  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ IX4#5117^2JD!   F1\  !D              ("!9[T  'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "GA0-52G5/LHL"  #?!@
M&0              @(%"P@  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( *>% U41%S+*.@,  .P3   -              "  03%  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ IX4#59>*NQS     $P(   L
M         ( !:<@  %]R96QS+RYR96QS4$L! A0#%     @ IX4#53,ZJ%BB
M P  HAD   \              ( !4LD  'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( *>% U6WO<)+@0$  "D7   :              "  2'-  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *>% U5CUHH4FP$
M )07   3              "  =K.  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     N "X >0P  *;0      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>132</ContextCount>
  <ElementCount>209</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>31</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - SHARE-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATION</Role>
      <ShortName>SHARE-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2130109 - Disclosure - ACCELERATED SHARE REPURCHASE ("ASR")</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASR</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE ("ASR")</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/INVENTORIES</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2307302 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2311303 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/SHAREBASEDCOMPENSATION</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/LEASES</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/INVENTORIESTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails</Role>
      <ShortName>EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails</Role>
      <ShortName>EARNINGS PER SHARE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2412404 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - SHARE-BASED COMPENSATION - Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails</Role>
      <ShortName>LEASES - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails</Role>
      <ShortName>LEASES - Future Minimum Lease Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - DEBT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="med-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2431415 - Disclosure - ACCELERATED SHARE REPURCHASE ("ASR") (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRDetails</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE ("ASR") (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASR</ParentRole>
      <Position>38</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="med-20220630.htm">med-20220630.htm</File>
    <File>ex-101medifastformpsuagree.htm</File>
    <File>ex-102amendmentno2tomedifa.htm</File>
    <File>med-20220331xexx3111.htm</File>
    <File>med-20220331xexx3121.htm</File>
    <File>med-20220331xexx3211.htm</File>
    <File>med-20220630.xsd</File>
    <File>med-20220630_cal.xml</File>
    <File>med-20220630_def.xml</File>
    <File>med-20220630_lab.xml</File>
    <File>med-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="575">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>56
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "med-20220630.htm": {
   "axisCustom": 0,
   "axisStandard": 13,
   "contextCount": 132,
   "dts": {
    "calculationLink": {
     "local": [
      "med-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "med-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "med-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "med-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "med-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "med-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 310,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 5
   },
   "keyCustom": 11,
   "keyStandard": 198,
   "memberCustom": 10,
   "memberStandard": 19,
   "nsprefix": "med",
   "nsuri": "http://www.medifast1.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.medifast1.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - EARNINGS PER SHARE",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - SHARE-BASED COMPENSATION",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATION",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - LEASES",
     "role": "http://www.medifast1.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "role": "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://www.medifast1.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - DEBT",
     "role": "http://www.medifast1.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130109 - Disclosure - ACCELERATED SHARE REPURCHASE (\"ASR\")",
     "role": "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASR",
     "shortName": "ACCELERATED SHARE REPURCHASE (\"ASR\")",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.medifast1.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307302 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311303 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - LEASES (Tables)",
     "role": "http://www.medifast1.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)",
     "role": "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncashContributionExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - INVENTORIES (Details)",
     "role": "http://www.medifast1.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncashContributionExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails",
     "shortName": "EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "if7841ac501214a4ea7e05c285cf32e72_D20220401-20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - EARNINGS PER SHARE - Narrative (Details)",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails",
     "shortName": "EARNINGS PER SHARE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "if7841ac501214a4ea7e05c285cf32e72_D20220401-20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412404 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "SHARE-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "id55dd95aa3bc470e9e56ec5f8723d097_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - SHARE-BASED COMPENSATION - Stock Options Activity (Details)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Stock Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "id55dd95aa3bc470e9e56ec5f8723d097_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i829d85fe933a4eda921636a7a3a375d6_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i829d85fe933a4eda921636a7a3a375d6_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails",
     "shortName": "SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - LEASES - Narrative (Details)",
     "role": "http://www.medifast1.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)",
     "role": "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails",
     "shortName": "LEASES - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)",
     "role": "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails",
     "shortName": "LEASES - Future Minimum Lease Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME - Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)",
     "role": "http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ib1dcc3e3e12645c08f3789a998da9d93_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndEquitySecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)",
     "role": "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i88c992e95e9b4995a92a40903056360e_I20210413",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "med:MaximumTotalNetLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - DEBT - Narrative (Details)",
     "role": "http://www.medifast1.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i88c992e95e9b4995a92a40903056360e_I20210413",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "med:MaximumTotalNetLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - ACCELERATED SHARE REPURCHASE (\"ASR\") (Details)",
     "role": "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRDetails",
     "shortName": "ACCELERATED SHARE REPURCHASE (\"ASR\") (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i18c77be8472d4605bfa303d562fd60b2_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i420f82e6dd774834a5ff44c9e9ab77df_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "ibf8fcce8f57b4164b5fd496a4762fb6c_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - INVENTORIES",
     "role": "http://www.medifast1.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20220630.htm",
      "contextRef": "i6c76fc1c8c254528b5f797d36515d993_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 31,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "med_AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Paid In Capital, Share Repurchases Not Yet Settled",
        "label": "Adjustments To Paid In Capital, Share Repurchases Not Yet Settled",
        "negatedTerseLabel": "Stock repurchases, not yet settled"
       }
      }
     },
     "localname": "AdjustmentsToPaidInCapitalShareRepurchasesNotYetSettled",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_AmortizationOfPremiumOnInvestmentSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense charged against amortization of premium on investment securities.",
        "label": "Amortization of Premium on Investment Securities",
        "terseLabel": "Amortization of premium on investment securities"
       }
      }
     },
     "localname": "AmortizationOfPremiumOnInvestmentSecurities",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_CashAndCashEquivalentsAndMarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "N/A",
        "label": "Cash And Cash Equivalents And Marketable securities [Line Items]",
        "terseLabel": "Cash And Cash Equivalents And Marketable securities [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAndMarketableSecuritiesLineItems",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_CashAndCashEquivalentsAndMarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "N/A",
        "label": "Cash And Cash Equivalents And Marketable securities [Table]",
        "terseLabel": "Cash And Cash Equivalents And Marketable securities [Table]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAndMarketableSecuritiesTable",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_DenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator [Abstract]",
        "label": "Denominator [Abstract]",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "DenominatorAbstract",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_GovernmentAgencySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Agency Securities [Member]",
        "label": "Government Agency Securities [Member]",
        "terseLabel": "Government &amp; agency securities"
       }
      }
     },
     "localname": "GovernmentAgencySecuritiesMember",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2019",
        "label": "Granted In 2019 [Member]",
        "terseLabel": "Granted In 2019"
       }
      }
     },
     "localname": "GrantedIn2019Member",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2020",
        "label": "Granted In 2020 [Member]",
        "terseLabel": "Granted In 2020"
       }
      }
     },
     "localname": "GrantedIn2020Member",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2021",
        "label": "Granted In 2021 [Member]",
        "terseLabel": "Granted In 2021"
       }
      }
     },
     "localname": "GrantedIn2021Member",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2022",
        "label": "Granted In 2022 [Member]",
        "terseLabel": "Granted In 2022"
       }
      }
     },
     "localname": "GrantedIn2022Member",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_InventoryNonFoodFinishedGoods": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before last-in first-out (LIFO) and valuation reserves of (Non-food) merchandise or goods held by the entity that are readily available for sale.",
        "label": "Inventory Non Food Finished Goods",
        "verboseLabel": "Non-food finished goods"
       }
      }
     },
     "localname": "InventoryNonFoodFinishedGoods",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Operating Lease Liability Payments Due Year Five And After Year Five",
        "label": "Lessee Operating Lease Liability Payments Due Year Five And After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility, accordion feature, increase limit, subject to certain conditions by obtaining additional commitments from existing and/or new lenders.",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "terseLabel": "Accordion feature, increase limit"
       }
      }
     },
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_MarketAndPerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market And Performance Shares",
        "label": "Market And Performance Shares [Member]",
        "terseLabel": "Market and Performance-Based Shares"
       }
      }
     },
     "localname": "MarketAndPerformanceSharesMember",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_MaximumTotalNetLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum ratio as of any date, of (a) Total Net Funded Indebtedness on such date to (b) Consolidated EBITDA for the Reference Period ended on such date under credit facility.",
        "label": "Maximum Total Net Leverage Ratio",
        "terseLabel": "Maximum Total Net Leverage Ratio"
       }
      }
     },
     "localname": "MaximumTotalNetLeverageRatio",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "med_MinimumInterestCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Interest Coverage Ratio",
        "label": "Minimum Interest Coverage Ratio",
        "terseLabel": "Minimum Interest Coverage Ratio"
       }
      }
     },
     "localname": "MinimumInterestCoverageRatio",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "med_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator [Abstract]",
        "label": "Numerator [Abstract]",
        "verboseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_OperatingLeaseArrangementForEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the operating lease arrangement for equipment.",
        "label": "Operating Lease Arrangement For Equipment [Member]",
        "terseLabel": "Operating Lease Arrangement for Equipment"
       }
      }
     },
     "localname": "OperatingLeaseArrangementForEquipmentMember",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_OperatingLeaseArrangementForRealEstateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the operating lease arrangement for real estate.",
        "label": "Operating Lease Arrangement For Real Estate [Member]",
        "terseLabel": "Operating Lease Arrangement for Real Estate"
       }
      }
     },
     "localname": "OperatingLeaseArrangementForRealEstateMember",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_OperatingLeaseExpenseNonCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Expense, Non-Cash",
        "label": "Operating Lease, Expense, Non-Cash",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpenseNonCash",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_OptionsAndRestrictedStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options And Restricted Stock",
        "label": "Options And Restricted Stock [Member]",
        "terseLabel": "Options And Restricted Stock"
       }
      }
     },
     "localname": "OptionsAndRestrictedStockMember",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_PaymentsForRepurchaseOfCommonStockNotYetSettled": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Repurchase of Common Stock, Not Yet Settled",
        "label": "Payments for Repurchase of Common Stock, Not Yet Settled",
        "negatedTerseLabel": "Stock repurchases, not yet settled"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStockNotYetSettled",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage",
        "terseLabel": "Additional performance-based shares, percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period",
        "terseLabel": "Performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod",
     "nsuri": "http://www.medifast1.com/20220630",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r171",
      "r203",
      "r221",
      "r222",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r317",
      "r349",
      "r350",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r171",
      "r203",
      "r221",
      "r222",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r317",
      "r349",
      "r350",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r171",
      "r203",
      "r212",
      "r221",
      "r222",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r317",
      "r349",
      "r350",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r171",
      "r203",
      "r212",
      "r221",
      "r222",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r317",
      "r349",
      "r350",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax",
        "verboseLabel": "Unrealized gains on investment securities"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r43",
      "r47",
      "r48",
      "r49",
      "r276"
     ],
     "calculation": {
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r47",
      "r48",
      "r49",
      "r339",
      "r355",
      "r356"
     ],
     "calculation": {
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income",
        "totalLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r46",
      "r49",
      "r56",
      "r57",
      "r58",
      "r93",
      "r94",
      "r95",
      "r265",
      "r351",
      "r352",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r19",
      "r252",
      "r306"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r249",
      "r250",
      "r251",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Net shares repurchased for taxes"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Recognition and Exercise",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to cash provided by operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r224",
      "r245",
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based payment arrangement, expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Anti-dilutive awards"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r89",
      "r133",
      "r136",
      "r142",
      "r149",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r263",
      "r266",
      "r277",
      "r304",
      "r306",
      "r320",
      "r338"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r42",
      "r89",
      "r149",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r263",
      "r266",
      "r277",
      "r304",
      "r306"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r148",
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r225",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r225",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r30",
      "r83"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash &amp; Cash Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r78",
      "r83",
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of period",
        "periodStartLabel": "Cash and cash equivalents - beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r78",
      "r278"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "(Decrease) Increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Cash dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r93",
      "r94",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18",
      "r306"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, par value $.001 per share: 20,000 shares authorized; 11,594 and 11,594 issued and 11,593 and 11,593 outstanding at March\u00a031, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r55",
      "r64",
      "r330",
      "r345"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r63",
      "r72",
      "r329",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r68",
      "r89",
      "r149",
      "r157",
      "r158",
      "r159",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r277"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesRealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Realized Gain (Loss)",
        "terseLabel": "Realized loss or gains"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r87",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r185",
      "r192",
      "r193",
      "r195",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r15",
      "r16",
      "r88",
      "r91",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r197",
      "r198",
      "r199",
      "r200",
      "r288",
      "r321",
      "r322",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Applicable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r196",
      "r322",
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r36",
      "r88",
      "r91",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r197",
      "r198",
      "r199",
      "r200",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r36",
      "r88",
      "r91",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r194",
      "r197",
      "r198",
      "r199",
      "r200",
      "r205",
      "r206",
      "r207",
      "r208",
      "r286",
      "r287",
      "r288",
      "r289",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r255",
      "r256"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r81",
      "r131"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r225",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r209",
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "verboseLabel": "Dividends declared included in accounts payable"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared to stockholders"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r65",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r107",
      "r109",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r273",
      "r274",
      "r331",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "Basic earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r65",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r109",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r273",
      "r274",
      "r331",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Earnings per share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "Diluted earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Foreign currency impact"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Employee service share based compensation nonvested awards total compensation cost not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation cost recognition weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Total income tax benefit recognized related to restricted stock awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r56",
      "r57",
      "r58",
      "r93",
      "r94",
      "r95",
      "r97",
      "r103",
      "r105",
      "r120",
      "r150",
      "r204",
      "r209",
      "r249",
      "r250",
      "r251",
      "r258",
      "r259",
      "r272",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r351",
      "r352",
      "r353",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r183",
      "r197",
      "r198",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r275",
      "r307",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r183",
      "r213",
      "r214",
      "r219",
      "r220",
      "r275",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1:"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r183",
      "r197",
      "r198",
      "r213",
      "r214",
      "r219",
      "r220",
      "r275",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2:"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r183",
      "r197",
      "r198",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r307",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "verboseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r67",
      "r89",
      "r133",
      "r135",
      "r138",
      "r141",
      "r143",
      "r149",
      "r157",
      "r158",
      "r159",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r277"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r133",
      "r135",
      "r138",
      "r141",
      "r143",
      "r319",
      "r327",
      "r332",
      "r347"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r90",
      "r104",
      "r105",
      "r132",
      "r257",
      "r260",
      "r261",
      "r348"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Income taxes, prepaid"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r40",
      "r306"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r40",
      "r152"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "negatedLabel": "Reserve for obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r357",
      "r364",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Investment Owned, at Fair Value",
        "terseLabel": "Investment Securities"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r372",
      "r373",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]",
        "terseLabel": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Maturity of the Company's Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022 (excluding the six months ended June\u00a030, 2022)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "verboseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r34",
      "r89",
      "r137",
      "r149",
      "r157",
      "r158",
      "r159",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r264",
      "r266",
      "r267",
      "r277",
      "r304",
      "r305"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r89",
      "r149",
      "r277",
      "r306",
      "r323",
      "r341"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r35",
      "r89",
      "r149",
      "r157",
      "r158",
      "r159",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r264",
      "r266",
      "r267",
      "r277",
      "r304",
      "r305",
      "r306"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r13",
      "r321"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Marketable Securities, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market accounts"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal bonds"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash flow used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash flow used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r78",
      "r79",
      "r82"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash flow provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r50",
      "r53",
      "r58",
      "r62",
      "r82",
      "r89",
      "r96",
      "r98",
      "r99",
      "r100",
      "r101",
      "r104",
      "r105",
      "r110",
      "r133",
      "r135",
      "r138",
      "r141",
      "r143",
      "r149",
      "r157",
      "r158",
      "r159",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r274",
      "r277",
      "r328",
      "r343"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Accounting Pronouncements Adopted in 2022"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashContributionExpense": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash charitable contributions made by the entity during the period.",
        "label": "Noncash Contribution Expense",
        "terseLabel": "Donated inventory"
       }
      }
     },
     "localname": "NoncashContributionExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other (expense) income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r133",
      "r135",
      "r138",
      "r141",
      "r143"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "verboseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease obligations, net of current lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r293",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurements of lease liabilities - Operating cash flow used in operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r290"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r299",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r298",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "auth_ref": [
      "r202",
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.",
        "label": "Option Indexed to Issuer's Equity, Type [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r92",
      "r106",
      "r128",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "verboseLabel": "Presentation of Financial Statements"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r44",
      "r45",
      "r47"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized losses on investment securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r51",
      "r54",
      "r56",
      "r57",
      "r59",
      "r63",
      "r204",
      "r279",
      "r284",
      "r285",
      "r329",
      "r344"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Stock repurchases, settled"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfOtherEquity": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to reacquire equity classified as other.",
        "label": "Payments for Repurchase of Other Equity",
        "negatedLabel": "Net shares repurchased for taxes"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Cash dividends paid to stockholders"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance-Based Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r28",
      "r29"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r5",
      "r7",
      "r154",
      "r155"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Income taxes, prepaid"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "verboseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r76",
      "r88"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowing under revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-term Investments",
        "terseLabel": "Sale and maturities of investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r75",
      "r248"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock options exercised",
        "verboseLabel": "Options exercised by executives and directors"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r12",
      "r156",
      "r306",
      "r333",
      "r342"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment - net of accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for repurchase agreements (also known as repos), resale agreements (also known as reverse repurchase agreements or reverse repos), securities borrowed transactions, and securities loaned transactions.",
        "label": "Repurchase Agreements, Resale Agreements, Securities Borrowed, and Securities Loaned Disclosure [Text Block]",
        "terseLabel": "ACCELERATED SHARE REPURCHASE (\"ASR\")"
       }
      }
     },
     "localname": "RepurchaseAgreementsResaleAgreementsSecuritiesBorrowedAndSecuritiesLoanedDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASR"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSCashandFinancialAssetsThatareMeasuredatFairValueonaRecurringBasisforEachoftheHierarchyLevelsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of items used in storage, presentation or transportation of physical goods that are targeted for sale to end users.",
        "label": "Retail Related Inventory, Packaging and Other Supplies",
        "terseLabel": "Packaging"
       }
      }
     },
     "localname": "RetailRelatedInventoryPackagingAndOtherSupplies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r209",
      "r252",
      "r306",
      "r340",
      "r354",
      "r356"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r93",
      "r94",
      "r95",
      "r97",
      "r103",
      "r105",
      "r150",
      "r249",
      "r250",
      "r251",
      "r258",
      "r259",
      "r272",
      "r351",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r60",
      "r89",
      "r129",
      "r130",
      "r134",
      "r139",
      "r140",
      "r144",
      "r145",
      "r146",
      "r149",
      "r157",
      "r158",
      "r159",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r277",
      "r332"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Senior Secured Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r297",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "verboseLabel": "Right-of-use assets obtained in exchange for lease obligations - Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r49",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Cash and Financial Assets That are Measured at Fair Value on a Recurring Basis for Each of the Hierarchy Levels"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of the Table Sets Forth the Computation of Basic and Diluted EPS"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r25",
      "r26",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r225",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r229",
      "r240",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general, and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "verboseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Shares granted in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "periodStartLabel": "Outstanding at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Share-based compensation arrangement, fair value of awards vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Shares, Exercisable at end of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Weighted-Average Exercise Price, Exercisable at end of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, options, grants in period, gross"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r231",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares, Outstanding at end of the period (in shares)",
        "periodStartLabel": "Shares, Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-Average Exercise Price, Outstanding at end of the period (in dollars per share)",
        "periodStartLabel": "Weighted-Average Exercise Price, Outstanding at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "verboseLabel": "Share-based compensation (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r223",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted-Average Exercise Price, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "verboseLabel": "Share-based compensation, shares authorized under stock option plans, exercise price range, lower range limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "verboseLabel": "Share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life of options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedLabel": "Net shares repurchased for taxes (in shares)",
        "terseLabel": "Shares withheld for employee taxes"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r14",
      "r324",
      "r325",
      "r337"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r86",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r37",
      "r56",
      "r57",
      "r58",
      "r93",
      "r94",
      "r95",
      "r97",
      "r103",
      "r105",
      "r120",
      "r150",
      "r204",
      "r209",
      "r249",
      "r250",
      "r251",
      "r258",
      "r259",
      "r272",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r351",
      "r352",
      "r353",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r120",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r17",
      "r18",
      "r204",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Options and restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r18",
      "r204",
      "r209",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Shares, Exercised (in shares)",
        "terseLabel": "Options exercised by executives and directors (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r204",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Options exercised by executives and directors"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r18",
      "r22",
      "r23",
      "r89",
      "r147",
      "r149",
      "r277",
      "r306"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r18",
      "r204",
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Treasury stock retired from stock repurchases"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r18",
      "r204",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Initial amount received (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/ACCELERATEDSHAREREPURCHASEASRDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r18",
      "r204",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "negatedTerseLabel": "Treasury stock retire from stock repurchases (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r204",
      "r209",
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Treasury stock from stock repurchases"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "verboseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive common stock equivalents (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r108",
      "r113"
     ],
     "calculation": {
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares of common stock outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted average shares outstanding -"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r107",
      "r113"
     ],
     "calculation": {
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90198-114008"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "860",
   "URI": "http://asc.fasb.org/topic&trid=2197590"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r377": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r378": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r379": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r381": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r382": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>57
<FILENAME>0001628280-22-020656-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-020656-xbrl.zip
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MO#BU]C".3$I+ID]#/FZSA&CAHO7#\"U3E9+>5!EH\W0I!$'ZN!\+9[%X&>M
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M ''H&[>9Y=EC_81<WX!G8E)HP')1O>!2I ('59F3@\R=I*JRHG(V+SC-H C
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M.%;L/\5*VL34JO,Q]@Q2I;H0&!)^7)2MKS&>V6#[+/Y.Y',%$\@PR>T]VB*
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MMF@"WY>W - "2,2.SXRS].V;0IN[XXFZBY/=CQ=@?U0%)C'[@.4*SEO5H87
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MS93-LM>:L8VG!S<80@]2F.;RS9<EA;?'1;J$_YO6L^SU_P-02P,$%     @
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M$,,DBI(KE/I2E4T0R'!CK&0,E[*64%\#-<D%$.P$GDZO=*8LQ0E%DN(-'"6
MJ0&>F,&+1U/UGZE.U<\_[;U\_=CP\!K2NUKN<Q#'4QF)MQ( ?"8CF3:!K9NM
M1\PAC!C@[#*:G9A('2*KDN*31$JK@2?E @ZSQ/]H,? X("A@6P0J"& @\"_D
M6X,DGF;P_@RU"T#'(!F/=98A(; 7"0OA4+)"5%QFID6#J!@.:"XFB/YEQOBM
M]'Z-E'-(&8*:IK,<Y-XD;1@^#I3;<Q5G+)@?(B;EN5)M(=9(L"0D>)O(-&S8
MYN/.T[SPZ!\!,PH 0:L"\IH.+$W1E"!R- P%-N0FR$"A#G(R=B6HR\27F@7*
M89*VB(< ?U#(M  S+J8ZRF=X-899LW2#[ 3H2(*J_E!%24SWD4^)(-5 _(#Y
MR""'#UTFT24*5.,DA6OY- 6A;!JB$+3_6FP,-L5%FF29 $8& X?3@&9TI:-H
M.(U(+</OZ7@*$M90ZFA*GR5=#72N7,.R@*6J%"8^-AH?+2L$E1G F,(B@!,.
MX"&4OE2&6O9@5E('<;EQH0S"DH8@+J*0F,*R-W8ZFR*4LPQ!V7WQ6ERE2"EC
M  8P;X6#!0KX^%##R&.8(4(AFP8CX:W'S+Q%"R)!TRS%'#Q?$H#5I6JLPMFB
M40SH@DTQ3.4T; E8]T#]_7>D<.6T?0!-.0')=))J)O!&@I#C9$I2PA#V(U:\
M:2B?@NB:*18?\#6%*R\3!?/5<+.R5;&Z@,.O4$D&R1INQ$8W(0V:A!^THZIL
M3@VOP%U<C32LE\PA_OZ"/ .J-J"B&@Y50))2913\TPW#\X2K&VI37.HD*@%@
M#$^D..@DB71076,+E@ R%^HTY:73SF?P=TA;=FB6C[OYUJZN#P@3@,ISI%#9
M@!-@OTM$P)Q 8+YC&2H?!>>9, (2[1-9 EIX"-!.%3ZPYLU+),PC&5\0H&$O
M\S2)FD.DG3)J]$X!!Q/I,IPFS:A_,$;Z&Q+ZG0))(V=%K]/MB;,1FER/8[3
MH.) .F["@C]0DP#P%,]+PJ0%58#V&J?N#:?$)Q@H::((V-M%^@\8-:$9 EF"
MG29D,]0U1(),['QN56N,6:(?(FR:=(B;?XSF6Y3@3M6E LG+\;WN_LOG+;1R
M2:9 ;7AB"(*@8?Z%60W-&TARC"C@N&SH\<%0H92#CS+3549"@9&=*:.@661F
M0U-'YLB7'1W)(+Z:JHLI<WMK[_ ?6RLUR_2>S0LM#<3C!=)55:XUPMV\6KQ&
MF:7YS$ET1XGD"!A+PU#E3$URU*!2T>VU4([:7V_\LC;^MR1!&165\(;M>LG\
M[HA JC+82*>Z>0:%Z<2(1DD03%/F>1NHXR;3O*K#N^% _T9KAK$8@'*<P5";
M.#):862ACJ8*%4K\JI'QZT:;=W4@CSP'E 0-X2TZ!UID4?'&#=$6,[UI8#F%
M9< D00$V=A,8%SU@,&$] +T:K[7(Y"#A>I0$TN?K"U8>XZ5(7"7I%^%> <5W
MG* -!\1*L=<1L-DX-.KKX2:Q<6./,))#"O,VO\,K.<$PU_F4G/;%.@>IDL#K
M8?2%1]</FIHD'#/V"A8CD2[-A5'9M\Q)[Q2OR 'HY?#]NT9>\<]1:D>>R NU
MA?/^LD4&IU<RNI*S[-D]17O=BG*MB%"5[#ELJ+%G1EZD2O$!))&.C415FYEQ
MPF8@[*67&D1&M@)9WVQ+C)(KC.5H$1*UT':'1Q=-3,[8 RJVNDC@K];<\&,Y
MPU<,=1 HY@)B(IIZ! +>%QZY@_E&:!;:T)MSXZ&-R_F-_<63S0RP'&VO^9P%
MLD).C $2 .9-2*-QUA@1:;+5:6TP!,W+8]AW%,;=;' &0"E %U3XZ7W[Z<(S
M7J&!A@:@II!O9)MB,L5XKYPE^^*T^G/8Y-U!N7U#&_!8""!H&-2@'&@#'B#:
MZ@)^=^8\_)"9*=ZO ,IJM<6<T9H&0IW2D]R99QD":U:_M#"P L&SAO%ZX&YH
M/UX4#V8,9'"5K*ZE,+ 1:++ KH9I,A8Y3!.QFOX?&DD![7"9?[HSY+0R")(T
MI- Q.M,V8*?7[GQS6-4:Y1H:>5A&M=M'</JFE!;@W63"+AP.)AHG(3N5YG&O
M!L$0<RG(:8U=R\*N_P5A&R""_..\\.@T#-_JU9CSL@>J7T@IJ'=4_)\V''8N
M_A4U&W9>H7@^<"_ZHDQ%O%ACW[*PSU?K&H9SBW2^G*=L@MBT\T)1W-H:,Y:&
M&=[A;IXYK<7\R,3/6D^ ARZL7H%.CTAB_4R+4&HA(5NCTWV@4PG$S<(K5O10
M^KD:*?[+"O1;YA>T61D'T$A/0*W-KY2:(U<N!J<B_COV5XT*$9I%*\W2_M \
MSZ%%!MTI9LGCF%XD24L,X"KJM, ^KR2-'NFQSFFF&$#EQXL,9KX-LD7A'R.D
MJ_"KDOFHA<HM@)=BG'0FR3HW8WM=KE.2'ZO&#S*<D<YKT&WAEENPEZULYJU,
M3:1)Y"*1U-A:[#N>/FXC%V#L<P33%&!ZZKQSHLA>V.WL'VQU-T:;C^XXWYB7
M,6A07D9G!R%";MT)H(GD:*)5GF]0C IW<<O:RJ0((B4I(#%/\2"R-8N<O),)
MW$$CM&2#T16H/YE%S9%*E8Y;%A6]J\G07L1C[]T@<Z*]EZ(;F]0KY\*F,#10
M_R-%;^+Y-;QL0K0$D#D5)E6JY5#:Q=,!-0$D)H\U&^53YRDWP]@T*WC%O-VB
M@Y/Q49V_+7@];#<+:J#@2(Y=U@8^2O0)E$5KZG:GL_26/<:;9@X>^;*$C8B6
MM0!>J!@T6:8];+$-51:D>D(SG:"QC2RKM!8D<&UQCJ%+9E4XL6)9$A_-!.\B
MVUM,6*J*-5L9XX@5%68(N!N2PP%-PDV6IU,?2M])4):0HMO,I+[>HTSJZ[\_
M_NWX[?'[X_-_4U+?V_Y)_]WQ^=/+Y@L:PS6Z[9V7")$^0$P/ '/ZUGSJQ:&N
M@G6<.Q*-7@^D"T,3 VQ3FXSX5IC_?>MLRY!S0Z>=49@$JPS#EZ,6$91IE$L3
MAH0H,E&$)X8W<=J$BV52%DB8@FP_EE>"HCCRDMP0EQSL1'4DZ MFZDP##6NZ
M8Y9@:?M>.(PWZ+VUTVOO=U>&XAMZ<W4X4P9-K]NFHWXXTFKHV68_#H<@S:8D
M/"\3[L_;O=T5PKVI@'\'"D@<H._>!SP>SF4"?[^]]V*5P&\>] ]L2K)0#O43
MWH$YQYCU?H44$0>D"SV[Q5/U!XCC,>$MR<)9\<#OZ''^A.HM[@Y,ZU)%I'T/
M$KB[T0!;R$<"C)MQ$PROUZC&#Q31\O +[S[OO)[_V9L#Q-.)N%FVHM%M[ZU<
MU=AYE*I&4=0)%8W3_ON#\_Z1..^??C@^H1(B3U?Y:%PID7H/[&HM5WU7 Z24
MEV7!N-/N]%HVUI*"HMC\6J[VH.-@FJ*!J7Z%Y"*),21@\)=QHGCC[[38JN(/
M6&@B,16="WU5 Z=2E#)RJD8Q?QBW_W6D!Z ['0#;SF4P@A%0%<F3M67V_BVS
M]5@@WCD%]IHDK%6<@>,J>F/<<.JR9A?DP;6^Y1#@,)%64RMT.NR=R)E$C7L"
M8TQ-WK1W2+JVI%?] :KZA##A?!G'Y^W<\7ETV7*/T$:%^=A<<0KW[;0(]"SB
MK=Z:;5OEL6D#=:U/.G 39O_"S%9F<,C&P<]D2[+BU?'Q<4'V PL!C!V+J[A?
M91?NRT8%-&_$2;R5JDLONE]:.[^XDG 46+<##<.6A@@BJ<<4\#B4EUP HI1.
M[_D$Y602Z8".+'EQ.48W(^-=,8URF'$UTJ$UQW9I92Y&_/$%F=QXV!XH>_@.
MS(IU9&]KLN:$#;2!9YIZ$)>)YO!(F%R83 <Y265Q8K@6GYPJ&ZAP +]>EG<"
MV?@\)^)5!V,_?A%*YT?A6S\AU85SP059N8()F9.O\?JWRFY_^K,<JU")],.S
M1N$)3^^</% 4U!V8TDDBCJ9$\RPU;08/.JGDO@!B()&^8/>W\IWOOHO^1I4F
M*QV=&H&IJ$'GNUX(UQT%;WDO%JD_F FN 1@R]2[>,KP'DWT\H<TR3"L^5H[U
MTSL8P\8<C%[[!3F@B'Q^CH<(^I"M_M[^_9*)4W:+?8XS$ M2M=("&ARV8 EH
M$7TP<.4\"=VQ"LL@TMF(0\DFBCP;B+<<-*4$+I?"^N47Y1V"3 %"7S@2@4]Q
M$4>NQX1,*,NHZ-5(%9+AL,2:G,^P+6BV7)[>/#176JI0:@I=RF9_#3F+#*,P
MW$F1F,IF=H(%/CB$4L=9[@>"N )2RZPD]X2-H[N/TCAZ^/[@^,.9^'3Z\;!_
M]/FTO[:!WKL-]!AK*</Y.B15:[5VGX.RS62$C#72P+ Q;H&H'?RO(@A(1[4L
MJS5EJ4B&L.F> ^3DAC:%E&\+ZNM8HY#ALN>)] Q]K=A(+#2<436?=SA?U=;P
M4Q7>LLBDS."%!233*"2R%X8@P&>FS%;&2;77!V4T)I^ZG'_6_/D>CJ0N&0\6
MEY=I[B+@IZV<9*HO'Z6 S4OA@ ^]EK<RRC76:6B)#T>BU^UUYIVO/Z@7>N<I
M>J&;D@YS/)<)!"2;"3^PE1"C@4-213DPFT+S*.!NL45_.$UCD,M-:8.:X@E4
M[@Y&1B,G\Y#].1Y2JN?]2\EB.S_?$L-RL>U6)R@U#+$Z! K9L - ]FQ9%321
M#KGN&59 LQ91,R9! ,LX!&B(E;;@@0E2QS8%L-[N2[,. @7:7V=M<6RJ']1^
M4+L) 93K(56\- ]@RXY+!K5A8I272E54O*2-;+/?V?+*-G#0.@S.$>6F7OEU
M\+/0<9,K"NUR@ID%EX0Q PK*)S'E*Z:H\<1)GZ.JQF%;_'$=DM3N.>,HS1KM
M)])82[P*%#%6**;5+RNR<_$)7@=[5J/>' 8-=6 RM]AXBK]E+H+XQBU>5G3H
M=7NW#ABM;)Y+G7$2O]M*$OV]VI#NI-_RP(+Z@;TYPH?8UW4L:G5C92EIR-8H
M+]J7>$2336>N6IJQO!G_1HD]&RL7EBX+:U5 WOH-@TK$,W+//;EI"HHB>P#L
M<@SK:F0JLKMID/A1S! X2JR06<MTMLQ@YNMPZN5JZ?QE\U'*&@A(:KO4\&42
MJ<)I:MJ^D>1#N6U9R4EMBV2[I_WJ\%)0V6UKC9U',K;!HF"1\O.!OM21+6O'
MIA!K=MKK]#"K$;VHI\=G!Y[4()V-EY'64K38K.7N1L1&&=LNFF9L.\ L4^(8
M1Z1K-,+J=ANEB#"YL,%=H4!N*B4;,YII?\'IZ_8H>)*M->[/:U+H$R@*S)E:
MD=A4+543.!: 3B:O=$K#(^ZRMZ(X9U:21\L:W'X("7BOO?=R=92Q>83Q\R2)
MJWKK]?N^<<N-WR1[[5!C6F\)S<I(9C V)L42B9MK$%)BW^AP,WIH91Q;JQ"_
M1!E\D63]7-Y@]B4KLS,N^WKM4)<KF3)]O1-5?71,^[)Y<N!YS7[ESI%94#$/
M>8ST5I;\4'S$IGC<'B\T?;CA5Y0'4W:LLMO5E]O85LEC>O@^[V^X9[S8[:U4
M\;MLH()P(V)42Y>VN$ZSI1[(%8<IUWRW951<2R@L0H3B.D=Z8:.IB>;BD.CY
MQAY(F@.NYO$('Y]')/)H$>V*U*7QMZ\4H?96JG%>-E'EI/B(A<(/6_!R#-'0
M,:)%$&##+$*(:PG+-0A1949,RW)BHXL)3U%V \-#4K)17HV4J2T2C$K?03-&
M,2R7SB#MU[:[+4RMA4VD^L6G%_K4O$2/JA_AE&NLD[;)NL=J58WS.99*!\)V
M59_WL=1Z5%"3=G;VA7[Y;_>I>$(AA6>EBB30P2(G 5L$%[I:\" \]ST0;:Q.
M9%IFL8NE52-L$&1(B)ROBEF1<LT9?#[GYB ? 35+].#EM8DK"[G=WCT"<6XH
M-Z-D+L;2Z9^>=&[GC61R&J-<7>\1\D#C'#U4]2F:L4V%E,,[9<T\.A%<?VT<
M7WP8!\D/%BNP^_AC!1Z=Y:5Y1ZM4^6V9WBO]@,ZKU1+,K\U3)'P/0*V<7XF#
M-/:G;U106V4-M57$/9*S"H,EYI22U@*MY-;JZ0,YL1[*[E%/NP&WFHU<QG9N
M8URN=S/%M_(P/3U5KW%AV_VO(XG08AW#DZW14W+*S6U6[%<Z)^^W/TW KTS9
MI%[/?0-$ KX6HF(P,S)_9MJZ8[;6S*:% +D)=3;!=C\RU12T5@[Z;HN#HG^G
M^8[W5E9R#*T"I>Y9[^@^A&"T@,YU&T/E=MN='L(!M%O"@5(!$TQT93L6]8]"
MFUO "5.1NI#.@VZ"/# GW:4#<.R'0E87D"L41D]1/3=U%BL)"',DTJ^UN]?M
M% YYN%Y-7G12&Y7SEE<M9YV#AS$.$PGX% \,1H#F.EIXN*C?-^4_F,/HC'8Z
M)0DB5?E#Q9.L$C][C<-/[5F!?.1KD<"%X4' B%F&TV/S1ZAR/S.^-D!IHZ8V
M/ 6@$-*WJF/(S#?^>E' QI-?[]>7%>\NVH@QU"5B5VVXZ67X#>%EVXIN++_J
M\11#3:S64IQ(6 V@^O=EKC5%>+")>'N/,A'OP_'98?_]^X.3_L?/E(_W^_'9
M\<>3IY>/U[QB,R>)^*!S?=& 6F0PE=HB8'YF\ICGRL9[.29W5J703"G]MU2R
M>( ]W-47ZN60DC8Z(<OM7 *_'[)6"?2O[Y;I@C^\+ARN(H;)8R[/-I#9Z!93
MKJ1HA]. "9<;(O#SRY1,8W._7$3 ^)D5EH&N= *FP4K5HXGI4^<.6XOCVUR\
MC^)$-J\BS0&VT+.%(AK2JHU]*MQ3'IU3U.:/)%1;G<4SX>2$G<B=K^U;B^X@
MUT_!G;"4QZ;UXY=L>+)IF"!#>#]#MF\:)OB%Q^=+!&!2+T994'$V)"&+RK.9
M9K3&I&G[.%T[O:+M:[' X33%D]3R;&@(DD#&Y@A[U6R\$/!H9ALGWJ;R'-"3
M:M43SLXI=_PMR$>Q2=1L""\9.VPRB SI)ZFLU/?3U6'P9'JD,QFU<<0B6=/H
M;L%ECX(@-*_T3I]50%,F:?5D8"AUA#4\2"ROA-96>."B1K2 :SK.0(5@^S&H
M$AK/<C@J-Y5!Q/6CWKD8W P;-DO25DOLT0L3D;;"FSW$F%4YLQ9&XN"AFF!"
MLW?;?LE8(7$NQC5]\VSYO--T?;VZNH"G=UR:5Y#G-S2C4$N@]Z#=-:2YAQ-F
M+VAV5H@+;;,?IJC5-KB(-J"BNCHT9[EA3!]D.H-APR*NZD*S =.T$4KHS,'@
MPPAQE:TZ@/[32!E/BI<<,E0A%;WY#FVXN0C:N*R,<_E5_ &[-DHBO+EJ#*V6
M@R)F7XI*#5'MR+E+7GU%3T]6P"$,/K78[4/8%B6!Q%#$KRZ "7LJ^)K=@'%^
MI**0:2]^;]TMP/S<>_RQ%X^"6HP:1"U8'23VX7O<FJ )UE>U\2D(*@<<#T !
M@2;=!H0L-.)@1'+%+%QMLTOVG=*J770C5W D?PKS3K99VWZ0PM6 XS 4BDQ,
M. Q:NG8Q;/O&N$#T7A:IKB2_A9=8E312+E ,AIO@2]=-"&W?7(S"K=5Q?:]Z
ML1G.!<EX8SP]YJL;<YQVVCO$?<^F%(2"_<X0,0XRJFJ[ZA,U)R8.-"OVI' P
M>E/9Q,0O=5AM<$3/D:I56J/D-?K?L6$VA>5$R=H>#(L^BP-0>6&CFL)9 8&6
M!IGKYD#)G(79E!O3<<(Y^Z'*"7@@GW(%[00;I$K?UP1_HQ^1EU4X<MP"L1Y,
MU01D:J"%&JT?E-6'D");;,;MH P!L354:RJ,%_(-.\OXF/,8KB1.40'9F7--
M(U>_3JM>*.@C.2S3@VN+G8<*2 AU^D,@ O7U\L%"JM7,EUI"#UF@P@E8F]NM
MWFY=7VV=I#LR1EF1$-[PW=<&NZK!$W9U)LJ==X\-8I-(A1>%A;O49UUQJY+"
M[6TU(PPI4@;/0D05/:#RZT^/G/[5&')JE>T32I,H_ *K(*#BP*0N!,I/72I"
M]XG1WN1C&:AJ,'_!O:F4<Z@B-"E9RRUZG5M^7<7,N(TX[(<Z.^/)2\KEFXU9
MV/SM#M,DU3$B>F2ZU]F!*04>3Z"16LQ5X]"QA!]/$DE=H6FVSD>HDLN"1C58
M4,G(2T6YIBFH0RHSO89;ID%>D? @<]NWNM0K;Z[G894?;90GG]B.>ID]^N7I
M>J]NLHT".TTS#.>H 5;;+'B*Z<+GPRTV+B^3*EN>&9OZZP%;U!VH VMY/WV4
MJ0$E$,>^8XDVHRBMP\\"V8Q BM&LSNP>3J,96GA47. >0NQS3%$69!;*1( Y
MGF2<IYBV"R"%A*[X/(;1YM.TR)DW@1:(PS#C'+1#;'.-_,E16BZ+CHY&=D0
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MCG9GT4(OZB=<X#8U:*J4YP%1*#;;3[C@68T7A(*3YLC<QXIFP QUCHG Q$0
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MR7(J;!Q3BVH5R"SW$MY<$OSM1);'CW!KM_-Z'[Q]6 /YZ7F#C4OE02FK:RP
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M%OF7MRZ;:_4"2+^*.OX;4$L#!!0    ( *>% U5C\RH;?5@! $%P$0 0
M;65D+3(P,C(P-C,P+FAT;>R]:5=;2;(N_/W^"KWTN>=6K47BG =7-7=1!KOI
M:XFRD>T#7[QR!&$-M"1LX->_D5L"&PEL!LWLZG.,I#WESHAX8LC(B#__[WFK
M6?D:N[U&I_W/-;*!URK_=_//_P^A__GK_=O*=L>?M6*[7WG5C;8?0^5;HW]<
M^11B[TLE=3NMRJ=.]TOCJT6HN.95Y_2BVS@Z[E<HIG3D8/>E\8YP1RS2FD;$
MO;#(.F>1H88I:ZF3EJX?O0R8&TZ\08D$C;AA!%DL*1(Q.*JM9-+8]?"2"\E<
MXLI03#B7Q@6O?6 Q8FN4D2(_]K@/;P=OV.Z];/0ZG!+US[7C?O_TY8L7W[Y]
MVSAWW>9&IWOT@F+,7@S/6!M<<./$;ZPXC1AC7ISGFPY/>IGO$!K7Y_YX0_EB
M</#JU!!'SNM%OW'4^?H"#L#YE/R'7YW:BN'&X^%[(]E>GVSX3BN?2[%D^.KL
MLQXZLO;T^@HXTQ6#&!XH;HXP08Q<#[O9:'^Y^PWST>M3>XW;3H07)"_^I_IV
MWQ_'ED6-=J]OVSY>7=4XOVNB"4QT&QX0,X-=G3XVG)N4R8>=[<4?9[WQ,TJ.
MC::/8+9O7'$U^]\'\Z+?M>U>ZG1;M@_2D,<J$-8_3%NOVQ^?9?CQEAF&1]X^
MP)\]CV*$*2*TN,G+IFT?_7,MMM&'_35@Y6C#YI^MV+>5?%L4_W/6^/K/M5>=
M=A\$%-4O3N%U_>#;/]?Z\;S_HF#4%YO_ZW_]KS_[C7XS;@(?H2ON^?/%X+<_
M7PSN[#KA8O//T/A:Z?4OFO&?:Z'1.VW:BY?M3CO"\QOG+_.)L3OXV @AMHN/
M<+P&(-%M^,'CS_OO8_KG6D-Z)9,G()14<$&U$TD9%9@41 1CV.?M8B@$INT[
M1[=M*S\Z-E[NM&%\%Z_@;;JVN=L.\?S_Q8NU2@,DHQ'8QPNWW?GZEK[_>L"J
M9^%DY^OA&W.R=_*.U$YJC<.3=VROOONM6G^':R?-QN&;*C^@[RX//WWX=E#_
M L<.R%M6:QY<=G"M?G!YT#K M<LO%]7M'5S;/A 'K?<G>V]J7ZKT8[/Z9D?
M,5K[J/%;>GAQ\,G+VN719>W3Z^-:Z]W%7OV(U;:_7!Y\VKD\.#D^/CS9$K5/
M'YLUN Z>]S6\>=UP;SY(&,O%WIL/9&][%Q^V_GT"QR^J;W8I7$</6^^_U#Y]
M8(?UC\?5RZWA-1_A6:)]6.^<U[9W^6'] Z^>O&\=M*KX -[MX.3P^*!^V#I\
M\XX<UD.S!L^OOM87M08^?UO?Z5?W\65UVY/:T6>LI"<L<:2)-0B@-2)M.  J
MTS1A(SC5>&T3PW^&8$;-GR]ND'6:5'YUUNT"B5\W>MXV#Z+M[K3#-FB:M<I
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M>#!KFT(3I#%_=([%@@C];T-@SV[BWUU0S[G81V7G//JS/EB>E;T$_D[LK5<
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M^W*[KT!PCSK=BUOB2L5)A4C[X4E+'6+:^_2!'IQ4SZN?JKQV^8[6MJNL"I;
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MQ8W?Z.+VO=D38E>]GLYZZ,C:TY=#]NG=KZL3FW-7IUK#M'SK=7NO];%Y<'*
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M,DP<4HP:%",$SXFQ(3MM">MJ>ALT*VZ0QWS\4M3\SM5\AK%03K!Q5"":!(U
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M91"5&JL8C3/4YQ(EF,\W6&H?.C1RH-K@\=7R#E3O=9 /BEE>[M[ZHS\T0]?
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M#L]Q[L*WSI8D_OX58],(3B97?Z4%4TUX&A.?J71ZX<\\VAH;@0MF(TB=F"V
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MMNEB# 77"J[=^T,O@&L:7,SGY,2!!F!&*\N"<Q%3<,XK5SA;6\!M)I J&FK
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M5*!H-: H$JZX<H)K9H!A9;C-S <X(X)1S@KKN2NT83-H@[5A0G&!)+.)]="
MD1;,(2-E AW )!"]M@ZW;I-0H*9 S9U C<511*4UL10@6D@O-+96.,^T%ZJP
MGG;@$)_!H1B<8]0QI#$H!,PFUI.@!TF. 4O,J0P)APB'+N,%C H8K4BO7V-]
MC,YAGV@/> O*6B,$2.:XSKW:KD:C<7K,]*K TMWZH+^WU]M@Z??>0=I%!)8>
M11(%2GQ((6VE0I)0:R&PF&CLVCKOIA5WBQZ_!9 *(-T).PK4V?3_BJ7E#($G
M1 )+I8II-0>CK"[LJ"4P=/HC#&'KA!-:()]F%('" 6DP!G$O/.%4<V-XID>R
M2^'6U4X;1*.'W9QX&J8;)IW^S\/QKM&0>/5.W\\JDM^LDFZ+"HD7*14I%2D5
M*14I/0PI+>(KC"H9YT%%+BT0 99'#UH8D()&*]R[K9RKA-/_4/V"_8H6)RXP
MC<Q_/AJ/"R-NBA'W-N?\A3CRW*2!(HX#0< -0]JG?P*!B"43/+V3SRVZ6+"&
MJO\7#2XX6Z1T(Z^#4](9:D7P%$QP6CCBP#JJHR8FT(*SK<'9.<^#YS%:2@,B
MA ,")3VRW@KDB*$.*^,"]BT$VD>0!E 'HB-KIG5MCH[#<%R7""E) %<G 5#M
MI;2*.<X$Y.Z^4H-0C$5E#(N>+XQ$M1">91EL7A#!1E69X?NZHM"ST^^7O#"G
M^:V-SZ;R%],(=H8OTK./? &K1<!J?SYC0'!G!=8H2&81^$"1(M*B1!89LS)1
M>IU#>&^-4^T[KGG8.GXS0EBDU!(DGB>$/M&(H 155G((GFB-01JE'1?$2"(7
MAN$-_^%D/*DKN!V,OI<FR)4)=H9G)0EJQ+5S4#WTVU]"Y?KCL!?K8ZV]X_Q^
MH95-(O5LD+.5S#DI >%$_Q%( *09#DBJ&+"26&$BUM9IEVA5P'JU8*" =9%2
MD5*1TN.1TGUZP@KQ:3?QF8_DX3$Q'8>1MUXBT$G2QG".A*3""4@,6/GV,9]'
M$,=SMOH[X4PI?,>>YG^XDUS@>=PQ0]_Q_2JXR:BZNE#4XW+UWY&/+8/3U%.V
M=5*EJ9MZRZ8>M(O(=8YGQ9&V$$KUYQQI6ACKE2"(4XD1<"R08MR@M#PH=^ <
MT3G<\-:)&.7,;A7X9)%22^#V#AQI5V#M?\S@)!2H;0!J9SUA3EC""38H4IJ@
MEB70M2$R%(4. E/!,1-KZZ *UJZ8%A>L+5(J4BI2>CQ2ND\_6.$MRS819QU9
M1$ 01$7$.4O$Q0A 2A*!! _*Y[J-TO.V$9='$!66T]&F;IE.%8Y/*G=8!XC%
M4=69F"_A9IZKE77-7YVK?X?A8>/LC?]C5!V8+W_U)X<Y;3;-8GKC\N"Q@DR+
M(--\W5A)DB6%J4(L*(8 6X<4"8 ,!2>Y# 8;O[8N'U2Z_L/6XG(,N@I26J0N
MRC(#P%Z%NG?*P>C:>%O..QL#XUGW%N?".:HD(D8# L<,2F*/*#+N TVK/X'U
MVCKI*EP >754O0!RD5*1TMT7CX_$&F9,#):"H*#2WY%[Y0D6@5"H=TV*8;IK
M4BP8OJ-=,_:_!(^^AFI4-LP%K9?9BF,^AD2-J$"6N6R^!)P#A!SR1BL" (9Y
M_$VW6Q0B5)2]88Z\S%C!PI'O5>5G7*DV)GVWSB),DK8#]3XK?Q(KMT"Q93@2
MWBJ2_ C" ;_U,QSGTX-.K$9'9R^_NU4?61A@.84K4BI2*E(J4BI2*E(J4EJB
MZ4.=!V*\<B2"-%Q9%;APF ,W0"$N;/J<L[DZ%*0."MEP_SWI5]G*&4]VP^1P
M5)IY-F;C[&W.NS6,]-A819$)V"/@!",KHD0TG[8;*T6=4B"[_%:%U(M2MUBI
MF_9G%*6^<Z6><5R(8!137"')!$80@2#KA40Z"Y8Y3S2)K5+J1Q  MC<Y#%5=
M$*P*AV$X[G\*MZE/OK*NUG+Z5:14I%2D]'BDM,A),E803"2,0'K!63*P"'.:
M6FV4PLHLS,7J76?SXJ;SO4!K+TSVXH'Y4NC6(G1K?ZY79Y"1,QL 49T[ \?@
MD27.(\\"C]0;3V)B6^(!M@5^V'I;T+5(J4AI]7/0RA[8_!XX7S^)&1(X1,2)
M- @T=4@K[5!P5H<D-<F%;]DF^ BB)3;-^+#C^Y_Z/@S].&O)P%3!=R:C:=#$
M6:O $B]17-A%2D5*14I%2D5*JW!HUWB+M*USDI"(\M%H6)_=9?90#NH:ZQ]\
ML#'9FSE]9]0$XQQ!01% ( Q&1@:=Z_LY!2* #6YMG8BNXO/,N1R_MU63"]ZN
M@I3N-4BBX.U=X.WNP>YD&O&T^[GW]35]YR+CVGN,7' 6 ?816<D)4H+7V>Z6
M2=DNP#WS4IS_UOD*IK6B-NU[+/<H]RCW6/X]'H'K\9D9F*$+W<ZNJ=QAAY%N
M)^^,MW$UVE'E0X4FH^.G&4W'HT'?=\X?9/7XQV(UL)QVG@>,0:@(CA$CC&?<
M@O".1R'5NYU%2E]-2_(5LM$<V=B9S(56>_!.FH@"QPX!.(PTB8EU*&PD!<]"
M,+E:>U<QW5 QOFMKR#T;%LO5]!9!8:WH?UN:&!<07YL ;MZ^:@S=+IQJ;?_W
MI#\Y+3"V*(S-G.QF?Z+&T2 "A"23B3*D @A$I(],1F>!^P1CMS[9+1!6(&R5
M(8P)S"AE40/3@(.R%@>*#5BL"(U8WP;""DUK#M]Z,S2-Y%,4)C02.+?2B<(E
MFF;3*^445DHGLH;7UE57$B@05R#N,4.< &\(%@93+D!)E5W?3$@=@N8@-"\L
M[>Y0;(:EZ;3WQ/0?$L10E"B90 JS9'8:Z@1QUON0:Q5A5C"L8-ACQC"MP0&.
M(M?R@V"U L$9LY+Q2"EGM-"T=@#<;*@$5N!9) II*Y,9RA/4&9[^B;EF1AMJ
MK<O>-*FZ_/91Q@7D"LBU#N06B5?07&:<TY0K!RPI" Z22!P-"0":D:M1;IP>
M,[TJ<'?'7K=I3N'W2 6N@M/,<^2Y$P@P"*2U=\A385@BWUYIE=UNS11Q*$A7
MD*X]S[V024JQDRY$H2VH $9"Q"[X9/Q(ZGFA<ZW!MYE(K("M8U8[E#8GA4 J
MCA*-X\B1((-TAN@0,I^#KM)-]2I;.LH]@CHVN9%9J5M3\HR+E(J4BI2*E(J4
M5H8K,Z8EY;F2D)0 A%AK0J0VT6/#"*;G20QPGL3PRSXUB0M\+Z50^')S?'GW
M@OMS!_:V-MXQHD%BK9$TP!%@8Y!202$&)O(D+"9B;NLKNEK<^HBGJ' !VB*E
M6YTQ&4%T]M*Y""%@0SEQP2K/T_^2I5N MCU >\$Q<9K&^/D=$)?VQVA0)"$@
M\%$B)91#D@MNL9$<'&DATCZ"E)(Z=0'9NG&ZN] %ZW&5KUDL;41QL"ZM9H.Y
M!L>%94(K$I4DA@1I_<)0='DCLHVJ,L/W(3<Q>W;Z_9(7YC2_M?'95/YBXLG.
M\$5Z]EP&O*#5 FCU\D*.R906*J,CI'61P,H(E*!+)UI(+&*2D$"UBIC%'/;3
MD .U12=!#UO)2P6!59#2 I10N6!R3UB)J05OL86HB6-2)0RF1HJ%<?A"U\B#
MT4::N3P",WAA^@E=-\UQ?V(&->3:.:P>^NTOH7+]<=B+];G7WG%^OQ#+1J&Z
M-P/5B<,XZPU#(8))%KST*.W$R8+W,C#,A"+<YFZ20L]WDRPXT&H<*&B]"E*Z
M3T_I4M"Z /)"@#SK4O6$$\>#1]AZDM-]#-))FH@RPG&,BB=<3H ,3463%D4O
M<%RDU I_:B'/+<?J.:^L,U98QS#2CN+$GG.?0G "V<"EH='$Z''=B[VQ6AHE
M'NQZ?<VFR[\3SK3"=^QI_H<[F?0_I5\Q0]_Q_2JXR>B&A<8?WHG1'7EJ,SI-
M_:U;)U6:NJG/=>J'O0A=YX!6W+&+P=3K.7<L8Y@XI0-B'"0";0)2GN8#)"<Y
M]P%X#MIOT[%1.?HM!_0/1$KWZ8V] FOK[K<%:IN VEEWJB%&YE9YR%FF$'"!
MD8JY0)'VP1)J--=Z;9W26^<.%#4N8%ND5*14I%2D=._$I7%/6"$N2[<19UU9
MTAC/%18(3PLJ"H,46(^$QR8&!M)*U3;F\@BB"W-BX]0QTZG"\4GE#NM PSBJ
M.A/S)90F>>4,I4BI2&G)A5N6&2?V*@S,)/B#T8'Y\E=_<IC+':29_&-471[4
M6[;ZA;;Z-W,^"B$T>.4]8LP"2I+T2%F6F\]PD("-B-*FG5ZTH]-,T>6"N$5*
M14IMM'L9QK:NZA.]!"Z]X5$$K:R*8(GQ<+?;XL5(C]C_$CSZ&JI1V2X7W"XO
MU#R;6L948:4#$4A$2A%XHY$*7B#C PF.<H(M_:;<+0KS*-K>=/G")09\%1:\
M=+6><7C1Z)245",;141@,4/&<(ZT<=I1KREU+:+!#SMFJU;%O<EAJ.H4VBH<
MIG7>_Q0Z@]'XD85GE<.1(J4BI2*EQR.E12@83ZR+.4]$M!%H8$;(1,&U3AS<
M4ZZN$XYZ12GI>O?9O+CY?*]MT@N3O9B(62%="Y$N=Z$?R-3U*!V61%J7>[4%
M!-I)I*,CR%C/N&+)<'8L<2YU"\Y5M+=@;)%2FYQ:UT/6XKUJ!''GO5<!2! 1
M(ZV51@#1(!V,1E1SS+0@SLO0F/>JJ'5[J5,#WJM"G>Y2D6?\5292QBA0Q!D5
M""+UR')B4%)<13353&/3'N[T"$*S#JI@QB?5:?K9D?O8B=7HZ.SE]TBM$I]5
MSCR*E(J4BI2*E(J4BI2*E!JR9AKW4IRSN3J]I$XTV7#_/>E7^=A]/-D-D\-<
M&+944VG*PGE_B:LB1L8\$<B#4@@L$\@2Y1 A'!R+5$@IZ^:"E#707+"H=0O5
MNO$0FZ+6=Z_6,XZ+H+$#$0D*D6$$VC*DHQ H4",4UX$'Z]NEU@\[V.8RYT45
M)EDGFG1B/$"GZJ45DI8+6=.Z2*^FXBE8M! 6?9RKA$2DT40IB03)Y\\&(C+&
M:&0H%D*"#XF")"@BT XG:CD#*0?014I%2D5*14HW]9,T73/\!W9RQDN^FU(;
M1VF&)\6@:I+$S#5=I)#$"3F80QL$/+M)@J1(<>=M$,8%[-;6*>LR-5_3L?"8
MMFKUW3H_KPCE*-I]YR;*K!>4<]".&(F<,BRI-_5( Q5(\$B\Y=YH:JY4[[)S
M/Q0=7ZY;X5JJ7<(P;Z'5L^6U0"J-G4+IA4\[-S"4Y8L"5]1H@YVCLHUAF(\@
MCFO3C \[OO^I[\/0C[,.#4SVA4Y&4T]H3L4--ZP2O[*'-N7$O$BI2*E(J4BI
M2*E-4KI7W]?6.4G8'!T=C88UD\[LH5C$C7'G#QMS_BXJ"(Y" 0K4)>KL"4&6
MD8"2@02,4:VQ)&OK1'0US!>G+6%!;=7D@K>K(*5[#=XJ>'L7>#OGJ^ LF* M
M1TZ3F+O:Y7Y1D2*JM Q@07L:V@6X9UZ*\]\Z7\&T5M2F/9/E'N4>Y1[+O\?#
M=CW6N^LS,S!#%[J=?Y\,0X?A;B=OC+?Q--I1Y4.%I@_UE"4\]:,3.PB=_"SG
MGTY&QT\SU(Y'@[Z??K)ZS&2Q*$U&@Y4"(I;:@25>@="4:1 ",^RQ>;=SS<XD
M]<VGK4D*#6F.ANS,Q6KZX*FSAB.KM4HLA.4P38A(2^M=E)K4]1D)Z4HVG_-^
M,ZNB">6Y9VODWO"A;=#ZM_L0_@)";Q-B7N(Z:PHN+QR@;?_WI#\Y+;BX*"[.
MUE!3TFCE& I$"@0. [(&& )IL1#18PDFI],43"R86#"Q04P4*D1"N9"<._ X
M*F \&,V @_)<T]M@8B&2S0'F;+\;R243G%K$?;0(+!=(1Z50VM^8-50+GR2V
M3G!7X/EBWP4T"V@6T+PY:$H>K>4T,"4\1&6T=3'3%)78"N$X%B)Y=[@X0R2M
MYC'M91AADR 11 "DJ66(22&L]4"%\FOKDA=,+)A8,+%!3#12:!6QB3S9:E83
M*UV"0*MD!)DPD10BV0[ G$N\(@")[ULD-*'9\F;(*H.1Q8;)0 DXFRUOQ;L,
M;IV:45"SH.;#1\U%PDL\<PD2L:$18_"6*2J3&2YX *?3%+*K8?.*9+>"GTOV
M7,ZFMCEC+$^F .).< 316Z0# (K6@:&883 N 6B"3WG[N)*"G 4Y'S!R+@"<
M5A(92.::/@ -6&-B@I5!<[#.^I\ 9\'+N\7+F4 \#12H#A011B0"2P32/ABD
MP)'H:.Y9J!)>:N@*I1\ X:PC?GZ;F/1SZ6_?_[3^S_3'^9"/3/6^/YS^-OT1
MKUQ(R[UJ6A$)_I4FTJR)!X>A8USN6VB&IVD*.L/1)-W=5.GM8:>?1O:^,H/.
ML:DFG5'L3 [#.&0%]6$X#GFC&-;3F-M_=F)_:(:NGRX?3](;=6O0)]]$.#LC
M9\, GL9Y/!KWL]B?5KF3:/]3^/USWT\.S]'BPK?.1(N_?\78-(*3R=5?:<%4
M$Y[&)'^<BHM_YM'6* -<,)LL:4UQLM>$MMXIYUF.1]92"Y[,N+7S+QU^"QD]
M-N\#LE4P'Y&)Z0&?FL%G<SI>^^W')9C6W\5)OVJ^+BQ52IZ(>E._8KYB7-I\
M334DH?&HJGO&/DW:'JI\51J.:<U8.H=5WJ;^Y]>2DTG9,CAD-=K,.US2CG_^
M9M8O6Q7WNGKEI4"QN[VU\\?&_D&WL]/;?-+9Z&UU]E\_V]_9VMEXM;.]?Z6:
MMV7\O;V#[?W.P5YG<Z^WM=W;W][*K_;WGN]L;1RD?_RQT]OH;>YL/._L'Z0W
M=K=[!_N=O[_N;;S>VDF?_V/^ :^IL+"VV':0NRKWX^D]31-YTCDC9[V3HW0+
M-W.,[*2(CJ1GI!PX599'J:5G@A/NM69UED2:BFF6!)W2LADBEAZR'],V.IQL
MI(WG9#A)V\Z+M(FX?A@?I%]Z-DA,[7Y9U]?>-];UJK^[]>_$@%[U$X/ZNKN5
M6-?68?_-UV<?>W^]_K*W]9KL_MD[VOWP[# QJ$'XUZO3MW_Y8TM!O/TSC>OH
MCZ/>G_G[NY_3[^&]/__]8??/E^3MP3;T#M(8Z9O3W3__B+M?7_+=]^^B,$YY
MS9&UD>9^5Y!M3(4T +?!4RR9G/+C_O D^(W,74D.=I)..P,.H@2E*'4F!IN6
M8V)@":)"HK+'616KDP2>^Z]W=S=>O>GL_='9W_FSM_/'SN9&[Z"SL;FY][IW
ML-/[L_,B*<5FK=,_K(09I$J?G0VDQL2IO'X]F!\'3P437B7KV7@"3$23UU:
M* (GPEKYS518UFI\9L;]\5Z<68FGTS\?]6K\_,[ZR#6PM!!Y6HB07B*M0EJ<
MF'$"D7OFV>SJ6@F0JX6>]^$75:*SP\ET :/S]7T?/+PS1\1/AN;$]R=3DGU=
MNIT?:C?X?C3C2=JIA^Y)HO&^TT^??$[&[^ 4C3X/TW?')__/WILV-9(DZ\)_
M1<8Y]]YN,X*)?:D^AAG=4'6JWY'HJJ*Z#+Y@L8(H+8R$FN77OQZ9DA"2V 4(
MR&D;"K1D1D:X/_ZXAX>[ZS=#T_8 <VN_Y-.,%/\V_F+Q-_DML_W:\+T_RH&-
MWQJ^?!JG7QGTQZ]T>Z,7NX/>\,5?P:?PK4& ,1S&7FQV:H?VGUAS,79JQ[UX
M7!0O@5?S5/1"/E]0.VV>'-8.8B>"(](ZS^_$X_S\=JRS\$VX:O.X!0\#W\W#
M_MXIINY;GIEB5C8*_+#CA_VTL?'7>$P)AII]G5ZSG4M'=WO%5?/,'0]Z_0&8
MJEQ0)5^W-\@WR>_TXL&@54A.?^@9U;Y%/^B!5S+\Q-:9/[2=@UC+)P";_7X6
MLE\FYO3;UA^C$0"A*AX8;MLZ7ZUY<#1M,_M?98@B?S-?L73.3@[M2>&A=?*;
M>4YZL2P+7W/GM?Q@$Y-Z*3SPC-UV\P2F9:WVO]W3"-[LZFBZNL?-3KX)/ B(
M,K@369I6:W#QF@U964OIRO+7[!>3 Y\L;[\*=X?'[A4S-OU9H,EPYT[TL=^W
MO?-BHFTMV68OK_:E[@TG\%*D1^[=<*K[@U8IW-WCV!M.^N4SCD4J?_AR_/!F
MJPF/V2^N'9I]W^KV![W)&6S;$$MG-\ 4@JSD=6[;G['XRN3T#X<;BT6HP7*V
MHLW+M59H[C4JZLHC,K7^88QPPY/:)LQ$V\5>&=Y@I#PS X_2+Y\$Y@N\WV$I
M\SR$"0RX1?/AZL5CY8]<SLAP?8?J6QQ;5K_U:QL=,-NMVM="UFOP>!_A06L$
MH_^O6*)R+7($K'8>;:\6._E:UPQ^I%'%'^/KC"7[6L]@"<S#]3&1^2(WFIL3
M\/IB(6W]YEFM#5<\[ \G:?(P%!UJZ<E8 V"PL"0!@"A'.?+51S<JUJYMST$.
M:O'L./IBH>>O15:UN8M!UQ9E1_J'W4$KY,'T0,ZS&,%WC@:=,EY;0'(>6+'F
M]Y#1"0P#9#CIKH)9:OK#8IZF9?:J/$W)T30UO:]</2VKW.X=V$[SHI":/\:S
M G\,Z>8D[_A]T <)[/<W@4CUFL?YI8U.J%RC23+:V-CG,I_F4!89)Q7B/H)7
M!$XVDD%HHKWCD=$9,OH2Y/*O*;OV<:P(WRX5X>6YYL-@89J\#?\N354ILF,V
M-+0Y0&V 1?0OO?Z2:0T1ZO);&1M.>O!8Y0[ I'T',]Z&T63F,D:!:=?T0=;E
M:5'@KUZSV_L++MT-7W-=/F" J4!^T/ Q49I0^_>HV%_V:8Q6"NJ1$+FXI.(>
M6:)SS"-I$524,I"E4.SI-7QA)?YCZ"/8=JD_I=\R) W'6?1JQX7L36I2;_P,
M98U(%T></O/EL5G/?#Z_4%[@"E5?JS6Z$Y<93L709-\'2@Z!5EA@/-GK@G>:
M  >^H*+Y0E?N^)IT_GL_;J<MN%=^L/Y[U.B#?4R8#8X3I"TEB',7D?&4(Y."
M9Y@S@TE:"HV&Q<K&:KQ<+ZK/J##+90QD3!ZN,<)9;+-KVCPY+Y6V</J'48#^
MI L\<F?CZ!D+.PNZ.V@?EV:V](53 H^CC'",<&0$+# ,^'P<FNA6T[IFZS+(
M<>E6YP^6T=V#?.?KOE/>I?!29[S^*5=AWE!ZX-!W!J7SE?TD0)M^+0R*\,/E
M\(N@4 %>.;)RDGW=D:/E"\<F-.&)>V/X ;=LZ')W^Q.3]:J@!P1QPFOH=3OP
MJR]GLPIJ#\'I=!^X11#"$Q2\DSDM)2#'?3Z!G#QU0IMDP_0N14S46@S+0YSF
M,E*C<>0B6,4HCW%VB^5%P.QR[6M7%[^V$;I%P!1P(\O.BZ+<S0KUKZE-I0>I
MV.RNU*V[3%/K;6%I+?,2%AOH*.B?-4!"14S"Q^ 2O>X^M\O)U?MH154$&YFX
M-=S##^4)=LYZR@)\3;Y0_.MSIU:W/7^8I06O%JCZ<>/;[[5F43BF-B%HX-%V
M@NT!Q?Q^7"#Z+RL;W[ZO_%I\$V&^6GMB82NN^*%Y F+@[_!D@+7@M^:([-<\
M6O@SAY=^V>D> QYKKG_]4/MH?3955\+26X5U+,S/_"OD .K8B'T=6:!)6;\J
MU;.OO,0ZSQ?BAPK_[<(\"O8=][JY-"+,9T%!8,H.!LURKZ?<'\CN?@8LL,)%
M0#[:?AEB..YF/R5/LAOT0A'YG]P&RM_NC1>HEQ>H5RQ0&1;MP+2-[S0[B,PF
M0G-,/N)9WF<:AWWM\7&KB*?.WW8J,H)*&@8#SK.3,QG[J[7#& [R9\O,-KC:
M8?.XO$$WQT"OACQ*&E;NX\Q]D%HSC3>'?*]9D)=R(R/O+W0*GZZ\;K&34$:9
MFYT^V*4A=TQEZ!64&29ZN#\UW-LJXC+ ?8H;PB/UA\YDIGC#1UZME2A<[ #U
MQL^99P(&6H!QOD\QW[!FP$\Z8<CGX)ZQ>+QB2.TVS#7<)F_H%9LV1> [3W+V
M3&%Q^L?E1^$#$Q-::W?#V.OL#[=O.N&:62[RC0K#EZ>E5XO_V-:@\$BS;O?@
MCO!X<1Q*KUU&T7_D':'2:H[! 3X.]R@>?>CNIF8/9NL_ PLDM5?2]2).7X3^
M,R_O#O*JG%_GY0XC9/^O?Z^-K[6[ $JM]N"$)76'A*47XCCTR;.3/G? O3CI
M]LXWQW[-TA#F\Q%A_K-5/]HB>S_^/FS\V&L!L<6[1UL"B#/;.SK@NSO?S^M'
MC2.XEY@FS+MM>&_G[];>#_A^^_M%8Q/(]\Y/(,ZAO;UY>-C8^7Q>IXW#[9U6
M:AQMG._'9,$0>(PXEA9(LI1(DTB1<(HSI9D35DS3&A$Q"R11</8]T"UN>&)6
M\>2ED$)Q/$V7/S?^WFKL;'^]->7H-6P>SC>.MT_)U2DT/@&7)"$2#:O&G$Z!
M<ZPQ>"D21^DR22L%-?O4PQ#>R!X5[FQVE>WI&'G $L&THM3M%N&X9A\0LW;0
MS='!(LW!^I_V %YJQ\)5/F[9D?=P&%O7;B.? JH#R/6'L0" NWYWT .>D&W&
M2:_I!L44E(F?_;7:Y*"S02C\_3"*";2ZIR6,^BX\#.!S!XQ:#P;4O"@29S-Z
MQ]4:7!->&?G[!0:C9F=U^%N&W';1%6JT,]\_&492)A]ZN''1'X8MR\],35@Y
M*?E&_4%AF."UT.SE0,D\"*[RW,L\=WU]GGN5LKX$8WF:E/6YL'<[C+T*3"]2
MZ#I#U6]9E]V!,8$?OP&W&21@=V4L,F,*(-XV$+D10P14=GG_?W4R0-N+_S3C
M:0:D2VC,I'L 7D&KG'S Q*S[L<CK&7_J=276$#I,K!F:D%KH%ANZXR<:!K)A
M4/;@H!</LL\SPN7_OL]Y01*\9Y%%0B47'NL$- 5\6*.#-6', ?D5#CAQ<%#,
MA%6['6_[AUG^1P9MJXP[W^T H7QGM+&^\YDV-K]<;&_66?WH,Z]?;.TS S22
MF(2D"PSQ8 '[+5$(FR1=9,P9!AAIUO@UYP!!%EMYW<&-^_ZS!\YOT^:]S#0X
MB$/J40;N@:9T8AGI+#\7<X:CS\TCBW#5I_]KV\>_;4SN%Y2I7->G<)4LHI#6
MPN4\C:.TP>PUGW9K I-?_*^_L%]!42^S?B9R#'VW2.RT)Z-;7N%&</_NX*#P
M%(</5/,PR&*79VO0 [>OS. =/]':3!K^4Q[6\$"9!JVXG<:.T1_EWG!A&-ZQ
M:W2QGZC"A@2'O D2<2TTTM(:A 5+U'&N7'+W2(]_L6#OC!^1XR/#G;EN"TAY
MEMM?"@\ J#X(8__7#W>U/;F#16'$QK2V.((+#]>RQ_WX8?3+;Z 3X'.<?VAV
MBB$67_IM>+$A%\X$<.H$;F'9RK<ON>$:+OGAL/K^\,[#M]>*MZ;.$Y?O";TF
MN+GV;;Q&KGWOILL2O6;HPRY[\WM,\Z<8K&3Z3I>]I</!/3HKW-#SH'1DGJ=T
M@;E3".J*<;BVV<';GX?IH.G5Q@_7]+01-_2TN4\KCEL/\M]CMA=_OWOW_IC?
M\OAE:II,K_[\ML-?)R,ECVGM_,(57.[VM#,57.[4U&3>JJXQ=?_R$B_PQ/=P
MN(CV2KFHN:*!2RQ<L@RS("1-06)75I:>];-F"K2,"2;(5GTD6J^B1LM#Z>>P
M1LM>NWY19XVC[V<-^K4-KA/9V_G8W-WQ&.YQ#FX4J5_LTL;1X>%,C9;V[D7]
MPM/&SA;;^P1CW81Q_?CSL''Q!9XGNUY 8X]VZ79.?VD.ZP%^PQ?U34\:!_M$
M@U>F@T&,$8<XR"DR'"MD"0]"8^%IR*W2Z*KALP7Y[V#Z[MUUJ0*.]P0<SG =
M@\%*ZLBY3)9:%2PQ!CQ2H;TN*SL1RD@%'"\+'!=3P,&IQXYYA9R,X/D*(Y$V
M*B!*D_(FU\8FN2B]6"5FMBC]/)[X.MNDW4TC_AKM(CT(,><][R46O%R;LZ6E
M$5_CB6VVON;]M1C&T#!>A(U.V,YA^V_#';T*)Q:&$^<S! .6$U:.$40%\XC[
M9) 5PB$F<1**Y%:M?&4=^(6>+9FY"&UY4%?'=Z-QB[*_E<:]G,9-6V87-$T
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MH+RVR')G4>!184FC=%RLK--%;>XL4,]>>)_XI1%EB=#YGF3S"2;H=4+MTL<
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MZ[32_K>B_=>SA$="0,42W@I&3(<_"#=1<Q.0L3H"1AB?PQ] %2RS COFK&&
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M4ZT<K<J)7*T<;1,GPH82FA?=&R^:3^%(2.CZ3I*8@>=@GSL*/^%<*1KY;D2
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MO@#O^@+\Z,L(0HM8UF14*DE_B=B\%GFF6=DZK&P^I\ .7>[YU#+=.$"]*\"
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M(]_^U^V0\_=>RSQ'S%I[@RQ?U@^SUXNP8NO2D/T'3T-^FW99EZ>L?=0M^OE
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M8/7 LO,A\CJE[4[KF>BWD4((UD8NKD30L"=V4+)\'G'AD5ME)?T@$BP?NUE
MSV?*US(&M@ !T<;+?I'^*=<Z 4O 0->*\IQ4XF>T"#R:9K'1:P^4M;#?Z[53
M+AWVRM6R!@Z,I=%:: 9;>I&6V]UOP[ZZ^.)_T Y9?POP7=0[D@0U$2G:^@ Y
M*9+QWZ7GO-/6Z\:^1,KY1(/:PI?@[8\!\B$#%$)268\E"R_Q'&$S&C-"G9!'
M(26Q+WS;QW%8\=HL&2,01UT@QP'>X#^H5GSI@<T4'W>_L3S%W>/F[>?,CV&O
MGWZ$L17;PHW-@(7"I([+3>:%8!Z%8 @E)"9NY()15"?NC?RX4IT7(<?^/W=&
MBR#R/=?SA><2A]HLB+CC4("_[_.$)-':.IE&BUO1XF+_&FQEB\>$65YD6I83
MF)@%:3+9\Y*[5'@TMI@?2H7L1K2H*YZ@V%!;HH"4H&F7MP<Q2+N*URD@&/LQ
MBC E%2995SQ0L=K*8!L)F!T4DS?Z#Q#YP<2$:TK INV4N@305E><JU]X=BFZ
M3!I%I7*1HFD[)CL0"C-.KCF5HU8"0/J]1NNACZU6QG0RC-*@6@(RO&9(OQY*
M-!2N><I59(1%RM1:8$3/QJ:FS&@X2@86.>I/8TNZ\M0- '-BY;T#X93"+47P
MQ:XH"KGPQ&<C(Q]>GN:E15\S1/<<)1F(RX[(SS'LA"Y&_M]!JG),Y.]Q6O2R
M0D;OJ^=0CP/T26. C/Q.A_T4Y3W$J->E8'JJG8*: U:INGC 6WQ2?6]RNS45
M8E,!-M *NX4BCZ+TI@-\V^H2@%H*N:Y\8SHJ*%$GYBW6/5>^RZYT+I7W#4>.
M!D6*KQ+%*C[7$6J-E5(0^UWE!0%-A W:_2DX8;I0T<K:L=K(.="W*#6K20R:
M0AEUD?*EHR4K#)OX2XZ)T>6O^"IU?8#NL/HBL%\,XO/)1>O&47>$"[6;U<L<
MM,<4?7*32 KO[,!E2'<.NT&)2XPN?#/+$0# *M847@$/0R)"5X01!>;)0L*H
M%5J.Y7J.9PE58S0KL\BD,[@,=<@-POZJ[<G=;4T:W>.+**FY1-3AS+&8&48>
M1Q%EFT'@VF9HT<A.A!.[PMM[3>K^O(A"^-MURU(\I0S)HN'P)IN%/]@C;<'@
MH\>'/=B3 /MJ;]76GCGLKT$]^?3#2P3C)+1-2GF __'-@'/;C.+$8Y[C>HD?
M[[UVZNX"3WX)^QU5'<:E)L5ZH2DJ')]$-**44% %(ILD3AAX(=R;Y1%1AJ9F
M:PJ\FS7HJ@Y[7SIJ=21J"<JBXXNX%*Q9AYM1X +*!CYPJMBC)HT!#C'C@2\
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MZ7@+\5/]"?-_N_V7IAULHANTA)BT@;U'XFZ+D';ZNFQ:ESWBC[JJ\!&MBRU
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MGT77 HUJ@=SEM4"ZK&<+]O+893W;(_?'<3S4A#/))57@#WLA=J07>(K&X=7
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M6")4[2=N912/TTK;5 &*XF08&1\%NB=!+M,+^NPG8'$7AW%@!IBJQ)/C";O
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MHZD9O56?WZKLHU(> $EQN&EOU)$VP6&G^$M+[0G3OI2FKI'CP9!#99O'HS+
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M"6SV)6M?L6&Q]]>TB #Y,'F!R\X^(4H OSSI;U]R]B1YL+/?E"?\-]N:O1C
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M88TCWEHM#SL0,]5*1\N&#X*0HP52BWWRN)-BQ-7!DEW&GWI -<[3K$TYCM$
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MD7/_S,"!50(/>*&BA4W1']TT?6J!EA;!_)1"VP,31(==FVUW47ZD(_5)%.E
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M>@/+D#/1!*M]P!3TZ<?<ZO+TR9UWSMEEANL34>))!OCFF1_AGXP!A3KP8SB
M>-J,9B-H[T'OHM0\)DG 1X[^+WMT3QXPY0Y,V^0T,_+)";V,!'T*-,]*X6IF
M?X;2ZLWFSN;NUN#@]\'@\*#S0NJ!;Z]7-BTB3D=%TF;;PJP]]V.S(8]421>
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M[%"2"^ L2N?J3(0\AJI/[JP##G1F@$II_GY1XU[^V,)<V*%4WC,-A986*P]
M,3TB(3X&8Q7+DAK^!%G^+5A]2O([($5W)NBVB^Y<M&M3MI1FYRAW*%K9#L<#
M+4(JPIAV5-*<1:Q4\]T'IW_+C.NQ8&V5=V;]MY !'Y^^;4J_@%782&E4G'L"
M/#$B:8HDJ&Q)4EA@"LJ!JSKUW,.8^K=VN!8/.E)^S7('#&B7,6,W#C#/=MRB
M-P)/A 0A90AE>]JSE#LKY+TIC8I=_?B#'Z'.M_S):.;'0RPJG39<$9U*1Y?
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M=EYT&*MDL<Z9M)??CHH")JD=ALQXM)J2E+TE,I<[1C+R6J.,V0 XD>M4#?>
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MD7@6,'<*@#5)U@*UN\#BSZ,/Z=-R\=IV[U:EW5_J=Q.+T,@J@;FP2+$L/+)
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M+Q;,42[>+_\$3)E^_>'_ %!+ P04    " "GA0-5C4LH+F8F   :L $ %
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MB:51(6DSF7Z,B.W0HT&OO?W33R?#KXA'./I,T?]B/1\.!Y]Q7(=QE6E\/)S
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M#*>M#*<U:+9+Q7-WRDE6*-B_**K(*7%:<YG5Q3)MZME@G10S45F/1I@@=JR
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M*67 D&:7"ER6LM^E5V_.$5M+^<,N-->AKST% E\N '$\Z)*$8.#M]%X <AM
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MGX-\-W;\/)9OH6=.;XSGV@3-K**Z-D%=H-0*W%;C7"I6_7*BL*BGN"Z_ S!
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M7D[O]IM^V62T_:B_R@E6$:$4*4B$4A"E.(.$< I9&$F"-&VIP,EWU56 L>T
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M?19R+OY8'X2EC3#&(>[;GC@_CTFE/=A2OTX#7&@ -EE.UACH'TL41I#?I.O
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MI%K2GABH$8W^>&>WN[=CFT:U6SFF^8VN69"OYX7,R[HY\@,MZ.K*)8J(X"8
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MCDI'^#'TS,S;H7G;.F_'YYG28(TA?$;S5?#><N>#N0 K_4'SY]5W"%]O8S9
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M2\,M^7;X?;(+, 1U'GVR1O46%PP^=@^7+A_F#]ZK]5JIPT*F5O<:I&E*958
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MD]C;RUQ$)ZA;Z9<VJA^Y:/2QX[A\PW7]QU'S1JN<%-"V[34^ @-<HA10H0I
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M=YS'')@[_(SY@5=PIW)&7K#U&GJZ/NN_-.AR;"=H'R7MILW,?.FJ* 2 !58
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M_#$+G!7GH<#(^7+^T)QFT@UXQC /]_-RH9[J7FYO'Q=RO5TNISG3"#(@\ZP
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M_/2?_[;]C?F?38SXSW_[?U!+ P04    " "GA0-5FW9L2:Q2  ",NP, %
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MZS9RSA!A'\GG(U=, M;B=<6%@B 4*1EC<2$K'V(;V-Q/T[B-.P;$SD!B[P!
M9X1/D&FA!),@<ZR.?2(;6>=DA.2X5(7G5-K$6&?O'_<ZZ.#^\%;B[, 1?C$-
M<7IR5@<UR^O[,!_F)R3T9?7+5E\O12,,2JL]<,O)P<_.@*M7 TM0421G!(NV
M"4PVI;";8N@V9Y]-%-6!%;K"U\ULAC<E*HT<?)**.*%UZ5*VH VM(RZ<<:S-
M,<3]-(U[FM4& _<#;1^%= "MHY3FI[/5\G7X6@L_:]OZE!:G1,<M%B<R*"O1
MUOY:G(/RCO;NVJHM**<8Q0VT5AL5<&Q.9#?@VPL7-[?-1DKJ '\OZNSS5^4)
MO7FZ^L:#C-&8%$ FY8#\10DN< ;9,)$5%A<;]>FXBYIQ]\Q&B-I;[!U YWIN
MXT)07R^X<<4SC!XA1R?).R7_TD<;P8F@O':1N&K3K>IANL;-43:"TX"JZ !8
M=UA55,G;8#2PX.JACB,Q&2/ %B_L6CJQE47::8=KEIML9H_V$GD'0>(]2^!*
M[DQ+Z5&7 D&O1VP&!S%D6@J).<:2]UFT*>G_+FG=;''M//9AU=.7D9H4:W22
M%"X[Q2EF+H%,JXX(AEMD7AJA69NZD2M$=+.O'23JVTKD'5BG!R0B,?' LP+M
M- ,5)0.RN@$L<[R(K .J-B=P>Z:I#K'%M</20 KIP!!=Z1)T5M?+BK84*7"2
M0^UM51NDA604.)X91V&ESLV[-'505CV4AN]ORK2]N+LHHS[*>9WR#2>OPS0_
MGST)GZ9DYR9"%FD+5\!<K <+UH-C(D"T=2" (S9SF[M0]Q T=K*\"7R&$'X'
M1N<HI=./IR=AA7FCF\'(BRQ!)S FB;/!/2YP H.RM1.:44XT2UUN0^BX7E0K
MS#545@=8?(.K,)UAONBK?(7=IUBF:;J:"&:3Q42.HHZ2I&<0@DH%DDZY^,*"
MRFV*#;Y/V[B^5B/$#:R2#D!V6U 38YW3V5I:'*E./^$10JXM:8LDZ80D>:.F
M7+=I&;?JJ1&(]A1Y!U'?]R*9B4Y>Q6(81&<=1;$2(<:"P(3PR;BLM&N3(_\>
M9>,"ZM#9A/V5\XB[2KQ>J^0#KJ:)?.YK_ S46>+Z&P[57>(!O@[:80(#4X%\
M>A[J\!%1#,2B-42CT=)/.>HV2_P0'2:N!,,D[E>+]3OS.BZ^:%0\$5%H;S,#
M:PQM],%[\"I)X%)P)M&@2VW"R@V(&SM#,3!^'LA5#**>#ORP*RR=]5P_.EU]
MF"^F_ZBML(OS(I.MSDXD8B5F"(Q$52S/25OF0U"MD7:3J+&3&(=#V%[JZ!%9
MSY?+4V(CB%BDCQ8,J^+A]9)&UA&,Q")K;D;Y-D?/]Q T=HKBT(C:00T]HNGJ
M; BG"@^1!3 !.2BC.3@,FL*8R+FU*7#6J!O* U2-G8@X-*YV5<A@X#K\"(6C
MMW]^]N+57X=O)/>=MQQJ7,)W^!O>[:\==IZ=S'^_>CN#2>4)DU)9<J>8DA0^
MNEAGOS#N-7.IT8S&AZ@:8/Q!?>;KQ;Q.(<F_?/UM62\7?:OI.$JKZ>>S2/I"
M#@Z+TCD2F5XH6E%%0.#*@2Y*)%-HG9DV%]FWI[6;(& _--TQ-:&ETCK88Z_/
MA0C<BZ =!3*N("A-8G),)@@A%Z9K;K#1Y9^.IG*TUOF#@SFV44 G!^$73;67
M[^9O,,W)ZSC!:TR]FV\K3Q3"&)$1HE*6Y"DD13V^ +?2F)PQYM+HI+,!-^-&
MKP=&\^APZ,"D/D5Z,_G>5<7T_0F>SV(X^CA?K*;_6/]^DE@=>$NQEW6&W/!$
M/,7D- 3O5!5T4*I-GF43ZD;NY3@ZAFY=!1]8H2."E&*"&W7$YXV@7LYG5::3
M*+*F74:"019!22W!JYB &YU]R"GH*+\3WGSO'2.W1NH%7H.JH@.[MTX)_$)L
MK*=#$2-G"T.R8(5 !Z[H.CE>>HA26[#9>N&M3*%1W<C=](S<7ZD7\ VHM)&M
MV54K_*J\7N#'Z>G'5[/+?IJ7$V F4C KHL\@2W2@@M+@10R0K&.IMGY166Q@
MW+9XY<A=F'J!6TM%=6#Z;D[KN"+ \^+4*]*SFK$B0:=41P[9 C&D#+[H++,4
M@9<VCM_F-([<_ZD7S#96;I>PO6A>7==@2LYS(AER](9D%A%\I&#0:*69$\'(
M1C?8'R1KW-BD%1:^"[E=%;,]ROP9RF;XOA8Z-,+9M8;&%"Q%:[('[3& LMQ#
M,-%78R]RLM[SW";/_3!=XX8IHR%M9]7L"[5W#>W:.5,73=WN;'X\T8E1:.4U
M"%$+;3GM%(%31)_1:I4S-T;*P^+P07K'C63&QN=PJNS41*[9N?1ISO@RSED?
MB!N'NM24@"6_N(9I7MH<,,9B#[4GWT7?N-'.:)#<6U6=0G"3GDT35V3@QF;R
MI5D]7Q4:G"T);$%9N#;%ZT,%-)O0.VYP,QI$!U=E!^'+YF=;DVPDXU&1'T,^
M2YUJX" HEDFBQ6>FC=:J30'UYC2.VSGW0,!LI+(.[BG=P]E9=NONI(11L>@4
M:*497COA>P;>L002B^%U)+MK=,R]/:W=E& ?I+YG**5U8".)M828E\](J'4<
M^JMRY\2IVB6(),7 N>1(B";0<E8!2G3DN&B6L-THC WHZ[(B:#"4W!Z<,;3*
M>@!B^'J>TSU*_WTZ7>"]\T$F*C'GC)-0C*^5Q(9\Z,QI@S')D7^21/1MZC\W
MI['+HIYF@&RCNBZ"GLU%.>%HDO+D&"=MB3>A%7@DAR3;J$QVO#AQ4!_R#AK'
M30D=&):-5->O+WE^J>-.00H3@C(^@?:U'T0TY 5IX\D+DMZ*6**RZ9#@?(#6
M;BY?'<27'$II753[7G5-7EQMOSS!G!5+MB:ZZDR4E 1XC0&TCEXYZ;06;1IY
MW$M2ES[C8&AXP&?<73$]N(E7G=]ZT>S5IZJRY?$77*0IR7"BBC8J% 6L%L8K
MSCQM&=4-]MD9F45PL<TXXN^2UJ53> C$[:^H/JS;N9_[;+YX@Y].%^E#6%+T
MM<[NG_<S$8XDQ6E',+4-C]*E]C,A?P6)45><Y=ZV\0&_3UN7OE\S] VKJBY"
MD0N>7I6GTRK$65Y.G%+<>*D &5]/$N(0O2Y0N-,A!>&";G,AZPYBQCW<&PE@
MNRJC*T3=6"57KG%/DG9)2X? Y'H8(H7N+BD&/-99OL'PA&VNT7^?MG%/ZOHP
M:+NJ:E3XU6+?[_/S<K[Z&Z[>XFIU0I^W 0M'I@&EI\@K.091)#+>1<FB;'0Z
MW3A%OK,R>\O7CGOF=B"(M59'/W5?FPMT0JN%.<D56*XRQ4:U3B-06(36%IT*
M,2O;1!&;TSCNQ,P#V[]&JNL@F7=<"J;5JW+\A1;=[#V^(<R_6E_PJO^OSNKG
M<%+7YALD.4X3K8CZ#T>S?/T75SXY\<)Z+FT"JRVKX],].*<TR)1+<L6XE-I4
M*C9@IIN>.<.F \=6>P>YG+V8?8V+Z3S?+DM))Z>UW=!5L9Z)>I*-\-(6"<&@
MJ9-]$P0M,V14O/""W+LV%PT/R^?8?8H;K9>.P=+!)K*?W4"E [G)!I*OXZY=
MUF0WT(%'$1BQ'GBCV4KM-X9FSGF?0-]*E3OC]M-Z.9$$%JL.T.NEU!JQ0 GK
M,55)T%(EI\]@*8H+5;)KU.FO.7J;>>^=HG<;5>Z)WN/9,#FTMZ>?/IVL11E.
M+D3Y?%;FBX_A6E]%RU$4E0,P39)5*3)P2)*52F5%DG6)MYF,N"&!&^'1/3H\
MME!/!Z[SV5WG]1V\.N.(HN,)%I[7YQGDY%M0VB($D46]_VDY-QQ5:G,4<)N6
MD;O]M5#Y[0L4^\B_ P1].[98MY*1QFCI=*U]0EL[_R*XC E*T6BRD9:)1NVF
MKI(Q<A7Y 7"SN]0'/ $_?%/</Q^]_-/QV^<OW[Y[]>1__?G5BZ?';]X>_^_?
MGK_[6]LVN9N\]U"-<[>6P?"M=!^8\I*R2LBY@\!<+;2T FIC,D#A8AT6)7)J
M$P)N1-[^DZ7.7_*N7FZ;\*(I# J1W(A0$]&UQ[4W#(02PC#&%3=M+M9<IZ.;
MIK@#X>+V<*F=I=[!!OF-^C.)U/97\UF-4HZ^3)>3*(O.WG+P/I!<+#FF/D8+
MMD2,K-Z/#&TNQ#Q(5B>(VD'?]T%G;^%W@*0;/#R=?PS3V<249).S&23Y#*!"
M\;3&LB.'PH;DC,G2MT'0G>1T@IS]U7WSF&5OV7< H"O'\+_BQXB+B<E"%J(4
M=.**R,Z</,>(8(51*M _1=%\_O09*>,"9P#UWC_#8@=9=P"6>Z8?GS/#(RIM
M1 9,I<:FUH"WJ@":H$5DSA!G38#S(%GC!G[#@V@X'?0 J.^/-CYGK*8X4M(%
M!!<D*)42>$EVVWBM!7<R1]VF^\S&)(Y;!-T :$UTTP'H;DXWOK#%&((43)VU
M:%28+3CO'4B3@U*U[X1ML^_=3<^XM2G#PVD J7> G7?U=/]T\76]B9_MY^>,
M:)D-$:T@!5VCV5 @H*\MF 0WVBD7>9L2D'M)&K=:8W@$#2/[#D#T+21Y00OB
M.7V[G&CCG1;,@@^L5 X4A"CK@BC.%RQ1R#9]*&_3TDF_E0$#_=W$W -0KDY0
M=#5KGUD=\, 05%$&@@^.,*]83.C0-!HVOO7TRO:Q_(X:O:L!_2[B[::ZY:ZQ
MYX$%C)Y<?JQ#%FMS7E_/"CT:5BC6Y+;1<,H=I]"WMR0#@64_47<#F>M#OR*S
MSBD522*T*2LOZL"EO+:O*BL,//IF=Q&VG+K6OBW#,$#97<!=W$2^>RK'T6)1
MJUBKE'[Y>OF1\[L]1[^'1;YJ39_/SLIB)[:VX-$Y0,E(5C58"5%B JG12E[0
MEMSF\']0-CJY)S#@KC>*@KO ][49#_<DT]:<QELBFN6+#@/GYYKG?0<FP@AM
M@U0$1F2D#JR#C:,%EF,502(GM4WJH $SG=3X#X/UL97=0PQ1:3];M$]/%]/9
M^[.%>[:8[^Z>X9B,&DL!*7UUA5F=7<(4+7&;5!")I-_(:&]-:R>%^@.ZF.U4
MU2\8_Q).3O%N!BVYTL):30Z3JEW]2H 09!UU&+2+6J/+K8HAMB2UDZK[IE <
M2%$]('&]J.I&\&R^>!>^_'6Z^E"C.V*5?G'/:+J !I.U#(PQQ*-3$KQQ&83E
MQ041G55M.HWM0FTG5?=#IFH:JJN+IBE7W)4WN#YY>S??E%G#98GH$AA!+"IR
M22 F[2GD5#EG@=RJYH.KMR5Z(XCZ1P+10RFO"Z1>.XM9[PKG_7F)K^7J5UQ]
MH-@P1ATDKZ,[95;DG!@+T7 -EM9EL3EA;M1!:A/J-LMDLT<"OL'UT1_*SK:
M-[BJ7!$O#H.U'/3ZR"\Q#Z[82#^&4I %7V*;IK/WT[09HA[+X<A LN^G0\\U
MALY9N5P<1Q_KC)I)#B1X4^<E:9UK09Z'(%.&Q&10WA3)59O3DTVHVPQ@C^5
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M0;TU?WKVW'E9\Q^^\7_\>H^3L1U?U,;D[<)E:Y,HI6.9>U=GS]6.MMF 0Q]
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M2]ZW2;[X5F@<4\PF)D>64EM0*5GRMPPI7,3",<="KOLX^:?OTCZR]]M%0O7
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M/J(QJ(R&DDT")9#(5QJ!NVB)^N!EX5NJG/7@F;90^2XRZT?EW)^3[UARDKL
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M42*KEK[NG41UM9%M@X&[#<O^@A]Q,ULN5I,W-7&PK@S@-GL;#$7IA7FRLE*
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M#2];'C(G64I7[$LY$,)&S/&8!QUISDK3K$6=^9%=U(R]?CR8LE\]W'VBY!M
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M'V?<[N;ISET_^?_W-OBFA)'BY#8^61'OW&V*NY8X92)>)VZ!DW(&$ZW1[ZH
MT1!B$[-<5FJ2U.1JW)K5"2A\/3'2B.K_3,=X_#[O05_[ 6ZRYK[O"YSZ3 RE
M(8*EIMS@Y<H-T)9 5E2'X+GFE?9\A_66BQ5B^[?=G/?=M][=3.Y7E^5J432.
M=51 EY1ES7E91#(898@LT"PU\:!T4,QQE5*N,_%V((%-^;#W8./5$^@5%-)
MW'_1K]]J^KEF;W&)4KV;!)0:4K+D5$I"B0:AI $1N,?$UGJ(&-]R9WP.M$[8
MOX>H<6ON ^)I*,$W@*'=IC%/I0-?$IA'&WD2!VRMA?' 0[ 97+ 6V<WE0@_#
MT'B8,9SH*%*=.OOQ-(];=J_NT0976_V8:_M!^>.1R+__^@502P$"% ,4
M" "GA0-5S@Y9(BLE  ""TP  '@              @ $     97@M,3 Q;65D
M:69A<W1F;W)M<'-U86=R964N:'1M4$L! A0#%     @ IX4#5<^=D_*0)0
MRR ! !X              ( !9R4  &5X+3$P,F%M96YD;65N=&YO,G1O;65D
M:69A+FAT;5!+ 0(4 Q0    ( *>% U5H8:MIMP<  % F   8
M  "  3-+  !M960M,C R,C S,S%X97AX,S$Q,2YH=&U02P$"% ,4    " "G
MA0-5_6;)5*P'  #S)0  &               @ $@4P  ;65D+3(P,C(P,S,Q
M>&5X>#,Q,C$N:'1M4$L! A0#%     @ IX4#5>:DU<0K!0  Y1H  !@
M         ( ! EL  &UE9"TR,#(R,#,S,7AE>'@S,C$Q+FAT;5!+ 0(4 Q0
M   ( *>% U5C\RH;?5@! $%P$0 0              "  6-@  !M960M,C R
M,C V,S N:'1M4$L! A0#%     @ IX4#5194E$AB"P  !&8  !
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M2P$"% ,4    " "GA0-5FW9L2:Q2  ",NP, %               @ %/D0(
J;65D+3(P,C(P-C,P7W!R92YX;6Q02P4&      L "P#N @  +>0"

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
